<SEC-DOCUMENT>0001683168-25-002272.txt : 20250403
<SEC-HEADER>0001683168-25-002272.hdr.sgml : 20250403
<ACCEPTANCE-DATETIME>20250403163026
ACCESSION NUMBER:		0001683168-25-002272
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20250514
FILED AS OF DATE:		20250403
DATE AS OF CHANGE:		20250403

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Kartoon Studios, Inc.
		CENTRAL INDEX KEY:			0001355848
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MOTION PICTURE & VIDEO TAPE PRODUCTION [7812]
		ORGANIZATION NAME:           	07 Trade & Services
		EIN:				204118216
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37950
		FILM NUMBER:		25810006

	BUSINESS ADDRESS:	
		STREET 1:		190 N. CANON
		STREET 2:		4TH FLOOR
		CITY:			BEVERLY HILLS
		STATE:			CA
		ZIP:			90210
		BUSINESS PHONE:		310-273-4222

	MAIL ADDRESS:	
		STREET 1:		190 N. CANON
		STREET 2:		4TH FLOOR
		CITY:			BEVERLY HILLS
		STATE:			CA
		ZIP:			90210

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Genius Brands International, Inc.
		DATE OF NAME CHANGE:	20111109

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PACIFIC ENTERTAINMENT CORP
		DATE OF NAME CHANGE:	20060310
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>kartoon_idef14a.htm
<DESCRIPTION>DEFINITIVE PROXY STATEMENT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:TOON="http://kartoonstudios.com/20241231">
<head>
     <title>Kartoon Studios, Inc. DEF 14A</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_ECD%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_034_TOON_kartoonstudios.com_20241231 -->
<!-- Field: Set; Name: xdx; ID: xdx_04C_20240101_20241231 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05B_edei%2D%2DEntityCentralIndexKey_0001355848 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000004" name="dei:EntityCentralIndexKey">0001355848</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0010" name="dei:DocumentType">DEF 14A</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="toon-20241231.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2024-01-01to2024-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_AndyHeywardMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AndyHeywardMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_AndyHeywardMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_AndyHeywardMember_custom_FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember_ecd_PeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_AndyHeywardMember_custom_YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_PeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_AndyHeywardMember_custom_ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_PeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_AndyHeywardMember_custom_ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_PeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AndyHeywardMember_custom_FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember_ecd_PeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AndyHeywardMember_custom_YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_PeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AndyHeywardMember_custom_ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_PeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AndyHeywardMember_custom_ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_PeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_AndyHeywardMember_custom_FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember_ecd_PeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_AndyHeywardMember_custom_YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_PeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_AndyHeywardMember_custom_ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_PeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_AndyHeywardMember_custom_ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_PeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001355848</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000014" toRefs="Footnote000034 Footnote000038"/>
  <ix:relationship fromRefs="Fact000015" toRefs="Footnote000034"/>
  <ix:relationship fromRefs="Fact000020" toRefs="Footnote000034 Footnote000038"/>
  <ix:relationship fromRefs="Fact000021" toRefs="Footnote000034"/>
  <ix:relationship fromRefs="Fact000026" toRefs="Footnote000034 Footnote000038"/>
  <ix:relationship fromRefs="Fact000027" toRefs="Footnote000034"/>
  <ix:relationship fromRefs="Fact000016" toRefs="Footnote000039"/>
  <ix:relationship fromRefs="Fact000022" toRefs="Footnote000039"/>
  <ix:relationship fromRefs="Fact000028" toRefs="Footnote000039"/>
  <ix:relationship fromRefs="Fact000017" toRefs="Footnote000040"/>
  <ix:relationship fromRefs="Fact000023" toRefs="Footnote000040"/>
  <ix:relationship fromRefs="Fact000029" toRefs="Footnote000040"/>
  <ix:relationship fromRefs="Fact000018" toRefs="Footnote000041"/>
  <ix:relationship fromRefs="Fact000024" toRefs="Footnote000041"/>
  <ix:relationship fromRefs="Fact000030" toRefs="Footnote000041"/>
  <ix:relationship fromRefs="Fact000019" toRefs="Footnote000042"/>
  <ix:relationship fromRefs="Fact000025" toRefs="Footnote000042"/>
  <ix:relationship fromRefs="Fact000031" toRefs="Footnote000042"/>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-size: 12pt"><b><span id="xdx_90B_edei--DocumentType_dxL_c20240101__20241231_zhKma9e60tY4" title="::XDX::DEF 14A"><span style="-sec-ix-hidden: xdx2ixbrl0010">SCHEDULE 14A</span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Rule 14a-101)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SCHEDULE 14A INFORMATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Amendment No. &#160;&#160;)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Filed by the Registrant <span style="font-family: Times New Roman, Times, Serif">&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Filed by a Party other than the Registrant <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></td>
    <td style="width: 96%">Preliminary Proxy Statement</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></td>
    <td><b>Confidential, for Use of the Commission Only (as permitted by Rule&#160;14a-6(e)(2))</b></td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#9746;</span></td>
    <td>Definitive Proxy Statement</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></td>
    <td>Definitive Additional Materials</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></td>
    <td>Soliciting Material Pursuant to &#167;240.14a-12</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_902_edei--EntityRegistrantName_c20240101__20241231_znromioXfZ13"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000011" name="dei:EntityRegistrantName">Kartoon Studios, Inc.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in its Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name of Person(s) Filing Proxy Statement, if other
than the Registrant)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Payment of Filing Fee (Check the appropriate box):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 4%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9746;</span></td>
    <td style="width: 96%; text-align: justify">No fee required.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></td>
    <td style="text-align: justify">Fee paid previously with preliminary materials.</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></td>
    <td style="text-align: justify">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;<img src="image_001.jpg" alt=""/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Kartoon Studios, Inc.</b><br/>
<b>190 N. Canon Drive, 4th Floor</b><br/>
<b>Beverly Hills, California 90210</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">April 3, 2025</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dear Stockholder:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You are cordially invited to attend the 2025 annual
meeting of stockholders (the &#8220;Annual Meeting&#8221;) of Kartoon Studios, Inc., a Nevada corporation (the &#8220;Company&#8221;),
to be held at 10:00&#160;a.m., Pacific Time, on Wednesday, May 14, 2025. The Annual Meeting will be a virtual meeting of stockholders,
which will be conducted solely by means of remote communication via a live webcast. For purposes of attendance at the Annual Meeting,
all references in the accompanying proxy statement (the &#8220;Proxy Statement&#8221;) to &#8220;present in person&#8221; or &#8220;in
person&#8221; shall mean virtually present at the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Details regarding the Annual Meeting, the business
to be conducted at the Annual Meeting, and information about the Company that you should consider when you vote your shares are described
in the Proxy Statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At the Annual Meeting, we will ask stockholders
to approve the following matters:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top"><td style="width: 20px"/><td style="width: 20px">1.</td><td style="text-align: justify">Election
                                            of seven (7) directors named in the Proxy Statement to hold office until the next annual
                                            meeting of stockholders, or until their respective successors are elected and qualified or
                                            until their earlier resignation or removal (<a href="#p_010">Proposal&#160;1</a>);</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top"><td style="text-align: justify; width: 20px"/><td style="text-align: justify; width: 20px">2.</td><td style="text-align: justify">Ratification
                                            of the appointment of WithumSmith+Brown, PC as our independent auditors for the fiscal year
                                            ending December 31, 2025 (<a href="#p_013">Proposal&#160;2</a>);</td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify">&#160;</td><td style="text-align: justify">&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top"><td style="text-align: justify; width: 20px"/><td style="text-align: justify; width: 20px">3.</td><td style="text-align: justify">Approval
                                            of a proposed amendment to our 2020&#160;Incentive Plan (the &#8220;2020 Plan&#8221;) to
                                            increase the aggregate number of shares of our common stock, par value $0.001 per share (the
                                            &#8220;Common Stock&#8221;), available for awards under the 2020 Plan by 5,000,000 shares
                                            (<a href="#p_015">Proposal&#160;3</a>);</td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify">&#160;</td><td style="text-align: justify">&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top"><td style="text-align: justify; width: 20px"/><td style="text-align: justify; width: 20px">4.</td><td style="text-align: justify">Approval
                                            of the issuance of up to an aggregate of 17,447,366 shares of Common Stock upon the exercise
                                            of certain warrants issued in connection with the offering that closed on December 18, 2024
                                            (<a href="#p_016">Proposal&#160;4</a>);</td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify">&#160;</td><td style="text-align: justify">&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top"><td style="text-align: justify; width: 20px"/><td style="text-align: justify; width: 20px">5.</td><td style="text-align: justify">Approval
                                            of a proposal to adjourn the Annual Meeting to solicit additional proxies if there are insufficient
                                            votes at the time of the Annual Meeting to approve Proposal 3 and Proposal&#160;4 (<a href="#p_017">Proposal&#160;5</a>);
                                            and</td></tr>
<tr style="vertical-align: top">
<td style="text-align: justify">&#160;</td><td style="text-align: justify">&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top"><td style="text-align: justify; width: 20px"/><td style="text-align: justify; width: 20px">6.</td><td style="text-align: justify">Such
                                            other business as may properly come before the Annual Meeting or any adjournments or postponements
                                            of the Annual Meeting.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The board of directors recommends that you vote
FOR each of the seven (7) director nominees and FOR the approval of each of the proposals.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Value: 1; Name: PageNo -->i<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under Securities and Exchange Commission rules
that allow companies to furnish proxy materials to stockholders over the Internet, we have elected to deliver our proxy materials to the
majority of our stockholders over the Internet. This delivery process allows us to provide stockholders with the information they need,
while at the same time conserving natural resources and lowering the cost of delivery. On or about April&#160;3, 2025, we started mailing
to our stockholders a Notice of Internet Availability of Proxy Materials (the &#8220;Notice of Internet Availability&#8221;) containing
instructions on how to access the Proxy Statement and our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2024.
The Notice of Internet Availability also provides instructions on how to vote online or by telephone and includes instructions on how
to receive a paper copy of the proxy materials by mail.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We hope you will be able to attend the Annual
Meeting. Whether you plan to attend the Annual Meeting or not, it is important that you cast your vote either during the Annual Meeting
or by proxy before the Annual Meeting. You may vote over the Internet or by mail. When you have finished reading the proxy statement,
you are urged to vote in accordance with the instructions set forth in the Notice of Internet Availability and the accompanying proxy
statement. We encourage you to vote by proxy so that your shares will be represented and voted at the meeting, whether or not you can
attend.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Thank you for your continued support of the Company.
We look forward to seeing you at the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 45%">&#160;</td>
    <td style="width: 40%">Sincerely,</td>
    <td style="width: 15%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid"><i>/s/ Andy Heyward </i></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>Andy Heyward</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><i>Chairman and Chief Executive Officer</i></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img src="image_001.jpg" alt="" style="height: 80px; width: 200px"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTICE OF 2025 ANNUAL MEETING OF STOCKHOLDERS<br/>
TO BE HELD ON MAY 14, 2025</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td colspan="2">TIME:</td>
    <td>10:00 a.m., Pacific Time</td></tr>
  <tr style="vertical-align: top">
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="2">DATE:</td>
    <td>Wednesday, May 14, 2025</td></tr>
  <tr style="vertical-align: top">
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="2">PLACE:</td>
    <td><i>www.virtualshareholdermeeting.com/TOON2025</i></td></tr>
  <tr style="vertical-align: top">
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td colspan="2">PURPOSES:</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 7%">&#160;</td>
    <td style="width: 7%">&#160;</td>
    <td style="width: 86%; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>1.</td>
    <td style="text-align: justify">To elect seven (7) directors named in the Proxy Statement to hold office until the next annual meeting
    of stockholders, or until their respective successors are elected and qualified or until their earlier resignation or removal (<a href="#p_010">Proposal&#160;1</a>);</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">2.</td>
    <td style="text-align: justify">To ratify the appointment of WithumSmith+Brown, PC as our independent registered public accounting
    firm for the fiscal year ending December&#160;31, 2025 (<a href="#p_013">Proposal&#160;2</a>);</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">3.</td>
    <td style="text-align: justify">To approve a proposed amendment to the 2020 Plan to increase the aggregate number of shares of Common
    Stock available for awards under the 2020 Plan by 5,000,000 shares (<a href="#p_015">Proposal 3</a>);</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr>
    <td style="text-align: justify; vertical-align: bottom">&#160;</td>
    <td style="text-align: justify; vertical-align: top">4.</td>
    <td style="vertical-align: top; text-align: justify">To approve the issuance of up to an aggregate of 17,447,366 shares of Common
    Stock upon the exercise of certain warrants issued in connection with the offering that closed on December 18, 2024 (<a href="#p_016">Proposal&#160;4</a>);</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">5.</td>
    <td style="text-align: justify">To approve a proposal to adjourn the Annual Meeting to solicit additional proxies if there are insufficient
    votes at the time of the meeting to adopt Proposal 3 and Proposal&#160;4 (<a href="#p_017">Proposal&#160;5</a>); and</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">6.</td>
    <td style="text-align: justify">To transact such other business that is properly presented at the Annual Meeting and any adjournments
    or postponements thereof.</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Who May Vote</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You may vote if you were the owner of shares of
Common Stock at 5:00 p.m. Pacific Time on March 17, 2025 (the &#8220;Record Date&#8221;). A list of stockholders of record will be available
during the Annual Meeting and the 10 days prior to the Annual Meeting at our principal executive offices located at 190 N. Canon Drive,
4th Floor, Beverly Hills, California 90210.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All stockholders are cordially invited to attend
the Annual Meeting. You can attend the Annual Meeting online and vote your shares during the online meeting. To be admitted to the Annual
Meeting&#8217;s live webcast, you must register to attend the virtual meeting by 11:59 p.m., Eastern Time, on Tuesday, May 13, 2025, by
visiting <i>www.proxyvote.com</i>, entering your 16-digit control number as shown in the Notice of Internet Availability), your proxy
card, or the voting instruction form, and selecting &#8220;Attend a Meeting.&#8221; You will receive a confirmation email with information
on how to attend the Annual Meeting. On the day of the meeting, you will be able to participate in the Annual Meeting by visiting <i>www.virtualshareholdermeeting.com/TOON2025</i>
and entering the same 16 digit control number you used to register and as shown in your confirmation email. Electronic entry to the Annual
Meeting will begin at 9:45 a.m., Pacific Time, on the day of the meeting. If you encounter any difficulties accessing the virtual meeting,
please call the technical support number that will be posted on the virtual meeting page. For purposes of attendance at the Annual Meeting,
all references in the Proxy Statement to &#8220;present in person&#8221; or &#8220;in person&#8221; shall mean virtually present at the
Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Whether you plan to attend the Annual Meeting
or not, we urge you to vote by following the instructions in the Notice of Internet Availability that you previously received and submit
your proxy by the Internet or mail in order to ensure the presence of a quorum. You may change or revoke your proxy at any time before
it is voted at the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 45%">&#160;</td>
    <td style="width: 40%">By Order of the Board of Directors:</td>
    <td style="width: 15%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid"><i>/s/ Michael Jaffa</i></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>Michael Jaffa</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><i>Corporate Secretary</i></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>Dated: April 3, 2025</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Important Notice Regarding the Availability
of Proxy Materials<br/>
for the Annual Meeting:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>The Proxy Statement is available at <i>www.proxyvote.com</i>.
To view these materials please have your 16-digit control number(s) available that appears on your Notice of Internet Availability, proxy
card or voting instruction form. On this website you can also elect to receive future distributions of our proxy statements and annual
reports to stockholders by electronic delivery. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iv<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TABLE OF CONTENTS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 90%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 10%; text-align: center"><b>Page</b></td></tr>
  <tr style="vertical-align: top">
    <td><a href="#p_001">Proxy Statement</a></td>
    <td style="text-align: center">1</td></tr>
  <tr style="vertical-align: top">
    <td><a href="#p_003">Important Information About the Annual Meeting and Voting</a></td>
    <td style="text-align: center">3</td></tr>
  <tr style="vertical-align: top">
    <td><a href="#p_010">Proposal&#160;1 &#8212; Election Of Directors</a></td>
    <td style="text-align: center">9</td></tr>
  <tr style="vertical-align: top">
    <td><a href="#p_011">Management and Corporate Governance</a></td>
    <td style="text-align: center">12</td></tr>
  <tr style="vertical-align: top">
    <td><a href="#p_012">Executive Officer and Director Compensation</a></td>
    <td style="text-align: center">19</td></tr>
  <tr style="vertical-align: top">
    <td><a href="#p_013">Proposal&#160;2 &#8212; Approval of the Auditor Ratification Proposal</a></td>
    <td style="text-align: center">32</td></tr>
  <tr style="vertical-align: top">
    <td><a href="#p_014">Report of Audit Committee</a></td>
    <td style="text-align: center">35</td></tr>
  <tr style="vertical-align: top">
    <td><a href="#p_015">Proposal&#160;3 &#8212; Approval of the Incentive Plan Increase Proposal</a></td>
    <td style="text-align: center">36</td></tr>
  <tr style="vertical-align: top">
    <td><a href="#p_016">Proposal&#160;4 &#8212; Approval of the Warrant Exercise Proposal</a></td>
    <td style="text-align: center">44</td></tr>
  <tr style="vertical-align: top">
    <td><a href="#p_017">Proposal&#160;5 &#8212; Approval of the Adjournment Proposal</a></td>
    <td style="text-align: center">46</td></tr>
  <tr style="vertical-align: top">
    <td><a href="#p_018">Security Ownership of Certain Beneficial Owners and Management</a></td>
    <td style="text-align: center">47</td></tr>
  <tr style="vertical-align: top">
    <td><a href="#p_019">Certain Relationships and Related Person Transactions</a></td>
    <td style="text-align: center">49</td></tr>
  <tr style="vertical-align: top">
    <td><a href="#p_020">Code Of Conduct and Ethics</a></td>
    <td style="text-align: center">50</td></tr>
  <tr style="vertical-align: top">
    <td><a href="#p_021">Other Matters</a></td>
    <td style="text-align: center">50</td></tr>
  <tr style="vertical-align: top">
    <td><a href="#p_022">Annual Report on Form 10-K</a></td>
    <td style="text-align: center">50</td></tr>
  <tr style="vertical-align: top">
    <td><a href="#p_023">Stockholder Proposals For the 2026 Annual Meeting</a></td>
    <td style="text-align: center">51</td></tr>
  <tr style="vertical-align: top">
    <td><a href="#p_024">Appendix A &#8212; Form of Incentive Plan Amendment</a></td>
    <td style="text-align: center">A-1</td></tr>
  <tr style="vertical-align: top">
    <td><a href="#p_025">Appendix B &#8212; Amended and Restated 2020 Incentive Plan, as amended</a></td>
    <td style="text-align: center">B-1</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;<b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->v<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img src="image_001.jpg" alt="" style="height: 80px; width: 200px"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Kartoon Studios, Inc.</b><br/>
<b>190 N. Canon Drive, 4th Floor</b><br/>
<b>Beverly Hills, CA 90210</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="p_001"></span>PROXY STATEMENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This proxy statement, along with the accompanying
Notice of 2025 Annual Meeting of Stockholders, contains information about the 2025 Annual Meeting of Stockholders of Kartoon Studios,
Inc. (the &#8220;Annual Meeting&#8221;), including any adjournments or postponements of the Annual Meeting. We are holding the Annual
Meeting at 10:00 a.m. Pacific Time, on Wednesday, May&#160;14, 2025, by means of remote communication via a live webcast accessible at
<i>www.virtualshareholdermeeting.com/TOON2025</i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In this proxy statement, we refer to Kartoon Studios,
Inc. as the &#8220;Company,&#8221; &#8220;we&#8221;, and &#8220;us.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This proxy statement relates to the solicitation
of proxies by our board of directors (the &#8220;Board&#8221;) for use at the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Voting Matters and the Board&#8217;s Recommendation</b></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 68%"><span style="font-size: 10pt"><b>Agenda Item</b></span></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 17%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Board Vote</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Recommendation</b></p></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 11%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Page</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Reference</b></p></td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-size: 10pt">Election of seven (7) directors named in the Proxy Statement to hold
    office until the next annual meeting of stockholders, or until their respective successors are elected and qualified or until their
    earlier resignation or removal (&#8220;Proposal&#160;1,&#8221; or the &#8220;Election of Directors&#8221;)</span></td>
    <td>&#160;</td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FOR each Director</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Nominee</b></p></td>
    <td>&#160;</td>
    <td style="text-align: center">9</td></tr>
  <tr style="background-color: White">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-size: 10pt">Ratification of the appointment of WithumSmith+Brown, PC as our independent registered public accounting firm for the fiscal year ending December 31, 2025 (&#8220;Proposal&#160;2,&#8221; or the &#8220;Auditor Ratification Proposal&#8221;)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><b>FOR</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">32</span></td></tr>
  <tr style="background-color: White">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-size: 10pt">Approval of a proposed amendment to our 2020 Incentive Plan (the &#8220;2020 Plan&#8221;) to increase the aggregate number of shares of our common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;), available for awards under the 2020 Plan by 5,000,000 shares (&#8220;Proposal&#160;3,&#8221; or the &#8220;Incentive Plan Increase Proposal&#8221;)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><b>FOR</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">36</span></td></tr>
  <tr style="background-color: White">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-size: 10pt">Approval of the issuance of up to an aggregate of 17,447,366&#160;shares of Common Stock upon the exercise of certain warrants issued in connection with the offering that closed on December 18, 2024 (&#8220;Proposal&#160;4,&#8221; or the &#8220;Warrant Exercise Proposal&#8221;)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><b>FOR</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">44</span></td></tr>
  <tr style="background-color: White">
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="text-align: justify"><span style="font-size: 10pt">Approval of the adjournment of the Annual Meeting to solicit additional proxies if there are insufficient votes at the time of the meeting to adopt the Incentive Plan Increase Proposal (Proposal&#160;3) and the Warrant Exercise Proposal (Proposal&#160;4) (&#8220;Proposal&#160;5,&#8221; or the &#8220;Adjournment Proposal&#8221;)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><b>FOR</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center">46</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On or about <span style="font-family: Times New Roman, Times, Serif">April
3, 2025</span>, we started mailing to our stockholders a Notice of Internet Availability of Proxy Materials (the &#8220;Notice
of Internet Availability&#8221;) containing instructions on how to access our proxy statement for the Annual Meeting and our Annual
Report on Form&#160;10-K for the fiscal year ended December&#160;31, 2024 (the &#8220;2024 Annual Report&#8221;), which includes our
financial statements for the fiscal year ended December 31, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 7 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Value: 1; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="p_002"></span>IMPORTANT NOTICE REGARDING<br/>
THE AVAILABILITY OF PROXY MATERIALS FOR THE<br/>
2025 ANNUAL MEETING TO BE HELD ON WEDNESDAY, MAY&#160;14, 2025</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>This proxy statement, the Notice of 2025 Annual
Meeting of Stockholders, our form of proxy card and our 2024 Annual Report to stockholders are available for viewing, printing and downloading
at <i>www.proxyvote.com</i>. To view these materials please have available your 16-digit control number(s) that appears on your Notice
of Internet Availability, proxy card or voting instruction form. On this website you can also elect to receive future distributions of
our proxy statements and annual reports to stockholders by electronic delivery.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Additionally, you can find a copy of our 2024
Annual Report, which includes our financial statements for the fiscal year ended December 31, 2024, on the website of the Securities
and Exchange Commission, or the SEC, at <i>www.sec.gov</i>, or in the &#8220;SEC Filings&#8221; section of the &#8220;Investors&#8221;
section of our website at <i>www.kartoonstudios.com.</i> You may also obtain a printed copy of our 2024 Annual Report, including our financial
statements, free of charge, from us by sending a written request to:</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>KARTOON STUDIOS, INC.<br/>
190 N. Canon Drive, 4th Floor<br/>
Beverly Hills, California 90210</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Exhibits will be provided upon written request and payment of an
appropriate processing fee.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 8 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="p_003"></span>IMPORTANT INFORMATION ABOUT<br/>
THE ANNUAL MEETING AND VOTING</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="p_004"></span><i>Who is Soliciting My Proxy?</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board is soliciting your proxy to vote at
the 2025 Annual Meeting of stockholders to be held by means of remote communication via a live webcast accessible at <i>www.virtualshareholdermeeting.com/TOON2025</i>
on Wednesday, May 14, 2025, at 10:00 a.m. Pacific Time, and any adjournments or postponements of the meeting, which we refer to herein
as the &#8220;Annual Meeting.&#8221; This proxy statement, along with the accompanying Notice of 2025 Annual Meeting of Stockholders,
summarizes the purposes of the meeting and the information you need to know to vote at the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have made available to you on the Internet
or have sent you this proxy statement, the Notice of 2025 Annual Meeting of Stockholders, the proxy card and a copy of our 2024 Annual
Report because you owned shares of our Common Stock on the Record Date (as defined below). On or about April&#160;3, 2025, we started
mailing to our stockholders a Notice of Internet Availability containing instructions on how to access this proxy statement for the Annual
Meeting and our 2024 Annual Report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span id="p_005"></span>Why Did I Receive a Notice of Internet Availability in the Mail
Regarding the Internet Availability of Proxy Materials Instead of a Full Set of Proxy Materials?</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As permitted by the rules of the U.S. Securities
and Exchange Commission (the &#8220;SEC&#8221;), we may furnish our proxy materials to our stockholders by providing access to such documents
on the Internet, rather than mailing printed copies of these materials to each stockholder. Most stockholders will not receive printed
copies of the proxy materials unless they request them. We believe that this process should expedite stockholders&#8217; receipt of proxy
materials, lower the costs of the Annual Meeting and help to conserve natural resources. If you received the Notice of Internet Availability
by mail or electronically, you will not receive a printed or email copy of the proxy materials, unless you request one by following the
instructions included in the Notice of Internet Availability. Instead, the Notice of Internet Availability instructs you as to how you
may access and review all of the proxy materials and submit your proxy on the Internet. If you requested a paper copy of the proxy materials,
you may authorize the voting of your shares by following the instructions on the proxy card, in addition to the other methods of voting
described in this proxy statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Why is the Company holding the Annual Meeting virtually?</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are holding the Annual Meeting online and providing
internet voting to facilitate stockholder attendance and participation by enabling all stockholders to participate fully, equally and
without cost, using an Internet-connected device from any location around the world, with procedures designed to ensure the authenticity
and correctness of your voting instructions. In addition, the virtual-only meeting format increases our ability to engage with all stockholders,
regardless of size, resources or physical location. Our stockholders will be afforded the same opportunities to participate at the virtual
Annual Meeting as they would at an in-person Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Where can I get technical assistance?</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you encounter any difficulties accessing the
virtual Annual Meeting, please call the technical support number that will be posted at <i>www.virtualshareholdermeeting.com/TOON2025</i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 9 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="p_006"></span><b><i>Who May Vote?</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have one class of voting stock. Each stockholder
who owned our Common Stock at 5:00 p.m., Pacific Time, on March 17, 2025 (the &#8220;Record Date&#8221;) will be entitled to one vote
per share at the Annual Meeting. On the Record Date, there were 47,784,964&#160;shares of Common Stock outstanding and entitled to vote
at the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If on the Record Date your shares of Common Stock
are registered directly in your name with our transfer agent, VStock Transfer LLC, then you are a stockholder of record.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If on the Record Date your shares are held not
in your name but rather in an account at a brokerage firm, bank, dealer or other similar organization, then you are the beneficial owner
of shares held in &#8220;street name&#8221; and the Notice of Internet Availability shall be forwarded to you by that organization. The
organization holding your account is considered to be the stockholder of record for purposes of voting at the Annual Meeting. As a beneficial
owner, you have the right to direct your broker or other agent regarding how to vote the shares in your account. You are also invited
to attend the Annual Meeting. However, since you are not the stockholder of record, you may not vote your shares at the Annual Meeting
unless you request and obtain a legal proxy from your broker or other agent authorizing you to vote your shares when you register for
the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You do not need to attend the Annual Meeting to
vote your shares. Shares represented by valid proxies, received in time for the Annual Meeting and not revoked prior to the Annual Meeting
will be voted at the Annual Meeting. For instructions on how to change or revoke your proxy, see &#8220;<i><a href="#p_009">May I Change or Revoke My Proxy</a>?</i>&#8221; below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="p_007"></span><b><i>How Do I Vote?</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If your shares are registered directly in your
name through our stock transfer agent, VStock Transfer LLC, or you have stock certificates registered in your name, you may vote:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><b>By Internet. </b>Follow the instructions included in the Notice of Internet Availability or, if you
received printed materials, in the proxy card to vote by Internet.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><b>By mail.</b> If you received a proxy card by mail, you can vote by mail by completing, signing, dating
and returning the proxy card as instructed on the card. If you sign the proxy card but do not specify how you want your shares voted,
they will be voted in accordance with the recommendations of our Board as noted below.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><b>At the Annual Meeting.</b> If you attend the Annual Meeting virtually, you may vote at the Annual Meeting
by following the instructions when you log in for the Annual Meeting at <i>www.virtualshareholdermeeting.com/TOON2025</i>. Have your proxy
card or Notice of Internet Availability in hand as you will be prompted to enter your 16-digit control number to vote at the Annual Meeting.
Electronic entry to the Annual Meeting will begin 15 minutes before the start of the meeting.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Internet voting facilities for stockholders of record will be available
24 hours a day and will close at 11:59 p.m., Eastern Time on Tuesday, May 13, 2025.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If your shares are held in &#8220;<i>street name</i>&#8221;
(held in the name of another holder of record, such as a brokerage firm, bank, dealer or other similar organization), you will receive
instructions from the holder of record. You must follow the instructions of the holder of record in order for your shares to be voted.
Telephone and Internet voting also will be offered to stockholders owning shares through certain banks and brokers. If your shares are
not registered in your own name and you would like to vote your shares at the Annual Meeting, you should contact your broker or agent
to obtain a legal proxy authorizing you to vote your shares when you register for the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 10 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span id="p_008"></span><i>How Does Our Board Recommend that I Vote on the Proposals?</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Board recommends that you vote as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>FOR</b>&#8221; the election of each of the Board&#8217;s nominees with respect to the Election of Directors (Proposal&#160;1);</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>FOR</b>&#8221; the Auditor Ratification Proposal (Proposal&#160;2);</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>FOR</b>&#8221; the Incentive Plan Increase Proposal (Proposal&#160;3);</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>FOR</b>&#8221; the Warrant Exercise Proposal (Proposal&#160;4).</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>&#8220;<b>FOR</b>&#8221; the Adjournment Proposal (Proposal&#160;5).</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any other matter is presented at the Annual
Meeting, your proxy provides that your shares will be voted by the proxy holder listed in the proxy in accordance with his or her best
judgment. At the time this proxy statement was first made available, we knew of no matters that needed to be acted on at the Annual Meeting,
other than those discussed in this proxy statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="p_009"></span><b><i>May I Change or Revoke My Proxy?</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you are a stockholder of record and you give
us your proxy, you may change or revoke it at any time before the Annual Meeting. You may change or revoke your proxy in any one of the
following ways:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">if you received a proxy card, by signing a new proxy card with a date later than your previously delivered
proxy and submitting it as instructed above;</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">by re-voting by Internet as instructed above;</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">by notifying our Corporate Secretary in writing before the Annual Meeting that you have revoked your proxy;
or</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">by attending the Annual Meeting virtually and voting online. Attending the Annual Meeting will not in
and of itself revoke a previously submitted proxy. You must specifically vote your shares online at the Annual Meeting to revoke your
previously submitted proxy.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Your most current vote, whether by telephone,
Internet or proxy card, is the one that will be counted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If your shares are held in street name, please
refer to information from your bank, broker, or other intermediary on how to revoke or submit new voting instructions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>What if I Receive More Than One Notice of Internet Availability,
Proxy Card or Voting Instruction Form?</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You may receive more than one Notice of Internet
Availability, proxy card or voting instruction form if you hold shares of our Common Stock in more than one account, which may be in registered
form or held in street name. Please vote in the manner described above under &#8220;<i><a href="#p_007">How Do I Vote</a>?</i>&#8221;
for each account to ensure that all of your shares are voted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 11 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Will My Shares be Voted if I Do Not Vote?</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If your shares are registered in your name or
if you have stock certificates, they will not be counted if you do not vote as described above under &#8220;<a href="#p_007"><i>How Do I Vote?</i></a>&#8221; If your shares are held in street name and you do not provide voting instructions to the bank, broker or other
nominee that holds your shares as described above, the bank, broker or other nominee that holds your shares has the authority to vote
your unvoted shares with respect to matters considered to be &#8220;routine&#8221; under NYSE rules, but not with respect to &#8220;non-routine&#8221;
matters. In this regard, we believe that the NYSE will treat the Election of Directors (Proposal&#160;1), the Incentive Plan Increase
Proposal (Proposal&#160;3), the Warrant Exercise Proposal (Proposal&#160;4) and the Adjournment Proposal (Proposal&#160;5) as &#8220;non-routine,&#8221;
meaning that your broker, bank or other nominee may not vote your shares on any of these proposals in the absence of your voting instructions.
However, we believe that the NYSE will treat the Auditor Ratification (Proposal&#160;2) as a &#8220;routine&#8221; matter under the NYSE
rules, meaning that if you do not return voting instructions to your broker, bank or other nominee by its deadline, your shares may be
voted by your broker, bank or other nominee in its discretion on such proposal. This belief is based on preliminary guidance from the
NYSE and may be incorrect or change before the Annual Meeting. In light of the foregoing, we encourage you to provide voting instructions
to your bank, broker or other nominee. This ensures your shares will be voted at the Annual Meeting and in the manner you desire. A &#8220;broker
non-vote&#8221; will occur if your broker cannot vote your shares on a particular matter because it has not received instructions from
you and does not have discretionary voting authority on that matter or because your broker chooses not to vote on a matter for which it
does have discretionary voting authority.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>What Vote is Required to Approve Each Proposal and How are Votes
Counted?</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 19%; text-align: center"><span style="font-size: 10pt"><b>PROPOSAL</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>VOTE REQUIRED</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 14%; text-align: center"><span style="font-size: 10pt"><b>VOTING OPTIONS</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 15%; text-align: center"><span style="font-size: 10pt"><b>EFFECT OF<br/>
ABSTENTIONS<br/>
(OR THE<br/>
WITHHOLDING<br/>
OF&#160;AUTHORITY)</b></span></td>
    <td style="width: 1%; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 15%; text-align: center"><span style="font-size: 10pt"><b>EFFECT OF BROKER<br/>
NON-VOTES</b></span></td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="text-align: center"><span style="font-size: 10pt"><b>Election of Directors (Proposal&#160;1)</b></span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Plurality&#8212;the seven director nominees who receive the most &#8220;FOR&#8221; votes will be elected to serve on the Board</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">&#8220;FOR&#8221;<br/>
&#8220;WITHHOLD&#8221;</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">No effect</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">No effect</span></td></tr>
  <tr style="background-color: White">
    <td style="text-align: center"><span style="font-size: 10pt"><b>Auditor Ratification Proposal (Proposal&#160;2)</b>&#160;</span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Approved by a majority of the votes cast by the stockholders entitled to vote thereon who are present in person or represented by proxy</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">&#8220;FOR&#8221;<br/>
&#8220;AGAINST&#8221;<br/>
&#8220;ABSTAIN&#8221;</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">No effect</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Not applicable-There are not expected to be any.</span></td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="text-align: center"><span style="font-size: 10pt"><b>Incentive Plan Increase Proposal (Proposal&#160;3)</b></span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Approved by a majority of the votes cast by the stockholders entitled to vote thereon who are present in person or represented by proxy</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">&#8220;FOR&#8221;<br/>
&#8220;AGAINST&#8221;<br/>
&#8220;ABSTAIN&#8221;</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">No effect.</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">No effect.</span></td></tr>
  <tr style="background-color: White">
    <td style="text-align: center"><span style="font-size: 10pt"><b>Warrant Exercise Proposal (Proposal&#160;4)</b></span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Approved by a majority of the votes cast by the stockholders entitled to vote thereon who are present in person or represented by proxy</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">&#8220;FOR&#8221;<br/>
&#8220;AGAINST&#8221;<br/>
&#8220;ABSTAIN&#8221;</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">No effect.</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">No effect</span></td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="text-align: center"><span style="font-size: 10pt"><b>Adjournment Proposal (Proposal&#160;5)</b></span></td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-size: 10pt">Approved by a majority of the votes cast by the stockholders entitled to vote thereon who are present in person or represented by proxy</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">&#8220;FOR&#8221;<br/>
&#8220;AGAINST&#8221;<br/>
&#8220;ABSTAIN&#8221;</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">No effect.</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">No effect</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Is Voting Confidential?</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will keep all the proxies, ballots and voting
tabulations private. We only let our inspectors of election, VStock Transfer LLC, examine these documents. Management will not know how
you voted on a specific proposal unless it is necessary to meet legal requirements. We will, however, forward to management any written
comments you make on the proxy card or otherwise provide.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 12 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Where Can I Find the Voting Results of the Annual Meeting?</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preliminary voting results will be announced
at the Annual Meeting, and we will publish preliminary, or final results if available, in a Current Report on Form&#160;8-K within four
business days of the Annual Meeting. If final results are unavailable at the time we file the Form 8-K, then we will file an amended Current
Report on Form 8-K to disclose the final voting results within four business days after the final voting results are known.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>What Are the Costs of Soliciting these Proxies?</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will pay all of the costs of soliciting these
proxies. Our directors and employees may solicit proxies in person or by telephone, fax or email. We will not pay these directors and
employees any additional compensation for these services. We will ask banks, brokers and other institutions, nominees and fiduciaries
to forward these proxy materials to their principals and to obtain authority to execute proxies. We will then reimburse them for their
expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have engaged Sodali &amp; Co., LLC. (&#8220;Sodali&#8221;) to act
as our proxy solicitor in connection with the proposals to be acted upon at the Annual Meeting. For such services, we will pay Sodali
an estimated fee of $25,000 plus reasonable expenses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>What Constitutes a Quorum for the Annual Meeting?</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The presence, in person or by proxy, of the stockholders
entitled to cast at least 33.34% of all the votes entitled to be cast at the Annual Meeting constitutes a quorum for the Annual Meeting.
Votes of stockholders of record who are present at the Annual Meeting in person or by proxy, abstentions, and broker non-votes are counted
for purposes of determining whether a quorum exists.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Attending the Annual Meeting</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Annual Meeting will be held at 10:00 a.m.,
Pacific Time, on Wednesday, May&#160;14, 2025, solely by means of remote communication via a live webcast accessible at <i>www.virtualshareholdermeeting.com/TOON2025</i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All stockholders may attend the Annual Meeting.
For stockholders who plan to attend the Annual Meeting, you must register at <i>www.proxyvote.com</i> by 11:59&#160;p.m., Pacific Time,
on Tuesday, May 13, 2025 (the &#8220;Registration Deadline&#8221;), as described in your Notice of Internet Availability, proxy card,
or voting instruction form. As part of the registration process, you must enter the 16-digit control number shown on your Notice of Internet
Availability, proxy card, or voting instruction form. After completion of your registration by the Registration Deadline, a confirmation
email with information on how to attend the Annual Meeting will be emailed to you.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You need not attend the Annual Meeting in order
to vote.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Householding of Annual Disclosure Documents</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">SEC rules concerning the delivery of annual disclosure
documents allow us or your broker to send a single Notice of Internet Availability or, if applicable, a single set of our proxy materials
to any household at which two or more of our stockholders reside, if we or your broker believe that the stockholders are members of the
same family. This practice, referred to as &#8220;householding,&#8221; benefits both you and us. It reduces the volume of duplicate information
received at your household and helps to reduce our expenses. The rule applies to our notices of internet availability of proxy materials,
annual reports, proxy statements and information statements. Once you receive notice from your broker or from us that communications to
your address will be &#8220;householded,&#8221; the practice will continue until you are otherwise notified or until you revoke your consent
to the practice. Stockholders who participate in householding will continue to have access to and utilize separate proxy voting instructions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 13 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If your household received a single Notice of Internet Availability
or, if applicable, a single set of proxy materials this year, but you would prefer to receive your own copy, please contact our transfer
agent, VStock Transfer LLC, by calling their toll-free number, 1-212-828-8436.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If you do not wish to participate in householding
and would like to receive your own Notice of Internet Availability or, if applicable, set of the Company&#8217;s proxy materials in future
years, follow the instructions described below. Conversely, if you share an address with another Company stockholder and together both
of you would like to receive only a single Notice of Internet Availability or, if applicable, set of proxy materials, follow these instructions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If your Company shares are registered in your
own name, please contact our transfer agent, VStock Transfer LLC, and inform them of your request by calling them at 1-212-828-8436 or
writing them at VStock Transfer LLC, 18 Lafayette Place, Woodmere, New York 11598. If a broker or other nominee holds your Company shares,
please contact the broker or other nominee directly and inform them of your request.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Electronic Delivery of Company Stockholder Communications</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Most stockholders can elect to view or receive
copies of future proxy materials over the Internet instead of receiving paper copies in the mail.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">You can choose this option and save the Company
the cost of producing and mailing these documents by:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">following the instructions provided on your Notice of Internet Availability or proxy card; or</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">following the instructions provided when you vote over the Internet at <i>www.proxyvote.com</i>.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 14 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="p_010"></span>PROPOSAL&#160;1 &#8212; ELECTION OF DIRECTORS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The directors of the Company are elected annually
and hold office for the ensuing year until the next annual meeting of stockholders and until their successors have been duly elected and
qualified. The directors are elected by a plurality of the votes of the shares present in person or represented by proxy at the Annual
Meeting and entitled to vote on the Election of Directors. Our Bylaws, as amended (the &#8220;Bylaws&#8221;) state that the number of
directors constituting the entire Board may be determined by action of the directors. The number of directors currently fixed by the Board
is seven.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On March 13, 2025 the Board nominated for election
at the Annual Meeting Andy Heyward, Joseph &#8220;Gray&#8221; Davis, Margaret Loesch, Lynne Segall, Henry Sicignano III, Anthony Thomopoulos
and Dr. Cynthia Turner-Graham. If elected, each director will serve on our Board until the annual meeting of stockholders to be held in
2026 (the &#8220;2026 Annual Meeting&#8221;), with all directors serving until their respective successors have been elected and qualified,
or until their earlier resignation or removal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Unless authority to vote for any of these nominees
is withheld, the shares represented by the enclosed proxy will be voted <b>FOR</b> the election of&#160;Andy Heyward, Joseph &#8220;Gray&#8221;
Davis, Margaret Loesch, Lynne Segall, Henry Sicignano III, Anthony Thomopoulos and Dr. Cynthia Turner-Graham. All of the nominees have
indicated their willingness to serve if elected, but if any should become unable or unwilling to stand for election, the shares represented
by the enclosed proxy will be voted for the election of such other person as the Board may recommend in that nominee&#8217;s place. No
nominations for directors were received from stockholders and no other candidates are eligible for election as directors at the Annual
Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A brief biography of each nominee is below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Nominees For Election as Directors</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Andy Heyward, Chairman and Chief Executive Officer</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Heyward has been the Company&#8217;s Chief
Executive Officer since November 2013 and the Company&#8217;s Chairman of the Board since December 2013. Mr. Heyward co-founded DIC Animation
City in 1983 and served as its Chief Executive Officer until its sale in 1993 to Capital Cities/ ABC, Inc., which was eventually bought
by The Walt Disney Company in 1995. Mr. Heyward ran the company while it was owned by The Walt Disney Company until 2000 when Mr. Heyward
purchased DIC Entertainment L.P. and DIC Productions L.P. corporate successors to the DIC Animation City business, with the assistance
of Bain Capital and served as the Chairman and Chief Executive Officer of their acquiring company DIC Entertainment Corporation, until
he took the company public on the AIM. He sold the company in 2008. Mr. Heyward co-founded A Squared Entertainment LLC in 2009 and has
served as its Co-President since inception. Mr. Heyward earned a Bachelor of Arts degree in Philosophy from UCLA and is a member of the
Producers Guild of America, the National Academy of Television Arts and the Paley Center (formerly the Museum of Television and Radio).
Mr. Heyward gave the Commencement address in 2011 for the UCLA College of Humanities and was awarded the 2002 UCLA Alumni Association&#8217;s
Professional Achievement Award. He has received multiple Emmys and other awards for Children&#8217;s Entertainment. He serves on the Board
of Directors of the Cedars Sinai Medical Center. Mr. Heyward has produced over 5,000 half hour episodes of award-winning entertainment,
among them Inspector Gadget; The Real Ghostbusters; Strawberry Shortcake; Care Bears; Alvin and the Chipmunks; Hello Kitty&#8217;s Furry
Tale Theater; The Super Mario Brothers Super Show; The Adventures of Sonic the Hedgehog; Sabrina The Animated Series; Captain Planet and
the Planeteers; Liberty&#8217;s Kids, and many others. Mr. Heyward was chosen as a director because of his extensive experience in children&#8217;s
entertainment and as co-founder of A Squared Entertainment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 15 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Joseph &#8220;Gray&#8221; Davis, Director </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Governor Davis has been a director of the Company
since December 2013. Mr. Davis served as the 37th governor of California from 1998 until 2003. Mr. Davis currently serves as &#8220;Of
Counsel&#8221; in the Los Angeles, California office of Loeb &amp; Loeb LLP and has served in such role since 2004. Mr. Davis has served
on the board of directors of DIC Entertainment and is a member of the bipartisan Think Long Committee, a Senior Fellow at the UCLA School
of Public Affairs and Co-Chair of the Southern California Leadership Counsel. Mr. Davis received his undergraduate degree from Stanford
University and received his Juris Doctorate from Columbia Law School. Mr. Davis served as lieutenant governor of California from 1995-1998,
California State Controller from 1987-1995 and California State Assemblyman from 1982-1986. Mr. Davis was chosen as a director of the
Company based on his knowledge of corporate governance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Margaret Loesch, Director</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ms. Loesch has been a Director of the Company
since March 2015. Ms Loesch previously held the positions of Executive Chairman of the Kartoon Channel! from June 2020 till December 31,
2022 and Executive Chairman of the Toon Media Networks from December 2016 till December 31, 2022. Beginning in 2009 through 2014, Ms.
Loesch, served as Chief Executive Officer and President of The Hub Network, a cable channel for children and families, including animated
features. The Company has, in the past, provided The Hub Network with certain children&#8217;s programming. From 2003 through 2009 Ms.
Loesch served as Co-Chief Executive Officer of The Hatchery, a family entertainment and consumer product company. From 1998 through 2001
Ms. Loesch served as Chief Executive Officer of the Hallmark Channel, a family related cable channel. From 1990 through 1997 Ms. Loesch
served as the Chief Executive Officer of Fox Kids Network, a children&#8217;s programming block and from 1984 through 1990 served as the
Chief Executive Officer of Marvel Productions, a television and film studio subsidiary of Marvel Entertainment Group. Ms. Loesch obtained
her Bachelor of Science from the University of Southern Mississippi. Ms. Loesch was chosen to be a director based on her 40 years of experience
at the helm of major children and family programming and consumer product channels.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Lynne Segall, Director</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ms. Segall has been a Director of the Company
since December 2013. Ms. Segall has served as the Senior Vice President and Group Publisher of The Hollywood Reporter and Billboard since
June 2011 to 2020. From 2010 to 2011, Ms. Segall was the Senior Vice President of Deadline Hollywood. From June 2006 to May 2010, Ms.
Segall served as the Vice President of Entertainment, Fashion &amp; Luxury advertising at the Los Angeles Times. In 2005, Ms. Segall received
the Women of Achievement Award from The Hollywood Chamber of Commerce and the Women in Excellence Award from the Century City Chamber
of Commerce. In 2006, Ms. Segall was recognized by the National Association of Women with its Excellence in Media Award. Ms. Segall was
chosen to be a director based on her expertise in the entertainment industry.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Henry Sicignano III, Director </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Sicignano has been a director of the Company
since May 2023. Mr. Sicignano currently serves as the President of Charlie&#8217;s Holdings, Inc., a publicly traded consumer goods company
with a global presence spanning more than 90 countries, where he has successfully expanded the company's product line, intellectual property
portfolio, and revenue base. Prior to this role at Charlie&#8217;s Holdings, Inc., from April 2015 to July 2019, he served as the Chief
Executive Officer, President and Director at 22nd Century Group, Inc., a publicly listed plant biotechnology firm, where he played a pivotal
role in dramatically increasing the company's sales and market cap. From April 2010 to March 2015, he served as President and Director
of 22nd Century. Mr. Sicignano also served as the General Manager at NOCO Energy Corp from August 2005 to April 2009, Vice President at
Kittinger Furniture Company, Inc. from March 2003 to July 2005, and as a director at Anandia Laboratories, Inc. (acquired in 2018), from
December 2014 to August 2018. Mr. Sicignano has consistently demonstrated a deep understanding of strategic planning, operational efficiency,
P&amp;L management, and capital markets. He holds both a B.A. degree from Harvard College and an M.B.A. degree from Harvard University.
Mr. Sicignano was chosen to be a director based on his expertise in competitive strategy, his extensive contacts within the investment
community and his financial expertise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 16 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Anthony Thomopoulos, Director</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Thomopoulos has been a Director of the Company
since February 2014. Mr. Thomopoulos served as the Chairman of United Artist Pictures from 1986 to 1989 and formed Thomopoulos Pictures,
an independent production company of both motion pictures and television programs in 1989 and has served as its Chief Executive Officer
since 1989. From 1991 to 1995, Mr. Thomopoulos was the President of Amblin Television, a division of Amblin Entertainment. Mr. Thomopoulos
served as the President of International Family Entertainment, Inc. from 1995 to 1997. From June 2001 to January 2004, Mr. Thomopoulos
served as the Chairman and Chief Executive Officer of Media Arts Group, a NYSE listed company. Mr. Thomopoulos served as a state commissioner
of the California Service Corps. under Governor Schwarzenegger from 2005 to 2008. Mr. Thomopoulos is also a founding partner of Morning
Light Productions. Since he founded it in 2008, Mr. Thomopoulos has operated Thomopoulos Productions and has served as a consultant to
BKSems, USA, a digital signage company. Mr. Thomopoulos is an advisor and a member of the National Hellenic Society and holds a degree
in Foreign Service from Georgetown University and sat on its Board of Directors from 1978 to 1988. Mr. Thomopoulos was chosen as a director
of the Company based on his entertainment industry experience.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Dr. Cynthia Turner-Graham, Director </i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dr. Turner-Graham has been a Director of the Company
since June 2021. Dr. Turner-Graham is a board-certified psychiatrist, Distinguished Life Fellow of the American Psychiatric Association,
and a member of the American College of Psychiatry who brings almost 40 years of experience in the healthcare industry as a practicing
psychiatrist serving the needs of children, adolescents, adults and families. She has also served as healthcare administrator, having
held several administrative positions in Tennessee, Maryland and Washington, D.C. Since 1988, Dr. Turner-Graham has served as a practicing
psychiatrist in private and public outpatient settings, retiring from clinical practice in March of 2024. Recognizing the relationship
between mental health, spiritual health and quality of relationships, she has combined these interests to promote emotional literacy among
professional and lay audiences. As founding President of The Company ForSoundMinds, her focus has been to develop educational workshop
experiences and lectures for the purpose of improving relationships. From February 2014 until November 2019, she served as Medical Director
for Inner City Family Services in Washington, DC in addition to running a private practice. Among her accomplishments, Dr. Turner-Graham
is a past president of the Suburban Maryland Psychiatric Society, a Director of the Washington Psychiatric Society and is the immediate
past president of Black Psychiatrists of America, Inc. She has previously served as Clinical Assistant Professor of Psychiatry at both
Vanderbilt University and Howard University Schools of Medicine and currently is Adjunct Clinical Professor at Morehouse School of Medicine,
Department of Psychiatry in Atlanta, Georgia where she now resides. Dr. Turner-Graham was chosen as a director of the Company based on
her career as a distinguished psychiatrist and her expertise with children.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Required Vote</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The seven director nominees who receive the most &#8220;FOR&#8221;
votes will be elected to serve on the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Recommendation of the Board</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>THE BOARD RECOMMENDS A VOTE &#8220;FOR&#8221;
THE ELECTION OF EACH OF THE DIRECTOR NOMINEES NAMED IN THIS PROXY STATEMENT.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 17 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="p_011"></span><b>MANAGEMENT AND CORPORATE GOVERNANCE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Our Board</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Bylaws provide that our business is to be
managed by or under the direction of our Board. Set forth below are the names of our directors, each of whom has been nominated for reelection
at this Annual Meeting, their respective ages as of the Record Date, their offices in the Company, if any, and any committees of the Board
on which they serve. The biographies of our directors are set forth in &#8220;Proposal&#160;1 &#8212; Election of Directors&#8221; above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 31%"><b>Name</b></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 9%"><b>Age</b></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 58%"><b>Position</b></td></tr>
  <tr style="background-color: #EEEEEE">
    <td><span style="font-size: 10pt">Andy Heyward </span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td><span style="font-size: 10pt">76</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">Chief Executive Officer and Chairman of the Board of Directors </span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt">Joseph &#8220;Gray&#8221; Davis * </span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">82</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Director </span></td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><span style="font-size: 10pt">Henry Sicignano III * </span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">57</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Director </span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt">Margaret Loesch *</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">78</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Director</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><span style="font-size: 10pt">Lynne Segall * </span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">72</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Director </span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt">Anthony Thomopoulos *</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">87</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Director </span></td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td><span style="font-size: 10pt">Dr. Cynthia Turner-Graham *</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">70</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Director</span></td></tr>
  </table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">*</td><td>Denotes directors who are &#8220;independent&#8221; under applicable SEC and the NYSE American LLC (&#8220;NYSE American&#8221;) rules.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board has reviewed the materiality of any
relationship that each of our directors has with the Company, either directly or indirectly. Based upon this review, our Board has determined
that the following members of the Board are &#8220;independent directors&#8221; as defined by the NYSE American Company Guide: Gov. Davis,
Messrs. Sicignano III and Thomopoulos, Mses. Loesch and Segall and Dr. Turner-Graham.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Family Relationships</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There are no family relationships between any
of our directors and our executive officers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Board Leadership Structure and Role in Risk Oversight</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board has responsibility for establishing
broad corporate policies and reviewing our overall performance rather than day-to-day operations. The primary responsibility of our Board
is to oversee the management of our company and, in doing so, serve the best interests of the Company and our stockholders. The Board
selects, evaluates and provides for the succession of executive officers and, subject to stockholder election, directors. It reviews and
approves corporate objectives and strategies and evaluates significant policies and proposed major commitments of corporate resources.
Our Board also participates in decisions that have a potential major economic impact on the Company. Management keeps the directors informed
of company activity through regular communication, including written reports and presentations at Board and committee meetings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board currently consists of seven directors,
including Mr. Heyward, our Chairman, who also serves as our Chief Executive Officer. Although we have not adopted a formal policy on whether
the Chairman and Chief Executive Officer positions should be separate or combined, we have traditionally determined that it is in the
best interest of the Company and its stockholders to combine these roles. Due to the small size of the Company, we believe it is currently
most effective to have the Chairman and Chief Executive Officers positions combined.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 18 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Delinquent Section 16(a) Reports</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Section 16(a) of the Exchange Act of 1934, as
amended (the &#8220;Exchange Act&#8221;) requires our officers, directors and any persons who own more than 10% of our Common Stock to
file reports of ownership of, and transactions in, our Common Stock with the SEC and furnish copies of such reports to us. Based solely
on our reviews of the copies of such forms and amendments thereto furnished to us and on written representations from officers, directors,
and any other person whom we understand owns more than 10% or our Common Stock, we found that during 2024, all Section 16(a) filings were
made with the SEC on a timely basis except that a Form 4 covering one transaction was filed late for Mr. Thomopoulos on each of March
22, 2024, May 8, 2024, November 8, 2024 and January 17, 2025, and one Form 4 covering one transaction was filed late for Mr. Parisi on
January 6, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Committees of the Board and Meetings</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the fiscal year ended December 31, 2024,
our Board held six meetings. No director attended fewer than 75% of the total number of meetings of our Board and of committees of our
Board on which he or she served during the fiscal year ended December 31, 2024. The Board has adopted a policy under which each member
of the Board makes every effort, but is not required, to attend each annual meeting of our stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth the four standing
committees of our Board and the members of each committee and the number of meetings held by our Board and the committees during 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 27%"><b>Director</b></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 11%; text-align: center"><b>Board</b></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 14%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Audit</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Committee</b></p></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 15%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Compensation</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Committee</b></p></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 14%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Nominating</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Committee</b></p></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 14%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Investment</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Committee</b></p></td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="vertical-align: bottom"><span style="font-size: 10pt">Andy Heyward</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Chair</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-size: 10pt">Joseph &#8220;Gray&#8221; Davis</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">X</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">X</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">X</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">X</span></td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="vertical-align: bottom"><span style="font-size: 10pt">Henry Sicignano III</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">X</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Chair</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">X</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-size: 10pt">Margaret Loesch</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">X</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">X</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="vertical-align: bottom"><span style="font-size: 10pt">Lynne Segall</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">X</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">X</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Chair</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Chair</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-size: 10pt">Anthony Thomopoulos</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Vice Chair</span></td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td style="vertical-align: bottom"><span style="font-size: 10pt">Dr. Cynthia Turner-Graham (1)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">X</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">X</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-size: 10pt">Dr. Stefan Pi&#235;ch (2)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">X</span></td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">Meetings in 2024:</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">4</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">1</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">1</span></td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">1</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td>(1)</td><td style="text-align: justify">Effective December 12, 2024, Dr. Cynthia Turner-Graham was elected to the
Nominating Committee.</td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td style="width: 0.5in">(2)</td><td style="text-align: justify">On March 5, 2025, Dr. Stefan Pi&#235;ch, then a member of the Board, notified the Company of his decision
to resign, effective as such date, from his position as a member of the Board. The resignation was due to personal reasons, and did not
relate to any disagreement with the Company on any matter relating to its operations, policies or practices.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To assist in carrying out its duties, the Board
has delegated certain authority to the Audit Committee, the Compensation Committee, the Nominating Committee and the Investment Committee
as the functions of each are described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 19 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Audit Committee</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Gov. Davis, Mr. Sicignano III and Ms. Segall serve
on our Audit Committee. Our Audit Committee&#8217;s main function is to oversee our accounting and financial reporting processes, internal
systems of control, independent auditor relationships and the audits of our financial statements. The Audit Committee&#8217;s responsibilities
include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>selecting, hiring, and compensating our independent auditors;</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>evaluating the qualifications, independence and performance of our independent auditors;</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">overseeing and monitoring the integrity of our financial statements and our compliance with legal and regulatory requirements as they
relate to financial statements or accounting matters;</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>approving the audit and non-audit services to be performed by our independent auditor;</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">reviewing with the independent auditor the design, implementation, adequacy and effectiveness of our internal controls and our critical
accounting policies; and</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td>&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>preparing the report that the SEC requires in our annual proxy statement.&#160;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board has adopted an Audit Committee charter,
and the Audit Committee reviews and reassesses the adequacy of the charter on an annual basis. The Board has determined that the Audit
Committee members meet NYSE American&#8217;s financial literacy requirements and are independent under applicable SEC and NYSE American
rules, and the Board has further determined that Mr. Sicignano III (i)&#160;is an &#8220;audit committee financial expert&#8221; as such
term is defined in Item 407(d) of Regulation S-K promulgated by the SEC and (ii)&#160;also meets NYSE American&#8217;s financial sophistication
requirements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A copy of the Audit Committee&#8217;s written
charter is publicly available on our website at <i>www.kartoonstudios.com</i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Compensation Committee</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mses. Segall and Loesch serve on the Compensation
Committee and the Board has determined that each of the Compensation Committee members are independent under the applicable NYSE American
rules. Our Compensation Committee&#8217;s main functions are assisting our Board in discharging its responsibilities relating to the compensation
of outside directors, the Chief Executive Officer and other executive officers, as well as administering any stock incentive plans we
may adopt. The Compensation Committee&#8217;s responsibilities include the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">reviewing and recommending to our Board the compensation of our Chief Executive Officer and other executive
officers, and the outside directors;</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">conducting a performance review of our Chief Executive Officer;</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">reviewing our compensation policies; and</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">if required, preparing the report of the Compensation Committee for inclusion in our annual proxy statement.&#160;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee may delegate matters
within its responsibility to subcommittees composed of certain of its members. The Board has adopted a Compensation Committee charter
and the Compensation Committee reviews and reassesses the adequacy of the charter on an annual basis.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 20 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee&#8217;s policy is to
offer our executive officers competitive compensation packages that will permit us to attract and retain highly qualified individuals
and to motivate and reward these individuals in an appropriate fashion aligned with the long-term interests of our Company and our stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A copy of the Compensation Committee&#8217;s written
charter is publicly available on our website at <i>www.kartoonstudios.com</i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Compensation Committee Risk Assessment</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have assessed our compensation programs and
concluded that our compensation practices do not create risks that are reasonably likely to have a material adverse effect on us.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Role of Our Compensation Consultant</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee has the authority under
its charter to retain compensation consultants to assist in carrying out its responsibilities. The Compensation Committee has from time
to time retained consultants to provide independent advice on executive compensation and to perform specific tasks as requested by the
Compensation Committee. Any such consultant reports directly to the Compensation Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Compensation Committee engaged Zayla Partners,
LLC, or &#8220;Zayla,&#8221; as its independent compensation consultant during 2024 to develop a Company peer group for use in executive
compensation benchmarking efforts, conduct a benchmarking study evaluating market competitive compensation levels for the CEO, to review
the design of the CEO&#8217;s incentive opportunities and to review other terms of the CEO&#8217;s employment agreement. The Compensation
Committee assessed the independence of Zayla pursuant to SEC rules and in accordance with NYSE American listing standards, noting that
Zayla does not provide any services to the Company other than advice for the Compensation Committee regarding executive and director compensation,
and concluded that no conflict of interest exists.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Nominating Committee</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Gov. Davis and Ms. Segall serve on our Nominating
Committee. The Nominating Committee&#8217;s responsibilities include:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>identifying qualified individuals to serve as members of our Board;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>review the qualifications and performance of incumbent directors;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>review and consider candidates who may be suggested by any director or executive officer or by a stockholder of the Company; and</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td>review considerations relating to board composition, including size of the board, term and age limits, and the criteria for membership
of the board.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board has adopted a Nominating Committee charter,
and the Nominating Committee reviews and reassesses the adequacy of the charter on an annual basis. For all potential candidates, the
Nominating Committee may consider all factors it deems relevant, such as a candidate&#8217;s personal integrity and sound judgment, business
and professional skills and experience, independence, knowledge of the industry in which we operate, possible conflicts of interest, diversity,
the extent to which the candidate would fill a present need on the Board, and concern for the long-term interests of our stockholders.
The Nominating Committee will consider potential candidates recommended by our stockholders. Any such potential candidates will be evaluated
using the same criteria as candidates identified by any director or executive officer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 21 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Nominating Committee considers issues of diversity
among its members in identifying and considering nominees for director, and strives, where appropriate, to achieve a diverse balance of
backgrounds, perspectives and experience on the Board and its committees, but it does not have a formal diversity policy .</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A copy of the Nominating Committee&#8217;s written
charter is publicly available on our website at <i>www.kartoonstudios.com</i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Investment Committee</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Messrs. Davis and Sicignano III serve on our Investment
Committee. The primary purpose of the Investment Committee is to assist the Board in reviewing our investment policy and strategies and
in overseeing our capital and financial resources. A material investment on behalf of the Company may not be made without the Investment
Committee&#8217;s approval or the approval of a delegate of the Investment Committee pursuant to an appropriate delegation of the Investment
Committee&#8217;s authority. In order to carry out its mission and function, and subject to the terms of the Company&#8217;s Articles
of Incorporation, as amended, the Investment Committee has the authority to:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">review the investment policy, strategies, transactions and programs of the Company and its subsidiaries
to ensure they are consistent with the goals and objectives of the Company;</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">evaluate and approve or disapprove each proposed material investment on behalf of the Company;</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">determine whether the investment policy is consistently followed and that procedures are in place to ensure
that the Company&#8217;s investment portfolio is managed in compliance with its policies;</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">review the performance of the investment portfolios of the Company and its subsidiaries; and</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">approve and revise, as appropriate, the Company&#8217;s investment policies and guidelines.&#160;</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Stockholder Communications to our Board</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Generally, stockholders who have questions or
concerns should contact our Investor Relations department at 844-589-8760. However, any stockholders who wish to address questions regarding
our business directly with the Board, or any individual director, should direct his or her questions in writing to Kartoon Studios, Inc.,
at 190 N. Canon Drive, 4th Floor, Beverly Hills, California 90210, Attn: Corporate Secretary or by using the &#8220;Contact&#8221; page
of our website <i>www.kartoonstudios.com/contact.</i> Communications will be distributed to the Board, or to any individual director or
directors as appropriate, depending on the facts and circumstances outlined in the communications. Items that are unrelated to the duties
and responsibilities of the Board may be excluded, such as:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">junk mail and mass mailings;</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">resumes and other forms of job inquiries;</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">surveys; and</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">solicitations or advertisements.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition, any material that is unduly hostile,
threatening, or illegal in nature may be excluded, provided that any communication that is filtered out will be made available to any
outside director upon request.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 22 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Insider Trading Policy</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have adopted an insider trading policy (the
&#8220;Trading Policy&#8221;) that is designed to promote compliance with federal and state securities laws and regulations, as well as
the rules and regulations of the NYSE American. The Trading Policy provides our standards on trading and causing the trading of our securities
while in possession of material nonpublic information. It prohibits trading in certain circumstances and applies to all of our directors,
officers and employees as well as independent contractors or consultants who have access to material nonpublic information obtained through
involvement with our company. Additionally, our Trading Policy imposes special additional trading restrictions applicable to all of our
directors and executive officers and to such persons&#8217; family members who live in such persons&#8217; households. The Trading Policy
also requires us to comply with all insider trading laws, rules and regulations, and any applicable listing standards when engaging in
transactions in our own securities.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Hedging Policy</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to our Trading Policy, we prohibit our
directors, officers, and employees from purchasing any financial instrument or engaging in any other transaction, such as a prepaid variable
forward, equity swap, collar or exchange fund, that is designed to hedge or offset any decrease in the market value of the Company&#8217;s
securities. Our Trading Policy also prohibits our directors, officers, and employees from: (i) participating in short sales of the Company&#8217;s
securities; (ii) participating in a transaction involving publicly traded options, such as puts, calls or other derivative securities,
related to the Company&#8217;s securities; and (iii) holding Company securities in margin accounts or pledging Company securities as collateral
for a loan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>* The disclosure under the caption "Hedging
Policy" is not to be incorporated by reference in any filing of the Company under the Securities Act of 1933, as amended or the Exchange
Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.</i></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Executive Officers</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth certain information
as of the Record Date, regarding our executive officers. Information regarding our Chief Executive Officer, Andy Heyward, can be found
under the caption &#8220;<i>The Board</i>&#8221; above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; width: 31%">Name</td>
    <td style="width: 3%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 8%; text-align: center">Age</td>
    <td style="width: 3%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 55%">Position</td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">Andy Heyward</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">76</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Chief Executive Officer and Chairman of the Board</span></td></tr>
  <tr style="background-color: White">
    <td><span style="font-size: 10pt">Brian Parisi</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">55</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Chief Financial Officer</span></td></tr>
  <tr style="background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">Michael A. Jaffa</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">59</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Chief Operating Officer, General Counsel and Corporate Secretary</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Brian Parisi, Chief Financial Officer</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Parisi started with the Company as Chief Financial
Officer during September 2023. Mr. Parisi brings 30 years of experience across the entertainment, media, and high-tech industries, specializing
in finance, accounting, M&amp;A, corporate strategy, and business development. Before joining Kartoon Studios, starting in 2019 he was
the Chief Financial Officer at Break the Floor Productions in Hollywood, California, an entertainment production company. In this role,
he notably prepared the company for sale, successfully completing two separate sale transactions with private equity firms. Previously,
Mr. Parisi served as the Chief Financial Officer from 2017 to 2019 at the NFL Hall of Fame Village (HOFV), where he oversaw a wide range
of financial activities including raising capital from numerous public and private sources, managing construction budgets, assisting the
company with its IPO, financial reporting, and cash management for the newly designed entertainment complex in Canton, Ohio. In addition,
he was a finance executive at Live Nation Entertainment (LYV) from 2009 to 2016, including his most recent role as the Head of Finance
for the Festivals Division at the company where he was responsible for managing all financial, strategic, and treasury functions for Electronic
Dance Music festivals in multiple countries with more than 1.3 million fans annually. Mr. Parisi has also held leadership positions at
Warner Bros. Entertainment (WBD) and NBC Universal (CMCSA).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 23 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Parisi is a CPA and holds a B.S. in Accounting
from Purdue University, Daniel School of Business, and an M.B.A. from the University of Southern California, Marshall School of Business.
He was recently awarded the 2024 Public Company CFO of the year by the Los Angeles Business Journal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Michael Jaffa, Chief Operating Officer, General
Counsel and Corporate Secretary</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Jaffa was promoted to Chief Operating Officer,
General Counsel and Corporate Secretary on December 7, 2020. Previously he served as the General Counsel and Corporate Secretary of the
Company since April 2018. From January 2017 through April 2018, Mike served as Thoughtful Media Group&#8217;s (TMG) General Counsel and
Global Head of Business Affairs. TMG is a multichannel network focused on Asian markets. At TMG, Mr. Jaffa oversaw all of TMG&#8217;s
legal matters, established the framework for TMG&#8217;s continued growth in international markets, including a franchise plan, the formation
of a regional headquarters in Southeast Asia and assisted with M&amp;A transactions. From September 2013 through December 2016, Mr. Jaffa
worked as the Head of Business Affairs for DreamWorks Animation Television, and before that served in a similar role at Hasbro Studios
from December 2009 through September 2013. Mr. Jaffa has over 20 years of experience handling licensing, production, merchandising, complex
international transactions and employment issues for large and small entertainment companies and technology startups.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 24 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="p_012"></span><b>EXECUTIVE OFFICER AND DIRECTOR COMPENSATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This section describes the material elements of
compensation awarded to, earned by or paid to (i)&#160;all individuals who served as our principal executive officer during 2024, (ii)
our two most highly compensated executive officers (other than the principal executive officer) who were serving as executive officers
of the Company as of December&#160;31, 2024 and (iii)&#160;up to two former executive officers who would have been among our two most
highly compensated executive officers for 2024 but for the fact that they did not serve as executive officers as of December&#160;31,
2024 (the &#8220;named executive officers&#8221;). Our Compensation Committee reviews and approves the compensation of our executive officers
and oversee our executive compensation programs and initiatives.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Summary Compensation Table</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The table below summarizes all compensation awarded
to, earned by, or paid to our named executive officers for all services rendered in all capacities to us during the fiscal years noted
below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name and Principal Position</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Salary ($)</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Bonus ($)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Stock</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Awards</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>($) (1)</b></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Option</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Awards</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>($)</b></p></td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>All Other</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Compensation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>($)</b></p></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total ($)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 30%; text-align: left">Andy Heyward (2)</td><td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: center">2024</td><td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">440,000</td><td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">220,000</td><td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#8211;</td><td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">&#8211;</td><td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">415,384</td><td style="width: 1%">&#160;</td>
    <td style="width: 9%; text-align: right">1,075,384</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Chief Executive Officer</td><td>&#160;</td>
    <td style="text-align: center">2023</td><td>&#160;</td>
    <td style="text-align: right">440,000</td><td>&#160;</td>
    <td style="text-align: right">220,000</td><td>&#160;</td>
    <td style="text-align: right">&#8211;</td><td>&#160;</td>
    <td style="text-align: right">&#8211;</td><td>&#160;</td>
    <td style="text-align: right">816,984</td><td>&#160;</td>
    <td style="text-align: right">1,476,984</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Michael A. Jaffa (3)</td><td>&#160;</td>
    <td style="text-align: center">2024</td><td>&#160;</td>
    <td style="text-align: right">450,000</td><td>&#160;</td>
    <td style="text-align: right">50,000</td><td>&#160;</td>
    <td style="text-align: right">&#8211;</td><td>&#160;</td>
    <td style="text-align: right">&#8211;</td><td>&#160;</td>
    <td style="text-align: right">&#8211;</td><td>&#160;</td>
    <td style="text-align: right">500,000</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Chief Operating Officer, General Counsel and Corporate Secretary</td><td>&#160;</td>
    <td style="text-align: center">2023</td><td>&#160;</td>
    <td style="text-align: right">419,826</td><td>&#160;</td>
    <td style="text-align: right">50,000</td><td>&#160;</td>
    <td style="text-align: right">&#8211;</td><td>&#160;</td>
    <td style="text-align: right">&#8211;</td><td>&#160;</td>
    <td style="text-align: right">8,364</td><td>&#160;</td>
    <td style="text-align: right">478,190</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Brian Parisi (4)</td><td>&#160;</td>
    <td style="text-align: center">2024</td><td>&#160;</td>
    <td style="text-align: right">331,439</td><td>&#160;</td>
    <td style="text-align: right">15,000</td><td>&#160;</td>
    <td style="text-align: right">&#8211;</td><td>&#160;</td>
    <td style="text-align: right">&#8211;</td><td>&#160;</td>
    <td style="text-align: right">&#8211;</td><td>&#160;</td>
    <td style="text-align: right">346,439</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Chief Financial Officer</td><td>&#160;</td>
    <td style="text-align: center">2023</td><td>&#160;</td>
    <td style="text-align: right">85,000</td><td>&#160;</td>
    <td style="text-align: right">&#8211;</td><td>&#160;</td>
    <td style="text-align: right">50,050</td><td>&#160;</td>
    <td style="text-align: right">&#8211;</td><td>&#160;</td>
    <td style="text-align: right">&#8211;</td><td>&#160;</td>
    <td style="text-align: right">135,050</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-top: black 1pt solid; vertical-align: top; width: 5%; text-align: center"><span style="font-size: 10pt">(1)</span></td>
    <td style="border-top: black 1pt solid; width: 95%; text-align: justify"><span style="font-size: 10pt">The aggregate fair value of the stock awards on the date of grant was computed in accordance with FASB&#160;ASC Topic 718.</span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Mr. Heyward entered into a five-year employment agreement on December 7, 2020, pursuant to which he is entitled to an annual salary of $440,000. During  2023 and 2024, Mr. Heyward was paid $220,000 in discretionary bonuses. See &#8220;Narrative Disclosure to Summary Compensation &#8211; &#8220;All Other Compensation&#8221;.</span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Mr. Jaffa entered into an employment agreement on December 7, 2020, as amended on January 8, November 13, 2023, and November 6, 2024 which extended the term through December 7, 2025. Under his employment agreement, Mr. Jaffa was entitled to an annual salary of $325,000 the first year, $375,000 the second year and $450,000 in each of the third, fourth and fifth years. He is also entitled to an annual bonus of $50,000 each year.</span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">(4)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Effective September 27, 2023, the Company entered into an employment
    agreement with Mr. Parisi, whereby Mr. Parisi agreed to serve as the Chief Financial Officer for a period of one year in
    consideration for an annual salary of $325,000. The Company had the option to extend the term of the agreement for an additional one
    year in consideration for an annual salary of $350,000, which option was exercised by the Company on September 22, 2024. Mr. Parisi
    is entitled to a discretionary bonus for each fiscal year as determined by the Company. In 2024, <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Parisi was paid a discretionary bonus of $15,000</span>. In 2023 the Company granted 35,000 RSUs to Mr. Parisi that vest annually
     over three years.</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 25 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Narrative Disclosure to Summary Compensation Table</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Base Salary</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Base salaries are used to recognize experience,
skills, knowledge and responsibilities required of all of our employees, including our executive officers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>All Other Compensation</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to his employment agreement, Mr. Heyward
is entitled to an executive producer fee of $12,500 per one-half hour episode for each episode for which he provides services as an executive
producer and creative producer fees of $100,000 per quarter. During the year ended December 31, 2024, Mr. Heyward did not earn any executive
producer fees, but did earn and was paid $400,000 in creative producer fees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Bonus Compensation</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our named executive officers are eligible to receive
an annual bonus award in accordance with their employment agreements and/or management incentive program then in effect with respect to
such executive officer and based on an annualized target of base salary, as specified in their respective employment agreements, if applicable.
In 2024, Mr. Heyward was paid a discretionary bonus of $220,000, Mr. Jaffa was paid a $50,000 renewal bonus pursuant to his employment
agreement, and Mr. Parisi was paid a discretionary bonus of $15,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Equity Based Incentive Awards</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We believe that equity grants provide our executives
with a strong link to our long-term performance, create an ownership culture and help to align the interests of our executives and our
stockholders. In addition, we believe that equity grants with a time-based vesting feature promote executive retention because this feature
incentivizes our named executive officers to remain in our employment during the vesting period. Accordingly, our compensation committee
and Board periodically review the equity incentive compensation of our named executive officers and from time to time may grant additional
equity incentive awards to them in the form of stock options or other awards. During the year ended December 31, 2024, no awards held
by our named executive officers have been modified or repriced.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Employment Agreements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>CEO Employment Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December&#160;7, 2020, the Company entered
into an amended and restated employment agreement, as further amended on each of February 22, 2021, June&#160;23, 2021, November 22,
2021, August 25, 2022 and February 27, 2023 (the &#8220;CEO Employment Agreement&#8221;) with Andy Heyward.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Mr. Heyward agreed to serve as the Company&#8217;s
Chief Executive Officer for a period of five years, subject to renewal, in consideration for an annual salary of $440,000, and an award
of 500,000 stock options and 1,500,000 RSUs. Mr. Heyward is also eligible to be paid a producing fee equal to $12,500 per one-half hour
episode for each series produced, controlled and distributed by the Company, and for which he provides material production services provided
as the executive producer for up to 52 one-half hour episodes. Additionally, under the terms of the CEO Employment Agreement, Mr. Heyward
is eligible for a quarterly discretionary bonus of $55,000 per fiscal quarter if the Company meets certain criteria, as established by
the Board. Mr. Heyward is also entitled to reimbursement of reasonable expenses incurred in connection with his employment and the Company
may take out and maintain during the term of his tenure a life insurance policy in the amount of $1,000,000. During the term of his employment
and under the terms of the CEO Employment Agreement, Mr. Heyward is also entitled to be designated as composer on all music contained
in the programming produced by the Company and to receive composer&#8217;s royalties from applicable performing rights societies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 26 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The options granted to Mr. Heyward were fully
vested on the date of grant. The initial vesting terms of the RSUs granted to Mr. Heyward on December 7, 2020 consisted of the following:
750,000 of the RSUs were to vest over time subject to Mr. Heyward&#8217;s continued employment (time-based), and 750,000 of the RSUs were
to vest in equal installments on the first, second, third and fourth anniversaries of the date of grant, subject to the achievement of
certain performance criteria (performance-based), to be determined by the Compensation Committee, and subject to Mr. Heyward&#8217;s continued
employment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On June 23, 2021, the Compensation Committee
amended the vesting terms of the RSU award granted to Mr. Heyward.&#160;According to the amended terms, 375,000 of the RSUs would continue
to vest over time subject to Mr. Heyward&#8217;s continued employment. The remaining unvested 1,125,000 RSUs were modified to vest as
follows: (i) 375,000 RSUs vest when the closing sale price of the Company&#8217;s Common Stock equals or exceeds $3.00 per share or the
Company&#8217;s market capitalization equals or exceeds $903,000,000 for 20 consecutive trading days; (ii) 375,000 RSUs vest when the
closing sale price of the Company&#8217;s Common Stock equals or exceeds $3.50 per share or the Company&#8217;s market capitalization
equals or exceeds $1,053,500,000 for 20 consecutive trading days, and (iii) 375,000 RSUs vest when the closing sale price of the Company&#8217;s
Common Stock equals or exceeds $3.75 per share or the Company&#8217;s market capitalization equals or exceeds $1,128,750,000 for 20 consecutive
trading days. In the event of a change in control of the Company, the Compensation Committee will determine the extent to which the stock
price and market capitalization vesting conditions set forth above are achieved based on the value of the consideration per share paid
to the Company's stockholders in the change in control transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The award agreement further provides that in addition
to vesting based on the stock price and market capitalization vesting conditions set forth above, the 1,125,000 RSUs had the opportunity
to vest in four equal installments on the first, second, third and fourth anniversaries of December 7, 2020, if not otherwise vested pursuant
to the stock price and market capitalization vesting conditions, based on the achievement of certain operating performance-based vesting
conditions established by the Compensation Committee and communicated to the Participant and subject to Mr. Heyward&#8217;s continued
employment. Pursuant to an amendment dated January 19, 2022, the Compensation Committee determined that Mr. Heyward would satisfy the
operating performance conditions as it related to 281,250 RSUs upon the execution of final definitive agreements to acquire WOW Unlimited
Media (&#8220;WOW&#8221;) and a final definitive agreement related to the Company&#8217;s investment in Your Family Entertainment. On
April 7, 2022, 281,250 of the 1,125,000 RSUs vested upon the achievement of completing the WOW and Ameba acquisitions. As of the December
7, 2025, the fourth anniversary of the grant date, none of the stock price, market capitalization or any of the further operating performance
conditions have been satisfied. Therefore, 843,750 of Mr. Heyward&#8217;s RSUs remain unvested.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 21, 2021, Mr. Heyward&#8217;s employment
agreement was amended to provide that he would be&#160;entitled to an executive producer fee of $12,500&#160;per one-half hour episode
for each episode he provides services as an executive producer up to a maximum of 52 one-half hour episodes per calendar year during the
term. Following the completion of the acquisition of WOW, the maximum of 52 one-half hour episodes shall be increased to 104 one-half
hour episodes per calendar year for episodes completed following the closing of the WOW acquisition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On August 25, 2022, Mr. Heyward&#8217;s employment
agreement was amended to include assignment of music royalties to Mr. Heyward for all musical compositions in which he provides services
as a composer for or on behalf of the Company, in the event that the Company acquires up to 50% of the writer's share of the royalties
for that musical composition. If the Company acquires more than 50% of the writer's share of the royalties on musical compositions Mr.
Heyward provided services for, he has the option to purchase the additional royalties from the Company at the price the Company paid to
acquire the additional royalties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of February 27, 2023, Mr. Heyward and the Company
agreed to reduce the maximum number of one-half episodes per calendar year for which Mr. Heyward is eligible to receive producer fees
to 52. As compensation for this reduction, Mr. Heyward&#8217;s employment agreement was further amended as of February 27, 2023 to provide
that Mr. Heyward shall be entitled to a creative producer fee of $100,000 per quarter for services rendered to WOW, prorated for the first
quarter of 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 27 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The CEO Employment Agreement also entitles Mr.
Heyward to separation payments in certain circumstances. In the event Mr. Heyward&#8217;s employment terminates due to his death or retirement
after the age of 65, in addition to accrued base salary and vacation and expense reimbursement, he is entitled to receive (i)&#160;any
unpaid quarterly bonus for the fiscal quarter preceding the fiscal quarter in which such termination occurs and (ii) if earned, a pro-rated
quarterly bonus for the fiscal quarter in which such termination occurs. In the event Mr. Heyward&#8217;s employment terminates due to
his permanent disability, in addition to accrued base salary and expense reimbursement, he is entitled to receive (i) any unpaid quarterly
bonus for the fiscal quarter preceding the fiscal quarter in which such termination occurs, (ii) if earned, a pro-rated quarterly bonus
for the fiscal quarter in which such termination occurs and (iii) for a period of six months (or for the remaining months of the term
of his employment, if less than six months), monthly payments equal to the amount, if any, of his monthly base salary in excess of any
disability benefits being received by Mr. Heyward, provided that he will not be entitled to any compensation under (i), (ii) or (iii)
unless he signs a release of claims against the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>COO and General Counsel Employment Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 7, 2020, the Company entered into
an amended and restated agreement, as further amended on each of December 16, 2021, January 8, 2023, November 13, 2023, and November 6,
2024 (the &#8220;COO and General Counsel Employment Agreement&#8221;) with Michael A. Jaffa, pursuant to which Mr. Jaffa would assume
the role of Chief Operating Officer (&#8220;COO&#8221;) and General Counsel commencing on December 7, 2020. The term of the agreement,
as amended, is five years. In addition, under the agreement Mr. Jaffa is entitled to an annual discretionary bonus based on his performance.
In the event of Mr. Jaffa&#8217;s death or resignation, all compensation then currently due would be payable to his estate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The COO and General Counsel Employment Agreement
provides Mr. Jaffa with, during the five year term (i) an annualized base salary of $325,000 for the first year of the term, $375,000
for the second year of the term and $450,000 for the third, fourth and fifth years of the term, (ii) discretionary annual bonuses determined
in the sole discretion of the Board&#8217;s Compensation Committee, and (iii) eligibility to receive renewal bonuses of $50,000 beginning
within 60 days following the effective date of the COO and General Counsel Employment Agreement and each anniversary thereafter during
the term, subject to Mr. Jaffa&#8217;s continued employment. Pursuant to the agreement, Mr. Jaffa was granted 100,000 stock options and
50,000 RSUs. The options granted to Mr. Jaffa were partially vested on the date of grant, and vested with respect to the unvested amounts
in substantially equal installments on the first three anniversaries of the grant date, subject to continued employment. The RSUs granted
to Mr. Jaffa vested in three equal installments on the first three anniversaries of the date of grant, subject to continued employment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The COO and General Counsel Employment Agreement
also entitles Mr. Jaffa to separation payments in certain circumstances. In the event Mr. Jaffa&#8217;s employment terminates due to his
death or retirement after the age of 65, in addition to accrued base salary and vacation and expense reimbursement, he is entitled to
receive any unpaid annual bonus for the fiscal year preceding the fiscal year in which such termination occurs. In the event Mr. Jaffa&#8217;s
employment terminates due to his permanent disability, in addition to accrued base salary and expense reimbursement, he is entitled to
receive (i) any unpaid annual bonus for the fiscal year preceding the fiscal year in which such termination occurs, and (ii)&#160;for
a period of two months (or for the remaining months of the term of his employment, if less than six months), monthly payments equal to
the amount, if any, of his monthly base salary in excess of any disability benefits being received by Mr. Jaffa, provided that he will
not be entitled to any compensation under (i) or (ii) unless he signs a release of claims against the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, the COO and General Counsel Employment
Agreement contains certain restrictive covenants regarding confidential information, intellectual property, non-competition and non-solicitation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 28 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>CFO Employment Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective September 27, 2023, the Company entered
into an employment agreement with Brian Parisi (the &#8220;CFO Employment Agreement&#8221;), whereby Mr. Parisi agreed to serve as the
Chief Financial Officer for a one year period in consideration for an annual salary of $325,000. Mr. Parisi is also eligible for a discretionary
bonus for each fiscal year as determined by the Company. In addition, on December 14, 2023, Mr. Parisi was granted 35,000 RSUs with a
fair value of $50,050 that vest annually over three years. The Company had the option to extend the CFO Employment Agreement for an additional
one-year period in consideration of an annual salary of $350,000, which the Company exercised on September 22, 2024. In connection with
such extension, we agreed to pay to Mr. Parisi a discretionary bonus of $15,000 upon receipt of funds from our fundraising in which our
net proceeds exceeded $4 million.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The CFO Employment Agreement also entitles Mr.
Parisi to separation payments in certain circumstances. In the event Mr. Parisi&#8217;s employment terminates due to his death or retirement
after the age of 65, in addition to accrued base salary and vacation and expense reimbursement, he is entitled to receive any unpaid discretionary
bonus for the fiscal year preceding the fiscal year in which such termination occurs.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company may terminate the CFO Employment Agreement
in the event Mr. Parisi becomes disabled and as a result is unable to perform substantially all duties and responsibilities for thirty
(30) consecutive days or an aggregate of sixty (60) days during any period of one hundred and eighty two (182) consecutive calendar days.
The Company may designate another employee to act in Mr. Parisi&#8217;s place during any period of such disability. Notwithstanding any
such designation, while Mr. Parisi is employed by the Company and has not yet become eligible for disability income benefits under any
disability income plan maintained by the Company, Mr. Parisi shall continue to receive his base salary and benefits. Upon becoming so
eligible, and until the termination Mr. Parisi&#8217;s employment because of disability, the Company shall pay Mr. Parisi, at his regular
pay periods, an amount equal to the excess, if any, of Mr. Parisi&#8217;s monthly base compensation in effect at the time of eligibility
(i.e. 1/12th of the base salary) over the amounts of disability income benefits that Mr. Parisi is otherwise eligible to receive. Upon
termination of the CFO Employment Agreement because of disability, the Company shall pay to Mr. Parisi (i) any base salary earned but
unpaid through the date of termination, (ii) any discretionary bonus for the fiscal year preceding the year of termination that was earned
but unpaid, and (iii) reimbursement of any reasonable expenses incurred in the performance of duties in accordance with the customary
policies of the Company. During the 2 month period (or the remaining months of the term if less than 6 months) following the termination
of employment because of disability, the Company shall pay Mr. Parisi, at his regular pay periods, an amount equal to the excess, if any,
of his monthly base compensation in effect at the time of termination (i.e. 1/12th of the base salary) over the amounts of disability
income benefits that Mr. Parisi is otherwise eligible to receive pursuant to the above-referenced disability income plan in respect of
such period, provided that Mr. Parisi signs an employee release.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, the CFO Employment Agreement contains
certain restrictive covenants regarding confidential information, intellectual property, non-competition and non-solicitation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Retirement Benefits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of December 31, 2024, we did not provide our
employees, including our executives, with a defined benefit pension plan, any supplemental executive retirement plans or retiree health
benefits, except as required by local law or custom for employees outside the United States. Our executives may participate on the same
basis as other U.S. employees in our 401(k) Plan with a Company-sponsored match component.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Potential Payments upon Termination or Change-in-Control</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Payments upon Termination</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our employment agreements with our named executive
officers provide incremental compensation in the event of termination, as described above under <i>Employment Agreements</i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 29 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, our equity incentive plans have provisions
for payments to our named executive officers if they are terminated as a result of death or disability. Under the Kartoon Studios, Inc.
2015 Incentive Plan (the &#8220;2015 Plan&#8221;), if a grantee is terminated due to death or disability, the following adjustments shall
be made to such grantee&#8217;s awards (unless any particular award agreement provides otherwise): (i) any outstanding options and stock
appreciation rights shall become immediately exercisable in full, (ii) any restricted stock award shall become immediately vested in full,
(iii) any restricted stock units and any unpaid dividend equivalents shall become immediately vested in full, and (iv) any cash awards
or other stock-based awards shall become immediately vested in full. Under the 2020 Plan, if a grantee is terminated due to death or disability,
the Compensation Committee may, in its sole discretion, make the following adjustments to such grantee&#8217;s awards: (i) termination
of restrictions in any award agreements (ii) acceleration of any or all installments and rights, and/or (iii) payment of the grantee&#8217;s
aggregated accelerated payments in a lump sum to the grantee (or the grantee&#8217;s estate, beneficiaries or representative, as applicable).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Payments upon Change in Control</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under our 2015 Plan, upon a Change in Control,
the Compensation Committee may, but is not required to, provide for one or more of the following: (i)&#160;acceleration, vesting or lapsing
of awards, (ii) cancellation of awards for fair value (as determined in the sole discretion of the Compensation Committee), (iii)&#160;issuance
of substitute awards that substantially preserve the terms of the original awards, (iv) provision that options and rights shall be exercisable
prior to such Change in Control and then be terminated following the Change in Control, or (v)&#160;any other action with respect to the
awards as the Compensation Committee determines to be appropriate in its discretion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under our 2020 Plan, upon a Change in Control,
the Compensation Committee may, but is not required to, provide for one or more of the following: (i)&#160;assumption of the 2020 Plan
and outstanding awards by the surviving entity or its parent, (ii) issuance of substitute awards that substantially preserve the terms
of the original awards, (iii) notice to holders of vested options and rights that such options and rights shall be exercisable prior to
such Change in Control and then be terminated following the Change in Control, (iv) settlement of the intrinsic value of outstanding vested
options and rights in cash, cash equivalence or equity (regardless of vesting status), (v) cancellation of all unvested or unexercisable
awards, or (vi) any other action with respect to the awards as the Compensation Committee determines to be appropriate in its discretion;
provided that in connection with an assumption or substitution awards under (i) or (ii), the awards so assumed or substituted shall continue
to vest or become exercisable pursuant to the terms of the original award, except to the extent such terms are otherwise rendered inoperative.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under our 2015 Plan and our 2020 Plan, &#8220;Change
in Control&#8221; is defined to mean any of the following events: (a) any &#8220;person&#8221; within the meaning of Section 13(d)(3)
or 14(d)(2) of the Exchange Act (other than the Company or any company owned, directly or indirectly, by the stockholders of the Company
in substantially the same proportions as their ownership of stock of the Company) becomes the &#8220;beneficial owner&#8221; within the
meaning of Rule 13d-3 promulgated under the Act of 30% or more of the combined voting power of the then outstanding securities of the
Company entitled to vote generally in the election of directors; excluding, however, any circumstance in which such beneficial ownership
resulted from any acquisition by an employee benefit plan (or related trust) sponsored or maintained by the Company or by any corporation
controlling, controlled by, or under common control with, the Company (or, under the 2020 Plan, the Company itself); (b) a change in the
composition of the Board since the date of stockholder approval, such that the individuals who, as of such date, constituted the Board
(the &#8220;Incumbent Board&#8221;) cease for any reason to constitute at least a majority of such board; provided that any individual
who becomes a director of the Company subsequent to date of stockholder approval whose election, or nomination for election by the Company&#8217;s
stockholders, was approved by the vote of at least a majority of the directors then comprising the Incumbent Board shall be deemed a member
of the Incumbent Board; and provided further, that any individual who was initially elected as a director of the Company as a result of
an actual or threatened election contest, as such terms are used in Rule 14a-12 of Regulation 14A promulgated under the Exchange Act,
or any other actual or threatened solicitation of proxies or consents by or on behalf of any person or entity other than the Board shall
not be deemed a member of the Incumbent Board; (c) a reorganization, recapitalization, merger, consolidation or similar form of corporate
transaction, or the sale, transfer, or other disposition of all or substantially all of the assets of the Company to an entity that is
not an Affiliate (each of the foregoing events, a &#8220;Corporate Transaction&#8221;) involving the Company, unless securities representing
60% or more of the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors
of the Company or the corporation resulting from such Corporate Transaction, including a corporation that, as a result of such transaction
owns all or substantially all of the Company&#8217;s assets (or the direct or indirect parent of such corporation), are held immediately
subsequent to such transaction by the person or persons who were the beneficial holders of the outstanding voting securities entitled
to vote generally in the election of directors of the Company immediately prior to such Corporate Transaction, in substantially the same
proportions as their ownership immediately prior to such Corporate Transaction; or (d) the liquidation or dissolution of the Company (or,
under the 2020 Plan, stockholder approval of such liquidation or dissolution), unless such liquidation or dissolution is part of a transaction
or series of transactions described in clause (c) above that does not otherwise constitute a Change in Control.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 30 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Clawback Policy</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Effective December 1, 2023, we adopted an executive
officer incentive compensation clawback which requires the clawback of erroneously awarded incentive-based compensation of past or current
executive officers awarded during the three full fiscal years preceding the date on which the issuer is required to prepare an accounting
restatement due to the material noncompliance of the Company with any financial reporting requirement under the federal securities laws.
Specifically, in the event of an accounting restatement, we must recover, reasonably promptly, erroneously awarded compensation in amounts
determined pursuant to the policy. Compensation that may be recoverable under the policy includes cash or equity-based compensation for
which the grant, payment or vesting (or any portion thereof) is or was predicated upon the achievement of specified financial results
that are impacted by the financial restatement, and the amount of compensation that may be impacted by the clawback policy is the difference
between the amount paid or granted, and the amount that should have been paid or granted, if calculated on the restated financial results.
Recovery under the policy with respect to an executive officer will not require the finding of any misconduct by such executive officer
or such executive officer being found responsible for the accounting error leading to an accounting restatement. Our Clawback Policy was
filed as an exhibit to our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Company Policies and Practices Related to the Grant of Certain Equity
Awards Close in Time to the Release of Material Nonpublic Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company does not have a formal policy on the
timing of awards of options in relation to the disclosure of material nonpublic information by the Company. The Compensation Committee
does not seek to time equity grants to take advantage of information, either positive or negative, about our company that has not been
publicly disclosed. Option grants are generally effective on the date the award determination is made by the Compensation Committee, and
the exercise price of options is the closing market price of our Common Stock on the date of the grant or, if the grant is made on a weekend
or holiday, on the prior business day.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Outstanding Equity Awards at Fiscal Year-End</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth outstanding equity
awards as of December 31, 2024 to each of the named executive officers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 8pt">&#160;</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Option
    Awards</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">Stock
    Awards</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Name</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Number of securities underlying unexercised
    options (#) exercisable</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Number of securities underlying unexercised
    options (#) unexercisable</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Option exercise price<br/> ($)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Option expiration date</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Number of shares or units of stock that
    have not yet vested<br/> (#)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Market Value of shares or
    units of stock that have not yet vested ($)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Equity incentive plan awards: number
    of unearned shares, units or other rights  that have not yet vested<br/> (#)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><span style="font-size: 8pt">Equity incentive plan awards:
    market or payout value of unearned shares, units or other rights that have not vested ($)</span></td><td style="padding-bottom: 1pt"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 14%; text-align: left"><span style="font-size: 8pt">Andy Heyward</span></td><td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-size: 8pt">500,000</span></td><td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 3%; text-align: left"><span style="font-size: 8pt">(1)</span></td><td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-size: 8pt">13.90</span></td><td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 9%; text-align: center"><span style="font-size: 8pt">12/07/30</span></td><td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 7%; text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="width: 1%"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 9%; text-align: right"><span style="font-size: 8pt">843,750</span></td><td style="width: 3%"><span style="font-size: 8pt">&#160;(2)</span></td>
    <td style="width: 1%; text-align: left"><span style="font-size: 8pt">$</span></td><td style="width: 7%; text-align: right"><span style="font-size: 8pt">497,813</span></td><td style="width: 1%; text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left"><span style="font-size: 8pt">Michael A. Jaffa</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">100,000</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">(3)</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">13.90</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 8pt">12/07/30</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left"><span style="font-size: 8pt">Brian Parisi</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">23,333</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">$</span></td><td style="text-align: right"><span style="font-size: 8pt">13,767</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td><span style="font-size: 8pt">&#160;</span></td>
    <td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td><td style="text-align: right"><span style="font-size: 8pt">&#8211;</span></td><td style="text-align: left"><span style="font-size: 8pt">&#160;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;<span style="font-size: 8pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 8pt">(1)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 8pt">Mr. Heyward&#8217;s options vested upon the grant date.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 8pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 8pt">(2)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 8pt">Mr. Heyward&#8217;s outstanding RSUS are subject to
    stock price and market capitalization vesting conditions. See &#8220;Executive Officer and Director Compensation - Narrative Disclosure
    to Summary Compensation Table -Employment Agreements - CEO Employment Agreement&#8221; for more information.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 8pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 8pt">(3)</span></td>
    <td style="font-size: 10pt"><span style="font-size: 8pt">All of Mr. Jaffa&#8217;s options were vested as of December 7, 2023.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 8pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 8pt">(4)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 8pt">On December 14, 2023, Mr. Parisi was granted 35,000
    RSUs that vest annually over three years.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 8pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 24px"><span style="font-size: 8pt">&#160;</span></td>
    <td style="width: 24px; font-size: 10pt"><span style="font-size: 8pt">(5)</span></td>
    <td style="font-size: 10pt; text-align: justify"><span style="font-size: 8pt">Calculated by multiplying the closing price per share
    of the Company&#8217;s common stock on December 31, 2024, $0.59, by the number of shares.</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 31 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Pay Versus Performance</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the Exchange Act, we are required
to disclose in this proxy statement certain information comparing the total compensation actually paid (&#8220;CAP&#8221;) to our principal
executive officer (the &#8220;PEO&#8221;) and the average CAP of our other named executive officers (whom we refer to below as our &#8220;Non-PEO
NEOs&#8221;) and certain other financial performance metrics of the Company using methodologies prescribed by the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000013" name="ecd:PvpTableTextBlock"><table cellspacing="0" cellpadding="0" id="xdx_883_eecd--PvpTableTextBlock_zkYLYdkzxeX1" summary="xdx: Disclosure - Pay vs Performance Disclosure" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center; padding-left: 2.75pt">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: top; padding-left: 1.4pt; text-align: center"><span style="font-size: 10pt">Andy Heyward (1)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 6%; padding-left: 1.4pt; text-align: center"><span style="font-size: 10pt">Year</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; width: 15%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center">Summary Compensation Table Total</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center">(2)</p></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; width: 15%; padding-left: 1.4pt; text-align: center"><span style="font-size: 10pt">Compensation Actually Paid</span></td>
    <td style="border-bottom: black 1pt solid; width: 19%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center">Average Summary Compensation Table Total
for Non-PEO NEOs</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center">(3)</p></td>
    <td style="border-bottom: black 1pt solid; width: 15%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center">Average Compensation Actually Paid to
Non-PEO NEOs</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center">(4)</p></td>
    <td style="border-bottom: black 1pt solid; width: 15%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center">Value of Initial Fixed $100 Investment
Based on Cumulative TSR</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center">(5)</p></td>
    <td style="border-bottom: black 1pt solid; width: 15%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center">Net Loss (in 000s)</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center">(6)</p></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="border-bottom: black 1pt solid; text-align: center; padding-left: 2.75pt"><span style="font-size: 10pt">2024</span></td>
    <td id="xdx_986_eecd--PeoTotalCompAmt_c20240101__20241231__ecd--IndividualAxis__custom--AndyHeywardMember_fKDEpICgyKQ_____zmkCphB2sB18" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2024-01-012024-12-31_custom_AndyHeywardMember" id="Fact000014" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,075,384</ix:nonFraction></span></td>
    <td id="xdx_98E_eecd--PeoActuallyPaidCompAmt_c20240101__20241231__ecd--IndividualAxis__custom--AndyHeywardMember_fKDEp_zRk01orpmrid" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2024-01-012024-12-31_custom_AndyHeywardMember" id="Fact000015" format="ixt:numdotdecimal" decimals="0" unitRef="USD">698,509</ix:nonFraction></span></td>
    <td id="xdx_98C_eecd--NonPeoNeoAvgTotalCompAmt_c20240101__20241231_fKDMp_zhorMkhADUL1" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000016" format="ixt:numdotdecimal" decimals="0" unitRef="USD">423,220</ix:nonFraction></span></td>
    <td id="xdx_98D_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20240101__20241231_fKDQp_zoiIMOi4zLM4" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000017" format="ixt:numdotdecimal" decimals="0" unitRef="USD">409,937</ix:nonFraction></span></td>
    <td id="xdx_988_eecd--TotalShareholderRtnAmt_pp2p0_c20240101__20241231_fKDUp_z8JauyUAInKd" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000018" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">6</ix:nonFraction></span></td>
    <td id="xdx_987_eus-gaap--NetIncomeLoss_c20240101__20241231_fKDYp_zVgB69Ze0O3g" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-12-31" id="Fact000019" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">20,941</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="border-bottom: black 1pt solid; text-align: center; padding-left: 2.75pt"><span style="font-size: 10pt">2023</span></td>
    <td id="xdx_983_eecd--PeoTotalCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AndyHeywardMember_fKDEpICgyKQ_____zZeeJsSMlkX6" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2023-01-012023-12-31_custom_AndyHeywardMember" id="Fact000020" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,492,368</ix:nonFraction></span></td>
    <td id="xdx_98E_eecd--PeoActuallyPaidCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AndyHeywardMember_fKDEp_zWQFyDRnVbEj" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">(<ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2023-01-012023-12-31_custom_AndyHeywardMember" id="Fact000021" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,861,069</ix:nonFraction>)</span></td>
    <td id="xdx_983_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_fKDMp_zNcwrWD4oBeb" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2023-01-012023-12-31" id="Fact000022" format="ixt:numdotdecimal" decimals="0" unitRef="USD">359,086</ix:nonFraction></span></td>
    <td id="xdx_982_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_fKDQp_zOgRqUrf4CM7" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2023-01-012023-12-31" id="Fact000023" format="ixt:numdotdecimal" decimals="0" unitRef="USD">247,838</ix:nonFraction></span></td>
    <td id="xdx_98D_eecd--TotalShareholderRtnAmt_pp2p0_c20230101__20231231_fKDUp_zl53Id9qCtRc" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2023-01-012023-12-31" id="Fact000024" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">13</ix:nonFraction></span></td>
    <td id="xdx_98D_eus-gaap--NetIncomeLoss_c20230101__20231231_fKDYp_z67WfJXLiLu3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31" id="Fact000025" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">77,103</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: center; padding-left: 2.75pt"><span style="font-size: 10pt">2022</span></td>
    <td id="xdx_985_eecd--PeoTotalCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AndyHeywardMember_fKDEpICgyKQ_____zcGmukttk2Cl" style="text-align: center"><span style="font-size: 10pt"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2022-01-012022-12-31_custom_AndyHeywardMember" id="Fact000026" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,450,384</ix:nonFraction></span></td>
    <td id="xdx_988_eecd--PeoActuallyPaidCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AndyHeywardMember_fKDEp_zrxsC3HzhIA8" style="text-align: center"><span style="font-size: 10pt">(<ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2022-01-012022-12-31_custom_AndyHeywardMember" id="Fact000027" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,369,928</ix:nonFraction>)</span></td>
    <td id="xdx_984_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_fKDMp_zZJEPx2OdNC6" style="text-align: center"><span style="font-size: 10pt"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2022-01-012022-12-31" id="Fact000028" format="ixt:numdotdecimal" decimals="0" unitRef="USD">494,981</ix:nonFraction></span></td>
    <td id="xdx_984_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_fKDQp_zO03IdrUvEUg" style="text-align: center"><span style="font-size: 10pt"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2022-01-012022-12-31" id="Fact000029" format="ixt:numdotdecimal" decimals="0" unitRef="USD">173,217</ix:nonFraction></span></td>
    <td id="xdx_984_eecd--TotalShareholderRtnAmt_pp2p0_c20220101__20221231_fKDUp_z2G4qW5ENAs8" style="text-align: center"><span style="font-size: 10pt"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2022-01-012022-12-31" id="Fact000030" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">44</ix:nonFraction></span></td>
    <td id="xdx_988_eus-gaap--NetIncomeLoss_c20220101__20221231_fKDYp_zAg3pUCmF2z8" style="text-align: center"><span style="font-size: 10pt">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31" id="Fact000031" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">45,595</ix:nonFraction>)</span></td></tr>
  </table></ix:nonNumeric>
<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000033" name="ecd:NamedExecutiveOfficersFnTextBlock"><p id="xdx_84B_eecd--NamedExecutiveOfficersFnTextBlock_dU_zIsBTIUCZq4d" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td id="xdx_F05_zt0c8QeZGnt9" style="width: 0.25in">(1)</td><td id="xdx_F11_zQZNX91jSvs5" style="text-align: justify"><ix:footnote id="Footnote000034" xml:lang="en-US">Mr. <span id="xdx_90C_eecd--PeoName_c20240101__20241231_zOtsbvXUYKe3"><span id="xdx_904_eecd--PeoName_c20230101__20231231_zVv5wMCiLhsi"><span id="xdx_90A_eecd--PeoName_c20220101__20221231_zoyWD43L29Pg"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000035" name="ecd:PeoName"><ix:nonNumeric contextRef="From2023-01-012023-12-31" id="Fact000036" name="ecd:PeoName"><ix:nonNumeric contextRef="From2022-01-012022-12-31" id="Fact000037" name="ecd:PeoName">Heyward</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></span></span> served as our  Chief Executive Officer and Chairman during each of the three years presented
in the table.</ix:footnote></td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td/><td id="xdx_F06_zjJ8m53QAZn1">(2)</td><td id="xdx_F19_zBoDoaRtiL47" style="text-align: justify"><ix:footnote id="Footnote000038" xml:lang="en-US">The values reflected in this column reflect the &#8220;Total&#8221; compensation set forth in the Summary
Compensation Table (&#8220;SCT&#8221;) in each applicable year.</ix:footnote></td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td/><td id="xdx_F0F_ziSMDf5zdzX4">(3)</td><td id="xdx_F18_zfizCwFNU2Tg" style="text-align: justify"><ix:footnote id="Footnote000039" xml:lang="en-US">The dollar amounts reported in this column represent the average of the amounts reported for Non-PEO NEOs
in the &#8220;Total&#8221; column of the SCT in each applicable year. The names of each of the Non-PEO NEOs included for purposes of calculating
the average amounts in 2024 were Brian Parisi and Michael A. Jaffa; in 2023 were Brian Parisi, Michael A. Jaffa, and Michael Hirsh; and
in 2022 were Michael A. Jaffa and Michael Hirsh.</ix:footnote></td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td id="xdx_F0E_zdztcojDxbia" style="width: 0.25in">(4)</td><td id="xdx_F17_zzropABX62I9" style="text-align: justify"><ix:footnote id="Footnote000040" xml:lang="en-US">The dollar amounts reported in this column represent the average amount of CAP to Non-PEO NEOs as a group,
as computed in accordance with SEC rules described below.</ix:footnote></td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td/><td id="xdx_F00_zHhSO0bkgHf2">(5)</td><td id="xdx_F1A_zwLAZA7Ml006" style="text-align: justify"><ix:footnote id="Footnote000041" xml:lang="en-US">The cumulative total shareholder return (&#8220;TSR&#8221;) is determined based on the value of an initial
fixed investment of $100 in the Company&#8217;s common stock at December 31, 2021. The Company did not issue dividends during any of the
covered periods.</ix:footnote></td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td/><td id="xdx_F00_zPMcDK90Mkub">(6)</td><td id="xdx_F1B_z3p1Zu6tYBg" style="text-align: justify"><ix:footnote id="Footnote000042" xml:lang="en-US">The dollar amounts reported in this column are the Company&#8217;s net income amounts reflected in the
Company&#8217;s audited financial statements for the applicable year.</ix:footnote></td></tr></table>

</ix:nonNumeric><p id="xdx_851_zkxqOoxURuQ1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 32 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000044" name="ecd:AdjToPeoCompFnTextBlock"><p id="xdx_84F_eecd--AdjToPeoCompFnTextBlock_dU_zn22kE0ORiI" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">SEC rules require certain adjustments be made
to the Summary Compensation Table totals to determine CAP as reported in the Pay versus Performance table. CAP does not necessarily represent
cash and/or equity value transferred to the applicable NEO without restriction, but rather is a value calculated under applicable SEC
rules. A significant portion of the CAP amounts shown relate to changes in values of unvested awards over the course of the applicable
reporting year. Our NEOs do not participate in a defined benefit plan so no adjustment for pension benefits is included in the table
below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following tables below detail these adjustments
to compensation as reported in the Summary Compensation Table:</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Andy Heyward</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 83%; font-weight: bold; text-align: left; padding-bottom: 1pt">Reported Summary Compensation Table Total for 2024</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_985_eecd--PeoTotalCompAmt_c20240101__20241231__ecd--IndividualAxis__custom--AndyHeywardMember_zmOfjsJDrrl7" style="border-bottom: Black 1pt solid; width: 13%; text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2024-01-012024-12-31_custom_AndyHeywardMember" id="Fact000045" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,075,384</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Deduct: Fair Value of Equity Awards Under the &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; Column in SCT</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eecd--AdjToCompAmt_d0_c20240101__20241231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zbhGV8mc2g0j" title="Adjustment to compensation amount" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_AndyHeywardMember_custom_FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember_ecd_PeoMember" id="Fact000047" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Add: Year End Fair Value of Equity Awards Granted During the Year that are Outstanding and Unvested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eecd--AdjToCompAmt_d0_c20240101__20241231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zavd5szJZFTl" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_AndyHeywardMember_custom_YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_PeoMember" id="Fact000048" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Add: Change in Year Over Year End Fair Value of Equity Awards Granted in Prior Years that are Outstanding and Unvested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eecd--AdjToCompAmt_d0_c20240101__20241231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zzmOaufRMo8f" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_AndyHeywardMember_custom_ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_PeoMember" id="Fact000049" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-style: italic; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Add: Change in Prior Year End Fair Value and Vesting Date Fair Value of Equity Awards Granted in Prior Years that Vested During the Year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eecd--AdjToCompAmt_c20240101__20241231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zcfttWJbQpci" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_AndyHeywardMember_custom_ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_PeoMember" id="Fact000050" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">376,875</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Compensation Actually Paid for 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eecd--PeoActuallyPaidCompAmt_c20240101__20241231__ecd--IndividualAxis__custom--AndyHeywardMember_zMrat5uOvS56" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2024-01-012024-12-31_custom_AndyHeywardMember" id="Fact000051" format="ixt:numdotdecimal" decimals="0" unitRef="USD">698,509</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Reported Summary Compensation Table Total for 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_987_eecd--PeoTotalCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AndyHeywardMember_z6c3P0u5yp29" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2023-01-012023-12-31_custom_AndyHeywardMember" id="Fact000052" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,492,368</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Deduct: Fair Value of Equity Awards Under the &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; Column in SCT</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zk5Gv7vOVjFl" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_AndyHeywardMember_custom_FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember_ecd_PeoMember" id="Fact000053" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Add: Year End Fair Value of Equity Awards Granted During the Year that are Outstanding and Unvested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zuMZLk6t5i5i" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_AndyHeywardMember_custom_YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_PeoMember" id="Fact000054" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Add: Change in Year Over Year End Fair Value of Equity Awards Granted in Prior Years that are Outstanding and Unvested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_ziw9bKIBIhrb" style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_AndyHeywardMember_custom_ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_PeoMember" id="Fact000055" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,056,250</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Add: Change in Prior Year End Fair Value and Vesting Date Fair Value of Equity Awards Granted in Prior Years that Vested During the Year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zXt0WvhLtYr7" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_AndyHeywardMember_custom_ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_PeoMember" id="Fact000056" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">297,188</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Compensation Actually Paid for 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eecd--PeoActuallyPaidCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AndyHeywardMember_zWPuAudMcavh" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2023-01-012023-12-31_custom_AndyHeywardMember" id="Fact000057" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,861,069</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Reported Summary Compensation Table Total for 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_981_eecd--PeoTotalCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AndyHeywardMember_zp8BBDWIKtu5" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2022-01-012022-12-31_custom_AndyHeywardMember" id="Fact000058" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,450,384</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Deduct: Fair Value of Equity Awards Under the &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; Column in SCT</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eecd--AdjToCompAmt_d0_c20220101__20221231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zcTtckllbGol" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_AndyHeywardMember_custom_FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember_ecd_PeoMember" id="Fact000059" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Add: Year End Fair Value of Equity Awards Granted During the Year that are Outstanding and Unvested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eecd--AdjToCompAmt_d0_c20220101__20221231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zhhixwzhhukf" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_AndyHeywardMember_custom_YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_PeoMember" id="Fact000060" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Add: Change in Year Over Year End Fair Value of Equity Awards Granted in Prior Years that are Outstanding and Unvested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eecd--AdjToCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zLa8BLae7O4a" style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_AndyHeywardMember_custom_ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_PeoMember" id="Fact000061" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">6,032,813</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-style: italic; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Add: Change in Prior Year End Fair Value and Vesting Date Fair Value of Equity Awards Granted in Prior Years that Vested During the Year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eecd--AdjToCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zsD04e6ep0Kc" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_AndyHeywardMember_custom_ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_PeoMember" id="Fact000062" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">787,500</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Compensation Actually Paid for 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eecd--PeoActuallyPaidCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AndyHeywardMember_zL6hkqS17CY5" style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2022-01-012022-12-31_custom_AndyHeywardMember" id="Fact000063" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">5,369,928</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>


</ix:nonNumeric><p id="xdx_858_z60GGIMlrKW4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 33 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000065" name="ecd:AdjToNonPeoNeoCompFnTextBlock"><p id="xdx_84E_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_z3GS7WQmaxm5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Average Non-PEO NEOs</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 83%; font-weight: bold; text-align: left; padding-bottom: 1pt">Average Reported Summary Compensation Table Total for 2024</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_987_eecd--NonPeoNeoAvgTotalCompAmt_c20240101__20241231_zAXUtODhzXn7" style="border-bottom: Black 1pt solid; width: 13%; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000066" format="ixt:numdotdecimal" decimals="0" unitRef="USD">423,220</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Deduct: Average Fair Value of Equity Awards Under the "Stock Awards" and "Option Awards" Column in SCT</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eecd--AdjToCompAmt_d0_c20240101__20241231__ecd--AdjToCompAxis__custom--AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zLARZr8GtEp4" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember_ecd_NonPeoNeoMember" id="Fact000067" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Add: Average Year End Fair Value of Equity Awards Granted During the Year that are Outstanding and Unvested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eecd--AdjToCompAmt_d0_c20240101__20241231__ecd--AdjToCompAxis__custom--AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zE03P9EB8hLb" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember" id="Fact000068" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Add: Average Change in Year Over Year End Fair Value of Equity Awards Granted in Prior Years that are Outstanding and Unvested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zmqNqzIbCbw6" style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember" id="Fact000069" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">8,680</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-style: italic; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Add: Average Change in Prior Year End Fair Value and Vesting Date Fair Value of Equity Awards Granted in Prior Years that Vested During the Year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zWryXa3DpnJb" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_NonPeoNeoMember" id="Fact000070" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,603</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Average Compensation Actually Paid for 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20240101__20241231_zNuRS21gwACi" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000071" format="ixt:numdotdecimal" decimals="0" unitRef="USD">409,937</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Average Reported Summary Compensation Table Total for 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_982_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_zR4oZBU5sNf3" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2023-01-012023-12-31" id="Fact000072" format="ixt:numdotdecimal" decimals="0" unitRef="USD">359,086</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Deduct: Average Fair Value of Equity Awards Under the "Stock Awards" and "Option Awards" Column in SCT</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_z56L4HEcjuWa" style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember_ecd_NonPeoNeoMember" id="Fact000073" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">16,683</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Add: Average Year End Fair Value of Equity Awards Granted During the Year that are Outstanding and Unvested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_z0bZskGjznd7" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember" id="Fact000074" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,217</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Add: Average Change in Year Over Year End Fair Value of Equity Awards Granted in Prior Years that are Outstanding and Unvested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--AdjToCompAxis__custom--AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_za5Dfub0Rpf6" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember" id="Fact000075" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Add: Average Change in Prior Year End Fair Value and Vesting Date Fair Value of Equity Awards Granted in Prior Years that Vested During the Year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zZB9IhnKCDV5" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_NonPeoNeoMember" id="Fact000076" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">110,781</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Average Compensation Actually Paid for 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_zAkmCFisuaR9" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2023-01-012023-12-31" id="Fact000077" format="ixt:numdotdecimal" decimals="0" unitRef="USD">247,838</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Average Reported Summary Compensation Table Total for 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_985_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_z2eYccZahR34" style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2022-01-012022-12-31" id="Fact000078" format="ixt:numdotdecimal" decimals="0" unitRef="USD">494,981</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Deduct: Average Fair Value of Equity Awards Under the "Stock Awards" and "Option Awards" Column in SCT</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zB6ua50Cvxua" style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember_ecd_NonPeoNeoMember" id="Fact000079" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">235,494</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Add: Average Year End Fair Value of Equity Awards Granted During the Year that are Outstanding and Unvested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_z0pG42yG0nh5" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember" id="Fact000080" format="ixt:numdotdecimal" decimals="0" unitRef="USD">143,403</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Add: Average Change in Year Over Year End Fair Value of Equity Awards Granted in Prior Years that are Outstanding and Unvested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zm8JnQZZ1Zii" style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember" id="Fact000081" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">138,690</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-style: italic; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Add: Average Change in Prior Year End Fair Value and Vesting Date Fair Value of Equity Awards Granted in Prior Years that Vested During the Year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zdWbnOv7E72g" style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_NonPeoNeoMember" id="Fact000082" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">90,983</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Average Compensation Actually Paid for 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_zywv8Bp7rDxf" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2022-01-012022-12-31" id="Fact000083" format="ixt:numdotdecimal" decimals="0" unitRef="USD">173,217</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

</ix:nonNumeric><p id="xdx_85D_ziIY0fRxBYBi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The valuation assumptions used to calculate fair
values did not materially differ from those disclosed at the time of grant. The value of RSU awards is based on the fair value as of the
end of the covered year or change in fair value during the covered year, in each case based on the closing sale price of our common stock.
The value of option awards is based on the fair value as of the end of the covered year or change in fair value during the covered year,
in each case based on our Black-Scholes option pricing model, the assumptions of which are described in Note 2 to our consolidated financial
statements included in our Annual Report on Form 10-K for the year ended December 31, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 34 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Pay Versus Performance Relationship Disclosures</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000085" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock"><p id="xdx_848_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_z1C49S1odVW6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Compensation Actually Paid and Cumulative Total Shareholder Return</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The graph below compares the compensation actually
paid to our PEOs and the average of the compensation actually paid to our remaining NEOs, with our cumulative total shareholder return
for the fiscal years ended December 31, 2024, 2023, and 2022. Total shareholder return amounts reported in the graph assume an initial
fixed investment of $100 on December 31, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img src="image_004.jpg" alt="" style="height: 353px; width: 619px"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</ix:nonNumeric><p id="xdx_855_z9GdYIl5NAng" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 35 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000087" name="ecd:CompActuallyPaidVsNetIncomeTextBlock"><p id="xdx_842_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zzpzDoXJ85Ih" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Compensation Actually Paid and Net Loss</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The graph below compares the compensation actually
paid to our PEOs and the average of the compensation actually paid to our remaining NEOs, with our net loss for the fiscal years ended
December 31, 2024, 2023, and 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img src="image_005.jpg" alt="" style="height: 317px; width: 619px"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

</ix:nonNumeric><p id="xdx_85F_zBUqEtAxIbyk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 36 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Director Compensation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth with respect to
each of our non-employee directors, compensation information inclusive of equity awards and payments earned for the year ended December
31, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 33%; text-align: center"><b>Name</b></td>
    <td style="border-bottom: black 1pt solid; width: 19%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.55pt 0pt 0; text-align: center"><b>Fees</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.55pt 0pt 0; text-align: center"><b>Earned or Paid in Cash</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.75pt 0pt 0; text-align: center"><b>($) (1)</b></p></td>
    <td style="border-bottom: black 1pt solid; width: 17%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Stock Awards</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>($) (2)</b></p></td>
    <td style="border-bottom: black 1pt solid; width: 17%; text-align: center"><b>All Other Compensation</b><br/>
<b>($)</b></td>
    <td style="border-bottom: black 1pt solid; width: 14%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.55pt 0pt 0; text-align: center"><b>Total</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.75pt 0pt 0; text-align: center"><b>($)</b></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 2.75pt">Joseph &#8220;Gray&#8221; Davis (3)</td>
    <td style="text-align: center">25,000</td>
    <td style="text-align: center">25,000</td>
    <td style="text-align: center">&#8211;</td>
    <td style="text-align: center">50,000</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 2.75pt">Henry Sicignano III (4)</td>
    <td style="text-align: center">20,000</td>
    <td style="text-align: center">20,000</td>
    <td style="text-align: center">&#8211;</td>
    <td style="text-align: center">40,000</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 2.75pt">Margaret Loesch (5)</td>
    <td style="text-align: center">22,500</td>
    <td style="text-align: center">22,500</td>
    <td style="text-align: center">&#8211;</td>
    <td style="text-align: center">45,000</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-left: 2.75pt">Lynne Segall (6)</td>
    <td style="text-align: center">32,500</td>
    <td style="text-align: center">32,500</td>
    <td style="text-align: center">&#8211;</td>
    <td style="text-align: center">65,000</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 2.75pt">Anthony Thomopoulos (7)</td>
    <td style="text-align: center">20,000</td>
    <td style="text-align: center">20,000</td>
    <td style="text-align: center">63,000</td>
    <td style="text-align: center">103,000</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-left: 2.75pt">Dr. Cynthia Turner-Graham (8)</td>
    <td style="text-align: center">22,500</td>
    <td style="text-align: center">22,500</td>
    <td style="text-align: center">&#8211;</td>
    <td style="text-align: center">45,000</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-left: 2.75pt">Stefan Pi&#235;ch (9)</td>
    <td style="text-align: center">&#8211;</td>
    <td style="text-align: center">&#8211;</td>
    <td style="text-align: center">&#8211;</td>
    <td style="text-align: center">&#8211;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(1)</td><td style="text-align: justify">Directors, other than Mr. Heyward, are compensated with a combination of cash and stock awards with an
aggregate value of $10,000 for each quarterly meeting attended; $10,000 for service as Chair of the Board&#8217;s Compensation, Audit
or Nominating Committees, and $5,000 for service as members of any such committees. The Board&#8217;s Compensation Committee determines
the portions of each director&#8217;s compensation that will be paid in cash and in stock awards.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(2)</td><td style="text-align: justify">Represents the grant date fair value in accordance with FASB ASC Topic 718. The assumptions applied in
determining the fair value of the awards are discussed in the Notes to our audited consolidated financial statements in our Annual Report
on Form 10-K for the year ended December 31, 2024.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(3)</td><td style="text-align: justify">Mr. Davis was paid compensation with an aggregate value of $50,000, including $40,000 for service on the
Board, $5,000 for service as a member of the Audit Committee and $5,000 for service as a member of the Nominating Committee. At the end
of the fiscal year ended December 31, 2024, Mr. Davis had 2,000 option awards outstanding.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(4)</td><td style="text-align: justify">Mr. Sicignano was paid compensation with an aggregate value of $40,000, including $30,000 for service
on the Board and $10,000 for service as Chair of the Audit Committee. At the end of the fiscal year ended December 31, 2024, Mr. Sicignano
no option awards outstanding.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(5)</td><td style="text-align: justify">Ms. Loesch was paid compensation with an aggregate value of $45,000, including $40,000 for service on
the Board and $5,000 for service as a member of the Compensation Committee. At the end of the fiscal year ended December 31, 2024, Ms.
Loesch had 2,000 option awards outstanding.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(6)</td><td style="text-align: justify">Ms. Segall was paid compensation with an aggregate value of $55,000, including $40,000 for service on
the Board, $10,000 for service as Chair of the Nominating Committee, $10,000 for service as Chair of the Compensation Committee and $5,000
for service as a member of the Audit Committee. At the end of the fiscal year ended December 31, 2024, Ms. Segall had 2,000 option awards
outstanding.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(7)</td><td style="text-align: justify">Mr. Thomopoulos was paid compensation with an aggregate value of $103,000, including $40,000 for service
on the Board and $63,000 for other consulting services. At the end of the fiscal year ended December 31, 2024, Mr. Thomopoulos had 2,000
option awards outstanding.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(8)</td><td style="text-align: justify">Dr. Turner-Graham was paid compensation with an aggregate value of $45,000, including $40,000 for service
on the Board and $5,000 for service as  a member of the Nominating Committee. At the end of the fiscal year ended December 31, 2024,
Dr. Turner-Graham had 2,000 option awards outstanding.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(9)</td><td style="text-align: justify">On March 5, 2025, Dr. Stefan Pi&#235;ch, a then member of the Board, notified the Company of his decision
to resign, effective as such date, from his position as a member of the Board. The resignation was due to personal reasons, and did not
relate to any disagreement with the Company on any matter relating to its operations, policies or practices. At the end of the fiscal
year ended December 31, 2024, Dr. Pi&#235;ch had no option awards outstanding.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 37 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="p_013"></span><b>PROPOSAL&#160;2 &#8212; APPROVAL OF THE AUDITOR
RATIFICATION PROPOSAL</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee has appointed WithumSmith+Brown,
PC (&#8220;Withum&#8221;) as our independent registered public accounting firm to audit our financial statements for the fiscal year ending
December 31, 2025. The Board proposes that the stockholders ratify this appointment. Withum audited our financial statements for the fiscal
year ended December 31, 2024. We expect that representatives of Withum will not be present at the Annual Meeting, and therefore will not
be able to make a statement and will not be available to respond to questions from stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In deciding to appoint Withum, the Audit Committee
reviewed auditor independence issues and existing commercial relationships with Withum and concluded that Withum has no commercial relationship
with the Company that would impair its independence for the fiscal year ending December 31, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Withum has audited our financial statements since
January 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ratification of the appointment of Withum by our
stockholders is not required by law, our Bylaws or other governing documents. As a matter of policy, however, the appointment is being
submitted to our stockholders for ratification at the 2025 Annual Meeting. If our stockholders fail to ratify the appointment, the Audit
Committee will reconsider whether or not to retain that firm. Even if the appointment is ratified, the Audit Committee, in its discretion,
may direct the appointment of different independent auditors at any time during the year if they determine that such a change would be
in our best interest and the best interests of our stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Changes in our Certifying Accountants and Accounting
Firm Services and Fees</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Current Principal Accountant Fees and Services</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 29, 2024, the Audit Committee appointed
Withum as our independent registered public accounting firm for the fiscal year ending December 31, 2023, effective immediately.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During our fiscal years ended December 31, 2023
and 2022, and the subsequent interim period from January 1, 2024 to January 28, 2024, neither we nor anyone on our behalf consulted Withum
regarding either (i)&#160;the application of accounting principles to a specified transaction, either completed or proposed, or the type
of audit opinion that might be rendered on our consolidated financial statements, and no written report or oral advice was provided to
us that Withum concluded was an important factor considered by us in reaching a decision as to any accounting, auditing, or financial
reporting issue, or (ii)&#160;any matter that was the subject of a &#8220;disagreement&#8221; or &#8220;reportable event&#8221; as those
terms are defined in Item&#160;304(a)(1) of Regulation S-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table represents aggregate fees
billed to us by Withum for the fiscal years ended December&#160;31, 2024 and 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: left">Audit Fees</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">590,476</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">410,072</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Audit-Related Fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">14,300</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Tax Fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Other Fees</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Fees</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">604,776</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">410,072</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Former Principal Accountants Fees and Services</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 23, 2023, as a cost saving measure,
the Audit Committee dismissed Baker Tilly US, LLP (&#8220;Baker Tilly&#8221;) as our independent registered public accounting firm and
approved replacing them with Mazars USA LLP (&#8220;Mazars&#8221;) on October 23, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 38 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The reports of Baker Tilly on our consolidated
financial statements as of and for the years ended December 31, 2022 and 2021 did not contain an adverse opinion or a disclaimer of opinion
and were not qualified or modified as to uncertainty, audit scope, or accounting principles.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Additionally, during the years ended December
31, 2022 and 2021 and through the date of Baker Tilly&#8217;s dismissal, there were no disagreements between us and Baker Tilly on any
matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure which, if not resolved to
the satisfaction of Baker Tilly, would have caused Baker Tilly to make reference to the subject matter of the disagreements in connection
with its reports for such fiscal years; and there were no reportable events as defined in Item 304(a)(1)(v) of Regulation S-K, except
for the disclosure of material weaknesses in our internal control over financial reporting as disclosed in Part II, Item&#160;9A of our
Annual Reports on Form 10-K for the years ended December&#160;31, 2022, and 2021, respectively and in Part&#160;I, Item&#160;4A of our
Quarterly Reports for the quarters ended March&#160;31, 2023 and June&#160;30, 2023. The material weaknesses related to insufficient segregation
of duties on certain controls or processes, limited resources to design and implement internal control procedures to support financial
reporting objectives, failure to appropriately evaluate revenue recognition under ASC 606 for our advertisement supported video on demand
and subscription video on demand revenue streams for contracts with streaming platforms, lack of risk assessment procedures on internal
controls to detect financial reporting risks in a timely manner, and insufficient procedures and documentation related to review type
controls and information technology controls including complex transactions such as business combinations. The material weaknesses identified
did not result in the restatement of any previously reported financial statements or any related financial disclosure, nor did management
believe that it had any effect on the accuracy of our financial statements for the reporting periods covered in such reports. Baker Tilly
discussed each of these reportable events with the Audit Committee, and we authorized Baker Tilly to respond fully to the inquiries of
Mazars concerning the subject matter of each such reportable event.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth fees billed to
us by Baker Tilly for the years ended December 31, 2024 and 2023 for (i)&#160;services rendered for the audit of our annual financial
statements and the review of our quarterly financial statements, (ii)&#160;services rendered that are reasonably related to the performance
of the audit or review of our financial statements that are not reported as Audit Fees, and (iii)&#160;services rendered in connection
with tax preparation, compliance, advice and assistance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: left">Audit Fees</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">581,839</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Audit-Related Fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">43,200</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">75,095</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Tax Fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">150,551</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">205,474</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Other Fees</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">195,000</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Fees</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">388,751</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">862,408</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 25, 2023, the Audit Committee appointed
Mazars as our independent registered public accounting firm for the year ending December 31, 2023, effective immediately.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the years ended December 31, 2022 and 2021,
and the subsequent interim period from January 1, 2023, to October 25, 2023, neither we nor anyone on our behalf consulted Mazars regarding
either (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion
that might be rendered on our consolidated financial statements, and no written report or oral advice was provided to us that Mazars concluded
was an important factor considered by us in reaching a decision as to any accounting, auditing, or financial reporting issue, or (ii)&#160;any
matter that was the subject of a &#8220;disagreement&#8221; or &#8220;reportable event&#8221; as those terms are defined in Item&#160;304(a)(1)
of Regulation&#160;S-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 39 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 24, 2024, the Audit Committee dismissed
Mazars as our independent registered public accounting firm. Because Mazars was appointed on October 25, 2023, after the filing of our
then most recent annual report on Form 10-K, Mazars has not issued any reports on our financial statements during the two fiscal years
preceding their dismissal. Accordingly, Mazars did not issue any reports during such time that contained an adverse opinion or a disclaimer
of opinion and were not qualified or modified as to uncertainty, audit scope, or accounting principles. Furthermore, for the period from
October 25, 2023 through January 24, 2024, there were no disagreements between us and Mazars on any matter of accounting principles or
practices, financial statement disclosure or auditing scope or procedure which, if not resolved to Mazars&#8217;s satisfaction, would
have caused Mazars to make reference to the subject matter of the disagreements in connection with its reports on our financial statements
for such periods. For the period from October 25, 2023 through January 24, 2024, there were no &#8220;reportable events&#8221; as that
term is described in Item 304(a)(1)(v) of Regulation&#160;S-K.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table sets forth fees billed to
us by our independent registered public accounting firm Mazars for the years ended December 31, 2024 and 2023 for (i) services rendered
for the audit of our annual financial statements and the review of our quarterly financial statements, (ii) services rendered that are
reasonably related to the performance of the audit or review of our financial statements that are not reported as Audit Fees, and (iii)
services rendered in connection with tax preparation, compliance, advice and assistance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2024</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2023</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: left">Audit Fees</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">70,720</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Audit-Related Fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Tax Fees</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Other Fees</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Total Fees</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">&#8211;</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td><td style="font-weight: bold; padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">70,720</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Policy on Audit Committee Preapproval of Audit
and Permissible Non-Audit Services of the Independent Registered Public Accounting Firm</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We obtain an engagement letter for all audit and
non-audit services proposed to be performed during the year. The Board pre-approves the services performed by the independent registered
public accounting firm. These services may include audit services, audit-related services, tax services and other services, as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Audit services include audit work performed in the preparation of financial statements, as well as work
that generally only the independent auditor can reasonably be expected to provide, including comfort letters, statutory audits, and attest
services and consultation regarding financial accounting and/or reporting standards.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Audit-Related services are for assurance and related services that are traditionally performed by the
independent auditor, including due diligence related to mergers and acquisitions, employee benefit plan audits, and special procedures
required to meet certain regulatory requirements.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Tax services include all services performed by the independent auditor&#8217;s tax personnel except those
services specifically related to the audit of the financial statements, and includes fees in the areas of tax compliance, tax planning,
and tax advice.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Other Fees are those associated with services not captured in the other categories. We generally do not
request such services from the independent auditor.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Vote Required</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The affirmative vote of a majority of the votes
cast by the stockholders entitled to vote for the Auditor Ratification Proposal who are present in person or represented by proxy is required
to adopt this proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Recommendation of the Board</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>THE BOARD, UPON THE RECOMMENDATION OF THE AUDIT
COMMITTEE, RECOMMENDS A VOTE &#8220;FOR&#8221; THE AUDITOR RATIFICATION PROPOSAL.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 40 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="p_014"></span><b>REPORT OF AUDIT COMMITTEE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee of the Board, which consists,
as determined by the Board, entirely of directors who meet the independence and experience requirements of NYSE American, has furnished
the following report:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Audit Committee assists the Board in overseeing
and monitoring the integrity of our financial reporting process, compliance with legal and regulatory requirements and the quality of
internal and external audit processes. This committee&#8217;s role and responsibilities are set forth in our charter adopted by the Board,
which is available on our website at <i>www.kartoonstudios.com</i>. This committee reviews and reassesses our charter annually and recommends
any changes to the Board for approval. The Audit Committee is responsible for overseeing our overall financial reporting process, and
for the appointment, compensation, retention, and oversight of the work of WithumSmith+Brown, PC (&#8220;Withum&#8221;). In fulfilling
its responsibilities for the financial statements for fiscal year ended December 31, 2024, the Audit Committee took the following actions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Reviewed and discussed the audited financial statements for the fiscal year ended December 31, 2024 with
management;</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Discussed with Withum the matters required to be discussed in accordance with the applicable requirements
of the Public Company Accounting Oversight Board; and</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">Received written disclosures and the letter from Withum regarding its independence as required by applicable
requirements of the Public Company Accounting Oversight Board regarding Withum's communications with the Audit Committee and the Audit
Committee further discussed with Withum their independence. The Audit Committee also considered the status of pending litigation, taxation
matters and other areas of oversight relating to the financial reporting and audit process that the committee determined appropriate.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on the review and discussion referred to
above, the Audit Committee recommended to the Board that the audited financial statements be included in our Annual Report on Form 10-K
for the fiscal year ended December 31, 2024 for filing with the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 45%">&#160;</td>
    <td style="width: 55%"><p style="margin-top: 0; margin-bottom: 0"><b>Members of the Kartoon Studios, Inc.</b></p>
                           <p style="margin-top: 0; margin-bottom: 0"><b>Audit Committee</b></p></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>Henry Sicignano III (Chair)</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>Joseph &#8220;Gray&#8221; Davis</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>Lynne Segall</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 41 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="p_015"></span><b>PROPOSAL&#160;3 &#8212; APPROVAL OF THE INCENTIVE
PLAN INCREASE PROPOSAL</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At the Annual Meeting, stockholders will be asked
to approve an amendment to our 2020 Plan (the &#8220;Incentive Plan Amendment&#8221;), which amendment was approved by the Compensation
Committee and Board on March&#160;13, 2025, effective upon approval by our stockholders at the Annual Meeting. If this proposal is approved,
the number of shares available for grant of awards under the 2020 Plan will be increased by 5,000,000 shares. The Form of Incentive Plan
Amendment is attached hereto as <span style="text-decoration: underline"><a href="#p_024">Appendix&#160;A</a></span> and is incorporated by reference into this proxy statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the Record Date, a total of 4,773,029
shares of Common Stock remain available for issuance under the 2020 Plan, and options to purchase 934,320 shares of Common Stock and
1,067,919 RSUs remain outstanding. As of the Record Date, no shares of Common Stock have been issued upon the exercise of
options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the Record Date and prior to the adoption
of the proposed Incentive Plan Amendment, our &#8220;equity overhang,&#8221; or the percentage of outstanding shares of our stock represented
by all equity awards granted and available for future grant under the 2020 Plan was 17.2%. Equity overhang is calculated as (x)&#160;all
shares issuable upon exercise or vesting of awards then outstanding, plus all shares available for future grant under all equity incentive
plans, (y)&#160;divided by the issued and outstanding shares of Common Stock on a fully diluted basis. For purposes of this calculation,
the denominator includes all shares authorized under all equity incentive plans and all shares underlying outstanding convertible securities,
including shares issuable upon the exercise, conversion, or vesting of all issued and outstanding warrants, notes, restricted stock units
(&#8220;RSUs&#8221;) and stock options (whether issued under or outside the 2020 Plan).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The 2020 Plan was adopted on August&#160;27,
2020, and was amended and restated on May 23, 2024. By its terms, the 2020 Plan may be amended by the Board provided that any amendment
that the Board determines requires stockholder approval is subject to receiving such stockholder approval. Approval by our stockholders
is required by NYSE American rules. In addition, stockholder approval is required in order to ensure favorable federal income tax treatment
for grants of incentive stock options under Section 422 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board, the Compensation Committee and management
all believe that the effective use of stock-based long-term incentive compensation is vital to our ability to achieve strong performance
in the future. Having an adequate number of shares available for issuance under the 2020 Plan will allow us to maintain and enhance the
key policies and practices adopted by our management and Board to align employee and stockholder interests. In addition, our future success
depends, in large part, upon our ability to maintain a competitive position in attracting, retaining and motivating key personnel. We
believe that the increase in the number of shares available for issuance under our 2020 Plan is essential to permit our management to
continue to provide long-term, equity-based incentives to present and future key employees, consultants and directors. Accordingly, our
Board believes approval of the amendment to increase the aggregate number of shares available for issuance under the 2020 Plan is in our
best interests and those of its stockholders and recommends a vote &#8220;<b>FOR</b>&#8221; the approval of the amendment to the 2020
Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The material terms of the 2020 Plan are summarized
below. This summary of the 2020 Plan is not intended to be a complete description of the 2020 Plan. This summary is qualified in its entirety
by the actual text of the 2020 Plan to which reference is made. A copy of the complete Amended and Restated 2020 Plan is attached as <span style="text-decoration: underline"><a href="#p_025">Appendix&#160;B</a></span>
to our 2024 Proxy Statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 42 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Material Terms of the 2020 Plan</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Purpose</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The purpose of the 2020 Plan is to enhance long-term
profitability and stockholder value by offering Common Stock and Common Stock-based and other performance incentives to those employees,
directors and consultants who are key to our growth and success.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Plan Administration</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The 2020 Plan may be administered by our Board,
our Compensation Committee or a similar committee comprised of at least two non-employee directors (in each case, the &#8220;Administrator&#8221;).
The Administrator has exclusive authority to grant awards under the 2020 Plan and to make all interpretations and determinations affecting
the 2020 Plan. The Administrator has the discretion to determine the individuals to whom awards are granted, the amount of each award,
any applicable vesting schedule and other terms of any award. The Administrator, in its discretion, may delegate to one or more of our
officers all or part of the Administrator&#8217;s authority and duties with respect to awards to individuals who are not subject to the
reporting and other provisions of Section 16 of the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Eligible Participants</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The persons who shall be eligible to participate
in the 2020&#160;Plan and to receive Awards under the 2020 Plan shall be such persons who are our full- and part-time employees (including
officers), non-employee members of the Board or independent contractors providing services to us or our Affiliates, in each case, as our
Compensation Committee shall select. As of the Record Date, we have <span style="font-size: 10pt">344 </span>employees, 6 non-employee
members of the Board, and <span style="font-size: 10pt">68 </span>independent contractors eligible to participate in the 2020 Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Number of Shares Available for Issuance</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The maximum number of shares of our Common Stock
currently reserved and available for issuance under the 2020 Plan 8,216,767, which is equal to the sum of (i) 3,000,000 shares of Common
Stock authorized for issuance at the time that the 2020 Plan was initially adopted; (ii) 216,767 shares of Common Stock that remained
available for issuance under the 2015 Plan at the time that the 2020 Plan was initially adopted and (iii) 5,00,000 shares of Common Stock
authorized for issuance in connection with amendment and restatement of the 2020 Plan on May 23, 2024. Any expired or terminated shares
from the 2015 Plan that have not been vested or exercised became available for issuance under the 2020 Plan and as of December 31, 2024,
12,000 stock options granted under the 2015 Plan remain outstanding. All of the shares reserved and available for issuance under the 2020
Plan are issuable pursuant to incentive stock options under Section 422 of the Code or as other types of awards. As of the Record Date,
a total of 4,773,029 shares of Common Stock remain available for issuance under the 2020 Plan. If this proposal is approved, the number
of shares available for grant of awards under the 2020 Plan will be increased by 5,000,000 shares of Common Stock. All of the increased
number of shares will be available for issuance under the 2020 Plan as incentive stock options under Section 422 of the Code or as other
types of awards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If any stock award under the 2020 Plan (or options
still outstanding under 2015 Plan) expires or otherwise terminates, in whole or in part, without having been vested or exercised in full
(as applicable), the stock not acquired under such stock award reverts to and again becomes available for issuance under the 2020 Plan.
Common Stock withheld from an award to pay the exercise price with respect to such award or to pay a participant&#8217;s tax obligations
with respect to an award shall not again be available for issuance under the 2020 Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 43 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Change in Control Provisions</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The 2020 Plan provides that we may, in our sole
discretion, and without the consent of participants, provide for one or more of the following in the event of a Change in Control (as
defined in the 2020 Plan): (i) the assumption of the 2020 Plan and outstanding awards by the surviving entity; (ii) the substitution by
the surviving entity of awards with substantially the same terms for such outstanding awards; (iii) notice to the holders of vested and
exercisable stock options and stock appreciation rights of their ability to exercise such vested and exercisable awards prior to the transaction,
followed by the cancellation of all unexercised awards (whether or not then vested and exercisable); (iv)&#160;settlement of the intrinsic
value of outstanding vested awards in cash or cash equivalents or equity followed by the cancellation of all such awards (whether or not
then vested or exercisable); (v)&#160;cancellation of all unvested or unexercisable awards; or (vi)&#160;taking of such other action with
respect to Awards as the Compensation Committee shall determine to be appropriate in its discretion (including accelerating the vesting
and exercisability of outstanding Awards). However, in the event that awards are either assumed or substituted, the awards will continue
to vest or become exercisable pursuant to the terms of the original award, except to the extent such terms are otherwise rendered inoperative.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Adjustments for Stock Dividends, Stock Splits,
Etc.</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The 2020 Plan requires the Administrator to make
appropriate adjustments to the number of shares of our Common Stock that are subject to the 2020 Plan, to certain limits in the 2020 Plan
and to any outstanding awards to reflect stock dividends, stock splits, extraordinary cash dividends and similar events. The Administrator
shall make necessary adjustments to the available shares of our Common Stock reserved for issuance under the 2020 Plan in connection with
a reverse stock split, if approved by stockholders, as required.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Substitute Awards</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The 2020 Plan provides that, in connection with
a merger or consolidation of an entity with us or the acquisition by us of property or stock of an entity, our Board may grant awards
in substitution for any options or other stock or stock-based awards granted by such entity or an affiliate thereof (such awards, &#8220;Substitute
Awards&#8221;). Substitute Awards may be granted on such terms as our Board deems appropriate in the circumstances, notwithstanding any
limitations on awards contained in the 2020 Plan, and except as otherwise determined by the Compensation Committee. Substitute Awards
shall not count against the overall share limit set forth in the 2020 Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Amendment to the 2020 Plan and Awards</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board at any time, and from time to time,
may amend the 2020 Plan. However, no amendment will be effective unless approved by our stockholders to the extent stockholder approval
is necessary to satisfy the requirements of the Code, any federal or state law or regulation or any securities exchange listing requirements.
Further, no award under the 2020 Plan may be amended or cancelled for the purpose of repricing, replacing or regranting such award with
an exercise price that is less than the exercise price of the original award unless otherwise approved by stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Termination of the 2020 Plan</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Board or stockholders may terminate the 2020
Plan at any time. As amended and restated, the 2020 Plan will be terminated on August&#160;27, 2034. No stock awards may be granted under
the 2020 Plan after it is terminated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 44 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Description of Material Terms of the Awards</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Stock Options</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A stock option is the right to purchase shares
of our Common Stock at a fixed exercise price for a fixed period of time. The 2020 Plan permits the granting of (i)&#160;options to purchase
Common Stock intended to qualify as incentive stock options under Section 422 of the Code and (ii) options that do not so qualify (referred
to as &#8220;non-statutory stock options&#8221;). Incentive stock options may only be granted to employees of the Company and its subsidiaries.
Non-statutory stock options may be granted to any persons eligible to receive incentive stock options and to non-employee directors and
consultants. The Administrator determines the exercise price and additional terms of stock options. The option exercise price of each
option will be determined by the Administrator but may not be less than 100% of the fair market value of our Common Stock on the date
of grant. Fair market value for this purpose will be the last reported closing sales price of the shares of our Common Stock on NYSE American
on the valuation date, or, if none, the closing sales price on the most recent trade date immediately prior to the valuation date. The
exercise price of a stock option may not be reduced after the date of the stock option grant, other than to appropriately reflect changes
in our capital structure.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The term of each stock option will be fixed by
the Administrator and, for incentive stock options, may not exceed ten years from the date of grant. The Administrator will determine
at what time or times each stock option may be exercised. Stock options may be made exercisable in installments and the exercisability
of options may be accelerated by the Administrator. Upon exercise of stock options, the option exercise price must be paid in full in
such form as the Administrator will provide (or as permitted by Section 422 of the Code in the case of incentive stock options). To qualify
as incentive stock options, stock options must meet additional federal tax requirements, including a $100,000 limit on the value of shares
subject to incentive stock options that first become exercisable by a participant in any one calendar year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Stock Appreciation Rights (&#8220;SARs&#8221;)</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Administrator has the authority to grant SARs
under the 2020 Plan. A SAR may be granted to a holder of an option with respect to all or a portion of the shares of Common Stock subject
to the related option (a &#8220;Tandem SAR&#8221;) or may be granted separately to an eligible employee (a &#8220;Free Standing SAR&#8221;).
A Tandem SAR may be granted either concurrently with the grant of the related Option or at any time thereafter prior to the complete exercise,
termination, expiration or cancellation of such related Option. Subject to the limitations of the 2020 Plan, SARs are exercisable in whole
or in part upon notice to the Company upon such terms and conditions as are provided by the Administrator. Tandem SARs are exercisable
only at the time and to the extent that the related Option is exercisable. Upon the exercise or termination of the related Option, the
Tandem SARs with respect thereto are canceled automatically to the extent of the number of shares of Common Stock with respect to which
the related Option was so exercised or terminated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Restricted Stock and Restricted Stock Units</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Administrator has the authority to grant awards
of restricted stock and restricted stock units pursuant to the terms of an award agreement. Each award agreement will be in such form
and will contain such terms and conditions as the Administrator will deem appropriate. These conditions and restrictions may include the
achievement of certain performance goals and/or continued employment with, or service to, the Company through a specified restricted period,
except as otherwise set forth in the applicable award agreement. During the vesting period, awards of restricted stock and restricted
stock units may be credited with dividend equivalent rights, but dividend equivalents payable with respect to awards shall not be paid
unless and until such awards of restricted stock or restricted stock units vest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Performance Awards</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Administrator may designate all or any party
of any other type of award granted under the 2020 Plan as a performance award. These awards may be denominated in either cash or shares,
and are subject to the achievement of performance goals set over performance periods, as established by the Administrator.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 45 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Cash Awards and Other Stock-Based Awards</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Administrator may also grant cash awards or
other stock-based awards under the 2020 Plan. Cash awards are subject to the terms, conditions, restrictions and contingencies as determined
by the Administrator. Other stock-based awards are valued in whole or in part by reference to, or otherwise based on, shares of Common
Stock. Other stock-based awards may be granted as a form of payment in the settlement of other awards granted under the 2020 Plan or as
payment in lieu of compensation to which a holder is otherwise entitled. Other stock-based awards may be paid in shares of Common Stock
or cash, as the Compensation Committee may determine.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>U.S. Federal Income Tax Consequences</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a brief summary of the general
U.S. federal income tax consequences relating to the 2020 Plan. This summary is based on U.S. federal tax laws and regulations in effect
on the date of this proxy statement and does not purport to be a complete description of the U.S. federal income tax laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Incentive Stock Options</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Incentive stock options are intended to qualify
for special treatment available under Section&#160;422 of the Code. A participant who is granted an incentive stock option will not recognize
ordinary income at the time of grant. A participant will not recognize ordinary income upon the exercise of an incentive stock option
provided that the participant was, without a break in service, an employee of the Company or a subsidiary during the period beginning
on the grant date of the option and ending on the date three months prior to the date of exercise (one year prior to the date of exercise
if the participant&#8217;s employment is terminated due to permanent and total disability).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the participant does not sell or otherwise
dispose of the shares of Common Stock acquired upon the exercise of an incentive stock option within two years from the grant date of
the incentive stock option or within one year after he or she receives the shares of Common Stock, then, upon disposition of such shares
of Common Stock, any amount recognized in excess of the exercise price will be taxed to the participant as a capital gain. The participant
will generally recognize a capital loss to the extent that the amount recognized is less than the exercise price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the foregoing holding period requirements are
not met, the participant will generally recognize ordinary income at the time of the disposition of the shares of Common Stock in an amount
equal to the lesser of (i)&#160;the excess of the fair market value of the shares of Common Stock on the date of exercise over the exercise
price or (ii)&#160;the excess, if any, of the amount recognized upon disposition of the shares of Common Stock over the exercise price.
Any amount recognized in excess of the value of the shares of Common Stock on the date of exercise will be capital gain. If the amount
recognized is less than the exercise price, the participant generally will recognize a capital loss equal to the excess of the exercise
price over the amount recognized upon the disposition of the shares of Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The rules described above that generally apply
to incentive stock options do not apply when calculating any alternative minimum tax liability. The rules affecting the application of
the alternative minimum tax are complex, and their effect depends on individual circumstances, including whether a participant has items
of adjustment other than those derived from incentive stock options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Nonqualified Stock Options</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A participant will not recognize ordinary income
when a nonqualified stock option is granted. When a nonqualified stock option is exercised, a participant will recognize ordinary income
in an amount equal to the excess, if any, of the fair market value of the shares of Common Stock that the participant purchased over the
exercise price he or she paid.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 46 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Stock Appreciation Rights</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A participant will not recognize ordinary income
when a SAR is granted. When a SAR is exercised, the participant will recognize ordinary income equal to the cash and/or the fair market
value of shares of Common Stock the participant receives.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Restricted Stock</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A participant who has been granted restricted
stock will not recognize ordinary income at the time of grant, assuming that the underlying shares of Common Stock are not transferable
and that the restrictions create a &#8220;substantial risk of forfeiture&#8221; for federal income tax purposes and that the participant
does not make an election under Section&#160;83(b) of the Code. Generally, upon the vesting of restricted shares, the participant will
recognize ordinary income in an amount equal to the then fair market value of the shares of Common Stock, less any consideration paid
for such shares of Common Stock. Any gains or losses recognized by the participant upon disposition of the shares of Common Stock will
be treated as capital gains or losses. However, a participant may elect, pursuant to Section&#160;83(b) of the Code, to have income recognized
at the date of grant of a restricted share award equal to the fair market value of the shares of Common Stock on the grant date (less
any amount paid for the restricted shares) and to have the applicable capital gain holding period commence as of that date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Restricted Stock Units</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A participant generally will not recognize ordinary
income when RSUs are granted. Instead, a participant will recognize ordinary income when the RSUs are settled in an amount equal to the
fair market value of the shares of Common Stock or the cash he or she receives, less any consideration paid.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Sale of Shares</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When a participant sells shares of Common Stock
that he or she has received under an award, the participant will generally recognize long-term capital gain or loss if, at the time of
the sale, the participant has held the shares of Common Stock for more than one year (or, in the case of a restricted share award, more
than one year from the date the restricted shares vested unless the participant made an election pursuant to Section 83(b) of the Code,
described above). If the participant has held the shares of Common Stock for one year or less, the gain or loss will be a short-term capital
gain or loss.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Tax Deductibility of Compensation Provided Under the 2020 Plan</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">When a participant recognizes ordinary compensation
income as a result of an award granted under the 2020 Plan, the Company may be permitted to claim a federal income tax deduction for such
compensation, subject to various limitations that may apply under applicable law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, to the extent that compensation provided
under the 2020 Plan may be deemed to be contingent upon a change in control of the Company, a portion of such compensation may be non-deductible
by the Company under Section&#160;280G of the Code and may be subject to a 20% excise tax imposed on the recipient of the compensation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Restrictions on Shares; Claw-back Provisions</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shares of Common Stock acquired in respect of
awards pursuant to the 2020 Plan are subject to such terms and conditions determined by the Board, including restrictions on the transferability
of shares, our right to repurchase shares, our right to require the transfer of shares in the event of certain transactions, tag-along
rights, bring-along rights, redemption and co-sale rights and voting requirements. The issuance of shares of Common Stock are subject
to recipients&#8217; consent to such terms and conditions and the recipient entering into an award agreement. All awards are subject to
the provisions of any claw-back policy implemented by us, including any claw-back policy adopted to comply with the requirements of the
Dodd-Frank Wall Street Reform and Consumer Protection Act and any rules or regulations promulgated thereunder, to the extent set forth
in such claw-back policy and/or in the applicable award agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 47 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>New Plan Benefits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The grant of options and other awards under the
2020 Plan is discretionary, and we cannot determine now the number or type of options or other awards to be granted in the future to any
particular person or group other than the anticipated annual director grants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Since it is not possible to determine the exact
number of awards that will be granted under the 2020 Plan, the awards granted during the fiscal year ended December&#160;31, 2024 under
the 2020 Plan are set forth in the following table.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name and position</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Dollar</b></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>Value</b></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Number&#160;of</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Shares</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Underlying</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>RSUs</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Granted</b></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; text-indent: -7.35pt; padding-left: 7.35pt">Andy Heyward, Chief Executive Officer and Chairman</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.35pt; padding-left: 7.35pt">Michael A. Jaffa, Chief Operating Officer, General Counsel and Corporate Secretary</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; text-indent: -7.35pt; padding-left: 7.35pt">Brian Parisi, Chief Financial Officer</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.35pt; padding-left: 7.35pt">All Current Executive Officers as a Group</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 66%; text-align: left; text-indent: -7.35pt; padding-left: 7.35pt">All Current Non-employee Directors as a Group</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">142,115</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">161,767</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; text-indent: -7.35pt; padding-left: 7.35pt">All Current Non-Executive Officer Employees as a Group</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Market Price of Shares</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The closing price of our Common Stock, as reported
on NYSE American on April&#160;2, 2025 was $0.66.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Equity Compensation Plan Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table provides certain information
with respect to compensation plan under which our equity securities are authorized for issuance as of December&#160;31, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">(a)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">(b)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">(c)</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Plan category</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">Number of securities to be issued <br/>upon exercise of outstanding options, vesting of restricted stock units and other rights</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">Weighted-average exercise price of <br/>outstanding options (1)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center">Number of securities remaining available <br/>for future issuance under equity <br/>compensation plans (excluding securities reflected in column (a))</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-style: italic">Equity compensation plans approved by shareholders:</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td><td>&#160;</td>
    <td>&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 52%; text-indent: 22.5pt">2015 Plan</td><td style="width: 2%">&#160;</td>
    <td style="width: 13%; text-align: right">12,000</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 13%; text-align: center">$26.10</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 13%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-indent: 22.5pt">2020 Plan</td><td>&#160;</td>
    <td style="text-align: right">1,913,101</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: center">12.55</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">4,881,094</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; padding-bottom: 1pt">Equity compensation plans not approved by shareholders:</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: right">&#8211;</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">1,925,101</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="padding-bottom: 2.5pt; text-align: center">$12.63</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: right">4,881,094</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">(1)</td><td style="text-align: justify">The weighted average exercise price calculation does not take into account any restricted stock units
or performance shares. This table does not include the additional shares proposed to be authorized under the 2020 Plan pursuant to the
Incentive Plan Amendment.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Page; Sequence: 48 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Interests of Directors and Executive Officers</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our directors and executive officers have substantial
interests in the matters set forth in this proposal since equity awards may be granted to them under the 2020&#160;Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Required Vote</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The affirmative vote of a majority of the votes
cast by the stockholders entitled to vote on the Incentive Plan Increase Proposal who are present in person or represented by proxy is
required to adopt this proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Recommendation of the Board</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>THE BOARD RECOMMENDS A VOTE &#8220;FOR&#8221;
THE INCENTIVE PLAN INCREASE PROPOSAL.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 49 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="p_016"></span>PROPOSAL&#160;4 &#8212; APPROVAL OF THE WARRANT
EXERCISE PROPOSAL</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Purpose and Background of the Share Issuance Proposal</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 16, 2024, we entered into a securities
purchase agreement (the &#8220;Purchase Agreement&#8221;) with an institutional investor (the &#8220;Investor&#8221;), pursuant to which
we issued to the Investor (i)&#160;4,375,000 shares of Common Stock (the &#8220;Shares&#8221;); (ii)&#160;pre-funded warrants (&#8220;Pre-Funded
Warrants&#8221;) to purchase up to 3,519,736 shares of Common Stock (the &#8220;Pre-Funded Warrant Shares&#8221;); (iii)&#160;Series A
common warrants (the &#8220;Series A Warrants&#8221;) to purchase up to an aggregate of 7,894,736 shares of Common Stock (the &#8220;Series
A Warrant Shares&#8221;) and (iv)&#160;Series B common warrants (the &#8220;Series B Warrants,&#8221; and, collectively with the Series
A Warrants, the &#8220;Common Warrants&#8221;) to purchase up to an aggregate of 7,894,736 shares of Common Stock (the &#8220;Series B
Warrant Shares,&#8221; and, collectively with the Series A Warrant Shares, the &#8220;Common Warrant Shares&#8221;). Each Share, together
with the associated Common Warrants, was sold at a combined public offering price of $0.57. Each Pre-Funded Warrant, together with the
associated Common Warrants, was sold at a combined public offering price of $0.569. Such offering of securities is referred to herein
as the &#8220;Offering.&#8221; The Offering closed on December 18, 2024 (the &#8220;Closing Date&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under NYSE American listing rules, the Common
Warrants are not exercisable without the approval of our stockholders (the &#8220;Stockholder Approval&#8221;). We agreed to use reasonable
best efforts to hold a meeting of stockholders at the earliest practicable date after the date of the Offering, but in no event later
than May&#160;14, 2025, in order to obtain Stockholder Approval. If we do not obtain Stockholder Approval with respect to the terms of
the Common Warrants at the first meeting of the stockholders, we are required to call a meeting every seventy-five (75) days thereafter
to seek such Stockholder Approval until the date on which Stockholder Approval is obtained or the Common Warrants are no longer outstanding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Common Warrants have an exercise price of
$0.57 per share and are exercisable on or after the effective date of the Stockholder Approval and the NYSE American approves of the supplemental
listing application related to such Stockholder Approval (the &#8220;Warrant Exercise Date&#8221;). The Series A Warrants will expire
five years after the Warrant Exercise Date and the Series B Warrants will expire eighteen months after the Warrant Exercise Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Offering, on December 16,
2024, we entered into a placement agency agreement (the &#8220;Placement Agency Agreement&#8221;) with Roth Capital Partners, LLC (the
&#8220;Placement Agent&#8221;), pursuant to which the Placement Agent agreed to act as placement agent on a reasonable best efforts basis
in connection with the Offering. Pursuant to the Placement Agency Agreement, the Placement Agent also received warrants (the &#8220;Placement
Agent Warrants&#8221; and, together with the Common Warrants, the &#8220;Warrants&#8221;) to purchase up to 1,657,894&#160;shares of Common
Stock (the &#8220;Placement Agent Warrant Shares&#8221; and, together with the Common Warrants, the &#8220;Warrant Shares&#8221;). The
Placement Agent Warrants will become exercisable on the Warrant Exercise Date, at an exercise price equal to $0.71 per share (125% of
the public offering price), and will terminate five years from the date of the commencement of sales in the Offering.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Shares, the Pre-Funded Warrants, the Pre-Funded
Warrant Shares, the Warrants and the Warrant Shares were offered by us pursuant to a registration statement on Form S-1 (File No. 333-282385),
which was declared effective by the SEC on December 16, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our Common Stock is currently listed on the NYSE
American and, as such, we are subject to the rules set forth in the NYSE American Company Guide. Section 713 of the NYSE American Company
Guide requires stockholder approval when additional shares will be issued in connection with a transaction involving the sale, issuance
or potential issuance by an issuer of Common Stock (or securities convertible into Common Stock) equal to 20% or more of presently outstanding
stock for less than the greater of book or market value or when the issuance or potential issuance of additional shares will result in
a change of control of the issuer. The respective exercise prices of the Common Warrants and the Placement Agent Warrants as initially
in effect are less than the book value on the date of issuance of the Common Warrants. As noted above, the terms of the Common Warrants
provide that no Common Warrant Shares may be issued, unless Stockholder Approval is obtained. Therefore, we are asking stockholders to
approve the issuance of more than 20% of our issued and outstanding Common Stock as of December 16, 2024 pursuant to the Purchase Agreement,
including upon exercise of the Warrants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 50 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrants provide for the Exercise Price to
be adjusted in various circumstances such as stock splits. We may be required to adjust the Exercise Price pursuant to the Warrants or
pursuant to a modification or amendment thereto, subject to the rules of NYSE American or other applicable law. To the extent that the
Exercise Price of the Warrants is reduced, the gross proceeds received by us upon exercise of the Warrants may be less than anticipated.
Accordingly, we are asking stockholders to approve the issuance of up to an aggregate of 17,447,366 shares of our Common Stock upon the
exercise of the Warrants at the initial Exercise Price as well as an unknown lower Exercise Price in effect at the time of any such future
exercise.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board is not seeking the approval of our stockholders
to authorize our entry into the Purchase Agreement, as we already entered into the Purchase Agreement on December 16, 2024, and the Warrants
have already been issued. We are only asking for approval to issue to the Investor, pursuant to the Common Warrants, or the Placement
Agent, or its designees, pursuant to the Placement Agent Warrants, more than 20% of our issued and outstanding Common Stock as of December
16, 2024 (the date we entered into the Purchase Agreement).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each Common Warrant has an initial exercise price
of $0.57 per share. Accordingly, assuming that the Common Warrants are exercised at the initial exercise price, we could realize an aggregate
of up to approximately $10.2&#160;million in gross proceeds if all of the Common Warrants were exercised for cash ($11.4&#160;million
including the Placement Agent Warrants). We cannot predict when or if these Warrants will be exercised. It is possible that these Warrants
may expire and may never be exercised, or they could be exercised at a lower price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Potential Consequences if the Warrant Exercise Proposal is Not Approved</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The failure of our stockholders to approve the
Warrant Exercise Proposal will mean that (i)&#160;we cannot permit the full exercise of the Warrants, and (ii)&#160;we may incur substantial
additional costs and expenses associated with holding additional stockholder meetings in order to seek Stockholder Approval.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Potential Adverse Effects of the Approval of the Warrant Exercise
Proposal</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the Warrant Exercise Proposal is approved,
upon exercise of the Warrants existing stockholders may suffer dilution in their ownership interests in the future upon the issuance of
the Warrant Shares. In addition, the sale into the public market of these shares could materially and adversely affect the market price
of our Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Vote Required</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The affirmative vote of a majority of the votes
cast by the stockholders entitled to vote on the Warrant Exercise Proposal who are present in person or represented by proxy is required
to adopt this proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Recommendation of the Board</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>THE BOARD RECOMMENDS A VOTE &#8220;FOR&#8221;
THE WARRANT EXERCISE PROPOSAL. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 51 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="p_017"></span>PROPOSAL&#160;5 &#8212; APPROVAL OF THE ADJOURNMENT
PROPOSAL</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stockholders are being asked to approve one or
more adjournments of the Annual Meeting, if necessary, to solicit additional proxies if there are insufficient votes at the time of the
Annual Meeting to approve the Incentive Plan Increase Proposal (Proposal&#160;3) and the Warrant Exercise Proposal (Proposal&#160;4).
If this proposal is approved, the Annual Meeting could be adjourned one or more times to a future date. We do not intend to call a vote
on adjournments of the Annual Meeting to solicit additional proxies if the Incentive Plan Increase Proposal (Proposal&#160;3) and the
Warrant Exercise Proposal (Proposal&#160;4) are approved at the Annual Meeting. Among other things, approval of the Adjournment Proposal
could mean that, even if proxies representing a sufficient number of votes against the Incentive Plan Increase Proposal (Proposal&#160;3)
or the Warrant Exercise Proposal (Proposal&#160;4) have been received to cause either such proposal to fail to pass, we could adjourn,
postpone or continue the Annual Meeting without a vote on the Incentive Plan Increase Proposal (Proposal&#160;3) or the Warrant Exercise
Proposal (Proposal&#160;4) and seek to convince stockholders to change their votes to votes in favor of the approval of the Incentive
Plan Increase Proposal (Proposal&#160;3) or the Warrant Exercise Proposal (Proposal&#160;4). If the meeting is adjourned to solicit additional
proxies, stockholders who have already submitted their proxies will be able to revoke them at any time prior to their use.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Required Vote</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The affirmative vote of a majority of the votes
cast by the stockholders entitled to vote on the Adjournment Proposal who are present in person or represented by proxy is required to
adopt this proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Recommendation of the Board</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>THE BOARD RECOMMENDS A VOTE &#8220;FOR&#8221;
THE ADJOURNMENT PROPOSAL. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 52 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="p_018"></span><b>SECURITY OWNERSHIP OF CERTAIN<br/>
BENEFICIAL OWNERS AND MANAGEMENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following table shows the beneficial ownership
of shares of our Common Stock as of the Record Date, known by us through our transfer agent and other records, held by: (i) each person
who beneficially owns 5% or more of the shares of Common Stock then outstanding; (ii) each of our directors; (iii) each of our named executive
officers; and (iv) all of our current directors and executive officers as a group.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information in this table reflects &#8220;beneficial
ownership&#8221; as defined in Rule&#160;13d-3 of the Exchange Act. To our knowledge and unless otherwise indicated, each stockholder
has sole voting power and investment power over the shares listed as beneficially owned by such stockholder, subject to community property
laws where applicable. Percentage ownership is based on 47,784,964 shares of Common Stock outstanding as of the Record Date. Unless otherwise
indicated in the footnotes to the following table, each person named in the table has sole voting and investment power and that person&#8217;s
address is c/o 190 N. Canon Drive, 4th Floor, Beverly Hills, California 90210.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><span style="font-size: 10pt"><b>Name of Beneficial Owner</b></span></td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Amount and Nature of Beneficial Ownership</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(1)</b></p></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Percent of</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Class (1)</b></p></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt"><b>Directors and Named Executive Officers</b></span></td>
    <td>&#160;</td>
    <td colspan="2" style="text-align: right"><span style="font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 67%"><span style="font-size: 10pt">Andy Heyward (2)</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: right"><span style="font-size: 10pt">2,563,884</span></td>
    <td style="width: 3%; text-align: center">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 14%; text-align: center"><span style="font-size: 10pt">5.29%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">Michael Jaffa (3)</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">150,000</span></td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">*</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">Brian Parisi (4)</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">11,667</span></td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">*</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">Anthony Thomopoulos (5)</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">83,891</span></td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">*</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">Henry Sicignano III (6)</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">49,214</span></td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">*</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">Joseph (Gray) Davis (5)</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">60,398</span></td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">*</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">Margaret Loesch (5)</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">52,563</span></td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">*</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">Lynne Segall (5)</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">76,706</span></td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">*</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">Dr. Cynthia Turner-Graham (5)</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">48,079</span></td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">*</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">All current executive officers and directors as a group (consisting of 9 persons)</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">3,093,402</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#8239;</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">6.37%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt"><b>5% Stockholders Other Than Executive officers and Directors</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">Armistice Capital Master Fund Ltd. (7)</span></td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">4,190,734</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">8.77%</span></td></tr>
  </table>
<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in">*</td><td>Indicates ownership less than 1%</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 23.4pt"/><td style="width: 27pt">(1)</td><td style="text-align: justify">Applicable percentage ownership is based on 47,784,964 shares of common stock outstanding as of the Record
Date, together with securities exercisable or convertible into shares of common stock within 60 days of the Record Date. Beneficial ownership
is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to securities. Shares
of common stock that a person has the right to acquire beneficial ownership of upon the exercise or conversion of options, convertible
stock, warrants or other securities that are currently exercisable or convertible or that will become exercisable or convertible within
60 days of the Record Date are deemed to be beneficially owned by the person holding such securities for the purpose of computing the
number of shares beneficially owned and percentage of ownership of such person, but are not treated as outstanding for the purpose of
computing the percentage ownership of any other person.</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 53 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 31px">&#160;</td>
    <td style="width: 36px"><span style="font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Consists of (i) 99,073 shares of Common Stock held by A Squared Holdings LLC over which Andy Heyward holds sole voting and dispositive power; (ii) 1,519,375 shares of Common Stock held by Andy Heyward; (iii) 187,500 shares of Common Stock issuable pursuant to vested RSUs held by Andy Heyward; (iii) 257,813 shares of Common Stock held by AH Gadget IDF LLC an entity controlled by Mr. Heyward; (iv) 123 shares held by Heyward Living Trust; (v) 500,000 shares of Common Stock issuable pursuant to a stock option which is exercisable within 60 days of the Record Date.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Consists of 50,000 shares of common stock held by Mr. Jaffa; and 100,000 shares of Common Stock issuable pursuant to a stock option which is exercisable within 60 days of the Record Date.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">(4)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Consists of 5,834 shares of common stock held by Mr. Parisi and 5,833 shares of Common Stock issuable upon RSUs that <span style="background-color: white">vest within 60 days of </span>the Record Date.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">(5)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Consists of 2,000 shares of Common Stock issuable upon exercise of stock options granted to each that are exercisable within 60 days of the Record Date. In addition, Mr. Thomopoulos held 81,891 shares of Common Stock, Mr. Davis held 58,398 shares of Common Stock, Ms. Loesch held 50,563 shares of Common Stock, Ms. Segall held 74,706 shares of Common Stock and Dr. Turner-Graham held 46,079 shares of Common Stock.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">(6)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Consists of 49,214 shares of Common Stock held by Mr. Sicignano.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">(7)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Information for Armistice Capital Master Fund Ltd. (the &#8220;Master Fund&#8221;) is based upon information available to the Company as of March 17, 2025. Consists of 4,190,734 shares of Common Stock. Does not include 15,789,472 shares underlying common stock purchase warrants (the &#8220;Armistice Common Warrants&#8221;). All of the foregoing securities are directly held by the Master Fund, a Cayman Islands exempted company, and may be deemed to be indirectly beneficially owned by (i) Armistice Capital, LLC (&#8220;Armistice&#8221;), as the investment manager of the Master Fund; and (ii) Steven Boyd, as the Managing Member of Armistice Capital. Armistice and Steven Boyd disclaim beneficial ownership of the reported securities except to the extent of their respective pecuniary interest therein. Under the terms of the Armistice Common Warrants, Armistice may not exercise the Armistice Common Warrants to the extent such exercise would cause Armistice, together with its affiliates and attribution parties, to beneficially own a number of shares of common stock which would exceed 4.99% of our then outstanding common stock following such exercise, excluding for purposes of such determination shares of common stock issuable upon exercise of such warrants that have not been exercised. The address for Armistice is 510 Madison Avenue, New York, New York 10022.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2in; text-align: justify"></p>

<!-- Field: Page; Sequence: 54 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.2in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="p_019"></span>CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Certain Relationships and Related Person Transactions</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">SEC regulations define the related person transactions
that require disclosure to include any transaction, arrangement or relationship in which the amount involved exceeds the lesser of $120,000
or 1% of the average of our total assets at year-end for the last two completed fiscal years in which we were or are to be a participant
and in which a related person had or will have a direct or indirect material interest. A related person is: (i) an executive officer,
director or director nominee of the Company, (ii) a beneficial owner of more than 5% of our common stock, (iii) an immediate family member
of an executive officer, director or director nominee or beneficial owner of more than 5% of our common stock, or (iv) any entity that
is owned or controlled by any of the foregoing persons or in which any of the foregoing persons has a substantial ownership interest or
control. Described below are certain transactions or relationships between us and certain related persons.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following is a summary of transactions since
January 1, 2023 to which we have been a party in which the amount involved exceeded $120,000 and in which any of our executive officers,
directors or beneficial holders of more than five percent of our capital stock had or will have a direct or indirect material interest,
other than compensation arrangements which are described under the sections of this proxy statement entitled Executive Officer and Director
Compensation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 21, 2020, the Company entered into a merchandising
and licensing agreement with Andy Heyward Animation Art (&#8220;AHAA&#8221;), whose principal is Andy Heyward. The Company entered into
a customary merchandise license agreement with AHAA for the use of characters and logos related to Warren Buffett&#8217;s <i>Secret Millionaires
Club</i> and <i>Stan Lee&#8217;s Mighty 7</i> in connection with certain products to be sold by AHAA. The terms and conditions of such
license are customary within the industry, and the Company earns an arm-length industry standard royalty on all sales made by AHAA utilizing
the licensed content. During the years ended December 31, 2024 and 2023, Mr. Heyward did not earn any royalties related to this agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On July 19, 2022, the Company entered into a Shareholder
Loan Agreement with Your Family Entertainment AG ("YFE") in the amount of $1.5 million (EURO 1.3 million), accruing interest
at the fixed annualized rate of 5%, with successive interest periods of three months due on the last day of each calendar quarter. The
principal plus interest must be repaid by no later than June 30, 2026. As of December 31, 2024 and December 31, 2023, $1.5 million and
$1.4 million, respectively, is included within Notes and Accounts Receivable from Related Party on the Company&#8217;s consolidated balance
sheets. During the years ended December 31, 2024 and December 31, 2023, YFE paid $68,504 and $69,462, respectively, in interest. As of
March 26, 2025, the outstanding principal balance of the loan was $1,351,892. Dr. Stefan Pi&#235;ch , a Director of the Company from June
23, 2022 until March 5, 2025, served as the Chief Executive Officer of YFE.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Review, Approval or Ratification of Transactions with Related Persons</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to the written charter of our Audit Committee,
the Audit Committee is responsible for reviewing and approving all transactions both in which (i) we are a participant and (ii) any parties
related to us, including our executive officers, our directors, beneficial owners of more than 5% of our securities, immediate family
members of the foregoing persons and any other persons whom our Board determines may be considered related parties under Item 404 of Regulation
S-K, has or will have a direct or indirect material interest. Certain of the transactions described in this section occurred prior to
the adoption of the Audit Committee&#8217;s charter on June 26, 2023. All of the transactions described in this section that occurred
after such date were approved by the Audit Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 55 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="p_020"></span><b>CODE OF CONDUCT AND ETHICS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have adopted a Corporate Code of Conduct and
Ethics and Whistleblower Policy that applies to all of our officers, directors and employees. A copy of the Code of Conduct and Ethics
may be obtained, free of charge, by submitting a written request to the Company or on our website at <i>www.kartoonstudios.com</i>. Disclosure
regarding any amendments to, or waivers from, provisions of the code of conduct and ethics that apply to our directors, principal executive
and financial officers will be posted on the &#8220;Investors &#8211; Corporate Governance&#8221; section of our website at <i>www.kartoonstudios.com</i>
or included in a Current Report on Form 8-K within four business days following the date of the amendment or waiver.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="p_021"></span><b>OTHER MATTERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of the date of this proxy statement, the Board
of Kartoon knows of no other matters to be presented for stockholder action at the 2025 Annual Meeting. However, other matters may properly
come before the 2025 Annual Meeting or any adjournment or postponement thereof. If any other matter is properly brought before the 2025
Annual Meeting for action by the stockholders, proxies in the enclosed form returned to Kartoon will be voted in accordance with the recommendation
of the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="p_022"></span><b>ANNUAL REPORT/FORM 10-K</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our 2024 Annual Report is being mailed to certain
stockholders concurrently with this proxy statement. Copies of the 2024 Annual Report as filed with the SEC and any amendments thereto
may be obtained without charge by writing to Kartoon Studios, Inc., 190 N. Canon Drive, 4<sup>th</sup> Floor, Beverly Hills, California
90210, Attention: Corporate Secretary. A complimentary copy may also be obtained at the internet website maintained by the SEC at <i>www.sec.gov</i>,
and by visiting our internet website at <i>www.kartoonstudios.com</i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 56 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="p_023"></span><b>STOCKHOLDER PROPOSALS FOR THE 2026 ANNUAL MEETING</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stockholders who intend to present proposals at
the 2026 Annual Meeting under SEC Rule 14a-8 must ensure that such proposals are received by the Corporate Secretary of the Company not
later than December 4, 2025. Such proposals must meet the requirements of the SEC to be eligible for inclusion in the Company&#8217;s
2026 proxy materials.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Stockholders who intend to submit proposals to
be presented at the 2026 Annual Meeting outside the processes of SEC Rule 14a-8 must ensure that such proposals are received by the Corporate
Secretary of the Company not later than February 17, 2026; provided, however, that if the date of next year&#8217;s annual meeting is
changed by more than 30 days from the date of the previous year&#8217;s meeting, then the deadline is a reasonable time before the Company
sends its proxy materials for the 2026 Annual Meeting. Proposals that are not received in a timely manner will not be voted on at the
2026 annual meeting. If a proposal is received on time, the proxies that management solicits for the meeting may still exercise discretionary
voting authority on the proposal under circumstances consistent with the proxy rules of the SEC. All stockholder proposals should be marked
for the attention of the Corporate Secretary at 190 N. Canon Drive, 4th Floor, Beverly Hills, California 90210.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In addition to satisfying the foregoing requirements,
to comply with the universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other than the Company&#8217;s
nominees must provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act no later than March 15, 2026.
If such meeting date is changed by more than 30 days, then notice pursuant to Rule 14a-19 must be provided by the later of 60 calendar
days prior to the date of the annual meeting or the 10th calendar day following the day on which public announcement of the date of the
annual meeting is first made.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>Beverly Hills, California</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;April 3, 2025</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 57 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b><span id="p_024"></span>Appendix A</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM OF AMENDMENT TO THE<br/>
GENIUS BRANDS INTERNATIONAL, INC.<br/>
2020 INCENTIVE PLAN</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">WHEREAS</span>,
the Board of Directors (the &#8220;<i>Board</i>&#8221;) of Kartoon Studios, Inc. (the &#8220;<i>Company</i>&#8221;) heretofore established
the Genius Brands International, Inc. 2020 Incentive Plan (the &#8220;<i>Plan</i>&#8221;); and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">WHEREAS, the Plan was amended and restated, effective
as of May 23, 2024, to increase the maximum number of shares of the Company&#8217;s common stock, par value $0.001 per share (the &#8220;Common
Stock&#8221;) available for grants of Awards thereunder by 5,000,000 shares of Common Stock; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">WHEREAS, the Board desires to amend the Plan to
increase the maximum number of shares of Common Stock available for grants of Awards thereunder by an additional 5,000,000 shares of Common
Stock; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">WHEREAS</span>,
the Board desires to further amend the Plan to reflect the change in the name of Genius Brands International, Inc. to Kartoon Studios,
Inc.; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">WHEREAS</span>,
pursuant to Section&#160;12.7(b) of the Plan, the Board has the right to amend the Plan with respect to certain matters; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">WHEREAS</span>,
the Board has approved and authorized this Amendment to the Plan and has recommended that the stockholders of the Company approve this
Amendment; now, therefore, be it</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-size: 10pt">RESOLVED</span>,
that the Plan is hereby amended, subject to and effective as of the date of stockholder approval hereof, in the following particulars:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in">1.</td><td style="text-align: justify; padding-right: 0.5in">The name of the Plan is hereby amended to be the &#8220;Kartoon Studios, Inc. 2020
Incentive Plan.&#8221;</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify; padding-right: 0.5in">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in">2.</td><td style="text-align: justify; padding-right: 0.5in">Subject to approval of the Company&#8217;s stockholders, Section&#160;4.1(a) of
the Plan is hereby amended by increasing the share references in such section by an additional 5,000,000&#160;shares of Common Stock,
such that Section&#160;4.1(a), as amended and restated, reads in its entirety as follows:</td></tr><tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify; padding-right: 0.5in">&#160;</td></tr>
                                                                                                   <tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify; padding-right: 0.5in">&#8220;Subject
to the provisions of this Article 4, the maximum number of shares of Common Stock with respect to which Awards may be granted during the
term of the Plan shall be the sum of (i) 13,000,000 Shares and (ii) the shares of Common Stock remaining available for issuance under
the Company&#8217;s 2015 Incentive Plan, subject to adjustment in accordance with Section 4.1(c) hereof. 13,000,000 Shares shall be available
for the grant of Incentive Stock Options and other awards hereunder.&#8221;</td></tr>
                                                                                                   <tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify; padding-right: 0.5in">&#160;</td></tr>

<tr style="vertical-align: top">
<td style="width: 0.75in"/><td style="width: 0.25in">3.</td><td style="text-align: justify; padding-right: 0.5in">Except as specifically set forth herein, the terms of the Plan shall be and remain
unchanged, and the Plan as amended shall remain in full force and effect.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<i>Signature page follows.</i>]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 58; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">IN WITNESS WHEREOF</span>,
the Company has caused this Amendment to be signed this ___ day of _____________, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td colspan="2"><b>Kartoon Studios, Inc.</b></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td colspan="2">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 45%; text-align: justify">&#160;</td>
    <td style="width: 5%; text-align: justify">By:</td>
    <td style="border-bottom: Black 1pt solid; width: 35%; text-align: justify">&#160;</td>
    <td style="width: 15%">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">Name:</td>
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: justify">Title:</td>
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 59 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b><span id="p_025"></span>Appendix B</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Amended and Restated 2020 Plan</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>KARTOON STUDIOS, INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2020 INCENTIVE PLAN</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Article 1 Purpose and Amendment of Plan</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.1 <b>Purpose</b>.
The purpose of the Plan is to promote the success of the Company by providing a method whereby (a) eligible employees of the Company and
its Affiliates, (b) members of the Board of the Company and its Affiliates, and (c) independent contractors providing services to the
Company and its Affiliates may be awarded additional remuneration for services rendered and encouraged to invest in capital stock of the
Company, thereby increasing their proprietary interest in the Company&#8217;s businesses, encouraging them to remain in the employ of
(or otherwise provide services to) the Company or its Affiliates, and increasing their personal interest in the continued success and
progress of the Company and its Affiliates. The Plan is also intended to aid in (i) attracting Persons of exceptional ability to become
officers and employees and directors of the Company and its Affiliates, and (ii) encouraging independent contractors to agree to provide
services to the Company and its Affiliates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.2 <b>Adoption of
Plan</b>. The Plan was originally approved by the Company&#8217;s Board on August 4, 2020 and by the stockholders of the Company on August
27, 2020. As most recently amended, the Plan was approved by the Company&#8217;s Board on March 21, 2024 and by the stockholders of the
Company on May 23, 2024 (the &#8220;<b>Shareholder Approval Date&#8221;</b>). The Plan replaced the Company&#8217;s 2015 Incentive Plan
(the &#8220;<b>2015 Plan</b>&#8221;) with respect to grants made after the original stockholder approval of the Plan, and the Company
will not make additional grants under the 2015 Plan after such date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Article 2 Definitions</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 2.1 <b>Certain Defined
Terms</b>. Capitalized terms not defined elsewhere in the Plan shall have the following meanings (whether used in the singular or plural):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Affiliate</b>&#8221;
means any individual, corporation, partnership, association, limited liability company, joint-stock company, trust, unincorporated association
or other entity (other than the Company) that, for purposes of Section 424 of the Code, is a parent or subsidiary of the Company, direct
or indirect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Agreement</b>&#8221;
means a stock option agreement, stock appreciation rights agreement, restricted stock agreement, stock units agreement, cash award agreement
or an agreement evidencing another type of Award, or more than one type of Award, as any such Agreement may be supplemented or amended
from time to time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Award</b>&#8221;
means a grant of Options, SARs, Restricted Stock, Restricted Stock Units, Performance Awards, Cash Awards, or Other Stock-Based Awards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Board</b>&#8221;
means the Board of Directors of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Cash Award</b>&#8221;
means an Award made pursuant to Section 10.1 of the Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Change in Control</b>&#8221;
means the occurrence of any of the following events:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) any &#8220;person&#8221;
within the meaning of Section 13(d)(3) or 14(d)(2) of the Act (other than the Company or any company owned, directly or indirectly, by
the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company) becomes the &#8220;beneficial
owner&#8221; within the meaning of Rule 13d-3 promulgated under the Exchange Act of 30% or more of the combined voting power of the then
outstanding securities of the Company entitled to vote generally in the election of directors; excluding, however, any circumstance in
which such beneficial ownership resulted from any acquisition by the Company, an employee benefit plan (or related trust) sponsored or
maintained by the Company or by any corporation controlling, controlled by, or under common control with, the Company;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 60; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) a change in the composition
of the Board since the Shareholder Approval Date, such that the individuals who, as of such date, constituted the Board (the &#8220;<b>Incumbent
Board</b>&#8221;) cease for any reason to constitute at least a majority of such Board; <i>provided</i> that any individual who becomes
a director of the Company subsequent to the Shareholder Approval Date whose election, or nomination for election by the Company&#8217;s
stockholders, was approved by the vote of at least a majority of the directors then comprising the Incumbent Board shall be deemed a member
of the Incumbent Board; and <i>provided further</i>, that any individual who was initially elected as a director of the Company as a result
of an actual or threatened election contest, as such terms are used in Rule 14a-12 of Regulation 14A promulgated under the Exchange Act,
or any other actual or threatened solicitation of proxies or consents by or on behalf of any person or entity other than the Board shall
not be deemed a member of the Incumbent Board;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) a reorganization, recapitalization,
merger, consolidation or similar form of corporate transaction, or the sale, transfer, or other disposition of all or substantially all
of the assets of the Company to an entity that is not an Affiliate (each of the foregoing events, a &#8220;<b>Corporate Transaction</b>&#8221;)
involving the Company, unless securities representing 60% or more of the combined voting power of the then outstanding voting securities
entitled to vote generally in the election of directors of the Company or the corporation resulting from such Corporate Transaction, including
a corporation that, as a result of such transaction owns all or substantially all of the Company&#8217;s assets (or the direct or indirect
parent of such corporation), are held immediately subsequent to such transaction by the person or persons who were the beneficial holders
of the outstanding voting securities entitled to vote generally in the election of directors of the Company immediately prior to such
Corporate Transaction, in substantially the same proportions as their ownership immediately prior to such Corporate Transaction; or</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) approval by the stockholders
of the Company of a complete liquidation or dissolution of the Company, unless such liquidation or dissolution is part of a transaction
or series of transactions described in clause (c) above that does not otherwise constitute a Change in Control.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Notwithstanding anything herein
to the contrary, for Awards that are subject to Section 409A of the Code that become payable upon the occurrence of a Change in Control
a Change in Control shall not be deemed to occur unless such event constitutes a &#8220;change in the ownership of a corporation,&#8221;
&#8220;change in the effective control of a corporation,&#8221; or a &#8220;change in the ownership of a substantial portion of a corporation&#8217;s
assets&#8221; within the meaning of Section 409A of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Code</b>&#8221;
means the Internal Revenue Code of 1986, as amended from time to time, or any successor statute or statutes thereto. Reference to any
specific Code section shall include any successor section.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Committee</b>&#8221;
means the Compensation Committee (or another committee) of the Board (or a subcommittee of such committee) appointed pursuant to Section
3.1 to administer the Plan. The Committee shall consist solely of two or more directors and each member of the Committee shall be a &#8220;non-employee
director&#8221; within the meaning of Rule 16b-3 and also shall satisfy the requirements relating to the administration of equity-based
awards under U.S. state corporate laws, U.S. federal and state securities laws, the Code, any stock exchange or quotation system on which
the Common Stock is listed or quoted and the applicable laws of any foreign country or jurisdiction where Awards are, or will be, granted
under the Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Common Stock</b>&#8221;
means the Company&#8217;s common stock, $0.001 par value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Company</b>&#8221;
means Kartoon Studios, Inc., a Nevada corporation, and includes any successor or assignee corporation or corporations into which the Company
may be merged, changed or consolidated; any corporation for whose securities the securities of the Company shall be exchanged; and any
assignee of or successor to substantially all of the assets of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Disability</b>&#8221;
means a permanent and total disability as defined in Section 22(e)(3) of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Dividend Equivalents</b>&#8221;
means, with respect to Restricted Stock Units, to the extent specified by the Committee only, an amount equal to all dividends and other
distributions (or the economic equivalent thereof) which are payable to stockholders of record during the Restriction Period on a like
number and kind of shares of Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 61 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Domestic Relations
Order</b>&#8221; means a domestic relations order as defined by the Code or Title I of the Employee Retirement Income Security Act, or
the rules thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Effective Date</b>&#8221;
means the Shareholder Approval Date, the date on which the Plan, as amended and restated, becomes effective.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Equity Security</b>&#8221;
shall have the meaning ascribed to such term in Section 3(a)(11) of the Exchange Act, and an equity security of an issuer shall have the
meaning ascribed thereto in Rule 16a-1 promulgated under the Exchange Act, or any successor Rule.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Exchange Act</b>&#8221;
means the Securities Exchange Act of 1934, as amended from time to time, or any successor statute or statutes thereto. Reference to any
specific Exchange Act section shall include any successor section.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Fair Market Value</b>&#8221;
of a share of Common Stock on any day means the last sale price (or, if no last sale price is reported, the average of the high bid and
low asked prices) for a share of Common Stock on such day (or, if such day is not a trading day, on the next preceding trading day) as
reported on the consolidated transaction reporting system for the principal national securities exchange on which shares of Common Stock
are listed on such day, or the Committee can, in its sole discretion, use averages or weighted averages either on a daily basis or such
longer period as complies with Code Section 409A (to the extent necessary to so comply). If for any day the Fair Market Value of a share
of Common Stock is not determinable by any of the foregoing means, then the Fair Market Value for such day shall be determined in good
faith by the Committee on the basis of considerations as the Committee deems appropriate and otherwise in accordance with Section 409A.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Free Standing SAR</b>&#8221;
has the meaning ascribed thereto in Section 7.1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Holder</b>&#8221;
means a person who has received an Award under the Plan that has not been fully satisfied or terminated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Incentive Stock
Option</b>&#8221; means an Option that is intended to be, is designated as, and actually qualifies as, an &#8220;<b>incentive stock option</b>&#8221;
within the meaning of Section 422 of the Code and granted under Article 6.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Nonqualified Stock
Option</b>&#8221; means an Option that is not an Incentive Stock Option and granted under Article 6.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Option</b>&#8221;
means a Nonqualified Stock Option or Incentive Stock Option, as applicable in that context.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Performance Award</b>&#8221;
means an Award made pursuant to Article 11 of the Plan to a Holder that is subject to the attainment of one or more Performance Objectives.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Performance Objective</b>&#8221;
means a standard established by the Committee to determine in whole or in part whether a Performance Award shall be earned and shall be
based on one or more of the performance measures set forth in Section 11.2.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Person</b>&#8221;
means an individual, corporation, limited liability company, partnership, trust, incorporated or unincorporated association, joint venture
or other entity of any kind.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Plan</b>&#8221;
means this Kartoon Studios, Inc. 2020 Incentive Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Restricted Stock</b>&#8221;
means an Award made pursuant to Article 8.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Restricted Stock
Units</b>&#8221; means an Award made pursuant to Article 9 of the Plan to a Holder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 62 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Restriction Period</b>&#8221;
means a period of time beginning on the date of each Award of Restricted Stock or Restricted Stock Units and ending on the Vesting Date
with respect to such Award.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>SARs</b>&#8221;
means stock appreciation rights, awarded pursuant to Article 7, with respect to shares of Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Tandem SAR</b>&#8221;
has the meaning ascribed thereto in Section 7.1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>Vesting Date</b>,&#8221;
with respect to any Restricted Stock or Restricted Stock Units awarded hereunder, means the date on which such Restricted Stock or Restricted
Stock Units cease to be subject to a risk of forfeiture, as designated in or determined in accordance with the Agreement with respect
to such Award of Restricted Stock pursuant to Article 8 or of Restricted Stock Units pursuant to Article 9. If more than one Vesting Date
is designated for an Award, reference in the Plan to a Vesting Date in respect of such Award shall be deemed to refer to each part of
such Award and the Vesting Date for such part.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Article 3 Administration</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.1 <b>Committee</b>.
The Plan shall be administered by the Committee. The Board or a committee of the Board may from time to time appoint members of the Committee
in substitution for or in addition to members previously appointed, may fill vacancies in the Committee and may remove members of the
Committee. The Committee shall select one of its members as its chairman and shall hold its meetings at such times and places as it shall
deem advisable. A majority of its members shall constitute a quorum and all determinations shall be made by a majority of such quorum.
Any determination reduced to writing and signed by all of the members shall be as fully effective as if it had been made by a majority
vote at a meeting duly called and held.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.2 <b>Powers</b>.
The Committee shall have full power and authority to grant Awards to eligible persons, to determine the terms and conditions (which need
not be uniform nor identical among types of Awards, grants of Awards, or recipients of Awards) of all Awards so granted, to interpret
the provisions of the Plan and any Agreements relating to Awards granted under the Plan and to supervise the administration of the Plan.
The Committee in making an Award may provide for the granting or issuance of additional, replacement or alternative Awards upon the occurrence
of specified events, including the exercise of the original Award. The Committee shall have sole authority in the selection of persons
to whom Awards may be granted under the Plan and in the determination of the timing, pricing and amount of any such Award, subject only
to the express provisions of the Plan. In making determinations hereunder, the Committee may take into account the nature of the services
rendered by the respective employees and independent contractors, their present and potential contributions to the success of the Company
and its Affiliates, and such other factors as the Committee in its discretion deems relevant. For the avoidance of doubt, the full Board
may take any action relating to an Award granted or to be granted to a Person eligible to receive an Award under this Plan who is then
subject to Section 16 of the Exchange Act in respect of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.3 <b>Interpretation</b>.
The Committee is authorized, subject to the provisions of the Plan, to establish, amend and rescind such rules and regulations as it deems
necessary or advisable for the proper administration of the Plan and to take such other action in connection with or in relation to the
Plan as it deems necessary or advisable. Each action and determination made or taken pursuant to the Plan by the Committee, including
any interpretation or construction of the Plan, shall be final and conclusive for all purposes and upon all persons.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Article 4 Shares Subject To The Plan</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 4.1 <b>Number of Shares;
Award Limits</b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) Subject to the provisions
of this Article 4, the maximum number of shares of Common Stock with respect to which Awards may be granted during the term of the Plan
shall be the sum of (i) 5,000,000 Shares and (ii) the shares of Common Stock remaining available for issuance under the Plan, as amended
and restated, immediately prior to shareholder approval thereof, subject to adjustment in accordance with Section 4.1(d) hereof (the &#8220;<b>Initial
Limit</b>&#8221;). 5,000,000 Shares shall be available for the grant of Incentive Stock Options and other awards hereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 63 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) Shares of Common Stock
will be made available from the authorized but unissued shares of the Company or from shares reacquired by the Company, including shares
purchased in the open market. If all or any portion of an Award expires or is cancelled, forfeited, exchanged, settled in cash or otherwise
terminated, the shares of Stock subject to such Award (including shares forfeited with respect to Restricted Stock) shall again be available
for purposes of the Plan. If an Award may be settled only in cash, such Award need not be counted against any share limit under this
Section 4.1. Notwithstanding the foregoing, (A) in the case of the exercise of a SAR for shares, the number of shares counted against
the shares available under the Plan shall be the full number of shares subject to the SAR multiplied by the percentage of the SAR actually
exercised, regardless of the number of shares actually used to settle such SAR upon exercise; (B) shares of Common Stock delivered (either
by actual delivery, attestation, or net exercise) to the Company by a Holder to (1) purchase shares of Common Stock upon the exercise
of an Award or (2) satisfy tax withholding obligations (including shares retained from the Award creating the tax obligation) shall not
be added back to the number of shares available for the future grant of Awards; and (C) shares of Common Stock repurchased by the Company
on the open market using the proceeds from the exercise of an Award shall not increase the number of shares available for future grant
of Awards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <b>Adjustments</b>. If the
Company subdivides its outstanding shares of any series of Common Stock into a greater number of shares of such series of Common Stock
(by stock dividend, stock split, reclassification, or otherwise) or combines its outstanding shares of any series of Common Stock into
a smaller number of shares of such series of Common Stock (by reverse stock split, reclassification, or otherwise) or if the Committee
determines that any stock dividend, extraordinary cash dividend, reclassification, recapitalization, reorganization, split-up, spin-off,
combination, exchange of shares, warrants or rights offering to purchase Common Stock or other similar corporate event affects any series
of Common Stock so that an adjustment is required to preserve the benefits or potential benefits intended to be made available under the
Plan, then the Committee, in such manner as the Committee, in its sole discretion, deems equitable and appropriate, shall make such adjustments
to any or all of (i) the number and kind of shares of stock which thereafter may be awarded, optioned or otherwise made subject to the
benefits contemplated by the Plan, (ii) the number and kind of shares of stock subject to outstanding Awards, and (iii) the purchase or
exercise price and the relevant appreciation base with respect to any of the foregoing, <i>provided</i>, <i>however</i>, that the number
of shares subject to any Award shall always be a whole number. The Committee may, if deemed appropriate, provide for a cash payment to
any Holder of an Award in connection with any adjustment made pursuant to this Section 4.2.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 4.2 <b>Substitute
Awards</b>. In connection with a merger or consolidation of an entity with the Company or the acquisition by the Company of property or
stock of an entity, the Board may grant Awards in substitution for any options or other stock or stock-based awards granted by such entity
or an affiliate thereof (such Awards, &#8220;<b>Substitute Awards</b>&#8221;). Substitute Awards may be granted on such terms as the Board
deems appropriate in the circumstances, notwithstanding any limitations on Awards contained in the Plan, and except as otherwise determined
by the Committee. Substitute Awards shall not count against the overall share limit set forth in Section 4.1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Article 5 Eligibility; Specific Terms of awards</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 5.1 <b>Eligibility</b>.
The persons who shall be eligible to participate in the Plan and to receive Awards under the Plan shall be such persons who are full-
and part-time employees (including officers) of the Company, non-employee members of the Board or independent contractors providing services
to the Company or its Affiliates, in each case, as the Committee shall select. Awards may be made to employees, members of the Board or
independent contractors who hold or have held Awards under the Plan, the 2015 Plan, or other awards under any other plan of the Company
or any of its Affiliates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 5.2 <b>General</b>.
Awards granted under the Plan may, in the discretion of the Committee, be granted either alone, in addition to, or in tandem with any
other Award. In addition, the Committee may impose on any Award or the exercise thereof, at the date of grant or thereafter (subject to
Article 12), such additional terms and conditions, not inconsistent with the provisions of the Plan, as the Committee shall determine.
Without limiting the scope of the preceding sentence, the Committee may use such business criteria and other measures of performance as
it may deem appropriate in establishing any performance goals applicable to an Award, and any such performance goals may differ among
Awards granted to any one Holder or to different Holders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 64 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 5.3 <b>Dividend Equivalents</b>.
Subject to the provisions of this Plan and any Agreement, the recipient of an Award other than an Option or SAR may, if so determined
by the Committee, be entitled to receive, currently or on a deferred basis, interest or dividends or Dividend Equivalents, with respect
to the number of shares of Common Stock covered by the Award, as determined by the Committee, in its sole discretion, and the Committee
may provide that such amounts (if any) shall be deemed to have been reinvested in additional shares of Common Stock or otherwise reinvested
and/or shall be subject to the same terms and conditions (including vesting and forfeiture provisions) as the related Award. Dividends
or Dividend Equivalents granted with respect to an Award will be accrued during the vesting and/or performance period applicable to such
Award, and such dividends or Dividend Equivalents will vest and be paid only if and when the underlying Award vests.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Article 6 Stock Options</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 6.1 <b>Grant of Options</b>.
The Committee shall, subject to the limitations of the Plan, have authority to grant to eligible persons Options. The Committee shall
designate from time to time those eligible persons to be granted Options, the time when each Option shall be granted to such eligible
persons, the number of shares of Common Stock subject to such Option, and, subject to Section 6.2, the purchase price of the shares of
Common Stock subject to such Option; <i>provided</i>, <i>however</i>, only a person who is a common-law employee of the Company, any &#8220;parent
corporation&#8221; of the Company, or a &#8220;subsidiary corporation&#8221; of the Company (each term as defined in Section 424 of the
Code) on the date of grant shall be eligible to be granted an Incentive Stock Option. To the extent that any Option is not designated
as an Incentive Stock Option or even if so designated does not qualify as an Incentive Stock Option, it shall constitute a Nonqualified
Stock Option. The determination made by the Committee pursuant to this Article 6 shall be specified in the applicable Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 6.2 <b>Exercise Price</b>.
The price at which shares may be purchased upon exercise of an Option shall be fixed by the Committee and, for Options that do not constitute
Substitute Awards, may be no less than the Fair Market Value of the shares of Common Stock subject to the Option as of the date the Option
is granted. If an Option which is intended to qualify as an Incentive Stock Option is granted to an individual who owns or who is deemed
to own shares possessing more than ten percent (10%) of the combined voting power of all classes of shares of the Company, a parent corporation
or any subsidiary corporation (each term as defined in Section 6.1) (a &#8220;<b>10% Owner</b>&#8221;), the exercise price shall not be
less than one hundred ten percent (110%) of the Fair Market Value per share on the date the Incentive Stock Option is granted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 6.3 <b>Term of Options</b>.
Subject to the provisions of the Plan, the term of each Option shall be for such period as the Committee shall determine as set forth
in the applicable Agreement. In the case of an Incentive Stock Option, the term of such Option shall not exceed ten (10) years from the
date the Incentive Stock Option is granted. If an Option which is intended to be an Incentive Stock Option is granted to a 10% Owner,
the term of such Option shall not exceed five (5) years from the date the Incentive Stock Option is granted. No Option which is intended
to be an Incentive Stock Option shall be granted more than ten (10) years from the date the Plan is adopted by the Company or the date
the Plan is approved by the stockholders of the Company, whichever is earlier.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 6.4 <b>Exercise of
Options</b>. An Option granted under the Plan shall become (and remain) exercisable during the term of the Option to the extent provided
in the applicable Agreement and the Plan and, unless the Agreement otherwise provides, may be exercised to the extent exercisable, in
whole or in part, at any time and from time to time during such term; <i>provided</i>, <i>however</i>, no Incentive Stock Option may be
exercised before the Plan is approved by the stockholders of the Company in the manner prescribed by Section 422 of the Code; <i>provided</i>,
<i>further</i>, however, that subsequent to the grant of an Option, the Committee, at any time before complete termination of such Option,
may accelerate the time or times at which such Option may be exercised in whole or in part. If an Option is designated as an Incentive
Stock Option, the aggregate Fair Market Value (determined on the date the Incentive Stock Option is granted) of the Common Stock as to
which such Incentive Stock Option which is exercisable for the first time during any calendar year (under the Plan or any other plan of
the Company or any parent corporation or subsidiary corporation) shall not exceed $100,000. Unless the Committee otherwise provides in
writing, or unless otherwise required by law (including, if applicable, the Uniformed Services Employment and Reemployment Rights Act),
the date or dates on which the Option becomes exercisable shall be tolled during any unpaid leave of absence. It is expressly understood
that Options hereunder shall, unless otherwise provided for in writing by the Committee, be granted in contemplation of, and earned by
the Holder through the completion of, future employment or service with the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 65 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 6.5 <b>Manner of Exercise</b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <b>Form of Payment</b>.
An Option shall be exercised by notice to the Company upon such terms and conditions as the Agreement may provide and in accordance with
such other procedures for the exercise of Options as the Committee may establish from time to time. The method or methods of payment
of the purchase price for the shares to be purchased upon exercise of an Option and of any amounts required by Section 12.9 shall be
determined by the Committee and may consist of (i) cash, (ii) check, (iii) whole shares of Common Stock (whether by delivery or attestation),
(iv) the withholding of shares of Common Stock issuable upon such exercise of the Option, (v) the delivery, together with a properly
executed exercise notice, of irrevocable instructions to a broker to deliver promptly to the Company the amount of sale or loan proceeds
required to pay the purchase price (a so-called &#8220;cashless&#8221; exercise), or (vi) any combination of the foregoing methods of
payment, or such other consideration and method of payment as may be permitted for the issuance of shares under the Nevada Corporation
Code. The permitted method or methods of payment of the amounts payable upon exercise of an Option, if other than in cash, shall be set
forth in the applicable Agreement and may be subject to such conditions as the Committee deems appropriate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <b>Value of Shares</b>.
Unless otherwise determined by the Committee and provided in the applicable Agreement, shares of Common Stock delivered in payment of
all or any part of the amounts payable in connection with the exercise of an Option, and shares of Common Stock withheld for such payment,
shall be valued for such purpose at their Fair Market Value as of the exercise date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <b>Issuance of Shares</b>.
The Company shall effect the transfer of the shares of Common Stock purchased under the Option as soon as practicable after the exercise
thereof and payment in full of the purchase price therefor and of any amounts required by Section 12.9, and within a reasonable time thereafter,
such transfer shall be evidenced on the books of the Company. Unless otherwise determined by the Committee and provided in the applicable
Agreement, (i) no Holder or other person exercising an Option shall have any of the rights of a stockholder of the Company with respect
to shares of Common Stock subject to an Option granted under the Plan until due exercise and full payment has been made, and (ii) no adjustment
shall be made for cash dividends or other rights for which the record date is prior to the date of such due exercise and full payment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 6.6 <b>Limitation
on Repricing</b>. Unless such action is approved by the Company&#8217;s stockholders, the Company may not (except as provided for under
Section 4.2): (a) amend any outstanding Option granted under the Plan to provide an exercise price per share that is lower than the then-
current exercise price per share of such outstanding Option, (b) cancel any outstanding option (whether or not granted under the Plan)
and grant in substitution therefor new Awards under the Plan (other than Awards granted pursuant to Section 4.3) covering the same or
a different number of shares of Common Stock and having an exercise price per share lower than the then- current exercise price per share
of the cancelled option, (c) cancel in exchange for a cash payment any outstanding Option with an exercise price per share above the then-
current Fair Market Value, other than pursuant to Section 12.1(b), or (d) take any other action under the Plan that constitutes a &#8220;repricing&#8221;
within the meaning of the rules of the NYSE American Stock Market (&#8220;<b>NYSE</b>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 6.7 <b>Exercise Limits
for Incentive Stock Options</b>. Any portion of any Incentive Stock Option that was vested and exercisable on the date of termination
of employment which was other than for death or disability (as defined in Section 22(e)(3) of the Code), shall expire and be forfeited
at midnight ninety (90) days from the date of such termination and if termination of employment was on account of death or disability
the portion of any Incentive Stock Option that is vested as of the date of termination of employment shall expire and be forfeited at
midnight one (1) year from the date of such termination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Article 7 SARS</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 7.1 <b>Grant of SARs</b>.
The Committee shall, subject to the limitations of the Plan, have authority to grant to eligible persons SARs. SARs may be granted by
the Committee to such eligible persons in such numbers, with respect to Common Stock, and at such times during the term of the Plan as
the Committee shall determine. A SAR may be granted to a Holder of an Option (hereinafter called a &#8220;<b>related Option</b>&#8221;)
with respect to all or a portion of the shares of Common Stock subject to the related Option (a &#8220;<b>Tandem SAR</b>&#8221;) or may
be granted separately to an eligible employee (a &#8220;<b>Free Standing SAR</b>&#8221;). Subject to the limitations of the Plan, SARs
shall be exercisable in whole or in part upon notice to the Company upon such terms and conditions as are provided in the Agreement. The
determination made by the Committee pursuant to this Article 7 shall be specified in the applicable Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 66 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 7.2 Tandem SARs.
A Tandem SAR may be granted either concurrently with the grant of the related Option or at any time thereafter prior to the complete
exercise, termination, expiration or cancellation of such related Option. Tandem SARs shall be exercisable only at the time and to the
extent that the related Option is exercisable (and may be subject to such additional limitations on exercisability as the Agreement may
provide) and in no event after the complete termination or full exercise of the related Option. Upon the exercise or termination of the
related Option, the Tandem SARs with respect thereto shall be canceled automatically to the extent of the number of shares of Common
Stock with respect to which the related Option was so exercised or terminated. Subject to the limitations of the Plan, upon the exercise
of a Tandem SAR and unless otherwise determined by the Committee and provided in the applicable Agreement, (a) the Holder thereof shall
be entitled to receive from the Company, for each share of Common Stock with respect to which the Tandem SAR is being exercised, consideration
(in the form determined as provided in Section 7.4) equal in value to the excess of the Fair Market Value of a share of Common Stock
with respect to which the Tandem SAR was granted on the date of exercise over the related Option purchase price per share, and (b) the
related Option with respect thereto shall be canceled automatically to the extent of the number of shares of Common Stock with respect
to which the Tandem SAR was so exercised.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 7.3 <b>Free Standing
SARs</b>. Free Standing SARs shall be exercisable at the time, to the extent and upon the terms and conditions set forth in the applicable
Agreement. The base price of a Free Standing SAR may be no less than the Fair Market Value of Common Stock with respect to which the Free
Standing SAR was granted as of the date the Free Standing SAR is granted. Subject to the limitations of the Plan, upon the exercise of
a Free Standing SAR and unless otherwise determined by the Committee and provided in the applicable Agreement, the Holder thereof shall
be entitled to receive from the Company, for each share of Common Stock with respect to which the Free Standing SAR is being exercised,
consideration (in the form determined as provided in Section 7.4) equal in value to the excess of the Fair Market Value of a share of
Common Stock with respect to which the Free Standing SAR was granted on the date of exercise over the base price per share of such Free
Standing SAR.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 7.4 <b>Consideration</b>.
The consideration to be received upon the exercise of a SAR by the Holder shall be paid in Common Stock with respect to which the SAR
was granted (valued at Fair Market Value on the date of exercise of such SAR) or cash equivalent thereto, as determined by the Committee
and provided in the applicable Agreement. No fractional shares of Common Stock shall be issuable upon exercise of a SAR, and unless otherwise
provided in the applicable Agreement, the Holder will receive cash in lieu of fractional shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 7.5 <b>Limitations</b>.
The applicable Agreement may provide for a limit on the amount payable to a Holder upon exercise of SARs at any time or in the aggregate,
for a limit on the time periods during which a Holder may exercise SARs, and for such other limits on the rights of the Holder and such
other terms and conditions of the SAR, including a condition that the SAR may be exercised only in accordance with rules and regulations
adopted from time to time, as the Committee may determine. Unless otherwise so provided in the applicable Agreement, any such limit relating
to a Tandem SAR shall not restrict the exercisability of the related Option. Such rules and regulations may govern the right to exercise
SARs granted prior to the adoption or amendment of such rules and regulations as well as SARs granted thereafter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 7.6 <b>Exercise</b>.
For purposes of this Article 7, the date of exercise of a SAR shall mean the date on which the Company shall have received notice from
the Holder of the SAR of the exercise of such SAR (unless otherwise determined by the Committee and provided in the applicable Agreement).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 7.7 <b>Limitation
on Repricing</b>. Unless such action is approved by the Company&#8217;s stockholders, the Company may not (except as provided for under
Section 4.2): (a) amend any outstanding SAR granted under the Plan to provide a base price per share that is lower than the then-current
base price per share of such outstanding SAR, (b) cancel any outstanding stock appreciation right (whether or not granted under the Plan)
and grant in substitution therefor new Awards under the Plan (other than Awards granted pursuant to Section 4.2) covering the same or
a different number of shares of Common Stock and having a base price per share lower than the then-current base price per share of the
cancelled stock appreciation right, (c) cancel in exchange for a cash payment any outstanding SAR with a base price per share above the
then-current Fair Market Value, other than pursuant to Section 12.1(b), or (d) take any other action under the Plan that constitutes a
&#8220;repricing&#8221; within the meaning of the rules of NYSE.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 67 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Article 8 Restricted Stock</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 8.1 <b>Grant</b>.
The Committee shall, subject to the limitations of the Plan, have authority to grant to eligible persons Restricted Stock. The Committee
shall designate those eligible persons to be granted Awards of Restricted Stock, shall determine the time when each such Award shall
be granted, and shall designate (or set forth the basis for determining) the Vesting Date or Vesting Dates for each Award of Restricted
Stock, and may prescribe other restrictions, terms and conditions applicable to the vesting of such Restricted Stock in addition to those
provided in the Plan. The Committee shall determine the price, if any, to be paid by the Holder for the Restricted Stock; <i>provided</i>,
<i>however</i>, that the issuance of Restricted Stock shall be made for at least the minimum consideration necessary to permit such Restricted
Stock to be deemed fully paid and nonassessable. All determinations made by the Committee pursuant to this Article 8 shall be specified
in the Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 8.2 <b>Dividends</b>.
Unless otherwise provided in the applicable Agreement, any dividends (whether paid in cash, stock or property) declared and paid by the
Company with respect to shares of Restricted Stock (&#8220;<b>Retained Distributions</b>&#8221;) shall be paid to the Holder only if and
when such shares vest and become free from the restrictions on transferability and forfeitability that apply to such shares. Each payment
of Retained Distributions will be made no later than the end of the calendar year in which the dividends are paid to stockholders of Common
Stock or, if later, the 15th day of the third month following the end of the year in which the Vesting Date occurred.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 8.3 <b>Issuance of
Restricted Stock</b>. When shares of Common Stock are issued at the beginning of the Restriction Period, the stock certificate or certificates
representing such Restricted Stock shall be registered in the name of the Holder to whom such Restricted Stock shall have been awarded.
During the Restriction Period, certificates representing the Restricted Stock and any securities constituting Retained Distributions shall
bear a restrictive legend to the effect that ownership of the Restricted Stock (and such Retained Distributions), and the enjoyment of
all rights appurtenant thereto, are subject to the restrictions, terms and conditions provided in the Plan and the applicable Agreement.
Such certificates shall remain in the custody of the Company or its designee, and the Holder shall deposit with the custodian stock powers
or other instruments of assignment, each endorsed in blank, so as to permit retransfer to the Company of all or any portion of the Restricted
Stock and any securities constituting Retained Distributions that shall be forfeited or otherwise not become vested in accordance with
the Plan and the applicable Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 8.4 <b>Restrictions</b>.
Restricted Stock issued at the beginning of the Restriction Period shall constitute issued and outstanding shares of Common Stock for
all corporate purposes. The Holder will have the right to vote such Restricted Stock and to exercise all other rights, powers and privileges
of a Holder of shares of Common Stock with respect to such Restricted Stock; <i>except</i>, <i>that</i>, unless otherwise determined by
the Committee and provided in the applicable Agreement, (a) the Holder will not be entitled to delivery of the stock certificate or certificates
representing such Restricted Stock until the Restriction Period shall have expired and unless all other vesting requirements with respect
thereto shall have been fulfilled or waived and the Company or its designee will retain custody of the stock certificate or certificates
representing the Restricted Stock during the Restriction Period as provided in Section 8.3; (b) the Holder will not be entitled to dividends
except as provided in Section 8.2, (c) the Holder may not sell, assign, transfer, pledge, exchange, encumber or dispose of the Restricted
Stock or his or her interest in any of them during the Restriction Period; and (d) a breach of any restrictions, terms or conditions provided
in the Plan or established by the Committee with respect to any Restricted Stock will cause a forfeiture of such Restricted Stock with
respect thereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 8.5 <b>Cash Payments</b>.
In connection with any Award of Restricted Stock, an Agreement may provide for the payment of a cash amount to the Holder of such Restricted
Stock after such Restricted Stock shall have become vested. Such cash amounts shall be payable in accordance with such additional restrictions,
terms and conditions as shall be prescribed by the Committee in the Agreement and shall be in addition to any other salary, incentive,
bonus or other compensation payments which such Holder shall be otherwise entitled or eligible to receive from the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 8.6 <b>Completion
of Restriction Period</b>. On the Vesting Date with respect to each Award of Restricted Stock and the satisfaction of any other applicable
restrictions, terms and conditions, (a) all or the applicable portion of such Restricted Stock shall become vested, (b) any Retained Distributions
with respect to such Restricted Stock shall become vested to the extent that the Restricted Stock related thereto shall have become vested,
and (c) any cash amount to be received by the Holder with respect to such Restricted Stock shall become payable, all in accordance with
the terms of the applicable Agreement. Any such Restricted Stock and Retained Distributions that shall not become vested shall be forfeited
to the Company, and the Holder shall not thereafter have any rights (including dividend and voting rights) with respect to such Restricted
Stock and Retained Distributions that shall have been so forfeited.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 68 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Article 9 Restricted Stock Units</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 9.1 <b>Grant</b>.
The Committee shall, subject to the limitations of the Plan, have authority to grant to eligible persons Awards of Restricted Stock Units
which may be in the form of shares of Common Stock or units, the value of which is based, in whole or in part, on the Fair Market Value
of the shares of Common Stock. Subject to the provisions of the Plan, including any rules established pursuant to Section 9.2, Awards
of Restricted Stock Units shall be subject to such terms, restrictions, conditions, vesting requirements and payment rules as the Committee
may determine in its discretion, which need not be identical for each Award. The terms of each Award need not be identical, and the Board
need not treat Holders uniformly. The determinations made by the Committee pursuant to this Article 9 shall be specified in the applicable
Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 9.2 <b>Rules</b>.
The Committee may, in its discretion, establish any or all of the following rules for application to an Award of Restricted Stock Units:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) Any shares of Common Stock
which are part of an Award of Restricted Stock Units may not be assigned, sold, transferred, pledged or otherwise encumbered prior to
the date on which the shares of Common Stock are issued or, if later, the date provided by the Committee at the time of the Award.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) Such Awards may provide
for the payment of cash consideration by the person to whom such Award is granted or provide that the Award, and any shares of Common
Stock to be issued in connection therewith, if applicable, shall be delivered without the payment of cash consideration; <i>provided</i>,
<i>however</i>, that the issuance of any shares of Common Stock in connection with an Award of Restricted Stock Units shall be for at
least the minimum consideration necessary to permit such shares to be deemed fully paid and nonassessable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) Awards of Restricted Stock
Units may provide for deferred payment schedules, vesting over a specified period of employment, the payment (on a current or deferred
basis) of dividend equivalent amounts with respect to the number of shares of Common Stock covered by the Award, and elections by the
employee to defer payment of the Award or the lifting of restrictions on the Award, if any, <i>provided</i> that any such deferrals shall
comply with the requirements of Section 409A of the Code. Restricted Stock Units shall not constitute issued and outstanding shares of
Common Stock, and the Holder shall not have any of the rights of a stockholder with respect to the shares of Common Stock covered by such
an Award of Restricted Stock Units, in each case until Awards have paid out in shares of Common Stock after the end of the Restriction
Period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) The Awards of Restricted
Stock Units may provide Holders with the right to receive Dividend Equivalents. Dividend Equivalents may be settled in cash and/or shares
of Common Stock and will be subject to the same vesting conditions and restrictions on transfer and forfeitability as the Restricted Stock
Units with respect to which paid, in each case to the extent provided in the Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) In such circumstances as
the Committee may deem advisable, the Committee may waive or otherwise remove, in whole or in part, any restrictions or limitations to
which a Restricted Stock Unit was made subject at the time of grant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Article 10 Cash Awards and Other Stock-Based Awards</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 10.1 <b>Cash Awards</b>.
The Committee shall, subject to the limitations of the Plan, have authority to grant to eligible persons Cash Awards. Each Cash Award
shall be subject to such terms and conditions, restrictions and contingencies as the Committee shall determine. Restrictions and contingencies
limiting the right to receive a cash payment pursuant to a Cash Award may be based upon the achievement of single or multiple performance
objectives over a performance period established by the Committee. The determinations made by the Committee pursuant to this Section 10.1
shall be specified in the applicable Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 69 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 10.2 <b>Other Stock-Based
Awards</b>. Other Awards of shares of Common Stock, and other Awards that are valued in whole or in part by reference to, or are otherwise
based on, shares of Common Stock, may be granted hereunder to Holders (&#8220;<b>Other Stock-Based-Awards</b>&#8221;). Such Other Stock-Based
Awards shall also be available as a form of payment in the settlement of other Awards granted under the Plan or as payment in lieu of
compensation to which a Holder is otherwise entitled. Other Stock-Based Awards may be paid in shares of Common Stock or cash, as the
Committee may determine. Subject to the provisions of the Plan, the Board or the Committee shall determine the terms and conditions of
each Other Stock-Based Award, including any purchase price applicable thereto. The determinations made by the Committee pursuant to this
Section 10.2 shall be specified in the applicable Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Article 11 Performance Awards</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 11.1 <b>Designation
as a Performance Award</b>. The Committee shall have the right to designate all or any part of any Award of Options, SARs, Restricted
Stock, Restricted Stock Units, Cash Awards or Other Stock-Based Awards as a Performance Award.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 11.2 <b>Performance
Objectives</b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) The grant or vesting of
a Performance Award shall be subject to the achievement of Performance Objectives over a performance period established by the Committee
based upon one or more performance measures that apply to the Holder, one or more business units, divisions or Affiliates of the Company
or the applicable sector of the Company, or the Company as a whole, and if so desired by the Committee, by comparison with a peer group
of companies, as determined by the Committee in its sole discretion. The Committee shall have the authority to determine whether the Performance
Objectives and other terms and conditions of the Award are satisfied, and the Committee&#8217;s determination as to the achievement of
Performance Objectives relating to a Performance Award shall be made in writing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) The Committee may specify
that such performance measures shall be adjusted to exclude any one or more of (i) extraordinary items, (ii) gains or losses on the dispositions
of discontinued operations, (iii) the cumulative effects of changes in accounting principles, (iv) the write-down of any asset, (v) fluctuation
in foreign currency exchange rates, and (vi) charges for restructuring and rationalization programs. Such performance measures: (y) may
vary by Holder and may be different for different Awards; and (z) may be particular to a Holder or the department, branch, line of business,
subsidiary or other unit in which the Holder works and may cover such period as may be specified by the Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Article 12 General Provisions</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 12.1 <b>Change in
Control</b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) In the event of a Change
in Control, the Committee may, but shall not be obligated to, provide for any one or more of the following (which may vary by Award) (i)
the assumption of the Plan and outstanding Awards by the surviving entity or its parent; (ii) the substitution by the surviving entity
or its parent of awards with substantially the same terms for such outstanding Awards; (iii) notice to the holders of vested and exercisable
Options and Rights of their ability to exercise vested and exercisable Options and Rights effective contingent upon and immediately prior
to such transaction followed by the cancellation of all unexercised Options and Rights (whether or not then vested and exercisable); (iv)
settlement of the intrinsic value of the outstanding vested Options and Rights in cash or cash equivalents or equity followed by the cancellation
of all Options and Rights (whether or not then vested or exercisable); (v) cancellation of all unvested or unexercisable Awards; or (vi)
the taking of such other action with respect to Awards as the Committee shall determine to be appropriate in its discretion; provided,
however, that in connection with an assumption or substitution of Awards under subsections (i) or (ii) above, the Awards so assumed or
substituted shall continue to vest or become exercisable pursuant to the terms of the original Award, except to the extent such terms
are otherwise rendered inoperative.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 70 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) If the outstanding shares
of the Common Stock of the Company are changed into or exchanged for a different number or kind of shares or other securities of the
Company or of another entity by reason of any reorganization, merger, or consolidation, or if a change is made to the Common Stock of
the Company by reason of any recapitalization, reclassification, change in par value, stock split, reverse stock split, combination of
shares or dividends payable in capital stock, or the like, the Company shall make adjustments to such Awards (including, by way of example
and not by way of limitation, the grant of substitute Awards under the Plan or under the plan of such other entity or the suspension
of the right to exercise an Award for a specified period of time in connection with a corporate transaction) as it may determine to be
appropriate under the circumstances, and, in addition, appropriate adjustments shall be made in the number and kind of shares or securities
and in the option price per share or security subject to outstanding Awards under the Plan or under the plan of such successor entity.
The foregoing notwithstanding, unless the Committee otherwise determines, no such adjustment shall be made to an Option which shall,
within the meaning of Sections 424 and 409A of the Code, as applicable, constitute such a modification, extension, or renewal of an option
as to cause it to be considered as the grant of a new option.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 12.2 <b>Termination
of Employment</b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <b>General</b>. Except as
otherwise provided in the applicable Agreement, if a Holder&#8217;s employment shall terminate or a non-employee&#8217;s service on the
Board or as an independent contractor shall terminate, any unvested Awards (and any Dividend Equivalents and Retained Distributions) shall
immediately terminate and be forfeited and of no further force and effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <b>Leave of Absence</b>.
The Committee may determine whether any given leave of absence constitutes a termination of employment or cessation of service; <i>provided</i>,
<i>however</i>, that for purposes of the Plan, (i) a leave of absence, duly authorized in writing by the Company for military service
or sickness, or for any other purpose approved by the Company if the period of such leave does not exceed 90 days, and (ii) a leave of
absence in excess of 90 days, duly authorized in writing by the Company provided the employee&#8217;s right to reemployment is guaranteed
either by statute or contract, shall not be deemed a termination of employment. Unless otherwise determined by the Committee and provided
in the applicable Agreement, Awards made under the Plan shall not be affected by any change of employment so long as the Holder continues
to be an employee of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) <b>Death or Disability</b>.
Except as otherwise provided in the applicable Agreement, if a Holder&#8217;s employment shall terminate or a non-employee&#8217;s service
on the Board or as an independent contractor shall terminate, by reason of death or Disability, the Committee may in its sole discretion
at any time (i) terminate restrictions in any Agreements; (ii) accelerate any or all installments and rights; and/or (iii) instruct the
Company to pay the total of any accelerated payments in a lump sum to the Holder, the Holder&#8217;s estate, beneficiaries or representative,
notwithstanding that, in the absence of such termination of restrictions or acceleration of payments, any or all of the payments due under
the Awards ultimately might have become payable to other beneficiaries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 12.3 <b>Right of Company
to Terminate Employment</b>. Nothing contained in the Plan or in any Award, and no action of the Company or the Committee with respect
thereto, shall confer or be construed to confer on any Holder any right to continue in the employ of the Company or any of its Affiliates
or interfere in any way with the right of the Company or any of its Affiliates to terminate the employment of the Holder at any time,
with or without cause, subject, however, to the provisions of any employment agreement between the Holder and the Company or any Affiliate
of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 12.4 <b>Nonalienation
of Benefits; Nontransferability of Awards</b>. Except as set forth below, no right or benefit under the Plan shall be subject to anticipation,
alienation, sale, assignment, hypothecation, pledge, exchange, transfer, encumbrance or charge, and any attempt to anticipate, alienate,
sell, assign, hypothecate, pledge, exchange, transfer, encumber or charge the same shall be void. No right or benefit hereunder shall
in any manner be liable for or subject to the debts, contracts, liabilities or torts of the Person entitled to such benefits. Awards shall
not be sold, assigned, transferred, pledged or encumbered by the person to whom they are granted, either voluntarily or by operation of
law, except by will or the laws of descent and distribution or pursuant to a qualified domestic relations order, and, during the life
of the Holder, shall be exercisable only by the Holder; <i>provided</i>, <i>however</i>, that the Board or the Committee may permit or
provide in an Award for the gratuitous transfer of the Award by the Holder to or for the benefit of any immediate family member, family
trust or other entity established for the benefit of the Holder and/or an immediate family member thereof if the Company would be eligible
to use a Form S-8 under the Securities Act for the registration of the sale of the Common Stock subject to such Award to such proposed
transferee and with respect to Incentive Stock Options such would not be contrary to Code Section 421 or 422; <i>provided</i>, <i>further</i>,
that the Company shall not be required to recognize any such permitted transfer until such time as such permitted transferee shall, as
a condition to such transfer, deliver to the Company a written instrument in form and substance satisfactory to the Company confirming
that such transferee shall be bound by all of the terms and conditions of the Award. References to a Holder, to the extent relevant in
the context, shall include references to authorized transferees. For the avoidance of doubt, nothing contained in this Section 12.4 shall
be deemed to restrict a transfer to the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 71 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 12.5 <b>Documentation</b>.
Each Award shall be evidenced in such form (written, electronic or otherwise) as the Committee shall determine. Each Award may contain
terms and conditions in addition to those set forth in the Plan. Any such Agreement may be supplemented or amended from time to time
as approved by the Committee as contemplated by Section 12.7(b).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 12.6 <b>Designation
of Beneficiaries</b>. Each person who shall be granted an Award under the Plan may designate a beneficiary or beneficiaries and may change
such designation from time to time by filing a written designation of beneficiary or beneficiaries with the Committee on a form to be
prescribed by it, <i>provided</i> that no such designation shall be effective unless so filed prior to the death of such person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 12.7 <b>Termination
and Amendment</b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) <b>General</b>. Unless the
Plan shall theretofore have been terminated as hereinafter provided, no Awards may be made under the Plan on or after the tenth anniversary
of the Effective Date. The Plan may be terminated at any time prior to the tenth anniversary of the Effective Date and may, from time
to time, be suspended or discontinued or modified or amended if such action is deemed advisable by the Committee. The Plan may be amended
by the Board and such amendment shall become effective upon adoption by the Board; provided, however, that any amendment shall be subject
to the approval of the stockholders of the Company at or before the next annual meeting of the stockholders of the Company if such stockholder
approval is required by the Code, any federal or state law or regulation, the rules of any stock exchange or automated quotation system
on which the shares of Common Stock may be listed or quoted, or if the Board, in its discretion, determines to submit such changes to
the Plan to the Company&#8217;s stockholders for approval.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) <b>Modification</b>. The
Board may amend the terms of any Award theretofore granted, prospectively or retroactively, but no such amendment shall (i) materially
impair the rights of any Holder without his or her consent or (ii) except for adjustments made pursuant to Section 4.1 or 12.1, reduce
the exercise price of outstanding Options or SARs or cancel or amend outstanding Options or SARs for the purpose of repricing, replacing,
or regranting such Options or SARs with an exercise price that is less than the exercise price of the original Options or SARs or cancel
or amend outstanding Options or SARs with an exercise price that is greater than the Fair Market Value of a share of Common Stock for
the purpose of exchanging such Options or SARs for cash or any other Awards without stockholder approval. Notwithstanding anything herein
to the contrary, the Board may amend the terms of any Award theretofore granted if the Board, in its discretion, determines that such
amendment is necessary to comply with the requirements of Section 409A of the Code, the rules of any stock exchange or automated quotation
systems on which the shares of Common Stock may be listed or traded, or changes in tax or other applicable laws or regulatory requirements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 12.8 <b>Government
and Other Regulations</b>. The obligation of the Company with respect to Awards shall be subject to all applicable laws, rules and regulations
and such approvals by any governmental agencies as may be required, including the effectiveness of any registration statement required
under the Securities Act of 1933, and the rules and regulations of any securities exchange or association on which the Common Stock may
be listed or quoted. For so long as Common Stock is registered under the Exchange Act, the Company shall use its reasonable efforts to
comply with any legal requirements (a) to maintain a registration statement in effect under the Securities Act of 1933 with respect to
all shares of the applicable series of Common Stock that may be issued to Holders under the Plan, and (b) to file in a timely manner all
reports required to be filed by it under the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 12.9 <b>Withholding</b>.
The Company&#8217;s obligation to deliver shares of Common Stock or pay cash in respect of any Award under the Plan shall be subject to
applicable federal, state and local tax withholding requirements. Federal, state and local withholding tax due at the time of an Award,
upon the exercise of any Option or SAR or upon the vesting of, or expiration of restrictions with respect to, Restricted Stock, Restricted
Stock Units, Cash Awards or Other Stock-Based Awards or the satisfaction of the Performance Objectives applicable to a Performance Award,
as appropriate, may, in the discretion of the Committee, be paid in shares of Common Stock already owned by the Holder or through the
withholding of shares otherwise issuable to such Holder, upon such terms and conditions (including the conditions referenced in Section
6.5) as the Committee shall determine. If the Holder shall fail to pay, or make arrangements satisfactory to the Committee for the payment
to the Company of, all such federal, state and local taxes required to be withheld by the Company, then the Company shall, to the extent
permitted by law, have the right to deduct from any payment of any kind otherwise due to such Holder an amount equal to any federal, state
or local taxes of any kind required to be withheld by the Company with respect to such Award.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 72 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If provided for in an Agreement
or approved by the Committee in its sole discretion, a Holder may satisfy such tax obligations in whole or in part by delivery (either
by actual delivery or attestation) of shares of Common Stock, including shares retained from the Award creating the tax obligation, valued
at their Fair Market Value; <i>provided</i>, <i>however</i>, except as otherwise provided by the Board, that the total tax withholding
where stock is being used to satisfy such tax obligations cannot exceed the Company&#8217;s minimum statutory withholding obligations
(based on minimum statutory withholding rates for federal and state tax purposes, including payroll taxes, that are applicable to such
supplemental taxable income). Shares used to satisfy tax withholding requirements cannot be subject to any repurchase, forfeiture, unfulfilled
vesting or other similar requirements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 12.10 <b>Nonexclusivity
of the Plan</b>. The adoption of the Plan by the Board shall not be construed as creating any limitations on the power of the Board to
adopt such other incentive arrangements as it may deem desirable, including the granting of stock options and the awarding of stock and
cash otherwise than under the Plan, and such arrangements may be either generally applicable or applicable only in specific cases.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 12.11 <b>Treatment
with Respect to Other Benefit Programs</b>. By acceptance of an Award, unless otherwise provided in the applicable Agreement or required
by law, each Holder shall be deemed to have agreed that such Award is special incentive compensation that will not be taken into account,
in any manner, as salary, compensation or bonus in determining the amount of any payment under any pension, retirement or other employee
benefit plan, program or policy of the Company or any Affiliate of the Company. In addition, each beneficiary of a deceased Holder shall
be deemed to have agreed that such Award will not affect the amount of any life insurance coverage, if any, provided by the Company on
the life of the Holder which is payable to such beneficiary under any life insurance plan covering employees of the Company or any Affiliate
of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 12.12 <b>Unfunded
Plan</b>. Neither the Company nor any Affiliate of the Company shall be required to segregate any cash or any shares of Common Stock which
may at any time be represented by Awards, and the Plan shall constitute an &#8220;unfunded&#8221; plan of the Company. Except as provided
in Article 8 with respect to Awards of Restricted Stock and except as expressly set forth in an Agreement, no employee shall have voting
or other rights with respect to the shares of Common Stock covered by an Award prior to the delivery of such shares. Neither the Company
nor any Affiliate of the Company shall, by any provisions of the Plan, be deemed to be a trustee of any shares of Common Stock or any
other property, and the liabilities of the Company and any Affiliate of the Company to any employee pursuant to the Plan shall be those
of a debtor pursuant to such contract obligations as are created by or pursuant to the Plan, and the rights of any employee, former employee
or beneficiary under the Plan shall be limited to those of a general creditor of the Company or the applicable Affiliate of the Company,
as the case may be. In its sole discretion, the Board may authorize the creation of trusts or other arrangements to meet the obligations
of the Company under the Plan, <i>provided</i>, <i>however</i>, that the existence of such trusts or other arrangements is consistent
with the unfunded status of the Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 12.13 <b>Governing
Law</b>. The Plan shall be governed by, and construed in accordance with, the laws of the State of Nevada.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 12.14 <b>Exemptions
from Section 16(b) Liability</b>. It is the intent of the Company that the grant of any Awards to or other transaction by a Holder who
is subject to Section 16(b) of the Exchange Act shall be exempt from Section 16 of the Exchange Act pursuant to an applicable exemption
(except for transactions acknowledged in writing to be non-exempt by such Holder). In addition, the Company intends any transaction by
which a Holder sells Shares issued in respect of the vesting or exercise of any Award granted hereunder for the purpose of settling any
withholding tax liability of such Holder (commonly referred to as a &#8220;net settlement,&#8221; &#8220;net exercise,&#8221; &#8220;sell
to cover&#8221; or &#8220;broker-assisted cashless exercise&#8221; transaction) that would otherwise be subject to Section 16(b) of the
Exchange Act shall be exempt from Section 16 of the Exchange Act pursuant to an applicable exemption. Accordingly, if any provision of
this Plan, subplan or any Agreement does not comply with the requirements of Rule 16b-3 then applicable to any such transaction, such
provision shall be construed or deemed amended to the extent necessary to conform to the applicable requirements of Rule 16b-3 so that
such Holder shall avoid liability under Section 16(b) of the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 12.15 <b>Section
280G</b>. Unless otherwise provided for in the Agreement or in any other agreement between the Company (or an Affiliate) and a Holder,
if any payment or right accruing to a Holder under this Plan (without the application of this Section 12.15), either alone or together
with other payments or rights accruing to the Holder from the Company or an Affiliate, would constitute a &#8220;parachute payment&#8221;
(as defined in Section 280G of the Code and regulations thereunder), such payment or right shall be reduced to the largest amount or
greatest right that will result in no portion of the amount payable or right accruing under the Plan being subject to an excise tax under
Section 4999 of the Code or being disallowed as a deduction under Section 280G of the Code. The determination of whether any reduction
in the rights or payments under this Plan is necessary shall be made by the Company. The Holder shall cooperate in good faith with the
Company in making such determination and providing any necessary information for this purpose.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 73 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 12.16 <b>Company&#8217;s
Rights</b>. The grant of Awards pursuant to the Plan shall not affect in any way the right or power of the Company to make reclassifications,
reorganizations or other changes of or to its capital or business structure or to merge, consolidate, liquidate, sell or otherwise dispose
of all or any part of its business or assets.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 12.17 <b>Interpretation</b>.
The words &#8220;include,&#8221; &#8220;includes,&#8221; &#8220;included&#8221; and &#8220;including&#8221; to the extent used in the
Plan shall be deemed in each case to be followed by the words &#8220;without limitation.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 12.18 <b>Compliance
with Section 409A of the Code</b>. Except as provided in individual Agreements initially or by amendment, if and to the extent (i) any
portion of any payment, compensation or other benefit provided to a Holder pursuant to the Plan in connection with his or her employment
termination constitutes &#8220;nonqualified deferred compensation&#8221; within the meaning of Section 409A of the Code and (ii) the Holder
is a specified employee as defined in Section 409A(a)(2)(B)(i) of the Code, in each case as determined by the Company in accordance with
its procedures, by which determinations the Holder (through accepting the Award) agrees that he or she is bound, such portion of the payment,
compensation or other benefit shall not be paid before the day that is six months plus one day after the date of &#8220;separation from
service&#8221; (as determined under Section 409A of the Code) (the &#8220;<b>New Payment Date</b>&#8221;), except as Section 409A of the
Code may then permit. The aggregate of any payments that otherwise would have been paid to the Holder during the period between the date
of separation from service and the New Payment Date shall be paid to the Holder in a lump sum on such New Payment Date, without interest,
and any remaining payments will be paid on their original schedule.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company makes no representations
or warranty and shall have no liability to the Holder or any other person if any provisions of or payments, compensation or other benefits
under the Plan are determined to constitute nonqualified deferred compensation subject to Section 409A of the Code but do not to satisfy
the conditions of that section.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 12.19 <b>Authorization
of Sub-Plans (including for Grants to non-U.S. Employees)</b>. The Board may from time to time establish one or more sub-plans under the
Plan for purposes of satisfying applicable securities, tax or other laws of various jurisdictions. The Board shall establish such sub-plans
by adopting supplements to the Plan containing (a) such limitations on the Board&#8217;s discretion under the Plan as the Board deems
necessary or desirable or (b) such additional terms and conditions not otherwise inconsistent with the Plan as the Board shall deem necessary
or desirable. All supplements adopted by the Board shall be deemed to be part of the Plan, but each supplement shall apply only to Holders
within the affected jurisdiction and the Company shall not be required to provide copies of any supplement to Holders in any jurisdiction
which is not the subject of such supplement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 12.20 <b>Limitations
on Liability</b>. Notwithstanding any other provisions of the Plan, no individual acting as a director, officer, employee or agent of
the Company will be liable to any Holder, former Holder, spouse, beneficiary, or any other person for any claim, loss, liability, or expense
incurred in connection with the Plan, nor will such individual be personally liable with respect to the Plan because of any contract or
other instrument he or she executes in his or her capacity as a director, officer, employee or agent of the Company. The Company will
indemnify and hold harmless each director, officer, employee or agent of the Company to whom any duty or power relating to the administration
or interpretation of the Plan has been or will be delegated, against any cost or expense (including attorneys&#8217; fees) or liability
(including any sum paid in settlement of a claim with the Board&#8217;s approval) arising out of any act or omission to act concerning
the Plan unless arising out of such person&#8217;s own fraud or bad faith.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 12.21 <b>Recoupment;
Forfeiture</b>. All Awards and any and all payments made or required to be made or stock received or required to be issued hereunder
and pursuant to any this Plan or any Agreement shall be subject to forfeiture and/or repayment to the Company by the Holder (and the
successors, assigns, heirs, estate and personal representative of the Holder) (a) pursuant to the terms of any clawback, recoupment or
other policy implemented from time to time by the Board (any such policy, as amended, amended and restated or superseded the &#8220;<b>Recoupment
Policy</b>&#8221;), (b) upon a termination for cause, (c) in the event of a material breach of an Agreement with the Company (including
any agreement related to confidential information, non-competition, non-solicitation, or other similar restrictive covenants, and (d)
upon a material breach of a material company policy. As additional consideration for any Award granted to a Holder and for any payment
made or required to be made or stock received or required to be issued hereunder and pursuant to any Agreement to any Holder, each Holder
agrees that he/she is bound by and subject to any Recoupment Policy as in effect at any time and from time to time (whether before, at
or after the granting or payment of any award).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 12.22 <b>Notice</b>.
All notices and other communications required or permitted to be given under the Plan shall be in writing or other form approved by the
Committee and shall be deemed to have been duly given as follows (a) if to the Company mailed first class, postage prepaid at the principal
business address of the Company to the attention of the Secretary of the Company; or (b) if to any Holder then delivered personally, mailed
first class, postage prepaid at the last address of the Holder known to the sender at the time the notice or other communication is sent
or delivered, or by e-mail, interoffice mail, intranet or other means of office communication determined by the Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<!-- Field: Page; Sequence: 74 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">AMENDMENT NO. 1 TO THE</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Kartoon Studios, Inc. (formerly known as</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Genius Brands International, Inc.) 2020 Incentive
Plan</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">THIS AMENDMENT NO. 1 TO
THE Kartoon Studios, Inc. (formerly known as Genius Brands International, Inc.) 2020 Incentive Plan has been adopted by the Board of
Directors (the &#8220;Board&#8221;) and the Compensation Committee of the Board of Kartoon Studios, Inc., a Nevada corporation (the &#8220;Company&#8221;),
on December 12, 2024, to be effective as of such date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, pursuant to Section 12.7 of the Plan,
the Board and the Compensation Committee of the Board has approved the amendment set forth below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">NOW, THEREFORE, the Plan is hereby amended, effective as of the date
hereof, as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top"><td style="width: 3%"/><td style="width: 3%">1.</td><td style="width: 94%"><span style="text-decoration: underline">Amendment</span>.
The Plan is hereby amended by the addition of the following sentence at the end of Section 3.2:</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;The Committee, in its discretion, may delegate
to one or more officers of the Company all or part of the Committee&#8217;s authority and duties with respect to Awards to individuals
who are not subject to the reporting and other provisions of Section 16 of the Exchange Act, The Committee may revoke or amend the terms
of a delegation at any time but such action shall not invalidate any prior actions of the Committee&#8217;s delegate or delegates that
were consistent with the terms of the Plan.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="vertical-align: top">
    <td style="width: 3%">&#160;</td>
  <td style="text-align: justify; width: 3%"><span style="font-size: 10pt">2.</span></td>
  <td style="text-align: justify; width: 94%"><span style="text-decoration: underline">No Other Changes</span><span style="font-size: 10pt">. Except as set forth herein, all other terms and provisions of the Plan remain
in full force and effect.</span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></p>

<!-- Field: Page; Sequence: 75 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;<img src="proxy_001.jpg" alt="" style="height: 838px; width: 650px"/>&#160;</p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 76 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"><img src="proxy_002.jpg" alt="" style="height: 842px; width: 650px"/>&#160;</p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="text-align: center; margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 77; Options: Last -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="text-align: center; margin-top: 0; margin-bottom: 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- 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 -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>toon-20241231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOa+PuaPty552mYkxvmRxfenqryomdp4Meii6DjQGsTMO -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:TOON="http://kartoonstudios.com/20241231" elementFormDefault="qualified" targetNamespace="http://kartoonstudios.com/20241231">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://kartoonstudios.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="toon-20241231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="toon-20241231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="toon-20241231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
    <element id="TOON_AndyHeywardMember" name="AndyHeywardMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TOON_FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember" name="FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TOON_YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember" name="YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TOON_ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember" name="ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TOON_ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember" name="ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TOON_AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember" name="AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TOON_AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember" name="AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TOON_AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember" name="AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="TOON_AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember" name="AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>toon-20241231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://kartoonstudios.com/role/Cover" xlink:href="toon-20241231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosureWithAdditionalMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosureWithAdditionalMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpTable" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsToCompensation" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsToCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListsByExecutiveCategory" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListsByExecutiveCategory" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpExecutiveCategoriesOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#IndividualsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTypeOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TradingArrangmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ForgoneRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ForgoneRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/OutstandingRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#OutstandingRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardsCloseToMnpiDisc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardsCloseToMnpiDisc" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangementsByInd" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangemenstByInd" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/Defaults" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#Defaults" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://kartoonstudios.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:loc xlink:type="locator" xlink:href="toon-20241231.xsd#TOON_FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember" xlink:label="loc_TOONFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_TOONFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="toon-20241231.xsd#TOON_YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember" xlink:label="loc_TOONYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_TOONYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="toon-20241231.xsd#TOON_ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember" xlink:label="loc_TOONChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_TOONChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="toon-20241231.xsd#TOON_ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember" xlink:label="loc_TOONChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_TOONChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="toon-20241231.xsd#TOON_AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember" xlink:label="loc_TOONAverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_TOONAverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="toon-20241231.xsd#TOON_AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember" xlink:label="loc_TOONAverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_TOONAverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="toon-20241231.xsd#TOON_AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember" xlink:label="loc_TOONAverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_TOONAverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember" xlink:type="arc" order="60" />
      <link:loc xlink:type="locator" xlink:href="toon-20241231.xsd#TOON_AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember" xlink:label="loc_TOONAverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_TOONAverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember" xlink:type="arc" order="70" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:loc xlink:type="locator" xlink:href="toon-20241231.xsd#TOON_AndyHeywardMember" xlink:label="loc_TOONAndyHeywardMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_TOONAndyHeywardMember" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>toon-20241231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="ecd_IndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_IndividualAxis" xlink:to="ecd_IndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_IndividualAxis_lbl" xml:lang="en-US">Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="toon-20241231.xsd#TOON_AndyHeywardMember" xlink:label="TOON_AndyHeywardMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TOON_AndyHeywardMember" xlink:to="TOON_AndyHeywardMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TOON_AndyHeywardMember_lbl" xml:lang="en-US">Andy Heyward [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis" xlink:label="ecd_AdjToCompAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAxis" xlink:to="ecd_AdjToCompAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAxis_lbl" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="toon-20241231.xsd#TOON_FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember" xlink:label="TOON_FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TOON_FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember" xlink:to="TOON_FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TOON_FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember_lbl" xml:lang="en-US">Fair Value Of Equity Awards Under The Stock Awards And Option Awards Column In S C T [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis" xlink:label="ecd_ExecutiveCategoryAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ExecutiveCategoryAxis" xlink:to="ecd_ExecutiveCategoryAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ExecutiveCategoryAxis_lbl" xml:lang="en-US">Executive Category [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember" xlink:label="ecd_PeoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoMember" xlink:to="ecd_PeoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoMember_lbl" xml:lang="en-US">PEO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="toon-20241231.xsd#TOON_YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember" xlink:label="TOON_YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TOON_YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember" xlink:to="TOON_YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TOON_YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_lbl" xml:lang="en-US">Year End Fair Value Of Equity Awards Granted During The Year That Are Outstanding And Unvested [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="toon-20241231.xsd#TOON_ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember" xlink:label="TOON_ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TOON_ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember" xlink:to="TOON_ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TOON_ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_lbl" xml:lang="en-US">Change In Year Over Year End Fair Value Of Equity Awards Granted In Prior Years That Are Outstanding And Unvested [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="toon-20241231.xsd#TOON_ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember" xlink:label="TOON_ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TOON_ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember" xlink:to="TOON_ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TOON_ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_lbl" xml:lang="en-US">Change In Prior Year End Fair Value And Vesting Date Fair Value Of Equity Awards Granted In Prior Years That Vested During The Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="toon-20241231.xsd#TOON_AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember" xlink:label="TOON_AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TOON_AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember" xlink:to="TOON_AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TOON_AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember_lbl" xml:lang="en-US">Average Fair Value Of Equity Awards Under The Stock Awards And Option Awards Column In S C T [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember" xlink:label="ecd_NonPeoNeoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoMember" xlink:to="ecd_NonPeoNeoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoMember_lbl" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="toon-20241231.xsd#TOON_AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember" xlink:label="TOON_AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TOON_AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember" xlink:to="TOON_AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TOON_AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_lbl" xml:lang="en-US">Average Year End Fair Value Of Equity Awards Granted During The Year That Are Outstanding And Unvested [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="toon-20241231.xsd#TOON_AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember" xlink:label="TOON_AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TOON_AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember" xlink:to="TOON_AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TOON_AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_lbl" xml:lang="en-US">Average Change In Year Over Year End Fair Value Of Equity Awards Granted In Prior Years That Are Outstanding And Unvested [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="toon-20241231.xsd#TOON_AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember" xlink:label="TOON_AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TOON_AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember" xlink:to="TOON_AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="TOON_AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_lbl" xml:lang="en-US">Average Change In Prior Year End Fair Value And Vesting Date Fair Value Of Equity Awards Granted In Prior Years That Vested During The Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable" xlink:label="ecd_PvpTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTable" xlink:to="ecd_PvpTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTable_lbl" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="ecd_PvpTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTableTextBlock" xlink:to="ecd_PvpTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTableTextBlock_lbl" xml:lang="en-US">Disclosure - Pay vs Performance Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="ecd_CoSelectedMeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureName" xlink:to="ecd_CoSelectedMeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureName_lbl" xml:lang="en-US">Company Selected Measure Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="ecd_PeerGroupIssuersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupIssuersFnTextBlock" xlink:to="ecd_PeerGroupIssuersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupIssuersFnTextBlock_lbl" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="ecd_ChangedPeerGroupFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ChangedPeerGroupFnTextBlock" xlink:to="ecd_ChangedPeerGroupFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ChangedPeerGroupFnTextBlock_lbl" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="ecd_PeoTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoTotalCompAmt" xlink:to="ecd_PeoTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoTotalCompAmt_lbl" xml:lang="en-US">PEO Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="ecd_PeoActuallyPaidCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoActuallyPaidCompAmt" xlink:to="ecd_PeoActuallyPaidCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoActuallyPaidCompAmt_lbl" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="ecd_AdjToPeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToPeoCompFnTextBlock" xlink:to="ecd_AdjToPeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToPeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid and Cumulative Total Shareholder Return</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid and Net Loss</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="ecd_TabularListTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TabularListTableTextBlock" xlink:to="ecd_TabularListTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TabularListTableTextBlock_lbl" xml:lang="en-US">Tabular List, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="ecd_TotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnAmt" xlink:to="ecd_TotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnAmt_lbl" xml:lang="en-US">Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="ecd_CoSelectedMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureAmt" xlink:to="ecd_CoSelectedMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureAmt_lbl" xml:lang="en-US">Company Selected Measure Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="ecd_OtherPerfMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OtherPerfMeasureAmt" xlink:to="ecd_OtherPerfMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OtherPerfMeasureAmt_lbl" xml:lang="en-US">Other Performance Measure, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="ecd_AdjToCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAmt" xlink:to="ecd_AdjToCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAmt_lbl" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="ecd_PeoName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoName" xlink:to="ecd_PeoName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoName_lbl" xml:lang="en-US">PEO Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="ecd_MeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureName" xlink:to="ecd_MeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xml:lang="en-US">Non-GAAP Measure Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="ecd_Additional402vDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Additional402vDisclosureTextBlock" xlink:to="ecd_Additional402vDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Additional402vDisclosureTextBlock_lbl" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="ecd_PnsnBnftsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PnsnBnftsAdjFnTextBlock" xlink:to="ecd_PnsnBnftsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PnsnBnftsAdjFnTextBlock_lbl" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock" xlink:label="ecd_EqtyAwrdsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="ecd_EqtyAwrdsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EqtyAwrdsAdjFnTextBlock_lbl" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="ecd_ErrCompRecoveryTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompRecoveryTable" xlink:to="ecd_ErrCompRecoveryTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompRecoveryTable_lbl" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="ecd_RestatementDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDateAxis" xlink:to="ecd_RestatementDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDateAxis_lbl" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="ecd_RestatementDeterminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDeterminationDate" xlink:to="ecd_RestatementDeterminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDeterminationDate_lbl" xml:lang="en-US">Restatement Determination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="ecd_AggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompAmt" xlink:to="ecd_AggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompAmt_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="ecd_ErrCompAnalysisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompAnalysisTextBlock" xlink:to="ecd_ErrCompAnalysisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompAnalysisTextBlock_lbl" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="ecd_OutstandingAggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingAggtErrCompAmt" xlink:to="ecd_OutstandingAggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingAggtErrCompAmt_lbl" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="ecd_ForgoneRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_ForgoneRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="ecd_OutstandingRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_OutstandingRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="ecd_OutstandingRecoveryCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryCompAmt" xlink:to="ecd_OutstandingRecoveryCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryCompAmt_lbl" xml:lang="en-US">Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xml:lang="en-US">Restatement does not require Recovery</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="ecd_AwardsCloseToMnpiDiscTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTable" xlink:to="ecd_AwardsCloseToMnpiDiscTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTable_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="ecd_AwardTmgMnpiDiscTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiDiscTextBlock" xlink:to="ecd_AwardTmgMnpiDiscTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiDiscTextBlock_lbl" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="ecd_AwardTmgMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMethodTextBlock" xlink:to="ecd_AwardTmgMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMethodTextBlock_lbl" xml:lang="en-US">Award Timing Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="ecd_AwardTmgPredtrmndFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgPredtrmndFlag" xlink:to="ecd_AwardTmgPredtrmndFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgPredtrmndFlag_lbl" xml:lang="en-US">Award Timing Predetermined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xml:lang="en-US">Award Timing MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="ecd_MnpiDiscTimedForCompValFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MnpiDiscTimedForCompValFlag" xlink:to="ecd_MnpiDiscTimedForCompValFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MnpiDiscTimedForCompValFlag_lbl" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="ecd_AwardsCloseToMnpiDiscIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="ecd_AwardUndrlygSecuritiesAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardUndrlygSecuritiesAmt" xlink:to="ecd_AwardUndrlygSecuritiesAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardUndrlygSecuritiesAmt_lbl" xml:lang="en-US">Underlying Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="ecd_AwardExrcPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardExrcPrice" xlink:to="ecd_AwardExrcPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardExrcPrice_lbl" xml:lang="en-US">Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="ecd_AwardGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardGrantDateFairValue" xlink:to="ecd_AwardGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardGrantDateFairValue_lbl" xml:lang="en-US">Fair Value as of Grant Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="ecd_UndrlygSecurityMktPriceChngPct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_UndrlygSecurityMktPriceChngPct" xlink:to="ecd_UndrlygSecurityMktPriceChngPct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_UndrlygSecurityMktPriceChngPct_lbl" xml:lang="en-US">Underlying Security Market Price Change</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable" xlink:label="ecd_TradingArrByIndTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrByIndTable" xlink:to="ecd_TradingArrByIndTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrByIndTable_lbl" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis" xlink:label="ecd_TradingArrAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrAxis" xlink:to="ecd_TradingArrAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrAxis_lbl" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="ecd_TrdArrIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_TrdArrIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="ecd_TrdArrIndTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndTitle" xlink:to="ecd_TrdArrIndTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndTitle_lbl" xml:lang="en-US">Title</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="ecd_TrdArrAdoptionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrAdoptionDate" xlink:to="ecd_TrdArrAdoptionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrAdoptionDate_lbl" xml:lang="en-US">Adoption Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="ecd_TrdArrTerminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrTerminationDate" xlink:to="ecd_TrdArrTerminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrTerminationDate_lbl" xml:lang="en-US">Termination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="ecd_TrdArrExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrExpirationDate" xlink:to="ecd_TrdArrExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrExpirationDate_lbl" xml:lang="en-US">Expiration Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="ecd_TrdArrDuration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrDuration" xlink:to="ecd_TrdArrDuration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrDuration_lbl" xml:lang="en-US">Arrangement Duration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="ecd_InsiderTradingPoliciesProcLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingPoliciesProcLineItems" xlink:to="ecd_InsiderTradingPoliciesProcLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingPoliciesProcLineItems_lbl" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryIndName_2_lbl" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryIndName_2_lbl" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndName_2_lbl" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>toon-20241231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.0b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://kartoonstudios.com/role/Cover" xlink:href="toon-20241231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://kartoonstudios.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:title="995410 - Disclosure - Pay vs Performance Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems" xlink:label="loc_ecdPayVsPerformanceDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable" xlink:label="loc_ecdPvpTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="toon-20241231.xsd#TOON_AndyHeywardMember" xlink:label="loc_TOONAndyHeywardMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_TOONAndyHeywardMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis" xlink:label="loc_ecdAdjToCompAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdAdjToCompAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAdjToCompAxis" xlink:to="loc_ecdAllAdjToCompMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="toon-20241231.xsd#TOON_FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember" xlink:label="loc_TOONFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_TOONFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="toon-20241231.xsd#TOON_YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember" xlink:label="loc_TOONYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_TOONYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="toon-20241231.xsd#TOON_ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember" xlink:label="loc_TOONChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_TOONChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="toon-20241231.xsd#TOON_ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember" xlink:label="loc_TOONChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_TOONChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="toon-20241231.xsd#TOON_AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember" xlink:label="loc_TOONAverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_TOONAverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="toon-20241231.xsd#TOON_AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember" xlink:label="loc_TOONAverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_TOONAverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="toon-20241231.xsd#TOON_AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember" xlink:label="loc_TOONAverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_TOONAverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="toon-20241231.xsd#TOON_AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember" xlink:label="loc_TOONAverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_TOONAverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis" xlink:label="loc_ecdExecutiveCategoryAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdExecutiveCategoryAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember" xlink:label="loc_ecdAllExecutiveCategoriesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdExecutiveCategoryAxis" xlink:to="loc_ecdAllExecutiveCategoriesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember" xlink:label="loc_ecdPeoMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllExecutiveCategoriesMember" xlink:to="loc_ecdPeoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember" xlink:label="loc_ecdNonPeoNeoMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllExecutiveCategoriesMember" xlink:to="loc_ecdNonPeoNeoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="loc_ecdPvpTableTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="loc_ecdCoSelectedMeasureName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdCoSelectedMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="loc_ecdNamedExecutiveOfficersFnTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNamedExecutiveOfficersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="loc_ecdPeerGroupIssuersFnTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupIssuersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="loc_ecdChangedPeerGroupFnTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdChangedPeerGroupFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="loc_ecdPeoTotalCompAmt" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="loc_ecdPeoActuallyPaidCompAmt" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoActuallyPaidCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="loc_ecdAdjToPeoCompFnTextBlock" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToPeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="loc_ecdNonPeoNeoAvgTotalCompAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNonPeoNeoAvgTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="loc_ecdAdjToNonPeoNeoCompFnTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:presentationArc order="2140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" />
      <link:presentationArc order="2150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" />
      <link:presentationArc order="2160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="loc_ecdTabularListTableTextBlock" />
      <link:presentationArc order="2170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdTabularListTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="loc_ecdTotalShareholderRtnAmt" />
      <link:presentationArc order="2180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="loc_ecdPeerGroupTotalShareholderRtnAmt" />
      <link:presentationArc order="2190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="2200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="loc_ecdCoSelectedMeasureAmt" />
      <link:presentationArc order="2210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCoSelectedMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="loc_ecdOtherPerfMeasureAmt" />
      <link:presentationArc order="2220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdOtherPerfMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="loc_ecdAdjToCompAmt" />
      <link:presentationArc order="2230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="loc_ecdPeoName" />
      <link:presentationArc order="2240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="loc_ecdMeasureName" />
      <link:presentationArc order="2250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="loc_ecdNonGaapMeasureDescriptionTextBlock" />
      <link:presentationArc order="2260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdMeasureName" xlink:to="loc_ecdNonGaapMeasureDescriptionTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="loc_ecdAdditional402vDisclosureTextBlock" />
      <link:presentationArc order="2270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdAdditional402vDisclosureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="loc_ecdPnsnBnftsAdjFnTextBlock" />
      <link:presentationArc order="2280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPnsnBnftsAdjFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock" xlink:label="loc_ecdEqtyAwrdsAdjFnTextBlock" />
      <link:presentationArc order="2290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdEqtyAwrdsAdjFnTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:title="995440 - Disclosure - Recovery of Erroneously Awarded Compensation">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems" xlink:label="loc_ecdRecoveryOfErrCompDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="loc_ecdErrCompRecoveryTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdErrCompRecoveryTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="loc_ecdRestatementDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdRestatementDateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="loc_ecdRestatementDeterminationDate" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdRestatementDeterminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="loc_ecdAggtErrCompAmt" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="loc_ecdErrCompAnalysisTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdErrCompAnalysisTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="loc_ecdOutstandingAggtErrCompAmt" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdOutstandingAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="loc_ecdAggtErrCompNotYetDeterminedTextBlock" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdAggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="loc_ecdForgoneRecoveryIndName" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="loc_ecdOutstandingRecoveryIndName" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="loc_ecdOutstandingRecoveryCompAmt" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:title="995443 - Disclosure - Award Timing Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems" xlink:label="loc_ecdAwardTmgDiscLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="loc_ecdAwardsCloseToMnpiDiscTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_ecdIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="loc_ecdAwardTmgMnpiDiscTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiDiscTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="loc_ecdAwardTmgMethodTextBlock" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="loc_ecdAwardTmgPredtrmndFlag" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgPredtrmndFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="loc_ecdAwardTmgMnpiCnsdrdFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiCnsdrdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="loc_ecdMnpiDiscTimedForCompValFlag" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdMnpiDiscTimedForCompValFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="loc_ecdAwardsCloseToMnpiDiscIndName" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="loc_ecdAwardUndrlygSecuritiesAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardUndrlygSecuritiesAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="loc_ecdAwardExrcPrice" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardExrcPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="loc_ecdAwardGrantDateFairValue" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="loc_ecdUndrlygSecurityMktPriceChngPct" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdUndrlygSecurityMktPriceChngPct" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="995445 - Disclosure - Insider Trading Arrangements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems" xlink:label="loc_ecdInsiderTradingArrLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable" xlink:label="loc_ecdTradingArrByIndTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTradingArrByIndTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis" xlink:label="loc_ecdTradingArrAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdTradingArrAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember" xlink:label="loc_ecdAllTradingArrangementsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrAxis" xlink:to="loc_ecdAllTradingArrangementsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="loc_ecdMtrlTermsOfTrdArrTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdMtrlTermsOfTrdArrTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="loc_ecdTrdArrIndName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="loc_ecdTrdArrIndTitle" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="loc_ecdRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="loc_ecdNonRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="loc_ecdTrdArrAdoptionDate" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrAdoptionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="loc_ecdRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="loc_ecdNonRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="loc_ecdTrdArrTerminationDate" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrTerminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="loc_ecdTrdArrExpirationDate" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="loc_ecdTrdArrDuration" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrDuration" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:title="995447 - Disclosure - Insider Trading Policies and Procedures">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="loc_ecdInsiderTradingPoliciesProcLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!PD'!@H)" D+"PH,#QD0#PX.
M#QX6%Q(9)" F)2,@(R(H+3DP*"HV*R(C,D0R-CL]0$! )C!&2T4^2CD_0#W_
MVP!# 0L+"P\-#QT0$!T]*2,I/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3T]
M/3T]/3T]/3T]/3T]/3T]/3T]/3T]/3W_P  1" !0 ,@# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#V:LQ_$>C1
MR,CZM8*ZDJRFX0$$=0>:TJ\I\%^$=(UZYUR74+;S'2_E (..KM2;L7"*=V^A
MZ$?$VB#KK&G_ /@2G^-+_P )-HG_ $&-/_\  E/\:X'QUX$T73=&CDL;3;(T
MH4DG/&#6SI'PTT$Z1:&ZLRTS1*SD-CDC-3S.]C5THJ*FWHSI#XGT,==8T\?6
MY3_&C_A)M$_Z#&G_ /@2G^->(_$?1]*TWQ+!I^FVX15V[\G.2>?\*]-TSX;>
M'I-,M7FLCYK1*S?-W(YH4FQ.E&*NWH=%_P )-HG_ $&-/_\  E/\:=_PD&D&
M SC5+'R0P0R?:$VAB,XSGKBL3_A6?AK_ )\C_P!]FO%]3TN.Q\=2:8%VVIN/
MFBS\IP2 ?K@G\Z')K<(THS^%GT#_ ,)+HG_08T__ ,"4_P :/^$ET4G U>P)
M/_3RG^-8H^&GAK:/]"/3^^:7_A6?AH_\N1_[[IWD3:GW9T4NIV,%K]IFO+>.
MWSM\UI5"9],]*K?\)-HG_08T_P#\"4_QKSKQA\.K?3+02Z9+*EE)(OG6Q;Y2
M1RIQT-=/;?#;PY):Q.UD=S("?G/I2YFW8ITHJ*DWHS>_X2;1/^@QI_\ X$I_
MC0/$NB9 _M?3\DX'^DIS^M8W_"L_#7_/D?\ OLUS?CGP'I.GZ1#)IEMY=P9U
M 8G.._\ ,"AR:5V$*<)OEB]3T:\U*RTY ]]=P6RGH9I N?SK/A\8^'KB0QQ:
MS8LX.,&91S^-<_I'PWM)E6_\122ZAJ$OSN97R%SV_P \5K3> /#<\1C.F1KG
MNI.:=WV)Y8+1LZ*-UD0.C!E;D,IR#3;BXAM8C+<2I%&.KNP4#\37FNH6=Y\,
M;Z&^TR6:YT69]LUFS9V^Z^A]_P ZET7PQ<>.?^)WXHGD>*5B;>T1L)&OL/Z]
M32YNG4?LK+F;T.N/C/PZ)A$=:L-Y_P"FRX_/I6I;7MM>0^=:SQ3Q?WXW##\Q
M6(O@/PXJ;/[+A( QDD_XUR?B[X<QZ?I%Y=^';BXM"8R)X8Y"!(G?IU_&G=K<
M2C"3M%ZG=_\ "3:)_P!!C3^/^GE/\:/^$FT3_H,:?_X$I_C7FGPS\%Z1J^B3
MMJ-KOECD"@@X[5V?_"L_#7_/D?\ OLTE)O5#E3A!\LGJ:_\ PDVB9_Y#&G_^
M!*?XTY?$>C22*B:M8,[$*JBX3))Z <UP>G>!-%E\7W]G-9_Z/&A9!G![=_QJ
M#QIX1TC09]$FT^V\N1[^($DY_C6DIMESH1B^6^MKGJU%%%:',%<'\,OOZ_\
M]?\ )_Z&U=Y7!_#+[^O_ /7_ "?^AM4O=&L/@E_74W/%EM]LBL+?&?,N57].
M:W?EC3T51^E5;Q8VO;'S.HD8J/?:?_KTS77ECT*^:W&91 ^W\J5K-L')RC&!
M\^ZS>G6_B(\A)*M,<?3/^%?1L2B*!%'1% _(5\V^"[=KOQ_;JWWO/7K]:^DK
MAQ';RN>BH2?RI0-:^MD5M(N3>:7!,S$E@<D]^2*\5\:6HM_BD" 0&E#<^^#7
MK_A202>';;'\.Y?U-><?$>VV>/K&8?QB,_KC^E*3O%,NC'EJRB>O+]U?I7)>
M%[B:7Q-J\<DCLB,VU6;('S'I76C[@^E9MEIMC9WES<6F&N)23( ^><YZ=N:J
M2;:9C3FHQFGU,[Q]/]F\)74HQE"I&?K7#?#KQYJVO^(8K*ZFS H(VX'0#BKG
MQ<U35$T46WV0Q6SG)<-NW$?3I7%_!GGQ=']&_D:EZNYK&\8*#\V>^:C*\&FW
M,L9PZ1,P/H0*\1M/'NJ:WXBM].OI/,A6=< J.N:]KU;_ ) ]Y_UQ?^1KYL\.
M?\CU#_UW'\Z)JXL.^577<^GNU<GX2N9IM<U=9)'=4?"AF) ^8UUM<;X,_P"0
M_K7^_P#^S&G+XHDT5^ZJ?+\RS\15#>%'R ?WJ?SK3\+ #PQIV/\ G@M9OQ$_
MY%23_KJG\ZT_"W_(L:=_UP6A?'\@?^[KU_0Q[FXF'Q%@@$CB(Q@E-QQ]T]JZ
M+5QG1[T'O __ *":YFZ_Y*;;_P#7(?\ H)KIM6_Y ]Y_UP?_ -!-*/VBJJUI
M^B.0^%G&EWV/^>P_E780W#27]S V-L00C\0?\*Y#X6_\@N^_Z[#^5=%;RX\5
M7D1/+6\; ?0G_&B#M%!B8WK3_KL5;>/R_'=R<_?M@WZ@?TK&^)O_ # O^PA'
M_P"A+71M$5\6QR8X:T8?DP_QKG/B;UT+_L(1_P#H2T[63]1<W-.+\OT.[HHH
MK0Y0K@_AE]_7_P#K_D_]#:N\KS?X>ZM8V$NNK=W<,+-?R8#MC/SM4RW1K35X
MR2.K\37/V/\ LZ?H$NE)^F"#6TZ+)&RMRK#!^E<'\0?$&GRZ)%]EO8)768$A
M'R<8-;VD^*]*GTBTDFU"W25HEWJSC(..:E2]YFDZ;]E%I:ZGFOA#0S9?%22,
MID12.?RS_P#6KV:>)9X'B?.UU*G'H:XN"ZTB'QU+J OK<1O#G>'&-QP"*T_$
M'B73/[ OO(U"W:4PL%"2<D^U*#23N77BY3C9=$;6F:?%IEDMM 6,:DD%CD\U
MP?Q+M<ZWI$^!C[OY,/\ &K?P_P#$]F="D&H7\22"8X\R3DC ]:;XXU+3;];!
M[>\MY6BEYVN"0./\*F33AH52A*.(UU\SO5^ZOTKC?"ISXMUCV9O_ $*MY?$N
MC[1_Q,K7I_ST%<9X:U^PM_&FJ&:[B2*0N5<M\I^;(YJI-7B31BU"HK=/U-[X
MDQ)+X*O-XSM*D?7->2_!P8\8I_P+^1KU3QIK&EZAX3OH(-0MGD*951(,G!KR
M?X475O8^+_,N9DBC4MEG.!T-#>HJ::C9^?Y'OFK_ /('O/\ KB_\C7S9X<X\
M=0_]=A_.OH'5/$6DR:7=HFHVS,T+  2#).*^:5OS8>(C<H?N29IRU>@J7NKW
MNY]:5QW@T$:]K)/=_P#V8U/X<\?:1K=C$SW4<%QM&])#CGV-;3:II5JK2F[M
M(P?O,'7FAV;3N3%RA&4+;F-\1#_Q2DG_ %U3^=:?A?\ Y%?3O^N"UYE\4?B#
M9W=HNG:9)YBJVYW'\1]O:MCX<_$/3I]&AT_4)UAFA&U7;H1Z'TI7]ZY3B_8J
M'6]S:N@?^%F6YQQY0_\ 0372ZM_R![S_ *X/_(U&-2TMR)Q=VA.,A]ZYQ7(^
M.OB%IFGZ-<6UG<K/<3(4RG(4'KS322OYB;E4<=-M"7X6_P#(+OO^NP_E6P)-
MGCLKQA[;']:Y/X4ZY8P:%<M>7<,+R2@@.V"1BM&\\0:>OCVUF6[A: Q[6D#C
M X/>HO:*-VN>K-]TSL9("=5AG .%B="?3)4_TKD/B;_S O\ L(1_^A+73?\
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MS9BOT)%?4E%)Q4MRH5)0=XNQ\FS>&?$5Q*TLNCZDSN<L3;/R?RJ/_A$]?_Z
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;))-'OT1+N)F9K=P  XR3Q7U-15$!1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>proxy_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxy_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" -X K$# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHIKNL:,[L%11DLQP /6
M@!U%4O[:T_\ Y_[7_O\ +_C1_;6G_P#/_:_]_E_QH NT55BU6RGD6..\MY';
M@*LJDG\,U:H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M.G [\/X _P""A#M^U-XO^%OCRRTO2-$M]9N-(T;6K19(]LD<SI&ET7=ES(%
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M@DBN+=P\<BD9#*PX(([B@"Q1110 4444 %%%% !1110 4444 %%%% !1110
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M-%4M&T73_#NEVNF:386VF:;:QB*WL[.%8884'1410 H'H!5V@04444 %%%%
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M%O8K92B$RD&2U^S>22QE0DA 5-O"4V$,6IZ1^Q[X-T:]\<S1:EK<T/C1+?\
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M"OX5Z5\(_#SZ3I=U>WR2&(O<Z@Z-*PBMXK:)?D1% 2&")!A1G:2<LS$]G10
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MOXA^%?&5Y=VGA_Q-H^NW5F%:Y@TV_BN'@#?=+JC$J#@XSUH$=!1110 4444
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M7^MO?>5/&L9GFMYE9+\S0+MLKB=(K<X55*[0[A&!FCXE_P"%,:_<:YIL^O\
MC#5(_%%U&##::3.+:%;Z.6,B*?[*J;/^)ZTK;Y'9#-&#@!4JS\.=!\#WWP_^
M%_BQQXNU>VL=;O-'L+K4+N"[N9I+VZDB-U?LRKNW.024R0T@^_RU:'A75/A#
MXD\&ZM+;>#_$%BOA:.T:>QEOG%W',9HH;> 2QW;!I3_9=B^6DVE'A9FQ(]2?
M\+@^&7P[T>[\%)X*UJTM?"TMKJEQI=O?6=T]C+Y-SJ(+E+UR'C-E+NC8Y+;-
MH>-@U SD-2^$OPT\*^']9U"YN/B$;3P=+?Z&=-,UK'$RS)%&TGF%5A"_Z>TT
M<D\B,!-,3\B;4T+C2?A?\1-=DM[ZZ\7Z);:+&?$CZE%?6C6ES'$IU"X@#6[R
MM+&(]>"N%&QUVA'?:2W3ZA\3]*TKP=_;VM^%=?L[SQ+XIU#19],T35GM;SSD
MD:"(DQ70C\XBQMT++*JKN<JP#,&Y;4K'P'I^K64_A_P5J.EKXT\*W/A.\U5Y
M1/=:'''=6NFQ1/%+=[!$DLN'%N'9W16RV2Q .@\0K\*KKP'I.LW7BWQ5;:1_
M:6J)!)%I$QN8Y+F0WTL<L!LC)&D3Q).C2(.(DWLZ,0^GXFT7P#X9^%_AWX@K
MJWB"ZT/PPN%\MK>UFNY7U*WE<W(NDB6)Q=0+O!,*H#*&"@ +Y_HGQ2^"K:#?
M:</"?B?4=#TJ"X-]J,FM1ZA;B;['?%E\Q=0E:662WAN%#IO 'E(SKY:A.EU#
MXK>!-$^'YLO'?A_6M!L==U;5(OL5K>RK]D-GK&YI&DBNCY4R&=[MW@?_ %=M
M,P.(D6@#FK?P3\'=)T?4_#NK^*?'6JZYXEATVZGDU6R;6KV;<);J!DD2UFM[
MA"$E5V0RPXC*D^LDMG\#?$7A.*PU'Q;XO_T_3+=Y3>6D[W7EM96=T7D86S*7
M6#3X9)&!(0R'=CS$%<S!X]^#'A?5]9\5Z[X(\06<>J7NG:G8:I-KK1C53;VE
ME/ EU]HU$!IXOMF\B<+&V!R\F >^\!Z+\%;G2_'>OZ5\.->METO1C+/-=W+2
MW&K6-O;WFGKY -V[@^5#<1!9O*<Y4D9^8 %'Q]H7A7Q'H_@[4=&T[Q%XQ\)?
M\)A<'48%\NQO;26\50EGY%R+9Q$]Y+;7.Z0LZE(RN4*F/#U'2_@MKD;6^M?$
M/QW;/KT5A_:,ESI82"Z00VQM$FN([#[.@A6:WRT;J%,H\UCD5Z5X=^.WPQ\4
M>($T:U\.ZPMEJVNO<V^KR/%]CO;RQCAD6=&6X+[/*CM'4E KB1."=X&=XS\0
M?!3P?X?\!PZAX4N;VS\76:S:9IR7<33%1;VLD44D,ERKMO%E:1[@&C#1@2.@
M<E@"I\;]9^&=[X7TCXH0R>)[B\LH_P"RM,72=/ECFCNK7=?0236\ML[1M&+>
M8*\D10)=2$J4?<MWP-X%^$FM_$#PS)I7B+Q#-J5C8LUGI&HV+V\2>5 =/D:8
M2VJ.DS)98,3LI_T<NJ ;B<2[UOX+_#WX>Z/X O?A_KOASPI_;/V:TM)-4BC;
M[:X87:+(M^9I#$9C%)&I;S!*5B69-V.M^%FJ?#?QCXTO_'.B_#[6M,\96FBW
M$V[5)(X[B2*6[N))[=(S<L@D^T>;OR (VD",R$%% /)OAZ_P^TOQ/JM[<:]K
MEC\.=-M8[719;BSN9//:WBM-9FGS]@C,2NELKA7>0S 2>3M  KI_%7AGX7:;
MK6CV<_BGQ-8>']3TO4-)?5K6-# '@6UT;9/)]C9E3<%96=U@:6-6VN"F/./!
M_C#X.Z+X)L?&VL_#O4_#NO6\-ZOAVYU+4)=2MVB=%L3&@FU >8(H1!&\;M$&
MVD0#)%>H:[J'P5\*ZEX-^%?B+2=<U34/"J6.@6++))!#=M(=/EA,R1S(DRRO
MB7$JE<V%V<?N_G .8O&^%6J^)O#FAQ:_XT30M(\/VI$T.D3&::ZM_MD=J\EO
M_9K2"9$:[G/S1(0L;>3(A<KV5EX9^%GQ&\:+#;?$+Q5J7BB_>22WU!;!(U\T
M1K;RS(_V$6Y\U=*GVYRC[)S$,*-G%_"/4_@KKU_H_AWPGX&U;3O!EU:VOV74
M;#5I$FL[B6YOH@LLT5\9"DGGNH$6\CSG278%VKOP^*/A1X7^-%OJ>G_"S4+'
M7?"=[-H0U(W2P-96\O\ :-Q/.+;SMI@Q%+(@8"0I."B!?+# &1X)\4?!BX_L
MJ2"_\7^%;/1;[39M&2?3)WEO,R274-LA-H[B1Y-2EA\J)_.EB5<$QNQ;MYOA
M_P#"RZ\3:UK.H>,?%FNW?C+3?,\Z\6:ZM[.SU*94MTB<6Y2V4N-L2.00 V0<
M$C(U*V^ ?BKX'^%Y-1\)WE[X1\7>(8K2UTVXUI3.+MI#:(ZL;WYXT"*JK;O)
MMC"E4VJ2M;4OB!X"\1:#H-EI/@#Q'8W=U!IFC+87FHB&*WTM9]/\F>7[/?%6
M9%U2%HG4O,CL3A<$T =/X#TGX8PP_$*2UU_Q-=Z=X=U73H[V:^L]L,#64QF@
MM;4I;JTZK(YC(_>2L<#)W(S<=\-]<\$Z)\6;OP+X=M/$WB*'Q38VNAWNL:W;
MW%F;:&*VO8S"JBPC56BCLUB^=PS-NS\T3DY?BF?X?_#:'XD)=_#":ZNM+N[N
MUTBZN)C=2VNVWM UZ]Q)?-+&TT]_ IDM]DY3RM_^JRG3Z#\6OAK\,Y+?5M6\
M+:I!+IWB";2I_$4%RUQ;VDQN[^-'N&GNC,Q$$US/+*5=0)'.<A5 !P^B_#/X
M*S:XFAGQ%\0[K3]!N/M)U-DNW36I+HJTEO<,MF!+$S:=;O&P;$LF/+9F7%>C
MZ!HOPQ\?:3>ZI>>./%=\++PQ%-?+JMG%;/%9/97)1SY=HBO)';ZD05C+8_<E
ME+'+X>DZ?\%_$MGIWQ,T#X=ZYJ6IZ;XBL=(C_M/4IT.EW4Y@+*89+DHJV[3K
M&T2+A9%9%& 6%3X)^-?@Y;ZAI_AF?P-?>'?&7CC2+'2-7M[G4$F\ZW%A%Y&T
MF]ED:)HI JF/=(H7,VS :@#?TGP_\&M2T'6-3;Q)XJU :'XDA\1:K?7>D3PW
M/]HR2>6(6C%FA+-)]Z"- ZEAD*"*BU;4O@]XF\):!X-O?B+XJM4T^*2Q@DN=
M):VN4L2T-N\,WF6 6.W$@AB,S*K"1=AEW[A18_&/X:>"-"\2Z8GP_P#%,FF1
M^(W%[=0W2W:76I6\ZR>8T\]T) RI"MS)))MC58WW.<?-!_9OP;^('Q)C_P"$
MF^%FI6NJZ+K-U:6&K76H)):2L;G47\P!+K=MD>TNV*R1X!*CD;30!PFD^&/@
M!X1LSX:'B;XD7L-[';R0ZI>6=RTU@RP7MK9QH3:B6.6)0?)B*%OD@959%:O0
M?!OP_P#@O_PGA/AC5];U?4-4M9ETSPWJ8NX]'ML65Q%-9AVMB+4NC.TD+-Y@
M,:ML^7:><\,/\'M%L?AU/X7^$>NVWAR>Y>33;ZXU@QPPM%J$$?G/$+N1Y=L]
M[(%+J64EE4"-RP33?B!X-M?BY!XUTKPAXN@L-(MC>RZ38VBSR3W6HH[6\K@:
MD\<C7"W 6-4M_,4R*KR(J[% '^"M7^'=CX!TC^T]<\4B+P_:QPS7UCILYB\3
M26]M%K<LK&>UW1EY6FEC^>-IAN(9QP/3O"OPQ^&'Q,O[VVTK5-:N+S3/"EMX
M8N+>Y@:W:&S=#Y;XE@7,PV.K%<A'1E958$#B+KP?\&/"DG@374^&NL:E#J&C
MZA/;7$FNM>RV">1;6/V5@]XZ-YB2Q6ZA79(R!]T;G76U'QA\._@3X/N?&W@_
MPEK4>M:]9RW\\DM[)-MGM MBAU#S+O,H$US'&WEF4LS>;\Q42  RM/N/@KX_
MO;35;3Q5KLUGILUCK5[;6(@O(;:YEO;^>%+WR(I7@:-Y[I7#,B*CIO).&&OH
M]C\'_B3XD_L;PWX]\46^O:@BW<%UI2SVTEO]JM[ZZC9+@VX6)VBO[IE!8-^Y
M*XW12"N6\>>,O@[>^&=/_P"$Q^&6K1:/H&DI=-#=ZO;6[6[V,D:06RC[<$F<
M)J32*/,;<'"C?)\B]/\ ":S^#]]\:+2^T?X;7VA^)]*U'5=%M-?6;=9FX,ES
M<30@"?<69'FD&^':@;8K *HH P])TWX':&ND7^F_$OQ)8MI6GVJV=X+;?]B*
M6-FZW$ADLV599K>*U7;,-K-N5$$H8#USX*^#?A_X0UZ#1/">H:I?ZAX>L+RU
MD-U;OL$<U\5D#S>2J,XGLI%50V=JL<$$-7@F@^*O@A'X0N&USPSK>KE9[Z[U
M:ZM(?L4,<UZQN?(>".[.XQRW#6L8!D,$L#G<F/-/T3\&Y/"&G>)M?T/PMHFL
MVTUE$5OM3U2]>[\XKJ%^FTR33R3.QF6[DW,,%77+=%4 ];HHHH)"BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH \-_:LO-$TOP_X=U/7O!]MXXL],NK[4?[)O&4Q/Y.F7DC9C:"42
M,55E53M 9E)8 8/E>C_M&>!_&EGHNMCX?^ 8S:6T*Z;>:QJ2VPMXENRD=Q$9
M;$216*LHQ.50K,T<?E MN'V-10,^!YOV@X/"/P[N;K2_ ^A:=:>+=12[DTS6
MM:M88[RRA$%G]BBB:S2$1+#;>2P8@0Q&.4LY=@/1_%_Q2^&OPZT?P7_9?PT\
M'7-UXU\.7&IMI\%N;8-;P:7+(B;OL)62$QE[?]YY;!)?EB8%E'UC10!\H:+\
M4-,NOB%\/_AK!X'\(>%8[76)I;K2[:>&51(K:LA:QA:UC+*);$2-.!$RF51@
M[B3J_#7XX:=XX\<67A/5?!OA.#4!JNH:=-'9WRRW$+Q7-U.98[=H 7AWV<9D
MEW)^_(^3(!KZ:HH ^*M:_: \#^ O"_BF2'X2>!H/#&F[([V.SN598'EDFMT@
MOH(;!S!+Y?VD.F)-OGQKDK,S(S6_VG?!6AZ'/9:?\-/"G_"*>'=6O-/N;-XG
M2.VDEL+QW1(OL85)24N$N/+$H$;2;3-O('VQ10!\D?%']H#P#I?PG\#ZYJ'P
MY\-:_'XTLIKF#0KY#B8(D!#(39.KQ$QVQ+2B)@B1$(S*$7J?&?QHMO ?PUTW
M4V\(6>BZ]K^OW'@^9-$D$WV><378WPRM:8F)D21T6:)$9YCO*@LQ^CJ* /A+
MX5_%[X?:II^B^!K[X9^$KF\M--T31;[4_$Q6W1H_L7F1_:I);1A\QMU\A5:4
M.=N3$<"MRW_:"TC7O!MAK7B?X5^ KJ32[5M,@N)M23[.C"S\RYL(#)9L8Y2C
MK"MMGYW$Z$@1Y?[1HH ^*U^+GABQU+2C?_!CP#H*SZ79:W:W>H3PQ6=O&CQ0
MV$MQ=FT'V;R4>9 !&^PM&J, QKN/$?Q:\/? ?Q;KFC:#\+- T9;&S@>35H)8
M]-L?LLOEM;&:9+8A$DF.HHH^;Y[8<#S_ )/IRB@#XGTOXPZ;+H&KZ1'\&O L
MVEZ-/.MOX=?;:BRMU-_>.)HQ:R"*<II\,GDA "TB2;QN4#T>S^-6D>+O$_BF
MZ3P?X;?5]!U32H$O#<)>7P#:I<6"&X3RD:WE1&N)(QO?"W!(.&8'Z1K!T3P1
MI/A_7M8UJTCNFU/5M@NI[N^GN<JC2,D<8E=A$BF60A(PJC<>* /DVV^-FD:)
MI)O[+X/> _#_ (CT+0;K6])9+Q66UC^R6]X1&5LDDC!CNW+D!$W*5WL7R-&7
MX]> M-T?3KN_^&'A"UUGQ-':^)8K&.ZMF-T)!>SI?2,;=681&UCDDF"-Y7GL
MV6V?/]?T4 ?&-Q\=M TV*'2[SX??#F[TCP_<-<:5%IU[')I>GGRM/GAN5NC;
M!85<WLNV1(1O8Q 8R6/3V_C+2_'7@?QCKS?"7PUI.K^%]'FUOPV=0A2>>)H7
MN+>,RHUJOV:5&TV+Y(S)@)&-WR"OJ>B@#XSU3XZ6%QIZ6>N_#'PKXTU_3?M3
M7=Q>:C#/*EQ;VUPL\MT5T\""><6*[ L8$D9W?($"'TCX<ZMX8^)7C+7-*\8_
M##P=HFLVZ36$$RR17YOU:XOHKJ%3):PL5+6UQ(5P=ZR.S ?-GZ$HH Q;CP3X
M=NM,N=-GT#2YM.NKK[=/:26<;12W'F"7SF0KAI/, ?>1G< V<\U73X<^$X]4
MT[4D\+Z*NHZ;S8WBZ?")K7,2Q?NGVY3]VB)\I'RHJ] !7144".7U3X6^"]:L
M)K'4?"&@W]E/=&]EMKK3(9(Y+@]9F5E(+_[1Y]Z+_P"%O@O58=7BO?"&@WD6
ML3)<:E'<:9"ZWTJ?<DF!7]XR]BV2.U=110!R-M\(/ =G-;S6_@GP[!-;W NX
M9(])@5HYPNT2J0G#A>-PYQQ3H?A)X&M]+O=-B\%^'HM.OMINK1-*@$-QABP\
MQ F&PQ)&0>237644 <Y<?#?PE>:7IVF3^%M%FTW3HY(;*SDT^%H;6-XVB=(D
M*X16C9D(4 %6(/!Q1??#?PEJEEI5G>>%M%N[325V:?;SZ?"\=FN N(5*XC&
M!A<< 5T=% '&3?!7X>W.CVNDS> _#,NE6BR);V+Z/;F"%9'620(A3:H9T1B
M.612>0*W+#P?H.ES":RT33K.7[0]YYEO:1HWGLI1Y<@??*LRENI!(S@UKT4
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M#-^DL4JS1)(AW(X#*?4&GT!<^$OB!^TA\9M0U'5[KPQX;^(^EQSRP2Z?8_\
M""RO!;0FPR(I&DM&D:5;X@3D$H8 WD$O@U@WOQ\_:(L-4%U:V/CC58+A[E'L
M)O 5PEM;[Y=42%E9;%)2B1II4GWRW[V0$,0RI]_7VMZ=I=Q;P7E_:VD]R=L$
M4\RHTIW(F%!.6^:2->.[J.I%7: N? 'BK4M=T7QS>W.D#XW:_P"%+?\ L1&M
M8;7Q-'=:C L=VFH+#Y@18IFD%A(6+1Y <(XW.#F_\)U\5_)T'SXOBI<:A';V
M@L[BWT/6HH-,1=0N'N8]03[/_IDKV+6\*R!9<2(QRO\ K&_0+^W],^W_ &'^
MT;3[;YWV?[-YZ^9YOE^;Y>W.=WE_/CKM^;IS5^@+GY>:#XV^-FD^$;[2_$&D
M?&CQ%J4EIH46GZQIFG:Q#-I[!;B6_D>,B);B6-IEA"R$I+Y4;,7"\['A?XB?
M%JQU70/[9\/?&BZ7^T]/FOM0MM,U=Q T4C/?RK;L5CE@N1Y$:1,,1(L["%&*
MA_T5L_%6D:AXBU#0;:_BGU;3X8I[NUC))@60L$W'H"=C';G.,'&""=!KVW2\
MCM&GC6[DC:5("XWLBE0S!>I +J">VX>HH'<^=OV']6\1W/P^UC3?$]OXQ_M"
MQO5\N_\ &]CJ-K?7L31*!*R7<T\:G>D@V6\S* %8K&9,'Z/K*T'Q-IWB;^T?
M[-F>X73[R2PG=H)$3SH\;U1F4"0*3M+(2H967.Y6 U:"0HJE%K>G3ZG+IL=_
M:R:C$"TEHLRF5  A)*9R,"2,]/XU]15V@ HHHH **** "BBB@ HHHH ****
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M9!);HM5^ 'PVT)O$/CF?QQX5$MCK,OB'4-8FTV"X>W3^T;=DC=UEW_))I]U
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M^8P4$@SZ&T'XR> /%6J6&FZ+XY\-ZOJ.H1O-9V=AJ]O/-<QJ7#/&BN2Z@QR
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH R/$7@_0?&$=DFO:)IVMI97*WEJNHVD=P()USME0
M.#M<9.&&",GFN#\=?LU> O'5C]C?0M/T>";4DU2^_LS2K%7OYEW<RO) [!CO
M;]Y&4EY.'&3GU.B@#CY_@YX!NHY(YO _AN9)+UM2=9-(MV#W;+M:X(*<RD<%
M_O$<9J?5/A5X*UR\U*[U'P?H.H7>IJB7T]UID$CW:H5*"5F4EP"B$!LXV+Z"
MNIHH X^W^#_@>Q\26'B"R\*:1IVMV+B2'4+&T2WFXMWMU5FC +H(I&4(V5'R
MD#*J1MOX3T234DU%]&T]M02225;MK5#*KO&L<C!\9!9$1"<\JH!X K5HH H_
MV'IITN#33I]J=.MQ$(;/R5\F,1E3'M3&!L*J5P."HQTJ.;PWI%S<&XFTNREG
M-REX97MT+>>B!$ER1G>J *&Z@#&<5I44 9LGAO2)I?-DTNRDD^U+?;VMT)^T
M*H19LX_U@4!0_7  SBK5CI]KIL)AL[:&UA,CRF.",(I=W+NV!W9F9B>Y8D\F
MK%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=&8X 96!Y!KS;_A5'BEOCQ:_$PG1P\FCV.D76CR7$DJ1 /<-<RPS>2")$\U
MC;0)%\U&$>X,OF'CC]C[Q3X@D\:ZEI>M:38:[JD%Y:6$[O*4-M=ZEJ,]S!.
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MWX"L#JNI//J0MD:V-BMQ"5_=LQ=Y6,6 "%5'=F!*1O1US]JU]#_M[-AX3O\
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M""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?^#I?_C5?7=% 7/D3_AV+\+/^A@\<?\ @Z7_ .-4?\.Q?A9_T,'CC_P=+_\
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MXOOXH9Y;65[7Q!'(J31N4DC8K&<.CJRLIY!!!Y%>?^(/V=_$7PCT/P]I^O\
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MZ?I5_<>/_"\%CJS.FGW4FLVRQ7C(5#B%B^)"I= 0N<;AGJ* .VHHHH ****
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M(?WBX5F!;G:#M;$FJ:Q8:'9F[U*]M]/M?,CB\^ZE6)-\CJD:[F(&6=E4#N6
M')H MT5%<W,5G;RW$\BPP1(9))'.%50,DD]@!7$^"?CEX'^(T'AN;PYKR:I%
MXCMKR[TMH[>91<1VLB1W!^9!L*/*@P^TG=P#@X .[HJI>:Q8:?=V-K=7MO;7
M5_(T-I#-*J/<2*C2,D:DY=@B.Q R0JL>@-1R:Y:QZ[!H[>=]NFMI+M,6\AB\
MM&1&S+MV!LR+A"P8C) (5B "_7R+XL_Y2A>#/^R>2?\ I5=U]=5\B^+/^4H7
M@S_LGDG_ *57= SZZHHHH$%%%% !1110!\B?$K_E);\(_P#L4K[^5U7UW7R)
M\2O^4EOPC_[%*^_E=5]=T#$8!@01D'@@U\J^*_V5/&.H^&GM]$URPT;68?%7
MB7Q'9WUG?7%J\'VV"^6QQ)''N!26YA,B_=VB0#>/E;ZKHH$>)?!_X4_$/P?\
M5/%WB'Q9XVOO$>D:J'-I8R:JTEM;[I%9%CLS;J(#&H9-ZS-Y@.2BGIX;\+_V
M//B_\// \]@OBS28]2<V-N\6FZO=V?VBVM[:ZCC1KN"WCDC5);A)501L6\ME
MDD8,-OV_10,^0]/_ &<_CV=0US^U/BM)=VVHPVL+3VNMWEN=T5_92M+#"(O]
M%=K6*\C81R,KM*O"JQ"]A\+?@%X[\(_&B_\ %6N>(H]4LETG5=+L[VXUB\OK
MDBXO;>>V/V>=/+@$44(C94D;>45CDLQ'T910!\K>%_V9?B--K7@V_P#&/C Z
MP/#_ (@L]5,8U[4)O,\JRNHKB=2P7:\\TMNWV?'E1HDJ*Q61U:WXT_9M\9>*
MOB]XCU>*X\/V7AW4?$>F>([?4?/F;5(7L[&&#R%C$01!(\1W.)#\C'Y<G%?3
MU% 'R'>?LO\ QAN?!:V@^*&JV^KQ_P!D1%--\4WMHDL%OI4-O<HLQ@D\EI+M
M'GWB%RZ_>VEVQ?C_ &:_B;=ZAH-[K7BC^W]3T7Q+;ZQ;ZG=^*-03S;9;>>'R
M3:)"MO&\7FJV]%_TC:RR!%=J^K:* /ESPA^S[\7[6^T4>(/B)<S:=:WT5S>P
MV7B&^:6[,=E<(TOF.@*K-<O;2-:X\J-8F"ELX/5:;\'_ (C2? ;0/!^J>,9E
M\2P:Q;SZCK-GK5Y]HEL%OA+-&+L@2-*UON3(6-,D *B@8]YHH ^2O#/[.?QJ
M\/V+)?\ Q'U'Q0W]L0WES:ZAXNN[>/48%2X!"2P6BS6(W20/Y*-,C>5M+ &K
M>G?L[_&.X>V@UGXD7#V(U"*:^%EXAU".6]18+]7F5U"M;;WN+/\ T6)O*7[.
M6#;L"OJJB@#Y"@_9K^.+^#8M/NOB?.^K6]C?&"ZB\2:BN;Z6TTT0O(P0,\27
M5OJ$FQ@55)U4*0S(NQ_PSS\7X?&FAWR?$W5&T#3;N]\K3T\17"?Z.][/+!]H
MWVTK7;?9WBA*NZ%#'E9&ZU]2T4 ?&/B']E?XV:Q\-;CPM<?$!-8AN=/DM9X-
M0\3:BHDGFTJUMY99)Q$TDL:W<=W(+=QY;)<#.TC:/3- ^%OC?PKX/^+D/B7Q
M9J#V6L0N=$GT>^O[V^TQ1%(H,*1QJ8]I,92*",M\AW-(37T%10!\E^ _A/\
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M<2>(K^.>*-([G:JF.'RK>/S)+<FWCB?>L;*TI.UA]:T4!<^:?AW\!?B9X/\
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M@'2R?M!?#=M/FO++QSX:U6&W"23FRUNS?R83,L33,3* $5G&><Y^50S$*8_
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M4;:CHQ^4DC3MOC9\.[S5+33;?Q[X8GU&\,(MK./6+=IIC,JM#L0/EO,61&7
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M\[\;?$?7M-\>:;X/\*^'M/US6;G39M6GDU?5GTZVA@26.( /';SLSLTGW=@
M"DEN@-GX5_$6^\='Q/8ZQH]OH>N^'=4_LN^MK.]:\MV8P0W"/%,T43,ICG3K
M&I!!'.,GGO'%CXC\-_&K2/&>E^$]1\7:8WA^YT>>WTBYLXKBWE-S#*CD74\*
MLC!7&58D$#C!S5KX(^']<L=3^(?B'7-%N/#K^)M?&HVVF7DT$MQ#"EE:VP,I
M@DDC#,UNS85VP",G.0 9ZE1110(\LNOB?XOUKQUXI\/^#?"FB:K#X;FM[2^O
M-<U^;3RT\MO'<!8TCLKC<HCFCRQ9>21CC)ZGX6^/(_B;\/\ 1?$T=D^G'4(2
M\EF\@D,,BL4=-P W ,K -@9 !P.E>>V*^*OAI\5/B1J,'@+7/%NF>)KZSU&U
MN]$NM.01>786]J\<BW5W"P;=;E@5!!#CG((KK/@%X1U3P+\(?#>BZU"EMJL$
M+R7-ND@D$+R2O(8]PX8KOVDC@D'&10,] KY%\6?\I0O!G_9/)/\ TJNZ^NJ^
M1?%G_*4+P9_V3R3_ -*KN@#ZZHHHH$%%%% !1110!\B?$K_E);\(_P#L4K[^
M5U7UW7R)\2O^4EOPC_[%*^_E=5]=T#"BBO/?A?\ %*;Q_KOB_2+BSTN*X\.W
MD=G+<:+JAU"W9V4LT3.88BDR8^>/:0NY?F)R%!'H5<-\0OA1;_$#5])U(^(-
M9T"ZT^UN[$MI#6Z_:+>Y,)FB<RPR%0?(CPT91QSAA7<UYW\;_C%!\%_"L&K-
MI4^NW4]P8X]/MI DC11QO<74H)!_U5M#/)MQEBBH,%P: ./L_P!CSP1HGB"?
M6?#\]YX;O_/%U9SZ=9Z>9;&7"@M'-+:O*ZD*1Y<KR1C=PH*H5MZ%^R?X-T'Q
M@/$D,UU+J0U.?5O,>SL$D:>9;@2[YTMEFD0M=2/M>1@I";=JJ%K>U3]H[X?:
M1JU[ID^LW,E[:-&ACM-*O+@3-(ULJK T<3"X.;VTR(BY7STSC-4X/VI/AM=>
M?]GUF^NFAD2%TM]#OY&\UH6G\D*L!)E6*-W>,?/&$8N%VG /4R-+_9)\*:/=
M:+);:QKPBTV2VD-N\UNR7?D#3O*64F'=@-I-H^4*$MOYPVT;7PE_9Q\+?!B:
MPDT"2Y L;2XL84>&UB!BE^RY,GD01F5P+.("60M(06W,W&&ZM^U-\+]%T&ZU
MJY\4*VE6O_'Q=V]C<SI"//F@#.8XFVJTEM.%8\,$+*2I!-B']H#PUI_A&/7_
M !%(^B0R7VIV@CCBFO"L=E<S0RW#^5&2D06'>SL D8<!FZ$@$,?[.WA_[-\0
MH[C4+^YF\<VWV35;E8;.VDV 2@%?(MXPS@3N/,E#N0%!8@ 5N^+OAS?>._"O
MBWP_JWBG4+>PUR<>1)I,,,$]C:>7$K6RLZ2"0.T<I9G4DB=E& %QRVE_M->&
M(OA=>?$#Q.+CPOX<BU>\TR*::TNY7*PW$D*RR1^0'C+>4Q(VD)G:6W9 W_&G
MQZ\#_#W5+BP\0:O-826UHE]/.-.NI;:&)Q*8R\Z1-$K/Y$H5"VYBN "2 0#G
M_$G[-.F^(BSCQ?XHTFXDC0R3Z5+:6[O=+:M9B\XM\)-]G=HOD"H %8('1&71
MT_X#6=E8>$]-D\3:U=:-X;DAFM-,,&GP0/)"Q:!W\FU1ALR  C(I"C<&RVZM
M-^U-\-K?3C?S:OJ,%I\JI+-H&HH)9"R+Y,>8/WDP:1084S(/FRHVMBV_[2GP
MYCA,S^(6C@6VENI)GT^Z6.(1PRSR12,8L).L4$SFW8B4"-CLXH ]&T^UDLM/
MMK>:[FOYH8EC>[N @EF8  NX150,QY.U57)X '%6*\GMOVIOAC>:K>Z7#XBE
MDU6SM+>]FT\:7>?:1'.\"0XB\G>SNUU;@(H+_O5XYINA_M+^$+OPKX9UO69I
M]!C\2:O=:/I<4UI<2&:6*\>U0/B(&%G*J=L@4J6*G[I- CUJBO'%_:\^%/\
M9D^HS^)+FPT^&$3/=:CHU_:18, N%4-+ H+M"PD5!EG4Y4$5-I_[67PJU6UM
M;JU\4-+9W-K)>1WG]FW8@\N-;IF#2F+:CXL;LB-B'/DMA3QD ]=HKPW1?VP/
M NI>(/$.D7:ZU87>EZC'8I#_ ,(_J4LLBR1Q&-Y(Q;;H&>5WB2-\,[(-N=ZB
MM2+]K3X4W.H26%KXI-]J"6EI??8[+3;N>=HKHP"W*QI$69F-U;_( 6'F#<!S
M@ ]>HKR./]J#P5=>$?'7B2S36[[2_!RQG4'ATB</(7A67;$K*"64/MD5MIB(
M/F!%PQZ2W^-'A.\U/5--MKV[GU#3K6XO);9--NMTB0;//6',>)GC,L:O'&6=
M6=58!CB@#N**\%\._MG?#W4K;5KW6+B[\+:;9V]O>P76J65PJS02V,%V,L(]
MBR@3%?)#L[!-R@J173_\+RA\6_\ "))\.;;3_%K^)=-N]8L[F^OY-/M/LEO)
M!%(2X@ED$GF7,2A#&.DF2I4!@#U.BO.=9_:"\"^']2O-.O=5N?MUK((&AMM+
MO+CSI?.A@:. QQ,)V66X@1UBW%&D4,%K$C_:X^%LB0,NO7S>=:-J"+_8.H[O
MLBJ&:Z(^SY$ &?WQPGRL-WRM@ ]AHKR[4/VF/AYINN:MHTFKWT^K:7=)97=E
M9Z)?7,R2-'/*N%C@8NI2VG;>N5Q&>>1D7]HKPCJ5O_:&BZA#K&B64%S?ZUJ,
M9=%TRRA%RIN60IF0--:O&JKRXRZ[E7) /4:*\G\9?M$:-X7F\#M:V-SJ5EXD
MD266ZD5K3^S[%I88!=RQRJ'V^?=6J;2%.V1WSB,U-=?M.?#C3]<NM*O-=N+*
M>VN)[66XNM)O8K-9(9?)E'VIH1"0LI6,L'QO=%SEU! /4J*\?\.?M<?"CQ=#
MILVC^*6U"#4+O[%#-#IEYY:R^9;QXE;R<0@O>6RAI"JDRK@]<8K?MJ_#"S\3
M2Z?JFM'1M.ECT_\ L[4+^TNH/M\EV9ROEQO"I\H+$C>?S&1*/F&.0#WJBO+=
M$_:'\-:]K'BE+879T#P_I,.K3:R;*Y5)T>6Y1O)0Q S(HMMPDBWJ^_"].:&B
M_M=?";Q%:_:].\4M<V'EM(;\:7>+:C;;/=,AF,(C$@ABD?R]V_Y"-N1B@#V&
MBOF_Q]^V3:^%/"^HZWI_AO[7#:^(9] CAUFZFTF6=XM-^V_+'+;&03.W[B.%
ME&]RAW -7=7W[4WPOT_Q+K?AV3Q2DNNZ-<0VE[IUK9W%Q-'-*VU(U6.-O,;=
M\I";MIX;% SU:BO$KK]L/X<:?H:ZA>7&LV4TL6I36VG7.BW4=Q<K8F<3A 4V
MAL6TI"LRG ^8*<@6[/\ :Z^%-]KT^A6_B2:?7X$1I-'ATF]DO S;/W8A6$NT
MB^8N^-063YMP7:V 1[%17C4GQ\U'_A"_ASXJC\.6)TOQ<=/1K6359%OX'NF7
M<(8!;$3B*-FE<EX\)%(<#;6#-^T]K:_#^^\4+X-TU/LNG6>LK83Z^XEN;.\0
MM9I"4M7#W<CH\7D?=W[0LCA@:!GT'17BS?M%RPZ;XQU&?PVL=EI&F:QJFFLF
MH!WOTTV=[>X651'B F14*X,F5D!.U@4&RO[27@3[4;-K[4SJ/GRVJ6<.A:A+
M+<RQ/(DRVRK 3<B-H90S0APNW)(!!((]0HKQB/\ ;&^$%Q#JLMKXN^WQZ5<-
M;7C6.F7EQY3+'/(S?NX6S&$M;AC(,H!&26Z9EC_:J\!C4(8[W4)-&M9)]7M1
M+JEG<P,\FG'-PZ?NBAA"+(?,+KRJH%+EE0 ]BHKR+4OVG/!MQX/^)&K>&;Z/
MQ%J/@2SFN-4TMUELVCD192(G>2/Y<M#(I(5MI4Y&1BN=T+]L+PU;V]U<>-H8
M_!]G$UO%%J$<LU]:7+SW=];Q.DB0+B%Q8B5)G"JRS+TQR#/?Z*\IB_:2\':U
MX0UK6_#EQ<ZS+86MO<06<]E<6+7IN9'AM!$T\2[UFF0QK(H9<USNC?MC>"K[
M69K?4H=4T#34MHY/[2U'3+I(TE-_<V+)-^YQ GFVZ[7E9=WFA2%96 !'O%%>
M5Z9\?-.^)7PNUGQ;\(K1/B7=6,PM8M,2X.F>?-^[9D,EP@"8CE#Y(P1P.M0>
M.?C=J7@7Q;<Z/<^&[6[C?3%O;*6VU1C(9Y+FUM88+E# %@$L]RRHX>3*P2-M
MX( !ZW17S[K7[4.J>%[.&]U?PC8BV_XG$<]OI^MM/>12::EP9Y!&ULB?9VDM
MTC69I%YN8=R*6*CM/#OQ.\6ZYKNFZ9_P@L)$&IW6F>([RVUI'@TEHX(YH)(]
M\:/<K*)8QPB%"3D<4#/3J*\#U?\ :DDT?XJ:UX2;PQ'<VFFZG::9)J%MJ1>6
M-IY=.17FA$/[L,-18QC>QD^R3#Y<9&GIW[7GPS\31R0^&M=;6=2++!'"=.OH
MH4N))OL\,5S-]G*VV^?;&#)C[P.#D9!'M-%>5P?M)>$&B\.RW7]IV<.M^'!X
MG@N&T^62)+<M"HB9T#9G+3HHB7<V2!U= ]G5?VA/!ND6&FZI/J>W2+R*Z(?[
M'=F[$L%W!:/$+58"^\3SK&R-M=6P C?,4 /2Z*\ON/VEOA[;Z7/J/]JW\UE;
MI&T\UMH=_,(&DE$20R;(#Y<Y<A?);$F2/EYK$A_;.^#5Q97]Y'XUA>SL+Z'3
M;JX%C=>7#/,TBQ!F\K 5C#(-_P!WY3S0![717DB_M8?"IM<T31V\5K%J6M7C
M6&G036-U&;F42K#\I:(#89&""0G86# ,2K8I7?[5/A;3_B)?^&;NRUBSMM.>
M\M[W5IM,N?)AF@-ER0L3;8"M\I\]RJ#9G)5U8@'M%%>8Z+^TM\-?$GASQ5KV
MD^*(M3TKPO/]GU>>SM9Y3;/G'W%0LZDYPR!E."<\'%1OVJ/ABJV3CQ#/)!>P
MI+;7$6DWKPS%[9+I(ED6$J9C#(CB$'S#O4;<D"@#UFBO'=:_:X^%?AO3;G4-
M7\0W>EV=M'YD\M[HE_"(C]IEMA&VZ $2F6"<"(_.1$[!=JEJEO/VL?A;86-_
M?3>([@6%E:R7LEZND7KV[P1SK!))%((2LJK*ZHQC+8)YQ@T >NT5XBW[9GPF
MM;A8]0\1RZ3'-J/]F6=Q?:?<1Q7K^3;R^;$VP@Q;;J']XVU?G!SM96;K-4^/
MG@?0_%$_A^_U6XM-1AO8M-8R:9=BW:ZE\DI D_E>4\A%Q$VU7) 8DX"L0 >A
M45Y3XE_:B^&WA&[N+?4]<NXGMVE29X-&OIXXVCDN8W5I(X64$-97?!/W8';[
MHS6*W[87P[T6SUB;Q5J<GAAM.U.^TX?:+.ZDCN?L]W]FWP2+#MF)+1,4B+E/
M, ;H30![A17(^ ?BMX8^*"WDGAB^FU.WM$MI)+K[%/% PGA6>()+(BI(3$Z,
M0A)3>NX*6 /74 %%>>?&3QQK7A&/PCIWAXV$.K^)M=CT:&\U.W>XM[4&WN+A
MY&B22-I/EMF4*'7EP<X&#1\&>+O&%C\5KSP5XLOM#UDMHJ:Q:W^BZ9-I^S]^
MT+Q/')<S[OX&#!E_B!'0T >HT444 %%>8>-_&'BVY^*6E^"?"=WHNCRR://K
M-UJ6M:=-J"E4GBA2)(H[B#!)D9BY<_= V\Y%GX/>-]>\3W7C71O$K:=<:OX8
MUK^RWOM*MI+:"Z1K6WN4<0R2RLA N I'F-RN0><  ]&HHHH **\@7Q9X^\<?
M$;QQHGA?5_#?A[3?"]U:V#MJ^AW&HS74LMI#=,X:.\MPBA9T4+ACE6.>0*ZK
MX+^.KOXD_##0/$>H6\-K?WD+"YBML^4)4=HW*;B2%+(2 22 0"3UH [6OD7Q
M9_RE"\&?]D\D_P#2J[KZZKY%\6?\I0O!G_9/)/\ TJNZ!GUU1110(**** "B
MBB@#Y$^)7_*2WX1_]BE??RNJ^NZ^1/B5_P I+?A'_P!BE??RNJ^NZ!A7)^&_
MA?H'A.\>\T]=2-Y),LTMU>:Q>7<LQ6-XT21YI69XU$CE8V)16;<%# &NLHH$
M%>6_&R/X6VLVCZK\2M,L=4%I#=K9KJ&G2:A%!$1')<SM"J.J*BQ1EIW4",$C
M>H<AO4JY;QY\,?#?Q,M(+;Q'I[WT,(D0".ZFMRT<B[)8G,3J7B=>'C;*, -R
MG H ^5_"_@7X=7GPYU#Q9>S:SX5TFY\6P:7HJ1G5IKN"TL;FSMX[:*(;98Y9
MSI2%I$7S%RH9V,>*Z"Q\5_ 73? ?B!=>L+_PG:Z-K4LE_M?53.DJM=:;'>+=
M1@2.)HK297D1BI+2+(Q9F+>_ZQ\(/"FN>"KCPC=:?./#UQ<3W,]E;7]Q )7F
ME>64.T<BLR,\KDH3MYQC  &%KW[-/PY\2020WV@2;9&D9FMM2N[=_G>[=QNC
ME4X8ZA>97.")BI& H ,\C\2:E^R_-JT_A_5'CT>_UK49D-O&FI::;B:SMI+&
M3RW0(/)$33P_(?*D8R@;WWUV7B(_!G6/ASX?N+^TU*Y\.:H]_>6$-G::K]JN
M8YVDDO2\,2^>UO(9&9UD7RF#ID8*5Z%%\&/"=K>075I9WVG7,/VD"73]6N[9
MG$\TD\HD,<J^8#++(X#Y"%R5VU5D^ W@IO#.FZ"FGWMO8:?)<26\EMJ]Y#<@
MW#,\X:Y283.)&<EE9R&.,CY1@ \QTF]^%OQ;^$&K7>K:)=6?@72_$]_;V#6E
MQJ*SWD\TLL$DL8B5)7%Q)>3H(XC*K"7;PVZ-,[QA<?!GQAXVUK5O%.HZQJ5O
M>Z79:6GA_P#LW5X48QRO"P$$:@7,ROJ<$;)L:2W<C.QB=ON$?PC\)V_@N7PG
M;Z3]CT![EKP6MG<2P&*8S_:/,BD1P\3"7YU*,NT@;<8%9=K^S_X%M=5BU+^R
M+B>]ADBFBENM3NY_+D2:"?S%$DI =Y;:"21@,RM&#(7.<@'@7Q"US]GOQUIL
MFS6=;T^XU!X-:#0:?KC)';QW$$TUW%;JH6W618]AO(U3!:0[R0XKJ8]:_9\T
M(0ZDMSJ.F&QM9WDGSK$#6;*+NU>:XZ&&\;R[V)9I=MPY5PC,<5ZA_P ,Z_#S
M_H75_P"0!_PB_P#Q]W'_ "#?^??_ %G3_:^__M4S6?V;_AWX@FOI+_P^TWV_
MS_MD:W]RD5SYLL\K&6-9 KD275PZ%@3&TI*;>* /.M)TGX"Z/\-_$&KV:ZOI
MGABUN[*WU*&276;>5+S=:26DOV9B)OM!/V)DG5/,(V8<C-4=-U+X#7UCHMI)
M8Z_IT7A74[ZWMOM4>KH;=UU%'GGN903F![N%'\RY8INB8'#1NJ^Y:I\+?#>L
M:3XBTZ>TN(K7Q"Z/J?V2_N+:2X*0QPC]Y'(K*/+AC0A2 P!!!W-GG(?V:OAW
M:J$@T.X@M][.]K#JMXEO*K.':*2(3;)(BX+^4P*;GD;;F1RP!YE;3?!77-;\
M(^#[7PY=S:/K<,EWI5U)'J4#2SVUK9V,+6ZLH>1/LDZD7*'RU$)DW;@77J?B
M/X9^#OA2XM-*\9VVH7DNI6C S7SZGJ6;:,36[/<7&9/+C4:K,A>9P )QSA%V
M]9:?L^>"-/?2);6POH;G1=XTJY;5KN233E8Q9CMR\K>7'B"-?*7]WLW)MV.Z
MM4UC]G_1_$6K>$9M9U35M8L/#VC2:1]GO+^?S=0+26KB6[ECD7S_ /CU^=)%
M97,A)'&" >>>!;[]GU?B-JWAC0);_4?&EYJ\+:E;W!U>\NC=V,BS12323;BJ
M1N5(D9A&W RPXI;O7OV>?A>A$VH2Z1:6M_9VLMOYVIM:07=I<_9K:2:,$QHX
METS8)G WK;_>9#SZEX+^ 7@3X>^)V\0Z#HLEGK!MY+07$E_<S[('<.T2+)(R
MHFX9"J %YP!DU2\2?LT?#;Q;K&JZKJ7AO?J&JS>??3V]]<V[7#&)82K^5(N4
M9% :/[C'+$%B20#S+0O&?P/TGX=_$6\UA%\,:-K&MZKH/B2UEO+V6*6Z3[2\
MC#'"22P*TFZ(!N8XPQ9$ =K_ ,2?AM\._ FF_&'P3I+>)[37+PZ.NJWNH7L5
MC9K-*$N9[@RI+]E1I;5!++Y67D"%R2=U>CWG[,?PWO[R6YET*X#2W,U])%%J
MUY'"US+YP>X,2S!#-^_EVR;=Z97:5V)MU/&OP/\ #'Q ^'\?@K6VUB[T!9EE
M>)];O&FN '+F.:9I3)-&<D%)&88QC!52H!Y+\/\ P?\ #WQ-<7'A2?P0VGZ!
M;2WEYH]VVNW5U-+_ &<?[(EE?+!X'1%C$8$CD*5;*2*0.=O/B]IOB*Q\/6VH
M^"-0ADT[P^?%,=_;^-+M+ZWT*7[/N;[7'MFFG8NI>W9S&3;@^:Q$>?HK2?A)
MX6T'5M0U/3K"XLKV^G%S-)#?W"@-]H-RPC7S,1H\S,\B(%60LV\-DUA6?[-7
MPXL?L?D>'W3[(0L.=0NFQ$/*VVQS+\UL/L\.+<YB'EKA.* .0TK2? .I>)/B
M9XE\0>%+C0?^$+U<O->76HSSJRQ16>HM>16\;E(0[QPR,J#=+Y*-("Q*#S7Q
M /V:]:\;^ TNM?FTPW&CR^%;;P\ZZK9SW=NSPQPPW"Y22.,!W79.H687 )W!
M5KZ5\7?#'3?$GA/QYI%H?[+NO&%I/!?7P#2_O'M%M5EV%@/EC2,;05!V>I)K
M)T']GWP7X;;3I;&SU&WO+,8-Y'K5\)KH94[;E_.W7*94828NJCY0 .* /+M<
M\0?!CX<>%5^*FFZ9J=W>:TE]K>CP3KJJ->S)#>22%()5/V:-Q>7;;S&L>+@R
M<C:U5?A;KWP>^&MCK:Q:O=:7_P )EJUKH<-O%I.IZ;-9A+*VAL[+<P\V-O*E
MCD$[,F][AW4CHOLGBKX$^"?&O@G2/"&L:5/<^&=)ACM[73(]1NH8A'&JK&KB
M.1?-VA%QYF[!&>O-,USX!>!?$7B*+7;[1YFU6.Y2[^T0ZC=0[Y$%J%WJDBJZ
MC[#:'8P*YA4XSDD \@\+V_[,?Q/U;2_!%G86&KZS?^'A'8:?K%G>K>)IVZ:0
M/$]RHDA=O/DE$BLLKJ4DRRK&PY[4?BA\']2N]/M-5\":K<6LFIEO/:&_NX9+
M6^N+G4([J,1HQN/.ETR*4Q@$*),;B$E0?2?AGX4>&?!NHVM[HEG<Z=);V,.G
M+##J%SY#0PQB*+?"9/+D=455$CJ7PH&[BL?0OV?_  =H>IV>I+93W%_8NWV6
M5[N94ACWW;11B)7$9$2WUS&A*E@C $G - ' _#^^^ _Q"\6-X.\.:S)XGUS1
MK5;I;>YU/4;PP6XGLIP$FF=E*K+!9-L5B%*XP-S@\MH/P_LO#WC"TT?2_A5+
MH/C!I+Q]*:\\>WT<3:-IS00PR+<0^:\,;F]C"V838%5MWW5!]\\!_"'PM\,Y
M#_PC-G=Z7;^0MN+%=2NI+15544,MN\AB5R(US(%WM\Q+$LV;WB[X>Z)XWDLI
MM3BO([NR\P6]YINH7%A<QJ^WS$$UO(C[&V(63=M)1"02JD 'B^H+\"O"LGBG
M0;D:GOOUBL+RSA.KW:OY=V@2"QV[@/*N;U 4M,>4TJ@A<#'-VOBC]F2S\+R:
M,D-_/I.I-/KTMO-IFM3O.LMJUM->R%HRYA:&:13,Q\LDN=VY21[I-\#/!-QX
MD?79=&:34FN5NU=[VX,<4RSPW!>.+S-D9::V@D?8H\QHP7W53_X9U^'G_0NK
M_P @#_A%_P#C[N/^0;_S[_ZSI_M??_VJ /,6US]GO3?#MY:WTU[-ILDM]JFH
M-K":M<21RR07.GW!NWG#/&[QV]U L<Q!8QD(I8"IO$L'PY\2?"OQCJWA[1]?
M\1V;7EO!J^B3ZEK>FJ7D\EGEF@(,BIY-PL\C+"WF+EB'.37HNL_LW_#OQ!-?
M27_A]IOM_G_;(UO[E(KGS99Y6,L:R!7(DNKAT+ F-I24V\5TMQ\.=#GM=;@2
M*\L?[9GAN;Z;3M2N;2>22*.*)")8I%=/D@B4A& (4YSN;(!\[V+? 6^UK5[C
M4-%U1]5A++>1:<=7U+3[O[7:S7<SVRQ I/ J:E<GS!$HC%R"!&)8]TBZY\%)
M/&F@^&]-'B"[L]:^T2VNIVFJZV(9+VVD@CW6;*VV>=MTIEG@8NHCE,K$2.3Z
MX?V;?AZL:1VVCW>G+'!#;)_9NKWMF5BB@6W5 8IEP#"D:-C[XBCW[MB82+]F
MGX<V^H6MY#H4T$UD\DE@L.J7B1Z<\DBR2-:1B4);%V4%C"$+98'(9@0#A8?"
M&EZ'KWA:[U_P%J7A:T\.:NOA'P[J%MXPNG7^SV5?LURT<4@!$\R0PM'+N<Y3
M>6 P*OQ4\,_ #X+Q^'+?Q=-J/AI1-)=Z0]KJ6KJ4D@M_+"1R6\AV^7#E(HL@
M*&98E&\@^S?$KX<VOQ.T6#3+S4]1TJ*&5YTN-*F$,Z2F&6..1'(.UXVD$J''
M$D49[$&MXJ^#/@_QOK^F:SKFE/?ZAIZQI"SWDZQNL<@EC$L:N$F"N-P\Q6P<
MGN: /)?$'C#X&>$E\3V G22]\26.KPS173ZD;2[2+[3)?QQSA)$B4NMRTA@&
M6<,V&?%<;XT^*7P4TVUT9M8TF^T_Q=8ZKJ2:7I^GZAJ4%V(YM;>UO;BWN+<
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M\'O!&O>&+KQKK/B5=.M]7\3ZU_:CV.E7,ES!:HMK;VR()I(HF<D6X8GRUY;
M'&3Z-10 4444 >/KX3\?^"/B/XYUOPOI'AOQ!IOBBZM;]AJ^N7&G36LL5G#:
ML@6.RG#J1 C!MRG+$8X!KJ_@OX&N_AM\,- \.:A<0W5_9PL;F6VSY1E=VD<)
MN )4,Y ) ) !('2NUHH *^1?%G_*4+P9_P!D\D_]*KNOKJOD7Q9_RE"\&?\
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M[J7V03:"_EVEK%:00Q:A=1Q(L<+012;%E"^<D3LBS$>8H/## K3O/@QX2O\
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M71YX[/3(/LL,,>I7:+-#YGF^7< 2_P"DIO);;-O&6;CYFSJ7/PC\+7'AG0M
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MMHI)_M>^2&>:)P;F9)YBK*X*'S(T*E2#&!M3:I(-S2/V=_A]H>CR:7:>'_\
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MENL9F9\?-@(?E!;[O- 'H]%>.:'^TWX?U[3_ (DZW;65]+X9\$V\<T]]':7
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M]F_P!8S">QTN_P!-N0RR?:-/UN^MIMXC\LOYD<RL6=0HD;.9=B%RQ12/3:*
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MXL8[J&2^MXTEFMED!DC1RP1F7.0&*/@GKL;'0U9KP/PO\$/%>E_$S1/%QO\
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M(]1BT]KJ%;^6)YX[4R 2O&A57<+G)52Z GH"Z^HKY6M_V;_C)J7B#Q9>ZO\
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M?ZAY"W$%A&%\V8*9U:2VNYB)!A#-&%!\M2OOU @HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *^1?%G_*4+P9_P!D\D_]*KNOKJOD7Q9_RE"\&?\ 9/)/
M_2J[H&?75%%% @HHHH **** /D3XE?\ *2WX1_\ 8I7W\KJOKNOD3XE?\I+?
MA'_V*5]_*ZKZ[H&%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OD7Q9_RE"\&?]D\D
M_P#2J[KZZKY%\6?\I0O!G_9/)/\ TJNZ!GUU1110(**** "BBB@#Y$^)7_*2
MWX1_]BE??RNJ^NZ^1/B5_P I+?A'_P!BE??RNJ^NZ!A7QYX-_;1\46)\.WGC
M+PQ<:MI?B'2FO--B\,>'KJ*^NKOS+53;PPS3L9419Y"9_E20 %.!\WV$S!02
M3@#DDU\C^-OVC_A[K?PPUG^R/A>=6N=(TN\6STS6-)L6LX;2!+&99L&<*]FS
M75BR^26+8#!?E4T =W-^V7X7AO[RR;PKXO2XM;.&^D\VPABC6-C&LP>1Y@D+
M6[2HLZRLAB8X-=A\,_CYIGQ6TWQ!J.D^&?%=IIVE+YD-UJ6D-!'JJ9D :R.3
MYP/E'C@_.F0-U>&WGQ8^#MUH-S??\*5CTE+O2EOX+[4?#FDSQ/"+.ZN;5WBC
MN=[*T>GSA4)4CR@"8P5)ZZU^-G@#2M6U^ST?X>7=A<7]]<1:E;V>@VLTOB%4
M755;8(9\NS2Z;=*/-4L=P&S][O4 OR?MB:%$US,GA_7[XQZ-_;+Z3;068N[6
M"-KL7#RR->",E/LV#"")$)P0Q++'W_@?XV:9XY\1W>CQZ/JVE/&+Y[:YU 6_
ME7R6EV;6X>+RIG8!)=HQ(J$AU(!YQ\W>-/%GPL^)'@F_T:;X<7F@>%[>^BTY
M9-#M] 'FQ'39K^<,\S%;801RW)9HF616<F-]S.%](\(_M*^%;N_N+BQ^&VLZ
M3'96L20R36EI;WGVN]UB6Q:R,1E!C>6Z@WEF8(Q!:0J0I8 M:#^VKX3UR30_
M-\+>,=#M]<=O[,O-<TV.QM[R-464SQR23!6B$#/,7S@+$P^^T:.6?[9.B:]X
M6\2ZIH?@WQ1>7OAZPO+_ %'3KV*VLWM$AB,B&1GFY648*-$)>""0 1F]\(;S
MX7_%*^\0VN@_"ZTTVVTV>-;^[N]&L(H6O28IVA^1V9Y8W6)F;;LW1J5=L*:P
M=$\:?":XU[P=H&G?!Z.(ZQ=R#P^\>C:7'"\+I)]HO(QYP,48CM\N&5964H!&
MY!  -_P3^T]::W\3-3\$:SHU[IFNOJ5K:Z7:K'&Q>.73ENY1(ZRLI>#;+YC+
M\H#P!2Y>IO$_[6?ACPOXNU_P[)H/B.^N='022WEG;0-92H)$CF=;AIEC00O(
M@E,I39N&:X[QYX^\"?"/QIK6OZ/X*U"ZU#P;IEWI=I9:;!8V>F_:/LEG=SHA
MR)1*+..TS(RE!%#LCR^4;"O?C!\.(;74-0\;_!7^T_$VJ:G?PVT6D^&K/4;C
M71;7\EMF-5D=VDC5(B_F[.<E,C% 'M?QC_:*\+? V2V3Q%#J$C75I)>VPL8H
MY#.D<T$<P0%P28UN$E88_P!6KD9*D53_ .&EM!M=:ET74M"UW2=:@G2WN-/N
M4MG>%GGT^%=S13NA!_M2U?*L<+OSAEVG@_B1\1+;QYX03XAZ3X1UJZNO#>KO
MH.EZ?KUG:+;W%S=7"Z=/.8&F24A!++'Y<DD(8L0P'WTYC4OBM\-M"CTQ;#X6
M:3<Z'X6\0:FM]?IX>LH(-->VAO;AEM(S.7%R?[/@;S578V 24;"( >X_\+WM
M9/A_X*\40^$_$-R_B^XC@TS1HOL9O#YD,L\;N3<B%5,4+2?ZW(#*" V0.4M_
MVQO"VH75E;Z;X<\3:G)?6-E>6IMX;54E:ZDLD2VWO<*J3J=0MBR.5PK;@2"I
M9_BSX[^$O#__  DNAZ5X9N;J?X?P23R36^GVLEKHXBM%,<J1M<1%EV3-$%B(
M;Y9%.Q2&/'1_'#X0Z?J^J7>C_".[OM<TRYCL5;3-"TY9[JWA@FN8;BVF:95E
M@5--<IM?<&@0*F5& #I[7]M#PS>2:';Q>#O&\^H:S';7=I86>DI>3FRG#;;Q
ME@EDVPC8P;)WC'W"""6Z7^U!<:A'H^[19(&OKRSN$DFA$<-QIUYJ$=G (29?
M,>>,7-O)+B,HI#QG:S)6CJ7BWX57WPK/CN'P19>(/#VG7T.FZ<MOI5HSSO#=
MFS@:V$C*H19I9 C,R  NPP&R?)/^%P?#;0?B'/#'\*]9U+4%G6]M[/0-$6]U
MD7<>H:@+Q;EHI&5X(;BTC=%5V56"%0=B[0#V[XC_ +3WAGX8^,+KP[J6EZU>
M7-OIL^HM=:?!%+;[HH'N#;%S*-D[11LZK(%##G=67=?M>>%=-O!#?Z#XBL8H
M(I)-1N9(+=DTYDO+FS\N4).SNQGM)5!A61<%6W '(\^^('QH^#GQ _X2^'6O
M ^K0W#1/H5_XKCTFS#I93QS1K<17K.P:%PDR(%+,[ HL;,=IW_".I?#2\T>+
MXKP?"W6=#GLQ9>&='T75_#]K8SQ^=<$0M9)(52-9I-1VLXD56VD'&TY +>M?
MMP^$?#7A?2]=U?PCXWTJVO5E=[>]T=8;BT1>(Y)HVE!6.9L+'(,HS<%@00+%
MU^TQJLEUK-K#X4O-)NVE.GZ6-7CA6&WO5L+>\VWTRW&Q/,^UQ(D<99SY,K#<
M,!?/-(^.'P'OK6X34?AA9VEO87MU8V.GS>%['S+<QFU6]1=DLBN4^T&9RFW,
M2/A7,>6WO&VK>&/B%\-8?'.G?"W4+?5_$>LV&@-'XLT9;:[LX[F6*SDND1YH
MV4O Z1K)#("V(<G$9V@SN_''[1P\(1^#=:@\/:CK'AG6O#>H>([M;**,7EI!
M;QVDHD(EFC7:$G?<HW.6V!1UK'E_;3\,1Z'=:S_PAGCA=(AN)(HKZ?28[>&[
MAC@N9Y;F!I94$L216<K$+F3E $)8"L+XI?M&:.T/PW70_#%C?Q^))M*L9TUZ
MP5Q#I>J&X1X4"OP_^@D.ARG"9#=I/BA\3/"'PB\8>+;:/X4V/FV4*:I/?6]A
M99UF2:PU29P6WJT1VVMPIE=9"0\J[,.&8$;][^V-H.E>&=4UW4_ WCG1[32+
M>&YU2'5-+AM+BQ6::2&WW12SJS^;)$P4Q!U'5BHSCT[X<_$JW^(UOJVW1M4T
M"]TJZ2TN]/U=81,C/;PW"',,LB$&.>,\-D'((!%?/_A/QC\--4^)7_"!ZA\$
MK;[?;WJVUFNF>$[>Y@T6UGLK:8_;)8]R1;I9YHRT>4.WGCYCV&O_ +1G@#P;
M\1?$-DG@O5;C7=*C+3ZSI^G6ODS1EK>&X879E556(K;)-YK)L$<8/"K@ XW4
M?VN?%=A\1+?P7_8^DOJ=TFIZ+#<"*;RUUZ.[9+&*3Y_EADMA'<,NXOME!W+M
MP=[PW^VA:#P3X<N_$/@GQ2_B;5+2QGCTO0M-CNWOOM$5U)YUM''.[^4!8W+8
M?:X4*=IS7;>.OB-X(\"?$O1=+U;PG(VJZI>6EW9ZXMA;"&2]N)$T]"DKNKO.
ML;(KF,,RPXR<$*?//%?Q6\$^)/#\D'AOX5V_BFRTO6=.\/7"W>FZ?]E3;J7V
M5;:)9)TRP625X3CRE\T99266@#UWP)\;-,\>>([K1X=&U?2Y$%Z]K<:@L'E7
MR6EV;2X>+RI78!9=HQ(J,0ZD#KCA;']KK1K[4##%X<\0O>211"+P^]M:0ZA'
M+MOY)!*7NPB,(K"5C$^QUVC[Q<*O3:AXVT6Q^"/B+XC>'/#]I87NDZ1K%Q#;
M7UI&CP3Q-*]S!+Y38P;F ^9L<AV7=N/#5X9\;/&/PCTOP#JVAMX3?PKIEN^^
M6\T7PUI4T5\EM=0P7<,,<V[:8Y-0P'=$(:1G0N P8 [2X_;F\+2>!4\61^'O
M$VG:))$]W;WEY8VLHO(8;RVMKE(T2[#*X:Z10S[0,E@'VE3T&K_M>:#H5KJ+
M7WA#Q5!?Z9%/=:AIK)8^?:6\45G*\[?Z5L9=NH6WRHS/EF!48-8_@7Q3X%\0
M>(/#WPM@^#\MCI]O:7D$UOK=KI[KIZ116%UAT6602"7[5:LQ4EO,52P)#,G&
M?'[XD?!WQ% __"7Z!K%GI%KJ-YONK32--D359+1GMI?GD#SQ_O;)+164PR,T
ML(4E/F0 ]T^(7Q^T?X<^-++PQ<Z)KVLZC=V4EXAT6T2Z *PW$J0LHD$@EE%I
M,(QMP[*0#PVVOXN_:,T#P;\)],\?W.EZM?:=?Y,>GZ:+:XO!MCDED^19MC&-
M(9&<([%0C$CY6QY?JG[2GPA\9R1>+;[X=7GB'3X])LY)/%,^D6%PEO8WSM;"
M,LTQF*^;)<021HK89)P01DFW'\9_A]XO\$Z5I%S\#?$MQH,-M=:C:^']3\+6
MD:V\%LD(\^*UED 96^V)&C1*V"TF[8JL: -JQ_:V$WB#[!=?#_7;>UDGO[6U
MNH[NSD-W-;ZG!IT:1IYPQYDMP@)D*!">K+EQH-^U=I<VO6FBV/@CQ9J6ISSB
MR:"V&G@P7?FWD9MW+W:C<#IUVQ=2T>(_ODL >:^,?CCP!H/@Z35H/AKI.K:A
MK7AZ_P#$%E>:AIEC-82RFU$KPRS"7$TLJ6\8986DW+$K%MB;AI^'?B_\.M/D
MM4T[X<76D#2;FWLKIHM-L(AHLIO[O3K=&V3<YG%TJF#S JRL25#F@"QI?[9O
M@O5/-NAH_B:TT&WBTZ2Z\0W6G+'IMJUX+0Q123F3 D47UN649(!9AE5)KLO%
MGQVTKP?\,?#_ (TN-!\17R:Z+1;+0].L!<:F\EQ'YBQ&)6VAU4,6^; VG!/&
M?!/%/C_X;^/-1TCP_I/@1TTWQ5HJ631Z/I=C;ZG>IY6E7<-DLLC");<VUYAP
MS*08L1L"$+=G8_$KPEI/P1^&]IXD\ 7_ (F_X3I?[3G\/Z-H[ZQ''//(+NZN
M)8Y&<^6LT^\DEB"PV@XX +^O?MH>&M"U5=(/@OQS?Z\4M7.BV.D)+?K]HMC<
MQ*8/-WAO+CN-RXRAMI-P7='YF_/^T]H-IH#ZY=>'?$=IH[2WT-M=3V\"-=26
M=O=S7*K$9O-1D%C,F)40EBF,C++P%C\2O@]X[UR]\)Z=\)(]8U2PD>."TFT+
M3OL\MJ%4&\AD>01O;?Z-$N4;>?)0!#L^6?P/XB^'OCCX3:CK?B+X-V3ZNNDZ
M7K^KZ+;Z!8W+:CYT#B&X@17D$B\W*IYK!T4/N"@G(!U&D_M6:=>0ZE+>^#]?
MLX]-N[N.\EC>TE2VM(;M[47;_OPQ5GCD&R-7<&)_E(V,_J/P[\:1_$;P/HGB
M>#3;[2+75K9;RWM=1,/GB%^8V;RI)$&Y-K@!B0& .&R!X%9_%CX6:QXJED'P
MWMM;O+?5;"Z.H6FCZ:W]FR7J6*PW#SFX/G.TDT0,L&XXB'!"([^D?L[^+/"7
MC+P]K.H>$O#5]X5AFNK::ZL;Y8E9C)IUF]NZ"*62-4^RFU554@*$V[5(H ]7
MHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %?(OBS_ )2A>#/^R>2?
M^E5W7UU7R+XL_P"4H7@S_LGDG_I5=T#/KJBBB@04444 %%%% 'R)\2O^4EOP
MC_[%*^_E=5]=U\B?$K_E);\(_P#L4K[^5U7UW0,*^1=/^+WP.U;2= T^#X'7
METNIW27EEHMGX/L[UUBE51_:)C@:14CQ&H8Y\T!%RF *^N&81J68X51DU\M?
M"36OA/%+X(^&>C_"F]G^V:?#XDL;G4M+TMQ);;0D>JSLLO\ K'QC.WSL]4&:
M -*W^-_PYU'2M \[X3:E;V6MZ?:_V/'>:5IJ1WL4DKV=M;0YN-I8K=./+SB.
M*X)?8KG,2_'?X6ZM-K$6H_#&YM;*POKW2-0OM2TW3!;1WT-M>75Q;.WGG)V&
M]R^#$6G?+XD),?B;XP?"&U;7DU'X4R:C+HJ7&@VL"Z)I\\NIV]M<^1-;6:>;
MN:-).?)<(2,LJ-AL4T^/'PQMXIM+TKX1O<^"8=(O-<GO8-/TV*V*Q:;:RE4M
MFE#,S6U_%"2RICS GS)O9 #FU^/'@2R\2:04^%VE:+X/O9;/2;V'4/#\$&H6
M4;#6K283('V+%%]C8$<X@DN.#NVUZ)X]\0?#CPS^SW8>+]&\&^$]-MM<LX-.
MT&W\0Z=;VMGMOIE>,3J!\EON87,B @[8V) <<<-X[^*/PF_L?Q3X!?X4^*?#
MQL--F77F\->&K)SHMN\5RQCEGA:2*'SX9+H*ZD@+<R'?&S,1UNH_'C3-!\4>
M#_#>D?";4K*YBOWO1I%Q9:=;W*K+IUY</<6(^U*A<$NDL@.W]Y,@9F)% &-\
M$_BIH/COX\>#8-!\+:!I>GS^ 6U6.XTZ$QRVTTDUO;W%M\CB)E3['%%G8640
M;58*2#'\/?VA_ &E^&;;Q-J7PQ_L3QA-IB^*-5;2=)LHG>W^SS/+J:/YVYHP
MK7*@,QG(=P(SN.>@^&WQ_P#AMK7BS3+G1?"+&]UAY=OB6QT:UM4BBN=3N88E
ME/G&9C+<1.S,JL&9_,<1[B%L^,_B7\+=&\0:MX<U/X8G47T 1PVNS2=/EBNI
M;?[((K>T5I0WF)_:T(C5E3)ED6/)." <=J7[0GA>>XO]:UCX>Z=?[-1U?0?%
M6O?V5;R(^G6\.HR+:C?+YTKO#90%E*-"0[#(. NQ_P +H^'&J^'[NSO_ (%>
M(+/2=(M(WNK#6O#5A:1V,=S=.0'BFF41QM);/,TF!#^[#,^[ JNOQT^$6H:A
M%X@'P@N[AH].EU$ZVVBZ9OM[5K6WN[MF+3^:-L>JJ9%"Y9II0HD).9X_&WPZ
M\1?!7XBZKX4^#T-CIOAS3WO;*/Q#X3BM=,U9H1<-"\ X$J*XE/\ "5\[/&\T
M#.M^*'QP\$?!JXN/#-SX$U#4M,M8XM5E71[*Q-I&[B[NU?RY)XR9!_9]Q-N"
M'E =VX@5C^,/B'\'M)FMM9N_AG%K%[-+J]F+J'0K(R0I;W7V>\>665E6*%VN
MY'+.RJ4DD+X+8.Y;_&'X>>.O%NF:%JG@Z=O$.MRR6$=MJVFVLCR/ ^HVUQ&S
MAW5A MO=AR"5V72!"_G$5R'B7XE? ^Y\8>*SK7PKMK_5=+>=+C5;CP_83B_\
MBWO9G:*8N3( -*GCP<%71%(&#M!&CINK?#2U^#T?C&^^"EAINGVNK7]@-+MM
M*TV5K4BXDM)[AWW+#$C+!B1V<* ,%F4!CS^D_'KX8Z%X=_M73? MSI=Q=6LU
M[)XDT#0],M2+\:0;^1DC>=V6?[-<,09 Z9E*EV!;,UU\9O#6H22VNL?"&#_A
M"6N=?U+5(9+/3[@K-97]O!)J;H90K*3-,TF%>;<O 9?F?F?%/B[X7V^M6WC<
M^!=8-W_80DTC2I-%T9K1--FT^Z9;LJDL<DL M[*YS;RS[@/E6)25P#.S;P5X
M$L?V/_&</AWPS<Z9I6EQ7%U=Z1K?ES23WNCE(MER%>2-T=M-B1]C;73.""V:
MBTWQ5X*A^$&O>)/%WPFTF;2]-\07&CZ5X>TO0K*6XGCM9I8D\F(S,LKAVNWP
M-C#=*%1A^\DV=4^/G@?0_$FJ^'V^%GB*^NM2O3I%VVCZ!;7T>H(Q>:>1Q!*Y
M:%/M7F2+( P-WRA9I $M?BMX.\7:9XX_MSP):Q?#+1="C\5+'J6F6TQO]T]Z
MTURL"NXPWV8.HD5)=S.6 R*!%B^\1?"#0[6Q\16'PSL;^!]'7QK-J-AHEC&]
ME;LID2ZD\QD<RMM?'EAW!4YQD$\SXB^+'@#2_#?C;X?6GPOUSPQ#IOV-]9T_
M2=)T0QPSW<T,=LACDFDMI))=T7)5U"CYBI7C*^+GQGBDUK0M.T7X46%S<Z/:
MS62V_B#2K&YETZX:]T^Q6W@VWBHJA+Y'8*^QP\2;TQ(8Y];\7?"B;X<>*M*B
M^&EW+X>L=8@T[5%\*:!8VZW%Q%J^VUL/LYF+SF20(#A"CB9C^[9BB@$_A/XH
M?"/X1_#V.73?A_JDFC^&3+)>:F^G:?YUIJ+PRK)$^)4)G=0T6^%3#B0*'6/.
MW7;]H#P1X3U2U\!:+\*+ZVFAU+3F.FPV>GP6$$TMY;Q22))'*T33VT\T*NJG
M<)"N#MS(O;?#FV^'OQ4N+V2#X5PZ3_8-K;Z2DVN:'9PR1QS6:S-9)&&:6(1Q
M7*H\;HBYE95W#=CNKGX5>"KR^U*^N/!^@SWNI,C7US)ID#2711TD0RL5RY5X
MXV&[.&12.0* /G;2?C5\(+'2;76D^%Z7U[?W>GN;[3?#MA ;[6)8H+B%%1IR
MZSA-060.[%%\R0"4MD'T'5_B5X)UR'3O$=S\.;K6_$EPVHZ<;.6PL'U&VCL)
M)H;I7EDF$?EHSR@!)6W"<[00S8])A^%O@NWO([R+PAH,5W'#%;I.FF0B18HF
M1XHPP7(5&CC91T4HI&,"IM:^'/A/Q)IHT[5_"^BZKIXN7O1:7NGPS1"X<LSS
M;&4C>Q=R6QDEFR>30!X]X;\??#34O!\/C?0?A:TMEIFLPZ/HDUOI.GPSW,[R
MQ62R6FZ5?*0%8H\R&([8P,84"N8U?XS?!36]2NKR7X3MK][JNG66K?:O^$>L
M)'U%[AK)8K=GDD'^D+_:%JQ24KA6#9P5+>]^,/A3X9\;>%_^$=U#3+=-%;48
M-3FLH8(Q%/+'<K<D2(5*LLDB_/D9;<W.3FIH?A7X+M]3;4HO"&@QZBT4,#7:
M:9 )3'$8S"A?;G:AAA*C.%\I,8VC !\_:O\ 'WX=^)H;G6_'7P=NFGMHOLNI
MWU]I^FZA]AM3JT]C"DK^:7<&XMV8QQ+(%()&X ,9_#?Q6^&;VND:EIGP#U_3
MKFWL;FZM(7\)65I=VUI;/;SB2)&D5C&TUU$4,6X"3<S;-K,/H.V^'OA:SEOI
M;?PUH\$E].MU=O'81*;B99C.LDA"_,XE9I QR0Y+=3FJ-K\(/ =CI<VFVW@G
MP[;Z=,KI+9Q:3 L,BN8RX9 F"&,,1((Y,29^Z, 'S]X1^.WA#Q3X7NM/U+X=
MVNGZ7XDUZXD5QI5C=:;J\::O:V9D=8[D^9-_I-MNF;*[@SIYBH%/I_PSO/AW
M\>M*UKQ OP_M;6YO&MHM3CU[2K1KFZ5K:WN[<RM&TBR+Y4T##+':1@@%<#O(
M_AMX3M]-M;"V\-:1:6EF&^RQ6]A$BVQ:1)28P%PA,D<<G'\4:-U4&LGX>?!/
MP=\+[/0H?#^D0V<NC::VEP7,:B-WC?R/->14"HTLAM8&>3;N)C'..* /#-5_
M:F\"QQ^&/&4/@*YMQ+J(F<W6D6\VJ2QS:;<_9IK3R)7_ 'DOV5(,,P8(-K*H
MVFM&+]H#X:?;]<D'PC\00ZI/:PZWJ4<OAFVCN9IH9K5PEP&<,L]NUU#.3-M"
M(/-#;=K-ZWX+^ G@+P/X)LO"UEX7TJXTRW3#_:]/@=[J0PF%YIL( \KQEE9R
M,L&8'@XJW_PH_P"'.VY7_A /"^VZMUM)U_L:VQ+"I0K$_P GS(#%$0IX!C3^
MZ, 'G/@#XJ^ ?%6F^)8O#_PNUJ/2/#5F1!-;^&8S9:DME/(5M]/DC+1S-'.K
M^6BD?.2R=VKB+?XU?"#1_#^N1V_PPM[O2(8+BZN=+TO1-+46UFL.G2W)F_TG
MRYOGN;7<$^;<BJ4)BW'Z-M?ACX.L6U9K;PGH=NVK0FWU%HM-A4WL9&"DV%_>
M+CC#9&*Y#QU^S/X#\>:3IVDRZ-8Z3H]I,)FL=,TNQ1)\+&H4L\#/'\D2)NA:
M-MH W<# !PMO\3OASXT\"ZUXC;X=#2CX=\))J>GOKFAV5P?[*F2XCC$$<<Y_
M=$02J82\65(' ;-/U+XF> ]2TWQ[XGT[X9PR^)? 5C?:Q97&I:=9!IV6YO8Y
M)K>5)&9 UQ9W!8ML<YW;26KW)?!/AV.QELET#2ULY;)-.DMQ9QB-[5-VR KM
MP8EWOA/NC>W')I4\%^'XX;Z%="TU8K^%[>[C6SC"W$3O([QR#;\ZL\TS$'()
ME<GECD ^:;SQ3\/=(\+6?AQ/AAX=BU^2_LK/4[&;PY:16'G23Z*+L^7'+( V
MW4+4K\[C=;C+,(U+=1;_ !*\&2_"KP/+X@\ 6NJ6UCX4M/%L]KINFVK6.APB
MWW*\4<TBE0"LBHL(=@%YP""?8IOAGX/N->FUR7PIH<FMSK&DNI/IT)N9%C:-
MHPTFW<0K0PD9/!B0C[HP^^^'/A/5%TI;WPOHMVNDPFWTX3Z?"XLXRH0I#E?W
M:E0%PN!@ =* /GO4?BE\*M%U3Q/I5Q\#KF+4M!N;&_U:U71M'/E7MS*J6;%A
M<['F<W&Y7#':&;<RG(K2U;]H3X5V_AJ^2[\ W4NB"S.FWMNVEV1B62TMKFZ7
M3'0RX9HX[><I@& '@2?-7J.L? #P!JOA*[\-0>%=(T?1[R6UDNK;2]/MX$N%
M@N5N$BD41[6C+J0RD8(=^A;-;/\ PJGP26A8^#M W06/]F1-_9<&8[3!'V=?
MEXBPS#8/EP3QS0!\N_$;QG\.=:\?>&=%C^'.M66J:#JVDS?8;.PT>&U\PW=E
M ?\ 2U\QM]K(+2&2*"5,X1"6BRR^\_L__$CPU\3/#MWJ/A;P7K/@_3/]',+:
MKH@TZ._A,"+!- 5RLL?E)&JD'*JJ# &!757/PJ\%7E]J5]<>#]!GO=29&OKF
M33(&DNBCI(AE8KERKQQL-V<,BD<@5?\ #?@OP]X-2[3P_H.F:$EW*9[A=-LX
M[<32'J[[%&YO<\T ;5%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>!__  G+/_XW1_PS+\'O^B4>!_\ PG+/_P"-UZ710!YI_P ,R_![_HE'@?\
M\)RS_P#C='_#,OP>_P"B4>!__"<L_P#XW7I=% 'FG_#,OP>_Z)1X'_\ "<L_
M_C='_#,OP>_Z)1X'_P#"<L__ (W7I=% 'FG_  S+\'O^B4>!_P#PG+/_ .-T
M?\,R_![_ *)1X'_\)RS_ /C=>ET4 >:?\,R_![_HE'@?_P )RS_^-T?\,R_!
M[_HE'@?_ ,)RS_\ C=>ET4 >:?\ #,OP>_Z)1X'_ /"<L_\ XW7GWPS_ &>/
MA5?^-?BU!=?#+P=<P6/B>"WM8YM M&6",Z+IDA2,&/Y5+R2/@8&YV/4FOHRO
M-/A/_P CY\9_^QMM_P#TQ:30,/\ AF7X/?\ 1*/ _P#X3EG_ /&Z/^&9?@]_
MT2CP/_X3EG_\;KTNB@1YI_PS+\'O^B4>!_\ PG+/_P"-T?\ #,OP>_Z)1X'_
M /"<L_\ XW7I=% 'D7P#\,Z/X-\1?%_1] TFQT/2;;Q;#Y%AIMLEO!%NT32G
M;;&@"KEF9C@<DD]Z]=KS3X3_ /(^?&?_ +&VW_\ 3%I->ET %%%% !1110 4
M444 %%%% !1110 5\B^+/^4H7@S_ +)Y)_Z57=?75?(OBS_E*%X,_P"R>2?^
ME5W0,^NJ***!!1110 4444 ?(GQ*_P"4EOPC_P"Q2OOY75?7=?(GQ*_Y26_"
M/_L4K[^5U7UW0,\T_::_Y-M^*_\ V*6K?^D<M'_#37P>_P"BK^!__"CL_P#X
MY7H.J:9::UI=YIVH6EOJ%A=PO;W%I=1B2&>-U*LCJP(96!((((()KXQ\/K\-
M-%\2V'A;QC\%_!MWXWNTD_XIC1O EC;2I(&@"JMS/=-#(FV21A("JNJG_5NA
MC8 ^C?\ AIKX/?\ 15_ _P#X4=G_ /'*/^&FO@]_T5?P/_X4=G_\<KP>T\5?
MLZ75J+MO@/I-M8O;Q/%=7'AG1T2:XDL4ODLU_>9,YAD& 0$+ J')(R>!?$'P
M#\<:[#:K\ -%TC3KE;9;>]U+PSIL3^=(M^9(YH?O1>6VFSQDG.7&,!=K, >\
M?\--?![_ **OX'_\*.S_ /CE'_#37P>_Z*OX'_\ "CL__CE>">#?%G[/GCJ3
MPH-+_9VCFA\37,T-C/'X*TZ95BAEAAFNI1$SM%!')<1JSL!@Y.,#-8GCKP_H
M.F_&N_\ !_AOX,_#&_MHKEX+6S/@1;FXN&CM=.G99)T=8[=6_M!AYTB;(_*&
M0Y<"@#Z6_P"&FO@]_P!%7\#_ /A1V?\ \<H_X::^#W_15_ __A1V?_QROGS2
M]'^'%X/A/=:A\+OAMH^G>(O#$WB+6)E\!B\6/RC:%E5X\"VCVW$A,LV]1M4'
MKSS?A/6/AQX[^&FK>)-/^%'PJM#HVII<ZQ<6_A>UU./3-#FM&N8;B2%'C9Y8
M_EAF"OE7AG8(0 * /J?_ (::^#W_ $5?P/\ ^%'9_P#QRC_AIKX/?]%7\#_^
M%'9__'*\>^''PO\ !GCOP7XZU.V^$7PYOM9T^]U.RT?3QX&2Q@9[>XN(85>X
MERESO\J,L\6Q5)8'!Z<)IMOX&U+Q=;>$(OA=\,?[9N&MK66ZNO $<#:==,FI
MSS12V8F=I6$6G*J+'+AC,'#,I4$ ^G/^&FO@]_T5?P/_ .%'9_\ QRC_ (::
M^#W_ $5?P/\ ^%'9_P#QROE'0/$GPSO?%$^F2?"/X:W^F7'B/2_#NE:PO@E=
M/^TW+R6JZA!+;3@R0S(MR[1JQY\B7(.SF_\ %#7/AE\)_B=#H.K?!/X=W&D6
MNNM:ZE/;>&+<SQ:?-91R6,RC;M#/<O)"2W#&!@%&X$ 'T_\ \--?![_HJ_@?
M_P *.S_^.4?\--?![_HJ_@?_ ,*.S_\ CE?*$VAVMIX934;SX4_!FTOK+1O$
M][J5DO@9)E:XTBX$)2*3SUVI)O7DJQ&P]=P"UO'WBGP/;^/KSP_X,^!/P_N<
M:%87MK'XD\#MILLMY<:E;VFPB:*-O*VS\.$(W#J=I6@=CZX_X::^#W_15_ _
M_A1V?_QRC_AIKX/?]%7\#_\ A1V?_P <KYSD_P"%8:]\,?$_BG0?A!\/[<V/
MBO3O#]NESX)CO)8$G^P+.LUK%MDDGBDNIT,:$?-&%P2#FKX2TOP?XN\$V/BU
M/A9\(-.L!<Z#IEWIS^%(9I7N-2M["0S),'4(B-J*[8BC%UA/[Q=X* CZ6_X:
M:^#W_15_ _\ X4=G_P#'*/\ AIKX/?\ 15_ _P#X4=G_ /'*^</AK9> _']_
MX<F;X1?"JVL;SQ%'X>NK2'PQ#).V-+N+QKN.0A0(9FCB:'*-NA8.3E\)]'_\
M,R_![_HE'@?_ ,)RS_\ C= !_P --?![_HJ_@?\ \*.S_P#CE'_#37P>_P"B
MK^!__"CL_P#XY1_PS+\'O^B4>!__  G+/_XW1_PS+\'O^B4>!_\ PG+/_P"-
MT '_  TU\'O^BK^!_P#PH[/_ ..5Y]\3/VB/A5?^-?A+/:_$SP=<P6/B>>XN
MI(=?M&6",Z+J<8>0B3Y5+R1IDX&YU'4BO0?^&9?@]_T2CP/_ .$Y9_\ QNN(
M^,/P/^&WA#PG:7.@_"KX<Q:G>:QINEQRZCX4MKB&,7-[#;LYC3RV8JLI(&\<
M@4 =O_PTU\'O^BK^!_\ PH[/_P".4?\ #37P>_Z*OX'_ /"CL_\ XY7S;?>+
M/@IX3T"6/6/@+X6U?Q!;)K(>31O#.GI8N]A+J$:EV<EX!.NFSN@8.!\RAG*$
MUZ#\,]!^"'Q.\6:EH%I^SY8Z5)IT3&XU+4O!5DNG>>AC$MLERBLCRHTFT@<'
MRW*E@,D ]1_X::^#W_15_ __ (4=G_\ '*/^&FO@]_T5?P/_ .%'9_\ QRC_
M (9E^#W_ $2CP/\ ^$Y9_P#QNC_AF7X/?]$H\#_^$Y9__&Z .1\4_&#P%\0/
MB=\'-.\+>-_#GB74(O$]S<26FD:M;W4J1C0]44N4C<D*"RC.,98#O7O->?:7
M^SQ\*M$U*TU'3OAEX.L-0M)DN+:[M= M(Y89$8,CHZQ@JRD @@Y! ->@T""B
MBB@ HHHH **** "BBB@ HHHH **** /&/B=XZ\-_#_\ : \ :CXI\0Z5X:T^
M7PQX@MX[O5[V*UB>0W>CL$#R, 6(5CC.<*3VK<_X::^#W_15_ __ (4=G_\
M'*P_VH-%TNX\(Z=K>J^$O#/B&PTBXDEU#4?$F@1ZPND6!A=Y[A(#)&Q&Z.'?
ML;(4%MK;<5Y!_P )!^S]I]OJLMU\#]#U"STR]U&SNM4L_"6E1012VR7DWD['
ME,C,8;-B'52C%E)\O<40&>]_\--?![_HJ_@?_P *.S_^.4?\--?![_HJ_@?_
M ,*.S_\ CE>#:EXF_9\TNZL;"?\ 9]T\:S<7G]GRZ8OA;2'ELKAEC-NMP5D*
MQK,9HE23<4W/AF4@XKQ^,/V?+?P/H.N7WP"T5-1U:ZT_3XM&L_#>E33-<W=E
M%=Q*C,45D*S*N\E?FZ@<X /H'_AIKX/?]%7\#_\ A1V?_P <H_X::^#W_15_
M _\ X4=G_P#'*\=M[?X'ZIX*^)7B"Q_9_P!)MX_!-M>22/JO@^RM[;4);;SU
MECMIU1DDV26SH[ X4X/0YK.DM_@YX1\6^(O#OBCX->"[^[TB9?,N=#\*6*QP
MVL=GITES=2K*V=BS:B@"1[Y-I&%8J20#W/\ X::^#W_15_ __A1V?_QRC_AI
MKX/?]%7\#_\ A1V?_P <KYNO/&WP+T_P3<ZO#^S[HNMSV^FQW*W$?A?2;.UN
M[@Z>E^85W2R/&1;L9#D, $8!G;:&[KX@?"KP'9>)+G2-!^%?PNT1]/\ #S^(
M;J3Q#X5MIQ*H=E\A?*9!'MV'?+F0+O3"G.: /5_^&FO@]_T5?P/_ .%'9_\
MQRC_ (::^#W_ $5?P/\ ^%'9_P#QROF;3_C)^R]=?:+.?X):/;Z]:Z3+JUSH
MX\*::9E6*3;-&N[:&=8@;G;P?(^? /RC3U[QY^SQX=DNK>Z_9Q:;4-/ADN-5
MLK'P-I]T^E1*J.)+EXF:-%9'5@0Y &2VW!H ^AO^&FO@]_T5?P/_ .%'9_\
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MD1=+8'8!&@"YP B\<"OMVB@#Y$_X;2^*?_1KGCC_ +^M_P#&*/\ AM+XI_\
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MBG_T:YXX_P"_K?\ QBC_ (;2^*?_ $:YXX_[^M_\8KZ[HH ^1/\ AM+XI_\
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M_&*/^&TOBG_T:YXX_P"_K?\ QBOKNB@#Y$_X;2^*?_1KGCC_ +^M_P#&*/\
MAM+XI_\ 1KGCC_OZW_QBOKNB@#Y$_P"&TOBG_P!&N>./^_K?_&*/^&TOBG_T
M:YXX_P"_K?\ QBOKNB@#Y$_X;2^*?_1KGCC_ +^M_P#&*/\ AM+XI_\ 1KGC
MC_OZW_QBOKNB@#Y$_P"&TOBG_P!&N>./^_K?_&*/^&TOBG_T:YXX_P"_K?\
MQBOKNB@#Y$_X;2^*?_1KGCC_ +^M_P#&*=^S]X!^)/Q3_:(O_CM\2_#B^!HH
M-'_L/P_X;:7S+E(2Y<R3' Z%Y/O!22_W5"C=]<T4 %%%% @HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>proxy_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxy_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" -[ K # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4Z*** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MCZ?_ &.=='V#RUM5NC/]L^SYQY; ;1$3NXZ<U%IO[7>O>,-6\-Z+X/\ AO\
MVSKFJV=[<7-M>ZZEI%826EVMK.C2>2^] Q)#J,G ^7GCT)?V6_AFNA_V6/#\
MXC^W'4_M@U6\%_\ :2GEF3[9YWGYV?)_K,;>.G%;_A?X*^"O!>IZ/J&B:%%I
MUWI&GRZ79/%-+B.WED6612I8ABSJ&+L"Q.>>3DTTO_7N_P#R5O\ -;">VG]:
M_P"7]/<^<_"G[97C/3_@[HWB+Q!X3TK6->U*[U,PV&G:C<^=+:VLS*[K##93
M.-A&PDC9A0S.N[:-_P 0_MLW.GPZCJFE> VU3PWI>B:1X@O[Z75Q;S1VU]G
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M48;B"21$:2:W@D\I^-P>'' (#C&?H*X_9@^&-YIT-A/X6CGLX8;^W2&2\N&
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MR<.:6FFMO_ E;Y\M[]WM;<R][E7?3_TG7Y<VWEO?8]NHHHK,H**** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4/+#.!D@ [BBO/M4^)GB.PU*[M8/A+XQU*"&9XX[RUN]%6*=0Q D02:@KA6
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MJ%PIY!P" =?17GVJ?$SQ'8:E=VL'PE\8ZE!#,\<=Y:W>BK%.H8@2()-05PK
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M.WEE<W.L2:@8M3GU>='$S":Y:%8(B&EFD<+'$#\K,V6((*A0M>DU6EEW_P"
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M?]^(O_BJ/^&1_B5_T<MXX_[\1?\ Q5?4=% 'RY_PR/\ $K_HY;QQ_P!^(O\
MXJC_ (9'^)7_ $<MXX_[\1?_ !5?4=% 'RY_PR/\2O\ HY;QQ_WXB_\ BJ/^
M&1_B5_T<MXX_[\1?_%5]1T4 ?+G_  R/\2O^CEO''_?B+_XJC_AD?XE?]'+>
M./\ OQ%_\57U'10!\N?\,C_$K_HY;QQ_WXB_^*H_X9'^)7_1RWCC_OQ%_P#%
M5]1T4 ?+G_#(_P 2O^CEO''_ 'XB_P#BJ/\ AD?XE?\ 1RWCC_OQ%_\ %5]1
MT4 ?+G_#(_Q*_P"CEO''_?B+_P"*H_X9'^)7_1RWCC_OQ%_\57U'10!\N?\
M#(_Q*_Z.6\<?]^(O_BJ/^&1_B5_T<MXX_P"_$7_Q5?4=% 'RY_PR/\2O^CEO
M''_?B+_XJC_AD?XE?]'+>./^_$7_ ,57U'10!\N?\,C_ !*_Z.6\<?\ ?B+_
M .*H_P"&1_B5_P!'+>./^_$7_P 57U'10!\N?\,C_$K_ *.6\<?]^(O_ (JC
M_AD?XE?]'+>./^_$7_Q5?4=% 'RY_P ,C_$K_HY;QQ_WXB_^*H_X9'^)7_1R
MWCC_ +\1?_%5]1T4 ?+G_#(_Q*_Z.6\<?]^(O_BJ/^&1_B5_T<MXX_[\1?\
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M(O\ XJC_ (9'^)7_ $<MXX_[\1?_ !5?4=% 'RY_PR/\2O\ HY;QQ_WXB_\
MBJ/^&1_B5_T<MXX_[\1?_%5]1T4 ?+G_  R/\2O^CEO''_?B+_XJC_AD?XE?
M]'+>./\ OQ%_\57U'10!\N?\,C_$K_HY;QQ_WXB_^*H_X9'^)7_1RWCC_OQ%
M_P#%5]1T4 ?+G_#(_P 2O^CEO''_ 'XB_P#BJ/\ AD?XE?\ 1RWCC_OQ%_\
M%5]1T4 ?+G_#(_Q*_P"CEO''_?B+_P"*H_X9'^)7_1RWCC_OQ%_\57U'10!\
MN?\ #(_Q*_Z.6\<?]^(O_BJ/^&1_B5_T<MXX_P"_$7_Q5?4=% 'RY_PR/\2O
M^CEO''_?B+_XJC_AD?XE?]'+>./^_$7_ ,57U'10!\N?\,C_ !*_Z.6\<?\
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MF1BOGCQIXNTOXP_%SQ]XN\'SMK?A72OA;J.F7&M01L+7[5)(T@A5R &<*I)
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M<[""&7.#C!.W#9'%2I?NU-[ZM^G*Y+YM1?S-'#WW%;:+YWC%_<Y(^S:*^&_
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MC>7+Z_@D_P!?S\KIZ1O_ %NU^GKMIO;ZUHHHJ1A1110 4444 %%%% !1110
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M_?B#D;@C=U!P>]5K/X?^%M-FT::T\-:1:RZ+"]OIDD-A$C6$3C#I 0O[M2
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MJ.GWUSI]Y)K=K:0W,-Q$0'C/V4>0X4]'3((/7.:;]U-OI_G8SO>UNMOQ2?\
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M86QN&3OZ5WWQV./^"=^H'I_Q1]E_Z+AI2]V$Y/IR_CS?Y+]0A:52G#^:]_\
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MU_O5_EOYV?<M<NC\W]VEOU3\UZ'7>%_%VF>,K&:[TN69TAF:WFCNK66UFAD
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MS%';ZA)+,;@0^3O+C%T(YEXVJ$QO8DU[C1I;[_NZ!K?[OZ_KTZ!7R?\ !/\
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M\D(K!=Q*^I^)/ VA>+M0T.^U?3TO;K0[O[?I\C.R^1/M9=^ 0&X8\-D9P<9
M(QW^$O@^SFO;Z:P;R9$N#)#<WT[VD(F4B=HX6D,4)8,^YD53\[\_,<X_9U\_
M^!_E\KZFL6E-.VFG]?KYW:TT.,U#]H;_ (1W6M/T;5+/1UODCL?[1B&N*MQO
MN6VK]E@:)6N H(=R?+P#A=Y!%>MZ[JD>AZ+?ZC+);0QVL#SM)>3>3"H52<O)
M@[%XY;!P.<&N!TGPQX DU;0YM*U2^FNYD:.TNK+Q!?.EX+9\E)9%F*SLA9AL
ME+':'7!56 WHO"^G:;X';PUXAU.;6X+F"=+F;4)V,UT&W/)CYMP !. I^50
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M::.XU!K@.MMJMS:/="4(9D;RI5+HPB0E#E?EZ=:'MIY_I;];DKXDWMI^3O\
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M )EU[]IN/P_:1I=Z7I5KJT*WTE[9WVO);+BUG,+):N\6;B1RI**5C&!\S(2
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M O3YR<9 (GA^$OAZU-Z+5M9L8KLL7@L]?OX(4+2"1C'&DX6(EESF,+PS#HS
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MZDUF\VOLFZ.RG\J1I0+4["^055=_7YBN*[#Q3HO@_P /VIFU:UE"ZD+/2Q'
MMQ/)/Y+/);QJD>YCM)=B0.@)8X'&M:> =!L6M6@L-AMDNTB_?2':MS())QRW
M.Y@#ST[8%7/6[AYV^[_AC.%TTI^5_P"O6YPUC\=+K5K$ZY8^'%?PK!-9V]W>
M3W^R[C>XCA?*0",JZH+B+<3*IX?:IPNZ]X!^*^K>*M6TBWU/PW;Z1::Q:75W
M83V^IFY<K!)&C"5#"@0L) PVL_ (.#6E9?"/P4;R":TLF/V!X(S:PZC.;8R6
MZ*L+30"3RY)$58\-(K,-B'/RKC=T[P7HNBMI<EI9^2VE036]H?-=O*CD*M(.
M6.[)1>3DC'&*<G&]UM_P/Z?^8HWM:6_]?U^B//\ Q]\6/$6C_P#";V&F:/IU
MI>:1ID]W83:IJ$L,MYLA1S+%%]F9'C4L02)"0R@,JA@0_P#X7%K=EI^H7ESX
M=LI;#05@37;F+5&\R*1XHYF^SQFW F"QRQL2S1]2 #CG4GTSP+KEO9^,+J:[
MU&S\011VMJ]W>7DMNR7:I$HCMG8I#O!52512-S9(RU7U^#/A19K:1K2^E,(C
M#)-JUY(EQY9S&;A&E*W!7C!E#D!5 X4 **:^+R3]5O\ @UII\NMR[+?7\;6_
M)G ^//C%J-MX'MO%UU:1:%X1CUFR\N^@U&1[R>$7J1L)(%B"HKC=QYK<$!@,
MD+Z7J7C.Z\/^ 9?$.K:3]GNTB#_V9;W*RMO=@L<?F8"[B64$_=!)Y8#)RM/^
M'O@JZUC5K2V@N9);6[CNKK3C?7?V.&=F6X5T@+^2I+8<[%P26S]YLZOA_1?"
M^M^")-*TZ!;SPU,9[0VLQD9 %D:.2-1(<JJLK*JC"J -N !27\-KK>_X)?H1
M_P O+]+?J_\ ,\R^(7CSQ=J4UKX6?1K/2]7&HZ:UX+#Q%<11R6EQ)(JB.XCM
MDD!+P2*P"K@ 8+;B![LHVJ![>N:Y32_A;X;TE1Y5I=7$WVF&[-S?ZA<W=PTD
M6?*S++(SE5R<(6VC<W')KK*>EFO._P""7YIC=^:_2WZO_@?ETN%?)_P3_P"4
M@7[1O_8/T+_TBBKZPKY/^"?_ "D"_:-_[!^A?^D45(H^L****!!1110!\N?#
M_P#Y2&?%7_L4M-_]"2OJ.OESX?\ _*0SXJ_]BEIO_H25]1T#*6M1M+H]^B*7
M=K>0*JC))*G  KYW\ Z9KWPY^#\^DZKX>U?5O$5YI=I(VKV:W44T\)$<9C=K
M?]]!);*Y_<QX+*A,?S,X7Z,U/4K;1]-N[^\E6"TM8GGFE;HB*"S$_0 UY7<_
MM)>'K.R9+E[2VUR!-,GO=)GU"-7M(;RY6$-(>H:-6#NN,#*C=A@U$=Y)=;+\
M[???\ M=Q?:]OP_KYG#_  \\,^(_%GB.PL=<O_& \.6\FKO%+Y^JZ3YHS8&#
M>9)O/(R]SL$DA)P^  -HS_">EWF@^$M+TN_@\?6ME8Z*EO8PZ:-5\U=65W$P
MD*\M'C[/Y9D)MR/,P<9KW]OB=X.CT:UU=O%FAKI-U,;>WOSJ4(@FE&<HDF[:
MS#!X!SP:/&WCVS\"PZ7+=65_?+J%V+2/[!$LFQBC-N?+#"X4C//)%-[*.VEO
M/U]=?OLPC*R[]?QO]W3TNCR"R_X3'^T+7^T_^$F_X3[^T[+/V?[5_8OV']U]
MH^[_ *)_J_M'WOWOF8Q_!6U\%]!\0>'YO!3ZA<^)+DZCX7:?6?[;O+FY"7RM
M;%01,Q$+XDG&U0N0IR#MX[SQ5\4='\'^+O#?AV^2Z:\UUW2*:&,-#;XP%,S$
MC8'=EC7 .68#U(N_\+&\)G6+G2!XGT8ZK;*[3V/]H0^?$J ERR;MRA0"3D<8
MYJHSLKV[_@K/_-^>I-K+D]/SNO\ )>6AQ'CF:71?'T<_AZ'6;C6-4-I9ZE8Q
MZ7<M97-MO93)]L5 EO)$CRL")1G !4LR$<7X%EO?AQ::"@L?&#:9:Q:U9WUO
M]DU*];[8T\#V[!6#%D,:2[95S&"S?,"QS[9H_P 0_"OB*&2;2O$VCZG#'-';
MO)9W\4JK*YPD9*L<,QX"]2>E)JWQ&\)^'[F&WU3Q1HVFW$TK01Q7>H0Q.\B[
M=R*&8$L-Z9 Y&Y?45GRZ<O5W_%?I?3S:]"E))\W8^<]4L/$>I>%--B\0V_CF
MYUZ2UT!M/AM$OGM\#R#=?:E3]UY@D$QD\_YMH7;SBMNZ_P"$H_L<?VU_PFW]
MI?V)'_87]D_;?^0AYLV_[3Y7R[L_9O\ CZ_=;<]O,KU+7OC'8^%_ OB7Q5J6
MFWDEEH=_)9/;Z>!//-MF6(,BG;DDL#MS^=7/$GQ<T#PW?^#+20W%])XLN5M]
M/-D@D4*4W^=(21MB&47=S\TB#'-4W[27,NK_ /2MK=F$?<WZ7W_N[W[KOY'"
M>#_%#^#/&6KMXCNM=O8KN9(O[3O+?4HK>&ZFN4BCLXH)!Y,@WO\ )-;KC8F7
MZ[W[/XL6%]>MX3>PM[B=[?5VF=K=&8Q+]CNE#''0;F49]6 [UK-X^\&:AIMY
MJ!\1Z%<Z?I<X6ZNC?0O%:3 X =]V(WR<<D'FLMOC=X-DUR71[/7=/U'48[."
M_$-M?V_[R&9]J,I:0 \8;K]UE(SN ,R7/'EZ^7;=?K\O.[;B^1N73_/3]5\_
M*R/*8] \7^&O"FCQVMSXPO([S0M-GUQIKVZN;P.+B+[7Y)=BT4QA>;*1;7X^
M1=P6O:_ ]]I7]EV]EI:ZYY&QYD;7(+_SL>800TEV-^=V<*QSMP0-N*FTSXA>
M%M:U*[T[3O$NCW^H6@=KBTM;^*26$(=KET5B5VG@Y'!ZUDS?&3PC-H=_J>C:
MU9^*8[%H!<0Z!=0WDL8FD$:,55^ 22<DCA6QG%7*>C?35_>_R6R^9G&#T2WT
M7X)?>^OJ>8?$[PV-0UKQ=!>PZM<7']MZ'K4(TB6Z6=M/C>"*0(MN0\GEM'<.
M54$J9%8 $@U+;>%O$.BWDNNZ%_PD U*\\2WX^R7%Q<BT-JUM.8R]NQ\L*91$
MWF,N[<0-V.*]2TSXAP:AJ^CVTMG+8VVL:3_:MG/<L%;Y=IEBD7HC*LL9^\<Y
M?ILR:>C_ !R\!:QX=;74\6Z-:Z4MY-8?:KK4((T,T;,K+N+XY"%ASDJ0W0U+
MBTG';=?^DK_VU+[^YIS*5G:Z_P#M7_FW]W5'&?L[S>);BYU!]975K6+[#:^?
M:ZQ/J,[_ &S+^;*CW=M"BANAC@9HUVJ5"A@6],U'P7ITVJ7VN6EK%;^))K*2
MS34>=ZJP7 ZXQE$/3^$50\7?$_1?!&J:%#K%_8:=INJ),PU.^O4@AC**A49;
MAMV_CD=.]:LOCCPY#?:992:_I<=YJB"2PMVO8Q)=J1D-$N[,@QW7-$[5+KY:
M>?\ 7W$Q]SWOZT_K4\[\+:]>Z=\*QX3T/1=4T?QGI^AO!!!=:3<K:+>I!QB[
M:/R) 9,'<'.[)[Y X^ZTS6-:DM+'P[-X]M]!GETY-6DU*?48+H3?;(O,\F28
MB1$\GS1(82(P"N"#DUZ[#\4]"C\<:CX6U#4=/TS4X9(8[2WN;Z-)KW?&K_NX
MVPQP6QQFF>(?BMH>EVMR=,O]/UR^M-1LM.O+&TOHS+;-<74=OF0+N*E2Y.T@
M9V$<=1<9<]13W;:]&[[>FOWV$X^Y[):=+]=;?CI^+[GBGC/2?%'@WP+KVK6>
MI^+4N(QXBMVEN=1NY1!9QV]TUHX#L0I#1PE)OOL2/G.ZK5Q=:I':Z@NE6OCF
MX\,W:Z=')<ZHVLFYL[O]^\\R)&RW<D>%MT9(B(BSC! $E>N7GQ'\,>(O%T/@
MF"ZTCQ#)>0W4>HV<=W%.;=8P T<T(SPVYE(;'0CFEU[XV>!/#>D:]?3^*M'E
M30HW>_M[:_A>:#:2I1DWY5MPVA3CYN.M1>Z2]/P_S_/4T[V75_*]K)>EONT/
M$M$T3QQJWA/6M2O;OQDNJ:7X9232(Q-?6OFW:7E_L+0%R99#&EKE)3(Q5DW;
MLY/<^$(_$.J?&+Q'X8U.XO9_#.AI+?+++=,XO/MX!C@?G)$.VZ 0\!7A(Z#'
MH?B;XD:3X9\-V&N!+K6-.OIH8H9M)C%PA$K +(7!V+&,YW%@#T&20#C-X\\.
M>$/$FH:99>'Y[:W;4H(-4U:QMH([6.^N=GEB;YQ(\C^9#EPC >8FYASBV^:5
MK=U;U_K[]#/>-UY?@K?UZM[HJ^(_#.E:!?> O#F@6,=E)'K3ZE#%#G]Q$J2M
M<R\G.&\[RS[SBJGQC\/)>>+/!FK/;ZU<+;R75N?[+>\=$>2!A&98H#C:6X+.
MNW!PQP:W_$GQ>TC06(L[2\\2)%;S7EU)HIAF6T@B<QR.Y:1<[75UV)N?*, I
M(-%G\7-+U#Q!!806&HOI\]V=/AUL)']CDN?+,GE#]YYF< C<8]FX;=V>*RDO
M:1<;[W_R_P"!Z_<7?E:EV_2\OUN_+7S/)--\/Z]X!\"Z38VUKXJU*VN_#.GQ
MWL<M]J+O:W/FQ([H(6\V)D1W9H8-A(3& !D+\.M#U.3Q3X*UO7AXJNA;W.KV
M-O<S1:K$ CSQ-;&:"21W2-E$GSW!(PJAFX4#V/7_ (HZ/X;\>^'_  E=)=-J
M&LJ[13Q1AH(" Q19FSE#)LD"<'<8V''&6>&_BQH?B;7/&6E1BYLKGPK.L-^U
MZBHC(8]XFC(8[H^'7)P=T;#'&3HYWDZGJ_E?7_P&]EVOV,XP<(J'I_Z3;\;7
M\VCB/CGX7-]XKT?55M-<NF_L75=/3^S&O)(A/(D1A62*$E &Q)EG7:<*&/"U
MRVO:%XN\$Z.UEH2^)]2TR33]'EO4FU"^>4'SIA="&5$EEB8H(MR0+E5^XJGF
MO:_AG\0M.^*G@O3_ !/I-O>6MA>F41Q:A"(IQLD:,[DR=N2A(!.<$9P>*Y*3
M]H338;;SY_#/B"!9M_V ,MH?[0V74=LPB(N"%(>6,_O3'E6R.A CE<)<O733
MTN[?CJ:<WM$EY->>K6ORM\KFC\,?[5;X73_VI=W\4S-=_9Y)$NYKNWAWOY:_
MZ3#'/*Z#@,\>YPJGYLY/E?A_1;N35O"&HW5IXNN'TO4[BTCU.>76]MV[VJ^7
M/):S,9(8S)E&W@Q#:WS;6KT[6/C=#H>AZ[?77A+Q MYH<'VS4=)!LOM,-KMD
M99P3<^6Z-Y4@&QV;*D$ @UU2>-;*R\-C6_$*?\(A:;@K_P!N7-O'Y>2 NYTE
M>,;B1CYL\^M.2W>VW]7[_KO>PM=+]W_5ON^6UKGS[+_PEXTO1_[+'CHW?V6+
M_A-/M7VS=GSX//\ L7F?+YFW[5C[%QL^[\WDULV>GZA#\6HM0TJU\5#P$VEV
M"75Q,NHC4'N$N[THC&X'GO"K/EU!SM:+CRBU>PS?%+P7;S:?%+XNT&.74(XY
M;-'U.$-<I(Q6-HQN^<,00",@D$"H=6^)NDZ)\2-"\%745VFIZU:SW5K<",&V
M_=8S$S;LB0KN91C!$;\\8.BD[VMK=_E>WHNBZ W[LEY+\UKZON>.V?A'Q?X6
M\,BZ\-GQ"NN7[^(/,M[BXE:",M+/);%()#Y,1R$V-M7=NY+;B3*;'5[[7+(^
M%K?Q5/H4-U9RH?$Z7S/'>".Y#.OVP>:$"F'<?]7DC;\V^O3+?XY>$6\1>+=)
MO-131T\,RVL%[J6J21VUFTDX;8D<KL Q!4J>GS<#)!QTMKXV\/7UFUW;:]IE
MQ:*D,AGBO(V0)*<1-N#8PYX4_P 7;-9-<ROTT_S7^:^\2]U.+ZW7Z?\  ]+H
M^7KJU\36YM[[0;#QU=ZI'H$$&MR:PVHQOYC7MJ;M;>5D=E<QK,?]$5A@9B&0
M*Z_PIX9\6>*-0@^U7_B&SL(M.U5]/A:^U...*9I(%@2Y>XC@DG*DSE?-4@H?
MXL9KVJ\\;VEGXXT_PN]G?F\O;:6Z2[%N1:J$QE#(2,N<YVKG 'S;<KFMH/Q(
MTKQ)XXU[PO91W3W>BQ0RW%VT8%LYD+CRXVSEF0QD-Q@$@9)# 5\2Y?\ %^-_
MROIV^9/*XWE?K'\++7UMKW^1XWH/B"ST2Z\/:F8]<N- @T5+:[T[R]0ALM'$
M%M(LH9E_T2<[U\HQL#('P03@*.\MM(U_0/V?] TV);R/7K2QTZ%X[1G:9"KQ
M!UW+\QPNX$]P#FND^(7Q$'PZT^74KOP_JVHZ/;0-<WNHV!MC':1J1N9UDF21
ML#+8C1SA3WP#6N/BUIT'B*33!IFI2VL5Y'ILFKHD7V1+N1%=(#F02;B'C&X(
M4W. 6!SAN3G=]W^K_65O7;<+*"79+]/\EKY;GDL]CK/B#Q=>^#%MO$NLZ3K.
MI^=J.O:C;ZC!:P6<<TDLEIY=R/)PVQ(5> !71\D# +8M\_C75_%&KQZ='XNT
MFUO[*Z%S:QKJQ%I,-0M5C,=S.YCW&)KA@+950+NY90N/99OC9;6,>M1ZEX7U
M[2M2TNVM[PZ;<?9&FN(II6BC,;1W#1_?4@AW4C&>G-=KH.J7.L6/GW>CWNAR
M[ROV6_>!I,#'S9ADD7!_WL\=*F.ENMD_Q5OP[=_.Y<MW?R_SO^._W:'AGAVU
M\6:;\8DTYAKEO96NIM'#<WE_JMY;7&FBV.V,AH'MMQ;YO-DG\W>N"<$(=+]H
M"X\5QZ_81:7#JXTIM-N##=Z3<:A']GOMR[))$LK:=I=J\JDH$;?,"&. /4M3
M\?:%IMG:7']IV5RMW>KI\"QWL"^;-YHB=%+NH9D;=N0$M\I 4MA3AS_'CX?0
M^*[3PVOC'0[C6;B9X#:0:E \D,B@DK(H?*$E2H!&21BC^6_3\=+?\'UU#JVO
M^&UO_P #TT.&TWPGXB?5+/4+Z]\327=[XDNK2^C34+Q+5; VTP!2+<%B3>$9
M9%"L"1AAG%<1I_@K4KCX1W/A\67BY;6P\.PI+:22ZDCF]CN"95BW,&D^4# C
M+*PQMSQ7TG?>-?#VEZ?]OO=>TRTL?LRWGVJ>\C2+R"0!+N+8V$LH#=.1SS7(
M:Q\;])L]2LDTYK/6=*N1:$:I:WZ- !-=FW8AE!4A""QY[$<=:76,>NWSLU_F
M_4F3]R3Z;O[[_JEZ'COB-?%%CJMZ=,TSQ*OA>\N[N>*>*75K2Y$WV2Q6WED^
MSVTUR^%$_P LB["ZD/E@HK3OM-U^]\1:0FOIXLU'Q+'XCTN97LX;W^QOL2K
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MTK4VO;^SM=,N+^,37?V:YE@W1J<,VXQ9P <;L<XR4Y*-IO9)+[G%_P#MJO\
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M?^P?H7_I%%7UA7R?\$_^4@7[1O\ V#]"_P#2**I+/K"BBB@04444 ?+GP_\
M^4AGQ5_[%+3?_0DKZCKY<^'_ /RD,^*O_8I:;_Z$E?4= S'\8^'8O&'A'6]"
MGD,4.IV4UD\B]5$B%"1],UY7JWPU\6>+IH[F^LM)MUO[?0QJ$-Q=,6BEL+XS
MRA$6-ED216;:2RD$ $<G'L>I7L>FZ?=7<LD,,5O$TKR7$GEQJ%!)+-@[5XY.
M.!7C&E_M":WJ]];:5:^$K.76KC4+>SC']IW,5FT<MM<3B99I;)'91]E<?+$5
M.00QY <6T].EG^.GXCN[+Y_HW^"*?C+X(>+K[QMJWB#1-2LTAOY;R-K%KE(-
MT$]O91G+R65R =UHP*JG*NIW\%3[9X=TI=!\/Z9IJ,[+9VT5N&DD\QB$0+DM
M@;CQUP,^@KQ[Q%\:/$&N>#]9BT'PW#_:UIH][<ZAYFKF#[(T4TUOBW<0DRL7
M@E92PB&%7)4GCKO$GCZ\\'>!_#UY;06>JZC>11(+6]NKB.6<^3N8QK#;SR2O
MQD@)T))/&"N;E@UT5E_Z4OSO]^@I*\EW=_\ VU_JCF/'/P&UGQ[JGC+59_%E
MUI%YJ"6T&E06,<$D$$=J1-;-(98&<.+EGD;RV7C:,Y&:=J7P;UW5_"HMIVTF
M'5YM:O-6N&BD<Q9GM)X<!O+#$@RJ.0/E!^E&C_M ZEKUE:ZO:>$XAX>9-)>X
MN9]3*749OA%M"0>20WEF5=V77(Z9/%=)X"^+@\=>(6T>+2OLMW96T[ZLOVG?
M]AG2Y:".+&P;_,,4SAOE^5%.#NX'3W@_-?=9O\EZ]"N9KW_ZU5E^#T,37/A'
MK#W5M>:4=+6>RL-&A@MYI'BCDDLKIYF1F6-MB%7PK!6(.?E]>1\8?!KXE>*_
M#?B;3GGT6)=>%^SV-OKEY;06\LRJL;L\=OON J@@HVQ2>H.["]%??M&2Z;X@
MU/3'T*VOU2&>33KK3;V>2&ZD2ZAMA$\DEM'&K%[B/=Y;R[,-GH-V3/\ %_7/
M!OBKQ'<>*+&:VCM[S']GZ9J*W<!C33'G&QI84/S,O0"+#\DLOWJ4G=5%UN_O
M:O\ DO2UT1\#7E9?^ JR_/YWU.VF^&>I3>"]5T?SK,W%WKR:HC%VV>4+N*8J
M?ESNVH1C&,D<XYKBX_V>->DDOHI]8L_LEK=0VOA_R]X>PTQ7>5D/R_ZW=(J
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M&&P7)B41EBIX&_ (.<\#%R48\SV2;^3_ . ]/+;:Y:3D^5=6OO7_  =_/[C
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MPIFE? (5>!QGGJ2:ZFBD];WZB6FQR-Q\)_"MUI4&G/IC"U@LH-/A"74R/%#
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5\G_!/_E(%^T;_P!@_0O_ $BBKZPKY/\
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M[IG)Z;Q)!\19?BMX2^*5C\,K^Y:WT>_T.]\-/J]@E]!YDT4D4X?SO(93Y1!
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MD?+MXQWYJ/2_V._ ^C^$_B5X>MKS65L_'UP]QJ4K7$1EMPSL_EVY\K"(K.Y
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MZKXMU+4KO58;WQ%!I\4DUK-&C6;V4C26\UN3&2L@9R26W XQCKDC9<C?3?\
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MXDBB18XD4*J(,!0.  .PK,M?".A6.CW.DVVBZ?;Z5=/*\]C%:QK!*TC%I&=
M-K%V)+$CDDDU4FN=R2TTT\DT[>EDUZ,4;\J4GKO?Y/7[VG\CPSX3WT_A7]HO
M6? ^A^+-5\8>$1X;AU6X.KZH^IRZ;>&<HB"X=F?$L>6\MFXV9  -<QJWA.>S
M_:D\5V$7BWQF--L_" \1P6!\47YMDO&NIE)\KSMOEX50(\; !P*^D_"/@/PU
MX L9++PQX=TGPW92/YCV^D645K&S?WBL:@$^]6Y/#.D3:M/JKZ58OJD]K]BF
MO6MT,TEN"6\EGQN*9).TG&2>*B:YDK/5*2OZJ5ON;5O1%1:7-INX_@XW^])_
M>SXL^$_Q-^)NKR?LSQZ^9+/2=4T^^=]1A\13W<^L[=.=U>[B:),$$!QN>3#=
M^,UW7[!<GB36_ 5GXA\17>H:E+J%CE;_ %#QG>:J]P1,P):RF79;$  91FR/
MK7T?;^!?#=G'HT<'A[2H8]%1H]+6.RB46"LFQE@ 7]T"ORD+C(XZ51\(_"CP
M1\/[RXO/"_@[P_X;N[E/+GGTC2X+625<YVLT: L,\X-;.:<Y2MO_ ,'_ #_#
M8SM[D8]K?A_7_!/C#1_'7B^Q_:7N;N?Q)K*Z(WQ(N=!6/_A(I[A)(S:[H[0:
M8_[M(M^#YZDLN?N@#-7=-\=:[_PJ?P]\3T^(.M7/Q/OO$T5A<>%6U5C9,SW_
M )$FG#3\[$V19.X+O&W<6YK[#L_A5X*TWQ9+XHM/!^@6OB:9F>36H=,@2\=F
M&&)F"[R2.I)YJ2/X:>$(?%;^*(_"FB1^)G!#:RNG0B\8$8(,VW>>/>LZ?N1@
MG]FWX6O_ .!6=_7KKS74]]S:ZW_'F_*Z^[TY?C;6/VE]3MOVIT\3IKNN#P%:
MZ\O@V;2EM+O^RC"4*/?M-L^S^8MXPC^]OVKTP:H>$_''BZ3]H=XCKOBJRMKC
MXA:QIHU#4-<DFT:>SAA=QI\=H9&$<V=I1MB# .UCC%?;I^'OA5O"\GAH^&='
M/AR1B[Z/]@B^R,Q?S"3#MV$E_FZ?>YZTC?#OPHT?EGPQHQC^W_VKL.GQ8^V_
M\_.-O^N_Z:?>]ZE*R2[)K[^7_*3^=MM"I/FYK=7^2DE^:_\  ;[ZGQE\"_&&
MLZ+IOP!U:R\?^(/$?B3QC>S6NO>']6UJ744EM LY>Y6.5F,!B*1\IM!S@YS7
MLGQ6OI_%?[1FE^!]=\6:MX/\)#PU)JMM_9&JOI<FHW@G\MU-Q&RN1%'M;RPP
MSOR00*]?\)?"?P1X!O)KOPQX-\/^'+J==LL^DZ7!:O(.N&:- 2/K5[Q=X#\,
M^/[&.R\4>'=)\26<;^8EOJ]C%=1HW]X+(I /O5R:DT[=6_O5DOD]5Y]M+1WU
MW2_!WO\ -:/R/ABU\7_$+XCZM\+=$LM:UCQ);27WB>T@N(/%5UH/]M6=I+$M
MM<RW-JC%R%S@[2&P3GDFO?\ ]J*6\M=,^$6CKKNK^'[34O%MGIVHSZ7K$]I.
M\!MYRR-<1LKD94$DGD@$\U[?'X1T*&ZTNZCT73X[G2HG@T^9;6,/9QN '2)L
M9C5@J@A< @#TJ'Q=X%\-?$#3H]/\4>'M*\26$<HF2UU>RBNHED (#A9%(#8)
M&>O)I=(K>S3?G9W_ !7]6'_-TNI)>5T[?=T].Y\<:'\1O$=O\1=$\,Z;XTU?
MQ%X3TSXDQZ39:Q+?M+)>6[:9-+-:33*1]H6*7 R^XY R25KRSX<_$KQS_P (
M9?W<GB?QCIMS<> _$6IRW>MZ_+=QZK+%(R02V ,KFW>$_>YC;&#M(^:OT7M?
M 'A>QL=)L[;PWI%O9Z3+Y^G6\5C$L=E)M*[X5"XC;#,,K@X8CO563X5^"IM/
MLK"3PAH+V-C'/#:VK:9 8K>.8$3)&NW"K("0P& P)SFI>L6K[JW_ ))RW^_W
MO^#J7"2C)-K2Z?W2<K?<[?U8^3+?Q'XM\&? ?PI/?:UJ'AV#Q-K>D66K>)&\
M8W.NS6EE-&3).)+E +-G;:F%R%,F<Y -=-^T%\/;+P?\-=)O_#'Q \<R3'Q)
MIE@]Q'XVU"4^5<74,<J%A/SE#D9R5W$C&:^BM!^$O@;POH^H:3HO@SP_I&EZ
MCQ>V-AI<$$%U@8_>(J!7X)'S TNE?";P/H6B'1M-\&^']/T@W27QT^UTN"*W
M^T(5*3>6J!?,4JI#8R-HP>*U<DY\UOM)_)<ON^FC^_9&$8N,%&_1KYZ^]ZZK
M[MSP#5["/5/C3XD\#>(?B'XE\)>'/"_AVSN]&$/B.>TN+SS#-Y]W-<%_,N/+
M*(N'9E'<'-?./B[XR?$/7M!TC6K[5?&$ES#\/7U%;W0=8DTZWBE74988-4NH
M%=1+&T8C9U$;DJWW<#(_1;Q9\.?"GC[[+_PD_AC1O$?V1M]O_:VGQ77DMZIY
MBG:?<58NO!7AZ^N)KBYT'3+BXFL3IDLLMG&S/:$Y-NQ*Y,62?D/R\]*R5]+^
M?Y2_S7W:=+;<RUT[?@XW^^S^_P!;_,&N>)->\$?'#PUK'C'Q'J7B/PSJLVDZ
M9IDOAOQ";:&RO)(E#"ZTY643QS2-YF\[RJL.  *]C^-_QNTSP#\#_%/C+0[^
MUUJ>TCDLK$:?*MP)=0+^3'"-A.7$Q"E>H(([5U5K\)? ]AKEKK=KX-\/VNM6
MD*6]OJ4.EP)<PQ*NQ$24+N554!0 < <"C1?A3X0\/^&-+\.VOA^RDT?2[G[;
M9VUY']J\FX\QI!,&EW-YF]F;>3NR2<TYI3@X;7;^Y_KO_2NXA[DE+>R7X?TO
MQ[GQQ\-?B]XAL?V9?C#X5U+Q;XBU#QCX?\-MK5IJ^KQWEGJ4:SVI+@-.J2'R
M;A)55UR-I3!XKE[[XQ>/])2'P5K'BC6D\2>'/A]KUW-J$-W-$-2C:UAEL+XD
M-\TJ@NF\DLKQN<\U]_ZMX%\-^(+RYO-4\/:5J5W<V3:;//=V44LDMJQRUNS,
MI+1$\E#\I/:H=0^''A+5KI;F^\+Z+>W*V+:8)KC3X9'%HPPUODKGRB"04^Z<
M]*=1\_,^ZM^$DG^*_'K8JG:#C?6SOZZQ;O\ <_P\SYN^"NO7OAOXO_#SP_H_
MC76?%UAXA\(OJNOZ;K&K2:FVG3JD)BN%DE9GB\QG=-A;:<9 XI]TWC+7OVOO
M':6!U75M%\/VNDW*6:^+KS3K:U9X96.+*-6BN=[(,JY4<=\FOH[P?\.?"?P]
MAGB\*^%]&\-13D-+'H^GPVBR$="PC49_&M.UT#3+'5K[5;;3;2WU.^6-+N]B
M@59KA8P1&)' W.%!(&2<9.*JI+G=XZ;_ (MM?=>R].FQG37)%Q>M[?A:_P!]
MG]_4^*?"_C35[?X>?"[XB6?Q&UO6?B%XC\06EGJGAR?5&ELY1-.4NK1;#.R#
MR$W'<JAE\O+$Y-4/V8_&WBW5/C9X3@O]<\50V^I7/B-[F77M;DO-/UB*"Y:.
M*&T@:1_)DARI.1'\J' 8'-?9]C\,_"&F>*9_$UGX4T2T\1W&1-K$&G0I>29X
M.Z8+O.<#J:FM?A_X7L?[.^S>&](M_P"S;B6[LO*L8E^RS2[O-EBPOR.^]MS+
M@G<<YR:(R2ES6[Z=KI*R\E:_S^94O>37I^%_SNE\K]D?*'Q6C^)?BS]J+Q7H
M_@>_\2+<Z;::'<6LUOKWV;2=-5Y93</<VC2 3B2-"-JQN<K_  ]:X[X2^//&
MC_'+3P=7\5#[7XG\30&;6-<DN=)U2"V,OE6-O;&1Q%*C;""5C^5&P6Z5]X6^
M@Z99ZQ>:M!IUI#JMY''%<WT<"K/.B9V*[@;F"[FP">-QQUK/C^'_ (7A^S>7
MX;TA/LM\^IP;;"(>5=OG?<)\ORRMN;+CYCN.3S6<?=27D_QM^5OGUW')\UWZ
M?@FOQ?\ P-3XY\+^--7M_AY\+OB)9_$;6]9^(7B/Q!:6>J>')]4:6SE$TY2Z
MM%L,[(/(3<=RJ&7R\L3DUSWP[\0?&6T\(^*OB#H5SXDO;#3+3Q(;JXUW6_[0
MM+^:*>5;-;2T:1WB,.P[OE0,%P V<U]PV/PS\(:9XIG\36?A31+3Q'<9$VL0
M:="EY)G@[I@N\YP.IK5T7P_I?AS3_L.DZ;9Z79;WE^S64"0Q[W8L[;5 &69B
MQ/<DD]:<M4[:-WMV5TE;O96;7FQIZJ^NJ^=FW^-TOEZ6^4O#>K7/A+QI\(3X
M2^)NL>,IO&-K<G6H-6U=M1@,0M&E%\D;$K;!)MJX0*A#[<<"N7\,?'#4O@9X
M-^(-GXKOM:UOXE66B17D%X?$+ZQIFJR33-#;RVL0/^C%I74>2J+\H&,@9K[
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MO.CHHHJ"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "OD_X)_\
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M/=Z*^=W_ &Q- T7Q#9:1JD<FHSZEXGN]!MY-#TZ_E6V2%-W[_?;@F8<!DCW
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M(F;@-+LQD!MI.*OE?,X]5;\;V_)DW3CS+;_*W^9[E17G/QV^.&C_  #\"_\
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M\:VX$>!(I_B!!K2L/V4;W2]0\.:[!XT5O%EAXAOO$&H:A-I6ZWO7NX?)GC2
M3 PCRPH0[WVD9.ZN)\-_M8>.;SQ5:F_C\)W.B7?C'4_"<>F:?#.-2A%N)FCN
M78S,NW$0W+L'!W C.!3\$?M0?%KQAI'@D72^ ?#M[XIT6Z\06]_>0W;VJ6\'
MEJ8"GG*3*S.7R'PB<88C)?,Y)S?5+_TE/_TF*;76W5Z XV?)Z_FX_G)I=KZ6
M1M>'_P!A.'PY'>6R>*;?6M.BLKFQT>T\0V-[?QV4<\BO(KQ/?B"12%QB.*+G
M:V<KSZYX)^!<7AWX$W'PTU?7KS7;:[M+NSN+_F)UCG+Y2(,SE$0/M12S8"@9
M-?/.H?MI>/-5L)=6T>T\(Z)8V?@2W\8SV.N).]Q<N994D@@99D&UA&"KE3C<
MN0V[C:\%?MF^*/&WQ"CMK7PR4\/R:G+I,E@=#U WEELMS(+J:\Q]FV&0;3%@
M.%8-N[4I1TE3EV=_1-K\[_F]-1J3NJB[W^=D_P K?DM33TG]AEK3P]?Z??\
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MP<Y&=W4'U_XV_"F?XM>&=+L;+65T'4]*U>TUJRO9+3[5&LUO)O4/%O3<IY!
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MBFTQ)WC>1C,0Z/Y.THH4]PW.!#E>+K/JKO\ \!O]_+/\?+2HP:<:4>CT^_\
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M'AJ[U&3Q%J,NH>(&O+FSV6E^\?E(&N?,,C[MY)DVH =J8PHEVY5?97MZ6O\
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M:T^GQ&]5<8P)MN\#'&,U?TOPSH^BZ5)IFG:58V&FR-(SV=K;)'"S2,6D)10
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M0F[A4 J%27;N4 $@ 'H:Z6BEY@<O?_"OP7JGAB#PW>^$-!O/#MN_F0Z1<:9
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\G_  3_
M .4@7[1O_8/T+_TBBKZPKY/^"?\ RD"_:-_[!^A?^D45 SZPHHHH$%%%% 'R
MY\/_ /E(9\5?^Q2TW_T)*^HZ^7/A_P#\I#/BK_V*6F_^A)7U'0,****!!111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %?)_P3_Y2!?M&_P#8/T+_ -(HJ^L*^3_@G_RD"_:-
M_P"P?H7_ *114#/K"BBB@04444 ?+GP__P"4AGQ5_P"Q2TW_ -"2OJ.OESX?
M_P#*0SXJ_P#8I:;_ .A)7U'0,****!!1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?)_P $
M_P#E(%^T;_V#]"_](HJ^L*^3_@G_ ,I OVC?^P?H7_I%%0,^L****!!1110!
M\N?#_P#Y2&?%7_L4M-_]"2OJ.OESX?\ _*0SXJ_]BEIO_H25]1T#"BBB@044
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7R?\
M!/\ Y2!?M&_]@_0O_2**OK"OD_X)_P#*0+]HW_L'Z%_Z114#/K"BBB@04444
M ?+GP_\ ^4AGQ5_[%+3?_0DKZCKY<^'_ /RD,^*O_8I:;_Z$E?4= PHHHH$%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5\G_!/_E(%^T;_ -@_0O\ TBBKZPKY/^"?_*0+
M]HW_ +!^A?\ I%%0,^L****!!1110!\N?#__ )2&?%7_ +%+3?\ T)*^HZ^7
M/A__ ,I#/BK_ -BEIO\ Z$E?4= PHHHH$%%%% !1110 4444 %%%% !1110
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MDOA2ZV_]MM_Z5=_<B[KGO;2^W_;S?_I-E\KGS58_M;>/+K3K;2SIVD0:Q?\
MB'3](L_$VHZ#J6FZ28KB"25G-O<LDK.AA>/ D 8NAR,XK6_9E\<_\(?\ _BQ
MXLU>]T]6T_Q3K]]<7=JCRVA99-Q9%!+LA(X .<'KWKWFU^#'P^L?#MYX?M_
MOAJWT&\D$USI<6D6ZVL\@QAWB";688')&>*UM%\"^&O#FAW&BZ3X>TK2]&N"
M[3:=9644-O*7&'+1JH4[AUR.>]4_MVW:LO\ R7]8O[_(G^1/9--^?Q+\5)>E
MO,^2]-_;"^(TVCZU93Z-H*>)+36M!L;>2>V,4#P:D[*"\45[.4=0NX9ESAAN
M0'BMJV_:@^(%YJMCX/D3PGI_B=O%6I^'[G7;NVN%TOR[2V2X#+#YX=9)!(%
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MI<#W8>,@QL)2F[*D#!SQ@8JYXL^'WA;Q[':IXF\-:1XC2U?S;==6L(KH0O\
MWD$BG:?<5'_+M06]VW\XJ-_O7-;_ +=V*NN:[[6_\F;_ "?+?Y[GRAK7[8WQ
M!GT?7/$NCZ+X?LM"T/PYHGB*[T_5(+A[R5;TL)(4D6554C&5<H>G*G.1[/\
M'KXI>,O!NM_#O1/!-KHDVI>*KZXM&?74F:*$1VKS!AY3 ]4Z<YZ<=:](U#X?
M^%M6&HB]\-:1>#4H8K:^^T6$3_:HHR3%'+E?G5"3M5L@9.*OWWA_2]3O=.O+
MS3;.[N]-=I;*XG@1Y+5V4HS1,1E"5)4E<9!(JI-/X=-;_+L1'3?M;YV2O]]W
M\SY!\%_M@?$OXA6&JW&@^&;"ZFN-(U'4-,@;0=2CCL9K5_DM[FXD*Q7!F0,
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M\4^&O_0!\<?^$[+_ (U]1T4 ?+G_  \4^&O_ $ ?''_A.R_XT?\ #Q3X:_\
M0!\<?^$[+_C7U'10!\N?\/%/AK_T ?''_A.R_P"-'_#Q3X:_] 'QQ_X3LO\
MC7U'10!\N?\ #Q3X:_\ 0!\<?^$[+_C1_P /%/AK_P! 'QQ_X3LO^-?4=% '
MRY_P\4^&O_0!\<?^$[+_ (T?\/%/AK_T ?''_A.R_P"-?4=% 'RY_P /%/AK
M_P! 'QQ_X3LO^-'_  \4^&O_ $ ?''_A.R_XU]1T4 ?+G_#Q3X:_] 'QQ_X3
MLO\ C1_P\4^&O_0!\<?^$[+_ (U]1T4 ?+G_  \4^&O_ $ ?''_A.R_XT?\
M#Q3X:_\ 0!\<?^$[+_C7U'10!\N?\/%/AK_T ?''_A.R_P"-'_#Q3X:_] 'Q
MQ_X3LO\ C7U'10!\N?\ #Q3X:_\ 0!\<?^$[+_C1_P /%/AK_P! 'QQ_X3LO
M^-?4=% 'RY_P\4^&O_0!\<?^$[+_ (T?\/%/AK_T ?''_A.R_P"-?4=% 'RY
M_P /%/AK_P! 'QQ_X3LO^-'_  \4^&O_ $ ?''_A.R_XU]1T4 ?+G_#Q3X:_
M] 'QQ_X3LO\ C1_P\4^&O_0!\<?^$[+_ (U]1T4 ?+G_  \4^&O_ $ ?''_A
M.R_XT?\ #Q3X:_\ 0!\<?^$[+_C7U'10!\N?\/%/AK_T ?''_A.R_P"-'_#Q
M3X:_] 'QQ_X3LO\ C7U'10!\N?\ #Q3X:_\ 0!\<?^$[+_C1_P /%/AK_P!
M'QQ_X3LO^-?4=% 'RY_P\4^&O_0!\<?^$[+_ (T?\/%/AK_T ?''_A.R_P"-
M?4=% 'RY_P /%/AK_P! 'QQ_X3LO^-'_  \4^&O_ $ ?''_A.R_XU]1T4 ?+
MG_#Q3X:_] 'QQ_X3LO\ C1_P\4^&O_0!\<?^$[+_ (U]1T4 ?+G_  \4^&O_
M $ ?''_A.R_XT?\ #Q3X:_\ 0!\<?^$[+_C7U'10!\N?\/%/AK_T ?''_A.R
M_P"-'_#Q3X:_] 'QQ_X3LO\ C7U'10!\N?\ #Q3X:_\ 0!\<?^$[+_C1_P /
M%/AK_P! 'QQ_X3LO^-?4=% 'RY_P\4^&O_0!\<?^$[+_ (T?\/%/AK_T ?''
M_A.R_P"-?4=% 'RY_P /%/AK_P! 'QQ_X3LO^-'_  \4^&O_ $ ?''_A.R_X
MU]1T4 ?+G_#Q3X:_] 'QQ_X3LO\ C1_P\4^&O_0!\<?^$[+_ (U]1T4 ?+G_
M  \4^&O_ $ ?''_A.R_XT?\ #Q3X:_\ 0!\<?^$[+_C7U'10!\N?\/%/AK_T
M ?''_A.R_P"-'_#Q3X:_] 'QQ_X3LO\ C7U'10!\N?\ #Q3X:_\ 0!\<?^$[
M+_C1_P /%/AK_P! 'QQ_X3LO^-?4=% 'RY_P\4^&O_0!\<?^$[+_ (T?\/%/
MAK_T ?''_A.R_P"-?4=% 'RY_P /%/AK_P! 'QQ_X3LO^-'_  \4^&O_ $ ?
M''_A.R_XU]1T4 ?+G_#Q3X:_] 'QQ_X3LO\ C1_P\4^&O_0!\<?^$[+_ (U]
M1T4 ?+G_  \4^&O_ $ ?''_A.R_XT?\ #Q3X:_\ 0!\<?^$[+_C7U'10!\N?
M\/%/AK_T ?''_A.R_P"-'_#Q3X:_] 'QQ_X3LO\ C7U'10!\N?\ #Q3X:_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
&%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '4 S0# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;(ZYSCD#%.N-&ENKR1)KR=M.?#FW+#EP<XSMR%X' :I3HQ_M*6^6_NTDDPI
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M1K>+S75@<CY<'/Y5@B\$NH65O>ZCJ9W3JT<<]@(P[ Y'.T&@#L.]+31G-.H
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M1LO/^>\'_?@__%U9HH IRP74T+Q-/#M=2IQ"1U_X%5L?C2T4 %%%% !1110
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M9'[J-02?H"0*QG5]1N[,0Z--:F&82-/.J+M4=0,,3ST_&@#HN]!X!- ZTIH
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M(F>&49,<T;$-&V",C!'8FF'1[(V;6@240NQ=]L[AG)Z[F#9;.>Y- %:0P_\
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MYUU_SYG_ +^B@"U157SKK_GS/_?T4>==?\^9_P"_HH M4AZ56\ZZ_P"?,_\
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M@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%)D>HH 6BC-&<T %%&:* "BC-% !1110 4444 %%%%
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M-(U]"JDLLP Y),#@#]* +5%(*6@ HHHH **** "BBB@ HHHH **** "BBB@
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MK=JAJ.G?;S$/,\O9G^'.<X_PJZ;M*Y,E='*T5N_\(Y_T]?\ D+_Z]'_".?\
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M^"JP@M@'')QT'.>:U <UR>AQWVF3_P!GH^B;C(SS+',WFD$Y/&.H!Q^%=8*
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M?DO^%'E/_P _$GY+_A4M% $7E/\ \_$GY+_A1Y3_ //Q)^2_X5+10!%Y3_\
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M)^2_X5+10!%Y3_\ /Q)^2_X4>4__ #\2?DO^%2T4 1>4_P#S\2?DO^%'E/\
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MH\U_^>$GYK_C0!+147FO_P \)/S7_&CS7_YX2?FO^- $M%1>:_\ SPD_-?\
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M_/"3\U_QH\U_^>$GYK_C0!+147FO_P \)/S7_&CS7_YX2?FO^- $M%1>:_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\T< Y[&N>KH_$'_'BG_74?R-<Y790^$YZGQ!1116YF%%%% !7:BX@_Y[1_\
M?0KBAUKN!7+B.AK2&?:8/^>T?_?0H^TP?\]H_P#OH5+17,;D7VF#_GM'_P!]
M"C[3!_SVC_[Z%2T4 1?:8/\ GM'_ -]"C[3!_P ]H_\ OH5+10!%]I@_Y[1_
M]]"C[3!_SVC_ .^A4M% $7VF#_GM'_WT*/M,'_/:/_OH5+10!%]I@_Y[1_\
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M@_Y[1_\ ?0H^TP?\]H_^^A4M% $7VF#_ )[1_P#?0H^TP?\ /:/_ +Z%2T4
M1?:8/^>T?_?0H^TP?\]H_P#OH5+10!%]I@_Y[1_]]"C[3!_SVC_[Z%2TE ")
M(D@RCJP]CFG4GX4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4'I10>E &3X@_X\(_^NH_D:YNND\0?\>$
M?_74?R-<W790^$YZGQ!1116YF%%%% !7<CI7#5W(Z5RXCH:TA:***YC<****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MX3GJ?$%%%%;F84444 %=H(G_ .>\GX!?\*XNNY%<N(Z&U(C\I_\ GXD_)?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MAF,4]F;>1XD)#1O(&4$XZ,0"?IDUA:/%;WMM?+?A98K>U)M#*,[(MT@WKGT
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M^>$GYK_C1YK_ //"3\U_QH EHJ+S7_YX2?FO^-'FO_SPD_-?\: ):*B\U_\
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M ,\)/S7_ !H EHJ+S7_YX2?FO^-!E?'_ ![R?FO^- $M%,1BW5&7ZX_H:?0
M4444 %%%% !1110 4444 %%%% !1110 'I5#4-)M=4$(NXED$3AQE0?J.0>#
MWJ_10!0GTY99K*6+;"UJY*A5X*%2I7MC@CZ8I[:=:M</<BWC2Z8$?:%C4..,
M=<5<HH STT>Q6P@LGM8I8(1A%E0-CWZ=:DETVRG*>?96\OE#;'OB4[1[9'%7
M** *MS86=XR&YM()BGW3)&&V_3-,^P[M72^=\A(3$D97A23EFS[@*/PJ[10
M4444 %%%% !1110 4444 %%%% !1110 44C=#SBLF[U&YLITWV:_97G2$2>;
M\^6( 8)MQC)]<^U &OD>M%8=UKKP?:YELQ)96CB.>7S<-GC=M7'.-PZD=ZF.
MI7,6H6UM<621Q7+ND;B;<PV@G+*!@ @=B>O- &M163_:5U#J5O;W-DL<5R[Q
MQNLVY\J"<LN.,@=B<<5J]Z %HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH ***1N%- "YHK)NM2NK6\B66R46TLZP))YWSDD<':!C&
M?]K/M4$VOR1>?.MF&L8)Q!)*9</G(4D+CD G'WOPH W<T5E+J5RNHV]M<V2Q
M+<;_ "6$V]@5Y^88XR/0GTHCU.Y74[>TN;)85N!)Y3+-O8;?[PQ@9'H3V% &
MK1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M&:1NE94NIW5K>0QSV06WFG\B.039<G!()7&,''KGVH UJ*PFUUU9Y_LH_L];
MG[,9_,RP;.W=LV_=W<?>SWQ4T.I7(U&"UNK$0_:%=HBLV]AMQD,,  X/8G%
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M:1SZT :E%4;'4$O)9HC#+!/"0)(I0N1D9!RI(/7UJ]0 4444 %%%% !1110
M4444 (:Y3^Q[['_'O^3K_C764E7";CL3*/,<I_8]_P#\\#_WTO\ C1_8]_\
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(4 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" '2 XX# 2(  A$! Q$!_\0
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M><T =!144$Z7%O'-'RDBAE)'8\BI,B@!:*3(SBES0 44F1ZT9% "T49%)D4
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 44A8#J:,B@!:*,TF10
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MQ1B@"/[1!_SVC_[Z%'VB#_GM'_WT*DQ1B@"/[1!_SVC_ .^A1]H@_P">T?\
MWT*DQ1B@"/[1!_SVC_[Z%'VB#_GM'_WT*DQ1B@"/[1!_SVC_ .^A1]H@_P">
MT?\ WT*DQ1B@"/[1!_SVC_[Z%'VB#_GM'_WT*DQ1B@"/[1!_SVC_ .^A1]H@
M_P">T?\ WT*DQ1B@"/[1!_SVC_[Z%'VB#_GM'_WT*DQ1B@"/[1!_SVC_ .^A
M1]H@_P">T?\ WT*DQ1B@"/[1!_SVC_[Z%'VB#_GM'_WT*DQ1B@"/[1!_SVC_
M .^A1]H@_P">T?\ WT*DQ1B@"/[1!_SVC_[Z%'VB#_GM'_WT*DQ1B@"/[1!_
MSVC_ .^A1]H@_P">T?\ WT*DQ1B@"/[1!_SVC_[Z%'VB#_GM'_WT*DQ1B@"/
M[1!_SVC_ .^A1]H@_P">T?\ WT*DQ1B@"/[1!_SVC_[Z%'VB#_GM'_WT*DQ1
MB@"/[1!_SVC_ .^A1]H@_P">T?\ WT*DQ1B@"/[1!_SVC_[Z%'VB#_GM'_WT
M*DQ1B@"/[1!_SVC_ .^A1]H@_P">T?\ WT*DQ1B@"/[1!_SVC_[Z%'VB#_GM
M'_WT*DQ1B@"/[1!_SVC_ .^A1]H@_P">T?\ WT*DQ1B@"/[1!_SVC_[Z%'VB
M#_GM'_WT*DQ1B@"/[1!_SVC_ .^A1]H@_P">T?\ WT*DQ1B@"-9XG.$E1OHP
M-24G-+0 444F10 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %<O<0^9KLTMCISW3P.&D+W7EQ"7:,$+@Y;!'.*ZBN4NWDL[^[^SW>K0K)
M*9&$-@)4!VC)#%3Z4 :^BF)K6:14DCF:=S.KD$K)GD9'!'3&.V*U*Q/#<D$U
MA-<07,UQYD[,\DT81M^ .@ XP!6W0 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MYQ@T)K]M)+$H@N!!++Y,5R5'EN_/ YW=CSC!H UZ*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@!,C.,TM9VIZI'I\:J(Y)KA^4@C5F9AD
M GY0>!GK4DFK6<4-O*9'9;A=T2QQ,[.,9R%4$XP1V[B@"[16=/KFGVS!999%
M;RQ*RB%R40]"X ^7_@6*6XUO3[:5HY9SE0I=DC9U0'IN8 A<^Y% &A11FB@
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M?DO^%2T4 1>4_P#S\2?DO^%'E/\ \_$GY+_A4M% $7E/_P _$GY+_A1Y3_\
M/Q)^2_X5+10!%Y3_ //Q)^2_X4>4_P#S\2?DO^%2T4 1>4__ #\2?DO^%'E/
M_P _$GY+_A4M% $7E/\ \_$GY+_A1Y3_ //Q)^2_X5+10!%Y3_\ /Q)^2_X4
M>4__ #\2?DO^%2TA8*"6( '4F@"+RV_Y^)/R7_"E\I_^?B7\E_PK+T_6)+Z=
MG^R3+92)OMY]H.\#KD DC/!&0,\U/::HMS=_9GMKBVF\KSE295!9,X)&TG&#
MC@X/(H N>6W_ #\2?DO^%+Y3_P#/Q)^2_P"%9B^(+$_V@V7\NQ4-(^W*MG/W
M>YP5(_"K%KJ:W-TUJ]M/;3K&)=DNW)0DC(*L1U!H M^4_P#S\2?DO^%'E/\
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MM8H<''?GW_D:L*@1555 5> !T H =1110 4444 %%%% !1110 4444 %%%%
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M_P#GSU/_ +]Q_P#Q=<A_PJ/Q)_SUL/\ O\W_ ,31_P *C\2?\];#_O\ -_\
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M_D04>=<_\^?_ )$% %JBJOG7/_/G_P"1!1YUS_SY_P#D04 6J*J^=<_\^?\
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MMA_W^;_XFC_A4?B3_GK8?]_F_P#B:Z_K-+N8^RGV."HKO?\ A4?B3_GK8?\
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M@ HHHH 2H+W_ (\+G_KDW\C4]07O_'A<_P#7)OY&A;H3V.-HHHKTSD"BBB@
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M.>W% ':4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !129'K1D>M
M"T44F10 M%)D49% "T444 %%%% !1110 4444 )VKAJ[GM7#5TX?=F-7H;_A
MYOW<Z^C _I_]:G:]]I:"**,3_9)&*71MT#RJA&!@$'(SUP"<=*B\.GFZ_P"
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** $QD<BH8+:.V0QQ+M0LS]2>6
M8L>>O))-3T4 5;&Q33[..UB+-''D*6QD G...W;\JL8.>G%.HH @%I$+M[G8
M#,R!"Q.< 9.!Z#GM4N#3J* &X-5[RQCOHDCF9PBR+(54\-M.0#ZC../:K5%
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MH-I%P;YK,T\6O_/P?_ AO\:,6O\ S\'_ ,"&_P :M?A1^%<9O8J[;7_GX/\
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M/_OH5F^'_P#CQ?\ ZZ'^0K6[UY]3XF=,/A0S[1!_SVC_ .^A1]H@_P">T?\
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M@ HHHH **** "BBB@ HHHH **** "BBC- !1FC-0/=1*Q127D'5$&3^/I^-
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M*** "H/L=M_S[Q?]\"IZ* (/LEM_S[Q?]\"C[);?\^\7_? J>B@5B#[);?\
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MGY+_ (5+10!%Y3_\_$GY+_A1Y3_\_$GY+_A4M% $7E/_ ,_$GY+_ (4>4_\
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M*0R+RG_Y^)/R7_"CRG_Y^)/R7_"I:* (O*?_ )^)/R7_  H\I_\ GXD_)?\
M"I:* (O*?_GXD_)?\*/*?_GXD_)?\*EHH B\I_\ GXD_)?\ "CRG_P"?B3\E
M_P *EHH B\I_^?B3\E_PH\I_^?B3\E_PJ6B@"+RG_P"?B3\E_P */*?_ )^)
M/R7_  J6B@"+RG_Y^)/R7_"CRG_Y^)/R7_"I:* (O*?_ )^)/R7_  H\I_\
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M/R"BQ1F)/*D:,[#C*DJ1D<=#FG7&BV=UY7F)*JPX\M(IWC5,=,!6 R,]>O\
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MQFCC^ZPW *Q]202,\Y% '2!@0"""#T(I:R?#<KS>'K%Y"6;R]N3W ./Z5K4
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M\3*AZNN.&^Z><]^?7J7171D=0RL,%2,@U3L-(L]-@DBMH(T$C$N0B@MDDX.
M,@9( [#B@#GWMD:P\/6D<<<LK0F18+@9BDP@W%N^[YL@X)R3P,DBM;:?%/IB
M7*364DMC!+')!>6XD53O8\8?A05*@\_**Z6VT>!-+M[&[CBNXX.$\V,$ #.W
M@YZ#C\*F;2=/D6,/I]JPC&$#0J=H]!Z4 8^JW\4GA5""MJT\4+>2'PRQED#
M8QP <9Q^%4-6CBL9M3@LE6"T>W@,Z0C:JEI=IZ?=)3.<=N>:Z@Z="][)=2 R
M.\/D[6P5"9R0![]\^@I\-A:V\#P0VL,<+YW1J@"MG@Y Z\4 <IJT<5C-J<%D
MJP6CV\!G2$;54M+M/3[I*9SCMSS1J\,5C-J:6,:0Q16L,Y2-0%282':0.@)
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M=/;FIGT6S>*%&68F'/EO]HDWKGKA]V['MGL*M_9+;_GWB_[X%'V2V_Y]XO\
MO@4 4GT*Q=$01/&D<?E*(9GC^3T.TC(^O?-']F%=4MID6-+2U@9(HUX(9B,G
M'IM&/Q-7?LEM_P ^\7_? I/LEM_S[Q?]\"@!J?\ '_-Z>4G\WJSVJ..&.+/E
MQJN?[H J2A@@HHHH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*X3I(_M$'_/:/_OH4?:(/^>T?_?0J3%&* (_M$'_ #VC_P"^A1]H@_Y[1_\
M?0J3%&* (_M$'_/:/_OH4?:(/^>T?_?0J3%&* (_M$'_ #VC_P"^A1]H@_Y[
M1_\ ?0J3%&* (_M$'_/:/_OH4?:(/^>T?_?0J3%&* (_M$'_ #VC_P"^A1]H
M@_Y[1_\ ?0J3%&* (_M$'_/:/_OH4?:(/^>T?_?0J3%&* (_M$'_ #VC_P"^
MA1]H@_Y[1_\ ?0J3%&* (_M$'_/:/_OH4?:(/^>T?_?0J3%&* (_M$'_ #VC
M_P"^A1]H@_Y[1_\ ?0J3%&* (_M$'_/:/_OH4?:(/^>T?_?0J3%&* (_M$'_
M #VC_P"^A1]H@_Y[1_\ ?0J3%&* (_M$'_/:/_OH4?:(/^>T?_?0J3%&* (_
MM$'_ #VC_P"^A1]H@_Y[1_\ ?0J3%&* (_M$'_/:/_OH4?:(/^>T?_?0J3%&
M* (_M$'_ #VC_P"^A1]H@_Y[1_\ ?0J3%&* (_M$'_/:/_OH4?:(/^>T?_?0
MJ3%&* (_M$'_ #VC_P"^A1]H@_Y[1_\ ?0J3%&* (_M$'_/:/_OH4?:(/^>T
M?_?0J3%&* (_M$'_ #VC_P"^A1]H@_Y[1_\ ?0J3%&* (_M$'_/:/_OH4?:(
M/^>T?_?0J3%&* (_M$'_ #VC_P"^A1]H@_Y[1_\ ?0J3%&* (_M$'_/:/_OH
M4?:(/^>T?_?0J3%&* (_M$'_ #VC_P"^A1]H@_Y[1_\ ?0J3%&* (_M$'_/:
M/_OH4?:(/^>T?_?0J3%&* (_M$'_ #VC_P"^A1]H@_Y[1_\ ?0J3%&* (_M$
M'_/:/_OH4?:(/^>T?_?0J3%&* (_M$'_ #VC_P"^A1]H@_Y[1_\ ?0J3%&*
M(_M$'_/:/_OH4?:(/^>T?_?0J3%&* (_M$'_ #VC_P"^A1]H@_Y[1_\ ?0J3
M%&* (_M$'_/:/_OH4?:(/^>T?_?0J3%&* (_M$'_ #VC_P"^A1]H@_Y[1_\
M?0J3%&* (UGB<X25&^C U)2<TM "9%1QW$4TDT:-EH6V.,'@X#8_(@_C3+L*
M;.=6F\@&-LRYQLX^]GMBN;M5317FMFLK6*]2R>1)[<\3*AZNN.&^Z><]^?4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%&110 44F14<=Q%-)-&C9:%MCC!X. V/R(/XT 2T4R.:*5=T<BNN2,J<C(.
M#^1XI^10 44F11D>M "T4F11D9H 6BF/-'%M\R14WMM7<<;CZ#U-/H ****
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M;0%[^M;M,DC66-HW4,C JRD9!![4 9GAN-XO#MBK@AC'NP>P))'Z&M:D"@*
M!@#@ 4M $7E/G_7R?DO^%'E/_P _$GY+_A4M% $7E/\ \_$GY+_A1Y3_ //Q
M)^2_X5+10!%Y3_\ /Q)^2_X4>4__ #\2?DO^%2T4 0^4^/\ CXD_)?\ "N+K
MN>U<-73A]V8U>@4445U&(4444 %;6@(7^TX=EQMZ >_KFL6MSP[UN?\ @/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*S7"GYE",?;/\)P?2KNJR'47LM*P5-S^]N4[K$N,@GW)4?3-:ZLR@*MNZJ.
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MQ_\ GA)^:_XT>8__ #PD_-?\: ):*B\Q_P#GA)^:_P"-'F/_ ,\)/S7_ !H
MEHJ+S'_YX2?FO^-'F/\ \\)/S7_&@"6BHO,?_GA)^:_XT>8__/"3\U_QH EH
MJ+S'_P">$GYK_C1YC_\ /"3\U_QH EHJ+S'_ .>$GYK_ (T>8_\ SPD_-?\
M&@"6BHO,?_GA)^:_XT>8_P#SPD_-?\: ):*B\Q_^>$GYK_C1YC_\\)/S7_&@
M"6BHU=F.#"Z^[8_H:DH 3(J..XBFDFC1LM"VQQ@\' ;'Y$'\:9=A39SJTWD
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MLHK9[9+*V6W<[FB6)0C'W&,=A^57** ,ZZTF*>RCLH@EO;+(K-'$@ 90VXJ
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4457N;VWM-OGR;=V<<$YQ]/K0E?8+V+%%4/[9L
M/^>__CC?X4?VS8?\]_\ QQO\*KDEV%S(OT50_MFP_P">_P#XXW^%6+:]M[O=
MY$F_;C/!&,_7Z4G%K= FF3YHK,BU=9Y<06ES+!YGE?:45=F<XX^;<1GC(&.#
MS@$U:74+)[HVJ7<#7 SF(2#>,=>.M(99HJE_:^F;BO\ :%IN4%B/.7@>O6GG
M4K%8$G:]MQ"X)20RKM8#K@YP<4 6J*K-J-BMJMTUY;BW;[LQD&P_0]*;)JNG
M11I))?VJ1NNY7:90&'J#GI0!;HJM-J-E;B(S7D$8E_U9:0 /TZ>O4?F/6E;4
M+-;G[,UW +C&?*,@W8QG..O3F@"QFBLBT\06%[%OMI4D_?"(J)4R"6VAOO="
M1D=SV!J\^H64=TMJ]W;K<-C;$9 '.>F!G- %FC-53J5B+@6YO;<3EMHC\U=Q
M/IC.<T7MY'8V<ES*&9$QD* 222  ,^Y% %K(HJE;ZC;3Z='?^:J6[H'W2$#:
M#USV&*K'7],%_!:B[A9IT+(XD7;P< =>I)/UQ0!K45"+NV9(W6XB*R-L0AQA
MFYX'J>#^1J"34[0"X6*Y@EF@1F>)9 6&.N1GB@"YD4M8]AK<5X6\Y$MU$4$F
M7<8)D!(7GOQBM59HFD:-9%+H 64'D ],_D: 'YHK'@U^&:2$&UN8HIY&ACF<
M+M9P2,<,2.0>H[5<_M*S9YHH[F&2:$$R1)*NY<=<C/'XT 7,TF167>:W:6>G
M-<O+")#;F>.!IE#.,9 &"<^F1D5-=ZG#8Z4VH7'RQK'O*@C/3H,XYH OT52_
MM?3A:QW+WUJD,GW7:90I(Z@'-+>WT-EITE^^7AC3>3'@DCVYQ0!<R*,BLTZQ
M;#1O[2Q(82.$"_.3G&W'3=NX]*6+6;"2UM[B2YB@%Q&KHLT@1B#[$T :.:3(
MIDL@BB:0Y(5=QQ5(:M!]CL;K;)LO&C6,8&1O&1GGCCKC- &C15=[^SCNA:O=
MP+<$9$32 ,1].M!OK18TD-U"(Y 61RXPP ))![\ GZ4 6**A-W;@D&>($)YA
M&\?<_O?3WIC:C8I)%&UY;AY@#&IE&7!Z8YYSVH LT9JL=1LA,T)NX/-4$E/,
M&X =<CVJM;:O;WFIR6EO)%-&D"R^='*&&2S+CC_=H TJ**ANKJ&RM)KJX?9#
M"C22-@G:JC).!ST% $U%<G_PLOPC_P!!;_R6E_\ B:/^%E^$?^@M_P"2TO\
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M5Y+ZTAN(X);J%)I,;(VD 9OH.]+%?6DT\D$5S"\T?WXU<%EYQR.W- $]%%%
M!1110 4444 %%%% !1110 4444 &*R-:L[B[,'D1[]N[/(&.GK]*UZ*<79W0
MFKJQR?\ 8]__ ,^__CZ_XT?V/?\ _/O_ ./K_C768HQ6OMYF?LHG)_V/?_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
.4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Kartoon Studios, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001355848<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Disclosure - Pay vs Performance Disclosure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_883_eecd--PvpTableTextBlock_zkYLYdkzxeX1" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Pay vs Performance Disclosure">
  <tr style="vertical-align: top; background-color: White">
    <td style="text-align: center; padding-left: 2.75pt">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td>
    <td style="text-align: center">&#160;</td></tr>
<tr>
    <td style="vertical-align: bottom">&#160;</td>
    <td colspan="2" style="vertical-align: top; padding-left: 1.4pt; text-align: center"><span style="font-size: 10pt">Andy Heyward (1)</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 6%; padding-left: 1.4pt; text-align: center"><span style="font-size: 10pt">Year</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; width: 15%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center">Summary Compensation Table Total</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center">(2)</p></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; width: 15%; padding-left: 1.4pt; text-align: center"><span style="font-size: 10pt">Compensation Actually Paid</span></td>
    <td style="border-bottom: black 1pt solid; width: 19%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center">Average Summary Compensation Table Total
for Non-PEO NEOs</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center">(3)</p></td>
    <td style="border-bottom: black 1pt solid; width: 15%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center">Average Compensation Actually Paid to
Non-PEO NEOs</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center">(4)</p></td>
    <td style="border-bottom: black 1pt solid; width: 15%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center">Value of Initial Fixed $100 Investment
Based on Cumulative TSR</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center">(5)</p></td>
    <td style="border-bottom: black 1pt solid; width: 15%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center">Net Loss (in 000s)</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center">(6)</p></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="border-bottom: black 1pt solid; text-align: center; padding-left: 2.75pt"><span style="font-size: 10pt">2024</span></td>
    <td id="xdx_986_eecd--PeoTotalCompAmt_c20240101__20241231__ecd--IndividualAxis__custom--AndyHeywardMember_fKDEpICgyKQ_____zmkCphB2sB18" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">1,075,384</span></td>
    <td id="xdx_98E_eecd--PeoActuallyPaidCompAmt_c20240101__20241231__ecd--IndividualAxis__custom--AndyHeywardMember_fKDEp_zRk01orpmrid" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">698,509</span></td>
    <td id="xdx_98C_eecd--NonPeoNeoAvgTotalCompAmt_c20240101__20241231_fKDMp_zhorMkhADUL1" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">423,220</span></td>
    <td id="xdx_98D_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20240101__20241231_fKDQp_zoiIMOi4zLM4" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">409,937</span></td>
    <td id="xdx_988_eecd--TotalShareholderRtnAmt_pp2p0_c20240101__20241231_fKDUp_z8JauyUAInKd" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">6</span></td>
    <td id="xdx_987_eus-gaap--NetIncomeLoss_c20240101__20241231_fKDYp_zVgB69Ze0O3g" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">(20,941)</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="border-bottom: black 1pt solid; text-align: center; padding-left: 2.75pt"><span style="font-size: 10pt">2023</span></td>
    <td id="xdx_983_eecd--PeoTotalCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AndyHeywardMember_fKDEpICgyKQ_____zZeeJsSMlkX6" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">1,492,368</span></td>
    <td id="xdx_98E_eecd--PeoActuallyPaidCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AndyHeywardMember_fKDEp_zWQFyDRnVbEj" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">(1,861,069)</span></td>
    <td id="xdx_983_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_fKDMp_zNcwrWD4oBeb" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">359,086</span></td>
    <td id="xdx_982_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_fKDQp_zOgRqUrf4CM7" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">247,838</span></td>
    <td id="xdx_98D_eecd--TotalShareholderRtnAmt_pp2p0_c20230101__20231231_fKDUp_zl53Id9qCtRc" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">13</span></td>
    <td id="xdx_98D_eus-gaap--NetIncomeLoss_c20230101__20231231_fKDYp_z67WfJXLiLu3" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt">(77,103)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(238,238,238)">
    <td style="text-align: center; padding-left: 2.75pt"><span style="font-size: 10pt">2022</span></td>
    <td id="xdx_985_eecd--PeoTotalCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AndyHeywardMember_fKDEpICgyKQ_____zcGmukttk2Cl" style="text-align: center"><span style="font-size: 10pt">1,450,384</span></td>
    <td id="xdx_988_eecd--PeoActuallyPaidCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AndyHeywardMember_fKDEp_zrxsC3HzhIA8" style="text-align: center"><span style="font-size: 10pt">(5,369,928)</span></td>
    <td id="xdx_984_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_fKDMp_zZJEPx2OdNC6" style="text-align: center"><span style="font-size: 10pt">494,981</span></td>
    <td id="xdx_984_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_fKDQp_zO03IdrUvEUg" style="text-align: center"><span style="font-size: 10pt">173,217</span></td>
    <td id="xdx_984_eecd--TotalShareholderRtnAmt_pp2p0_c20220101__20221231_fKDUp_z2G4qW5ENAs8" style="text-align: center"><span style="font-size: 10pt">44</span></td>
    <td id="xdx_988_eus-gaap--NetIncomeLoss_c20220101__20221231_fKDYp_zAg3pUCmF2z8" style="text-align: center"><span style="font-size: 10pt">(45,595)</span></td></tr>
  </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_84B_eecd--NamedExecutiveOfficersFnTextBlock_dU_zIsBTIUCZq4d" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td id="xdx_F05_zt0c8QeZGnt9" style="width: 0.25in">(1)</td><td id="xdx_F11_zQZNX91jSvs5" style="text-align: justify">Mr. <span id="xdx_90C_eecd--PeoName_c20240101__20241231_zOtsbvXUYKe3"><span id="xdx_904_eecd--PeoName_c20230101__20231231_zVv5wMCiLhsi"><span id="xdx_90A_eecd--PeoName_c20220101__20221231_zoyWD43L29Pg">Heyward</span></span></span> served as our  Chief Executive Officer and Chairman during each of the three years presented
in the table.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td></td><td id="xdx_F06_zjJ8m53QAZn1">(2)</td><td id="xdx_F19_zBoDoaRtiL47" style="text-align: justify">The values reflected in this column reflect the &#8220;Total&#8221; compensation set forth in the Summary
Compensation Table (&#8220;SCT&#8221;) in each applicable year.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td></td><td id="xdx_F0F_ziSMDf5zdzX4">(3)</td><td id="xdx_F18_zfizCwFNU2Tg" style="text-align: justify">The dollar amounts reported in this column represent the average of the amounts reported for Non-PEO NEOs
in the &#8220;Total&#8221; column of the SCT in each applicable year. The names of each of the Non-PEO NEOs included for purposes of calculating
the average amounts in 2024 were Brian Parisi and Michael A. Jaffa; in 2023 were Brian Parisi, Michael A. Jaffa, and Michael Hirsh; and
in 2022 were Michael A. Jaffa and Michael Hirsh.</td></tr>
</table>

<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
<td style="width: 0.25in"></td><td id="xdx_F0E_zdztcojDxbia" style="width: 0.25in">(4)</td><td id="xdx_F17_zzropABX62I9" style="text-align: justify">The dollar amounts reported in this column represent the average amount of CAP to Non-PEO NEOs as a group,
as computed in accordance with SEC rules described below.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td></td><td id="xdx_F00_zHhSO0bkgHf2">(5)</td><td id="xdx_F1A_zwLAZA7Ml006" style="text-align: justify">The cumulative total shareholder return (&#8220;TSR&#8221;) is determined based on the value of an initial
fixed investment of $100 in the Company&#8217;s common stock at December 31, 2021. The Company did not issue dividends during any of the
covered periods.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td></td><td id="xdx_F00_zPMcDK90Mkub">(6)</td><td id="xdx_F1B_z3p1Zu6tYBg" style="text-align: justify">The dollar amounts reported in this column are the Company&#8217;s net income amounts reflected in the
Company&#8217;s audited financial statements for the applicable year.</td></tr></table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_84F_eecd--AdjToPeoCompFnTextBlock_dU_zn22kE0ORiI" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">SEC rules require certain adjustments be made
to the Summary Compensation Table totals to determine CAP as reported in the Pay versus Performance table. CAP does not necessarily represent
cash and/or equity value transferred to the applicable NEO without restriction, but rather is a value calculated under applicable SEC
rules. A significant portion of the CAP amounts shown relate to changes in values of unvested awards over the course of the applicable
reporting year. Our NEOs do not participate in a defined benefit plan so no adjustment for pension benefits is included in the table
below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The following tables below detail these adjustments
to compensation as reported in the Summary Compensation Table:</p>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Andy Heyward</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 83%; font-weight: bold; text-align: left; padding-bottom: 1pt">Reported Summary Compensation Table Total for 2024</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_985_eecd--PeoTotalCompAmt_c20240101__20241231__ecd--IndividualAxis__custom--AndyHeywardMember_zmOfjsJDrrl7" style="border-bottom: Black 1pt solid; width: 13%; text-align: right">1,075,384</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Deduct: Fair Value of Equity Awards Under the &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; Column in SCT</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eecd--AdjToCompAmt_d0_c20240101__20241231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zbhGV8mc2g0j" style="text-align: right" title="Adjustment to compensation amount">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Add: Year End Fair Value of Equity Awards Granted During the Year that are Outstanding and Unvested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eecd--AdjToCompAmt_d0_c20240101__20241231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zavd5szJZFTl" style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Add: Change in Year Over Year End Fair Value of Equity Awards Granted in Prior Years that are Outstanding and Unvested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_982_eecd--AdjToCompAmt_d0_c20240101__20241231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zzmOaufRMo8f" style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-style: italic; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Add: Change in Prior Year End Fair Value and Vesting Date Fair Value of Equity Awards Granted in Prior Years that Vested During the Year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eecd--AdjToCompAmt_c20240101__20241231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zcfttWJbQpci" style="border-bottom: Black 1pt solid; text-align: right">(376,875</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Compensation Actually Paid for 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eecd--PeoActuallyPaidCompAmt_c20240101__20241231__ecd--IndividualAxis__custom--AndyHeywardMember_zMrat5uOvS56" style="border-bottom: Black 2.5pt double; text-align: right">698,509</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Reported Summary Compensation Table Total for 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_987_eecd--PeoTotalCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AndyHeywardMember_z6c3P0u5yp29" style="border-bottom: Black 1pt solid; text-align: right">1,492,368</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Deduct: Fair Value of Equity Awards Under the &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; Column in SCT</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zk5Gv7vOVjFl" style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Add: Year End Fair Value of Equity Awards Granted During the Year that are Outstanding and Unvested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zuMZLk6t5i5i" style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Add: Change in Year Over Year End Fair Value of Equity Awards Granted in Prior Years that are Outstanding and Unvested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_ziw9bKIBIhrb" style="text-align: right">(3,056,250</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Add: Change in Prior Year End Fair Value and Vesting Date Fair Value of Equity Awards Granted in Prior Years that Vested During the Year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_987_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zXt0WvhLtYr7" style="border-bottom: Black 1pt solid; text-align: right">(297,188</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Compensation Actually Paid for 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eecd--PeoActuallyPaidCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AndyHeywardMember_zWPuAudMcavh" style="border-bottom: Black 2.5pt double; text-align: right">(1,861,069</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Reported Summary Compensation Table Total for 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_981_eecd--PeoTotalCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AndyHeywardMember_zp8BBDWIKtu5" style="border-bottom: Black 1pt solid; text-align: right">1,450,384</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Deduct: Fair Value of Equity Awards Under the &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; Column in SCT</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eecd--AdjToCompAmt_d0_c20220101__20221231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zcTtckllbGol" style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Add: Year End Fair Value of Equity Awards Granted During the Year that are Outstanding and Unvested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_984_eecd--AdjToCompAmt_d0_c20220101__20221231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zhhixwzhhukf" style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Add: Change in Year Over Year End Fair Value of Equity Awards Granted in Prior Years that are Outstanding and Unvested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_98F_eecd--AdjToCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zLa8BLae7O4a" style="text-align: right">(6,032,813</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-style: italic; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Add: Change in Prior Year End Fair Value and Vesting Date Fair Value of Equity Awards Granted in Prior Years that Vested During the Year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eecd--AdjToCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zsD04e6ep0Kc" style="border-bottom: Black 1pt solid; text-align: right">(787,500</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Compensation Actually Paid for 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eecd--PeoActuallyPaidCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AndyHeywardMember_zL6hkqS17CY5" style="border-bottom: Black 2.5pt double; text-align: right">(5,369,928</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
  </table>


<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 423,220<span></span>
</td>
<td class="nump">$ 359,086<span></span>
</td>
<td class="nump">$ 494,981<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 409,937<span></span>
</td>
<td class="nump">247,838<span></span>
</td>
<td class="nump">173,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_84E_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_z3GS7WQmaxm5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Average Non-PEO NEOs</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 83%; font-weight: bold; text-align: left; padding-bottom: 1pt">Average Reported Summary Compensation Table Total for 2024</td><td style="width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td id="xdx_987_eecd--NonPeoNeoAvgTotalCompAmt_c20240101__20241231_zAXUtODhzXn7" style="border-bottom: Black 1pt solid; width: 13%; text-align: right">423,220</td><td style="width: 1%; padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Deduct: Average Fair Value of Equity Awards Under the "Stock Awards" and "Option Awards" Column in SCT</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eecd--AdjToCompAmt_d0_c20240101__20241231__ecd--AdjToCompAxis__custom--AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zLARZr8GtEp4" style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Add: Average Year End Fair Value of Equity Awards Granted During the Year that are Outstanding and Unvested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eecd--AdjToCompAmt_d0_c20240101__20241231__ecd--AdjToCompAxis__custom--AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zE03P9EB8hLb" style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Add: Average Change in Year Over Year End Fair Value of Equity Awards Granted in Prior Years that are Outstanding and Unvested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_988_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zmqNqzIbCbw6" style="text-align: right">(8,680</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-style: italic; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Add: Average Change in Prior Year End Fair Value and Vesting Date Fair Value of Equity Awards Granted in Prior Years that Vested During the Year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_988_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zWryXa3DpnJb" style="border-bottom: Black 1pt solid; text-align: right">(4,603</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Average Compensation Actually Paid for 2024</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20240101__20241231_zNuRS21gwACi" style="border-bottom: Black 2.5pt double; text-align: right">409,937</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Average Reported Summary Compensation Table Total for 2023</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_982_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_zR4oZBU5sNf3" style="border-bottom: Black 1pt solid; text-align: right">359,086</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Deduct: Average Fair Value of Equity Awards Under the "Stock Awards" and "Option Awards" Column in SCT</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_z56L4HEcjuWa" style="text-align: right">(16,683</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Add: Average Year End Fair Value of Equity Awards Granted During the Year that are Outstanding and Unvested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_z0bZskGjznd7" style="text-align: right">16,217</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Add: Average Change in Year Over Year End Fair Value of Equity Awards Granted in Prior Years that are Outstanding and Unvested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_987_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--AdjToCompAxis__custom--AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_za5Dfub0Rpf6" style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Add: Average Change in Prior Year End Fair Value and Vesting Date Fair Value of Equity Awards Granted in Prior Years that Vested During the Year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98D_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zZB9IhnKCDV5" style="border-bottom: Black 1pt solid; text-align: right">(110,781</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Average Compensation Actually Paid for 2023</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_zAkmCFisuaR9" style="border-bottom: Black 2.5pt double; text-align: right">247,838</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; text-align: left; padding-bottom: 1pt">Average Reported Summary Compensation Table Total for 2022</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">$</td><td id="xdx_985_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_z2eYccZahR34" style="border-bottom: Black 1pt solid; text-align: right">494,981</td><td style="padding-bottom: 1pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Deduct: Average Fair Value of Equity Awards Under the "Stock Awards" and "Option Awards" Column in SCT</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_983_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zB6ua50Cvxua" style="text-align: right">(235,494</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Add: Average Year End Fair Value of Equity Awards Granted During the Year that are Outstanding and Unvested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_z0pG42yG0nh5" style="text-align: right">143,403</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt">Add: Average Change in Year Over Year End Fair Value of Equity Awards Granted in Prior Years that are Outstanding and Unvested</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td id="xdx_986_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zm8JnQZZ1Zii" style="text-align: right">(138,690</td><td style="text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-style: italic; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Add: Average Change in Prior Year End Fair Value and Vesting Date Fair Value of Equity Awards Granted in Prior Years that Vested During the Year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: left">&#160;</td><td id="xdx_98A_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zdWbnOv7E72g" style="border-bottom: Black 1pt solid; text-align: right">(90,983</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">Average Compensation Actually Paid for 2022</td><td style="padding-bottom: 2.5pt">&#160;</td>
    <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_zywv8Bp7rDxf" style="border-bottom: Black 2.5pt double; text-align: right">173,217</td><td style="padding-bottom: 2.5pt; text-align: left">&#160;</td></tr>
  </table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid and Cumulative Total Shareholder Return</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_848_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_z1C49S1odVW6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Compensation Actually Paid and Cumulative Total Shareholder Return</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The graph below compares the compensation actually
paid to our PEOs and the average of the compensation actually paid to our remaining NEOs, with our cumulative total shareholder return
for the fiscal years ended December 31, 2024, 2023, and 2022. Total shareholder return amounts reported in the graph assume an initial
fixed investment of $100 on December 31, 2021.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_004.jpg" style="height: 353px; width: 619px"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid and Net Loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_842_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zzpzDoXJ85Ih" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Compensation Actually Paid and Net Loss</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The graph below compares the compensation actually
paid to our PEOs and the average of the compensation actually paid to our remaining NEOs, with our net loss for the fiscal years ended
December 31, 2024, 2023, and 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><img alt="" src="image_005.jpg" style="height: 317px; width: 619px"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">$ (20,941)<span></span>
</td>
<td class="num">$ (77,103)<span></span>
</td>
<td class="num">$ (45,595)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Heyward<span></span>
</td>
<td class="text">Heyward<span></span>
</td>
<td class="text">Heyward<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=TOON_AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember', window );">Average Fair Value Of Equity Awards Under The Stock Awards And Option Awards Column In S C T [Member] | Non-PEO NEO [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (16,683)<span></span>
</td>
<td class="num">$ (235,494)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=TOON_AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember', window );">Average Year End Fair Value Of Equity Awards Granted During The Year That Are Outstanding And Unvested [Member] | Non-PEO NEO [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">16,217<span></span>
</td>
<td class="nump">143,403<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=TOON_AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember', window );">Average Change In Year Over Year End Fair Value Of Equity Awards Granted In Prior Years That Are Outstanding And Unvested [Member] | Non-PEO NEO [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(8,680)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(138,690)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=TOON_AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember', window );">Average Change In Prior Year End Fair Value And Vesting Date Fair Value Of Equity Awards Granted In Prior Years That Vested During The Year [Member] | Non-PEO NEO [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,603)<span></span>
</td>
<td class="num">(110,781)<span></span>
</td>
<td class="num">(90,983)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=TOON_AndyHeywardMember', window );">Andy Heyward [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5],[6]</sup></td>
<td class="nump">1,075,384<span></span>
</td>
<td class="nump">1,492,368<span></span>
</td>
<td class="nump">1,450,384<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">698,509<span></span>
</td>
<td class="num">(1,861,069)<span></span>
</td>
<td class="num">(5,369,928)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=TOON_AndyHeywardMember', window );">Andy Heyward [Member] | Fair Value Of Equity Awards Under The Stock Awards And Option Awards Column In S C T [Member] | PEO [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=TOON_AndyHeywardMember', window );">Andy Heyward [Member] | Year End Fair Value Of Equity Awards Granted During The Year That Are Outstanding And Unvested [Member] | PEO [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=TOON_AndyHeywardMember', window );">Andy Heyward [Member] | Change In Year Over Year End Fair Value Of Equity Awards Granted In Prior Years That Are Outstanding And Unvested [Member] | PEO [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="num">(3,056,250)<span></span>
</td>
<td class="num">(6,032,813)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=TOON_AndyHeywardMember', window );">Andy Heyward [Member] | Change In Prior Year End Fair Value And Vesting Date Fair Value Of Equity Awards Granted In Prior Years That Vested During The Year [Member] | PEO [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (376,875)<span></span>
</td>
<td class="num">$ (297,188)<span></span>
</td>
<td class="num">$ (787,500)<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The dollar amounts reported in this column represent the average of the amounts reported for Non-PEO NEOs
in the &#8220;Total&#8221; column of the SCT in each applicable year. The names of each of the Non-PEO NEOs included for purposes of calculating
the average amounts in 2024 were Brian Parisi and Michael A. Jaffa; in 2023 were Brian Parisi, Michael A. Jaffa, and Michael Hirsh; and
in 2022 were Michael A. Jaffa and Michael Hirsh.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">The dollar amounts reported in this column represent the average amount of CAP to Non-PEO NEOs as a group,
as computed in accordance with SEC rules described below.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">The cumulative total shareholder return (&#8220;TSR&#8221;) is determined based on the value of an initial
fixed investment of $100 in the Company&#8217;s common stock at December 31, 2021. The Company did not issue dividends during any of the
covered periods.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">The dollar amounts reported in this column are the Company&#8217;s net income amounts reflected in the
Company&#8217;s audited financial statements for the applicable year.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Mr. <span id="xdx_90C_eecd--PeoName_c20240101__20241231_zOtsbvXUYKe3"><span id="xdx_904_eecd--PeoName_c20230101__20231231_zVv5wMCiLhsi"><span id="xdx_90A_eecd--PeoName_c20220101__20221231_zoyWD43L29Pg">Heyward</span></span></span> served as our  Chief Executive Officer and Chairman during each of the three years presented
in the table.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">The values reflected in this column reflect the &#8220;Total&#8221; compensation set forth in the Summary
Compensation Table (&#8220;SCT&#8221;) in each applicable year.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=TOON_AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=TOON_AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=TOON_AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=TOON_AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=TOON_AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=TOON_AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=TOON_AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=TOON_AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=TOON_AndyHeywardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=TOON_AndyHeywardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=TOON_FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=TOON_FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=TOON_YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=TOON_YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=TOON_ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=TOON_ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=TOON_ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=TOON_ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>30</ContextCount>
  <ElementCount>18</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>11</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="kartoon_idef14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://kartoonstudios.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="kartoon_idef14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="DEF 14A" isProxy="true" isUsgaap="true" original="kartoon_idef14a.htm">kartoon_idef14a.htm</File>
    <File>toon-20241231.xsd</File>
    <File>toon-20241231_def.xml</File>
    <File>toon-20241231_lab.xml</File>
    <File>toon-20241231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image_001.jpg</File>
    <File>image_004.jpg</File>
    <File>image_005.jpg</File>
    <File>proxy_001.jpg</File>
    <File>proxy_002.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="60">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "kartoon_idef14a.htm": {
   "nsprefix": "TOON",
   "nsuri": "http://kartoonstudios.com/20241231",
   "dts": {
    "inline": {
     "local": [
      "kartoon_idef14a.htm"
     ]
    },
    "schema": {
     "local": [
      "toon-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "toon-20241231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "toon-20241231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "toon-20241231_pre.xml"
     ]
    }
   },
   "keyStandard": 18,
   "keyCustom": 0,
   "axisStandard": 3,
   "axisCustom": 0,
   "memberStandard": 2,
   "memberCustom": 9,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 30,
   "entityCount": 1,
   "segmentCount": 11,
   "elementCount": 107,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2024": 60,
    "http://xbrl.sec.gov/dei/2024": 4,
    "http://fasb.org/us-gaap/2024": 3
   },
   "report": {
    "R1": {
     "role": "http://kartoonstudios.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kartoon_idef14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kartoon_idef14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kartoon_idef14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "kartoon_idef14a.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r67",
      "r77",
      "r87",
      "r112"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r70",
      "r80",
      "r90",
      "r115"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r108"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r108",
      "r116",
      "r120",
      "r128"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "auth_ref": [
      "r126"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://kartoonstudios.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://kartoonstudios.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "TOON_AndyHeywardMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kartoonstudios.com/20241231",
     "localname": "AndyHeywardMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Andy Heyward [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "TOON_AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kartoonstudios.com/20241231",
     "localname": "AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average Change In Prior Year End Fair Value And Vesting Date Fair Value Of Equity Awards Granted In Prior Years That Vested During The Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "TOON_AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kartoonstudios.com/20241231",
     "localname": "AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average Change In Year Over Year End Fair Value Of Equity Awards Granted In Prior Years That Are Outstanding And Unvested [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "TOON_AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kartoonstudios.com/20241231",
     "localname": "AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average Fair Value Of Equity Awards Under The Stock Awards And Option Awards Column In S C T [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "TOON_AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kartoonstudios.com/20241231",
     "localname": "AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average Year End Fair Value Of Equity Awards Granted During The Year That Are Outstanding And Unvested [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "TOON_ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kartoonstudios.com/20241231",
     "localname": "ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change In Prior Year End Fair Value And Vesting Date Fair Value Of Equity Awards Granted In Prior Years That Vested During The Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "TOON_ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kartoonstudios.com/20241231",
     "localname": "ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change In Year Over Year End Fair Value Of Equity Awards Granted In Prior Years That Are Outstanding And Unvested [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid and Net Loss"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid and Cumulative Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://kartoonstudios.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://kartoonstudios.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://kartoonstudios.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://kartoonstudios.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r67",
      "r77",
      "r87",
      "r112"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r64",
      "r74",
      "r84",
      "r109"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "TOON_FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kartoonstudios.com/20241231",
     "localname": "FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Of Equity Awards Under The Stock Awards And Option Awards Column In S C T [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r116"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r116"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r116"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r116"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r116"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r108",
      "r116",
      "r120",
      "r128"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "auth_ref": [
      "r126"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r63",
      "r131"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r63",
      "r131"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r63",
      "r131"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r132"
     ]
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r69",
      "r79",
      "r89",
      "r114"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r72",
      "r82",
      "r92",
      "r117"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r72",
      "r82",
      "r92",
      "r117"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "auth_ref": [
      "r95"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure - Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "auth_ref": [
      "r64",
      "r74",
      "r84",
      "r109"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r65",
      "r75",
      "r85",
      "r110"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r66",
      "r76",
      "r86",
      "r111"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r73",
      "r83",
      "r93",
      "r118"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r68",
      "r78",
      "r88",
      "r113"
     ]
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "TOON_YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://kartoonstudios.com/20241231",
     "localname": "YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year End Fair Value Of Equity Awards Granted During The Year That Are Outstanding And Unvested [Member]"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001683168-25-002272-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-25-002272-xbrl.zip
M4$L#!!0    ( ,R#@UI]L6='0A   "@1   -    :6UA9V5?,# Q+FIP9YU6
M>3C4;=O^,1A;)D)2F3*VR+X3DW5""-E#I:PA)$LTV;.') J/?:>R98_L/;8&
MDSW[5IH9VQAC?N_TO,_WO>_Q'M\?W_==]U_W<=_7=5SG=5_W=9[@-_ [<%)?
M5T\7H*&A 6Y3%P!. UH ,Q3*!&5@9F)D8F%A9H6=.0EC8X/Q<9_F."-P04@0
M<0'!+R*N+"4BJB#&CY#1EE%05;MZ]:J0E*Z!CKJ^,O*JVN\@-"PL++ 3L/,G
M3YY7NX2XI/9_-O 3P,X(W #Z(#3\ "T[#82=!NP"X ! 0T_SEP%_&PTMA(Z>
M <K(Q,Q"O5!W$J"E@4!HZ2#T]'1TU-,0ZCE QT[/<5%:@^&4R1THOS>G3&AR
M+B-"\WT'E^DH3D#VKD\8$S/W:9XSO()"PB*71.7D%125E%6TM'5T4=?T],UN
MFEM86EG;.-Z[[^3LXNKF^\COL7] 8%!X1&14]/.8V)34EVFOTE]G9.;E%Q06
M%9>4EGVHJ:VK;_C8V-3YN:N[I[>O?^ K9FQ\ OMM<FIA<6EY975M?6,33]C9
MW=L_(!Z2?N.B 2 T_V7_(RYV*BY:.CH('?0W+AI:_]\7V.GH+THS<&B80.]X
MG^*7"67DU$S.?=_!A) UQ7'=]1EEYA:06Q#$_X;V%[+_';"P_Q>R_P;V+UQ3
M "N$AOIX$'8 ">R[_8EF7Q_MZR/5A36E5!0MT-#Y03._5E_".40\2@A:NY5^
MHW[GO.0*$)Y8-?;F_<-8?Z_<=537U(6M"E<0('+D+!F  )-"# AH)"!!@-:,
M[!Z*QX;*V2GJ)AJ<-?P@EZLG?.7VQ% R#J.AHI/;5",NJUVQK*",D+\RM"__
M*"^O:"Y^ Q:S*XVUPO1.K"![DHAZM<8DUK^#VR/P<-37VGF.CN*-^@6NQ[_Z
MA_36R&*81\-1<WRIU^L"*Y(R1\44!V<274P?&+V\6S47K?,?^;C.XUZX,D"4
MQB\'O^A@S7$QS'T^))O]L<*8:/&4%P1R$" 0DHD/,39([.TU=0U]//4F*?,R
MN9CNV=./PCNY_96=<OG(R)RK(-!ID(<><30&@4\O08 7N2 XJO=I_ <3<I>0
MLV25OU <59^TB\ <K:93N'*BDLB-\*/MK&7#T@-G'8EB1_KJ*:>6AL1YU>")
M-$UGC)IH UE@2OB800X$R$S&^&H5?/3G\A"9$8,B U%K/?[#B>XV4Y2H]PC6
MV ,W_3G%INOG/7\9VJ>^&P89#7>S1$I*%?,5VQ>$1I'KTL4@\%T?G0#I:A*Z
M2L%B"$90DKXO:4*1+(8\@1Y.!H&V0=^GRCB^U.*-D_U%MH'^#'XT,4.J(" E
MXN-J%W&IT^N5I-EHM;R8N#)DWJ[C07%NYM5&\I8ZG(<8M*AUSF8P3DFI(P.%
M3/ EH3X_T4OS(NL(-$7E2@ZM6O;=V@>!*Q:U<P!N!L\SE,&[UI2:Z1\2LQ(V
M6I.7,*'-%G_&]L6 SPF%Q<6S5O$-' 4FB54_.&%=V,Q-;O\<5J_<-HQ@YII.
MQOZ@TV!6V]9Z" BHI.O@NGL3T8O^BS'+ 85W/7ZROTNN?D=I-93PS$+]J&A\
M,[*5%$]6$6(_[_8Y$ 2*OB0-%[K9VD_;:ZW9#'/BT4\569'25G'?D6RB#RA?
M(IY)IQ@3L<*+OZ*E-T@Z*_/1GA+B3/$Q"XF:=#'SQ0X]65,S^E*IM?;%_O_J
MFR12H#$^G\+A<8H2SHNFT!43L9G!LCC[Y/+UU/I\]S:K969&I9]V.?]684&A
M/:TT)0U"_Z8[M5,,\YPI6O_TQ*1W!<FEB I5WA[J$BWY>#TEB&;P89!_J)QU
ML /:63Z'=,7%FN'A$W^R&XPW '5MQ'E4"/.SI9&/<D%/F2)?4#3IF\O39KOE
MGEVIPVD1+64)Q7WYM04">R @3(D:G_N/O>0C=UB8 ];,M_O5_(/8SODS.Q+F
M:"-W_Y4$-2[4AKD7MT+K^QV5&)Z2@RDT:7?0;R5)L\W=.T,;UD H=%?HZ!^0
M#MW9K@GR:W^>=%&@_+KW[C#1<O2]2"R=R2@GK,]RL(VEP;T=/ET>\DLMZ-A]
M0RR:?7I@+2]7F% (L2%-<M7&I086=LA*"X;VJQWRMUCVO,J;7WQQX23OC9FC
M[]AJHJF&<+3'>[)J^I[\&IS]9WT J><.^:XL:8EDFMIB)A$?Z#8@7"TYZU#H
M8W_Z8Z;#*3=\/^(#0F'<J0\NO6'G<A2^85UOXY&0M3+87<2[:'K]F7K@4-#C
MU3*]^HP$Y9(>USW9EA#D9(N@GTC/C=(S).P)W%9O9GW[(D]%5=&?S(S3H2-L
MHFO=@V8W#3EM0UYT/U@3_.PY@\(4>J,9 O&/T+H4W<+-;?>S/<RPP>S#D@&<
M:X-,S\.-4U+J$<SXL\9\FYGSSRMWMS:N]%GX?1)566VMM@"!%VIKQ][H9??5
M839TWQ[LV!\^%%,>QW9HCO7=V![O)^JONM8-VMU+GC7!Y;Y^H>YHY^'=QDIU
MH]110(#RI^N7Q1@YR^VRX':9X2[S$PNH/NA!*7G+N/,3C-7U&PADLUBWLR.7
M;Z92FHIW*I$LZ+[WQ6@L?6XP^@)Z>PN[*[WM*01GO_WLVB*"1U#Q7 AFJDG\
MEC.J%=H" X$_,E<]VY>+ID$ >_'W;J/.ZQ RA\9"06#$4.0XKZS2E81X0;3N
M20]).OR!3'M\<D8N_4!*0:'K9%(7'%>EM>!%#OO5OO6.8CYJ^R6)RU[;6-SK
M+,VN,-DEO/;&7<<@#*69RV.)0/;W\3WX&?[T#[1^#_$-=;)('C&B0"!7_)$'
MNP-WKY"2NRX\%8:O\EWTLF.A=+*#P+J!T83QV*T93!SAF&T[5J22[485;"%]
M'@L"6Q3CXQ/E+=6*Q"?E5M\,JBIG9Z1J'/J?_8PG_S03'ZV4#^A'E./EAZG%
MJ2E>Y]C0(]T.MS6*$WA0.?"N@V0)Q4.[>(.;!!SNMX996H=>A OSR+<6$*OU
M<Z[5IGAHS@JZI ?5Q(<GNMUL7755\9K4*:PJSB1J:2DX< G$%VF;*I-K0&"B
MVBE;,!L:LU,W5MJ;6R7!4LD//V]0PK+E??9SUD*/XCE:,>,N/D$,\IUD2X+F
M;*'4NQLI/L9U(G*IC7Z+*TJ3CW0G,HJ[BZS%:^GCW?3H$XWE.\@&=4,-!<:A
M2<V'4E3^:,"!0->^L^8+M]-X@3#')!FC:Y_VBHA+IABOB8Z?O\177 K7W,.N
M+I%%[V&B(DTC\I]C'61;'9K:]9>"17T79QTGJ776K%S!2R35HKL&L,7D7:Z>
M '>'=PWXHA*GYAC^%XV6XH2<-XC,4OF 5%UQS;P&X[$Y8BJ'P??RP255_>2]
MP4#)CHXDGF(RRR'OGC&O.Z]][H+J^H4Q\6S-#',.UK>\!'3D:8M]=<D=":=K
M^::3SDKG3YS8%'4MF3RDH-K<0(  ;0&!*DER0O#DPM 5/]CQ8_A06^CX%9V"
M_L+9/#>%/P=9 +IP@<4V5]N=.XL(G^AMO4R?\751^\V#YAP;R_/?1W1;*U)G
M06#?T8SHVSNEV^!X2FWLX2V/LU^U$D,2/!1*"VW*]3U_(J"_I/Q6HYTPC=(^
M$?=9/!V#M9%X?3T0L#,[G,B)!(%E2TS[5A@V(]B$&.[L[]+T.$/X==ET5B\>
M[N7VC>B+AQGEZ$8;CPE;.45X6'I&!,'U+0^JS.+V1<][^;JMPXG6K];.!6I1
M1[_\U\WY?Z*"D1-TY<7%^][:39V*CYYK[/915R%&%KF2Y+OKL@:&O64X!WPX
M^5HP>F*',8TWO3$>3$^Y0:!/XHC2#%NQI37,5A7KX9N&3S0B(U56XGFYOMC;
M?6;I%[F@>CLY=K0%SY#=IE:7X;G@POK$YNH2)'PN;S]6T3V[8O[14,\UIO$[
M;R&1,2,YU].07QMA,>T[M"#P+@)-XL :4DE*(H&:J:K#$5$LD1A9;N70%E6?
M_O#/+VAN307OG4I7H0I?L_B7=:A\$QTN)UK+@: Z@FU JJ4U(GGGB81"GR5<
MN;I<;-F+ ]TW7$:="\OSI#,%XP>B,M[^VDEE-GU2^S7LZYXPHAG6) *55OOQ
MFVK,$#+-,3&OB?A+?88_J@=GVQ@O4I\B^1*_9356JW*^5E"T<JLTX;C:"P34
M=]#?-4" F:WRP:=P#VGX'@[=^6%5-]82M?#R!:I5RB)[2 C&;N+R0)#,V-[\
MX2-DRI'"F5!&G4]<M9-\#5"RZ'Y6Z2RZ$_E$.--_^H?5$'1 ]M:/#[5?Y5+.
M-9]+W71#G&UX&C7NIJ0K(8E&F!W9SU-"UJB"+)S"F3-ET7?4UB_E.#]\A9*6
M(N9EJ^E@V+E7?_VV7[%(MUQS*G.:,/>ONBCU<J^!NEH0T%*FYADC^2/_0>';
MV!#M-?*E.0&>B37X-I[(/%#,4WPVU:)B2?$TIF^2]ZT$F[@$([4IULBB#$T8
M@H&57O;A:Q"(=-$*5$N*O) RN:_\\;X V[<RTNC.[A%+HXGIXOW;1)XYFN]C
M.EN.;C$$^X/'QI[+TIL*#W-FI_3;]8:)-WNM(L= ('_HZM;1#H4KSM9&9"BY
MW!L$+EL>CAN)BJ[>=#/R63&:3ILB="3:=/?OR>;@<B4K')4-+G&28H:)%J[E
M4W+L=FX3>"/4*ZJ>I8R;QNJO/BR]I"?HWLY_L/^!\2#DU9IS=;8WN:PV?5_F
M;>O;^) UY(*-MUO#AZV<>P$=H06$P;;AEY+ZG6-YB?,W/L:>>OU5D_/(J2:L
MN0:EXZJGNS%OZQ;W?O-Q<L+[J8'\$2-T9_94A-+.B:P>9(LS<L&:7<K:/,-?
M1!DQT;3A>=:,H_=. &>M\S&'U?O0Q&>CIJ/N5_]8,5'SLV-%_XQ#'Q[D4-4X
MC'B39$ZP"TBZ9K64+/V$VU_?%JE4P<TCK.:.^IQ#D-UPV#N$4:+$S.GJE OM
M?2R<L3=-=$R>IQ$FVA="?+S8W7Q0^?--:C,5%?7;&O1#C(MM17G/U/5!(,+8
M@<IO$OD@\&R8PE7V:DY<^X:<^]>!9@NM>]//2(MM?^2]S"MLDN 2A$5^.Q0G
MBRU"[P[FNPEDZRD,4SC#.X- X)C&#TYF0..J*UV*- AO;6 Q%VLR)^4\M+Z\
M#J/R566VRN.R>5P,56OMTH^A<6>H,J^M+B_N1'_K<$IT!%5_D6@WD40JLR_8
M*$SPB=:%\MOQ[DT@&]L&7U>/)#N8FNAU&_CDFM[PCWM/>#!W!L_557FY2;U@
M:.VR80T!+9I$85=#4YXU)5$@2*+EQ)B98'-SS4JYG6HW]ZN\63G5GN?2M_GZ
MWT#Q7/8[&GAY\MS]GN22&D?(\9EGD!%6R_':FR4%V\F>%3.!MB.'PO\>S/Q-
M"+3K5?W.9[Z$$KHLS38/A^(5!XM1PX*#BWK=LW!!=*=P-54/G#:A?B1GZJ<P
MQU4_9P^72"BE9=/@IE9SKY"S*[AM8D[B'N*(GZAL5Z3A-(W?Z[X/9PX(;521
MR*,.XN+??J2)V-?=J'NW-HW0IQH)ID2S+N:.J+B291_D*%4IFU>VV/1]/N+;
M597 7/AP^]M?;Q+-)3ZB6;" :X8+PIG=URBW_\[X&-))6E;GQPBDHMJU#3YF
M9%3. )#XU.X00QT3&AW.&U!P\A]02P,$%     @ S(.#6OGLQ3LJ40  8W<
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M-<_NJ+_<ZL(5!KROW/:U[ZH4.BV:K:^W0$RN?[<PQM98P5[.+.?VQB=>FJQ
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M L<V-EA((A6[I9Z5QYQG\X]O&IENJ@^_.J2:Q$SF\7TR235R<!ZVBA$GRBV
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MHBS3)EL[S8$!XE:5_U"['CGBW&C7)0$O'2#>;P4#/!?$5&Y)&7^F%UN?OPA
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M(/8(!R$S/]ILP?AV\H09QVO+HW_V5/._DC?^1"ZQ(4Y<L\DU<8^+V_>[*^+
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MS9J&E)/+'CYE2X>!8%9SUU,]!93=EV\<^]#6R@%KX6+)TJ]12MQ(*KWA7[U
M>RK+7F/LELZW5CI>AM?)$U0F<&=*5B(S(("2#E!6X9#M6(V?9&A]KI\\]H O
M=W1G]>&3XJM+J3':)0 Q#%O@PL_-DZ*LFJ*\?_JUK9Q!:; Q_HG9+#@$_=;=
M3A()_O56!-]WO$$9;?;>ML\K%TQ#9T?>/V+HZZR4?E#D RBG&(8">TZ, 9I?
ML^]1OP.FGPK[#_,?S4/5.B;;$U\X0VR  \FLUOWSZ5AD'>\P&$#X</GD2W[-
M\]+KTI:#GBI%1Y,M3GHZ/]5GBHL0;6 C-_WMM@:QE'T:/G#Q=Z.JH:]_Q)7
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MY]RF6\>:828 &T=D/U#]<03G:\^?YSSQC\\YNL4_&R7_D_>?O/]S>$O$[<,
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M)M0DUYSL#&/6QDF:^DJ/!TB'A&K,52=]CLG@FV?DVNX6?J+FTM&5%/:<U'Z
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MX%P]FSS/TN[YARP;U'"S<>5J<L\WA$W6\4H%_ WIM[M-[(Z].&'HSWYE:S2
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M6U"FA,K=U/C49Q:R8X(51S5]C7L$ 6)=X"]6[G8/:H-- U3CN:]+7SN(O,E
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MP]#9MP4, 8Y<>GP_91_1WIQ]@-Z &H^.4>@4'-F1?C+5?@<!>"  CM3'3Q"
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M0:J'<_*BPMF\:[,EOTQ2F/-Z<[,/KQ-7@T2:J(+(2U0".XB$^K^&*E>9G9X
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M/WX.X*\5 S55?DG9]>%GIE+;F><EI:H1WH\!S^N0;#C/1MM0(5BY<D=64\M
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M%P3\4?2>*@'P(!0M:G9[8TMQ\$I$FS#DO9IU!)T1=I--6OVRFM@[:6.W7A<
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MYN;&FS8]*D[X4?JR]8;\*)5'HR%<F,>UZ[DXDE$4$XJ@T"+"*=UPK)MJ.##
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M"0HLO-F1073SG&P]QIU'7CD-/%*'*??).3_FDYO9F5:UQ"5OFE/VIDVJ[4^
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M&?QRUQ4EF/(E.;3R9^S$>JB?J!((=OM-SHA1$$ H",L?\<8*FUI*HX&VR!C
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M/[+VRL@YC]<Q1%4JBDSH8. BMIH=%@<#W)\C"N##:^:,)-Z8HZ(>XX3J/%W
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MMV(V=&]4;$* @>@>)3),$?R2RNX@C(*HCVC2>&BM)SPR)M_HR+^.4C=P:*;
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MKVO;1QM.U6DR;UE@9]/ F)(M(X"UC[QGB&FRJIT\VB(ZD&Z0#KH(QC5$3*=
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MZD#?"7AKY5,+PKB^QR $M$2;VISYX6_4IDX@EF#8!;[?<U513F#K$J/#@(Q
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M$*FK;(5"1Q5SC*X?=[,A8M@0D 9J6:"3E>@2Z_D@FY3 Q )@9R$G]S)#Y>S
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M=V!]$CXMGM0=,(V*,CZ+)[T9G,/)[)O'-9?C*FQ0_CKP@BO:TB#\$5)'UD=
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M_Q=[JG(<+O&N&;D/B?@==^$9R-9&2";X68[QB3X_24L??FD&%<7SY8<07=7
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MTA8E8QFBZ$=VX<FPH>R8),*H2"<8RO0R)9#$9E8)CY'?7@TDY5HA1>@\DT1
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MWB+M5C1R>JT2ZNERR,(,\;*L=NYPGP/WAX'H@H$A IO%?)"83(9\&0;%66X
MB6[*-Z8(&1X6A@PGQ??F%D'\/B*$U=6-$&ZC@6.21E))(FE%@5+-AK9T'-HC
M-NW1#2A3>]R@'0_""&W'K#]UPNW W@L0M=A Q9'U!AV0Y#W.M(U 1V!ULAN)
M+!@\#)# !TU+=\2QKZ$=Q,(+*G/3\'Z]L]L\>^J.REE"Z4PBJP!)1MZ,25<K
MN)YCCQ28)$TJJ;N/DM8O\J(8XAB=3%\8E2XEM58J-9$[079.NQV+=&J*.+A=
MT</&XMRW/;J<C"DG,>D[SSPQ T\,KE:@2G)BN:%-M9&CJ8_G*2="SHSL81B+
M.PQKW$EDR<%XXDEH<9=LHF;H/H MX$4][&P6J"4FD3OQH\1G@;&-7#H9^6W[
MV#69+(IDS%V+_]$?)0RNLBJ3_#4N2D(C20PM7])/%$/E#VW\B$\/&PE%@-+F
M.5T7!F\YE.?%YTG>6(WLK,0X42X1#*J@QSFK]GFCM(;*R7) (.+ _( W%!B7
M%H[.,A"+(76W[J-+@)QW?=O%KF"W-OK+=7U\ W0\S(*_O"3:RL+M;G1FO/+0
MC4N*)^P;HRPI?NI,>!4AJ1ZH3/@$(XJMOLE(4?FF>K,<7#H3/HO5782>II4$
MDLO1#L-XX!CL3.@39Y0@-RO7/4PPY;K/3A2C** "DG,LGP7$Z0>%B#R6D7B-
M++P(DE3U3#U7DA^;V)K)RDKAX8KRFU702=QITB-.Y9>I(+'Z@+HC-:6%<VNY
MXWRV,5V$X7-*3_8BS+*.$W\OREY;F.4DN(D*-T "D>8Y R4;RHFG42@0M97N
MLB?H@>F'=0*]'E>_E'0 M)1-SR-HMV8"B*9N<1T437LR#9 F'QZ+C);^$%U0
M:3+42Y\=';9)YF"'R)?).W) RI[7DTM*D[Q8O6 /$%_*FF*5*@-V4@!M+0>.
M&34-JO"$V1Q4*'\BXPEW%/B83'"+9CQ\5@E1KNH!,!2\#ML 3 -&LH^9*&R:
M+8NSGO08;%KL9.JD9197M:R*Q6CJ)2QC,B[%F [E7 282 GL/R;GDH]+/)"I
M3J>G5:X6*V<AD@AL!=IA8O0)*0 F8V(5IB?JD49M?\MSR/3\3R.U9#%+(N!
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MBKU6RH?[QN*T&##9;,-EX&.S X/PJ;30BM*M-5"J&I.@%$P[TWAE4R[8 ^F
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M,V30PY)*DS5JC>'#O$*&.%81I,"XP3/I"MF1,X.5E;J-^P*V1!.9)0H_1B:
MBJP;5:O*I3N87;@_EFSF43>SI:.YTM'X</&BZ$BK_KF^^7Q#16UAW/J'RW%I
M%IRTR"5E6'\I$L?2(%NJR!J+< D)*]R'$U)0>.>J/DAVAL>ASB1*6JH ;L_\
M: >,10I/R"I#FDODFS?Q )M,IE_Y1+2U5]A;",8[/1_;Z9X*:PG62JLAW#+0
MFC%0?18&FI3.Q]!=R#(4\\D)7@+,$M(W4RAWR. :6_I9,_II+%H 7WH: DM#
M0K!H'4\1@4* +)CU)D;Y:!8@F$6V+8%$VP00@&B^W.P5@4\([&1+<6M&<<U%
M4]QI@M+1&ID#!$0<<D617C3.5_L0F_A@PK?,J2_"+11 OJ&L)2_H3?I#9;]Y
MK+"EO4RAR'@:?8(UDRDR7K'7IH!<JQ9"KDTJ")@; MOW@;#67%V$M5?S15-[
M(B4__4YH83,D\P\G"./0O$H:QJ\=4,)5!K\JA9%,2&F!HU#"$.=4(H,P I=+
M35,?1F8"$B8[=NM(*(0XDL"6^;G&JHR_C(!<"+NT(_%\3ZX4>J\ "@*Q[6'3
MXWX>(BW5I^_J_%*]JO">$'<+E@;#2I@0KNTI;32X<]_S![@+U.R=>VST_7M2
M?N%M\:V/OK<'WS,^GE^&J8_*K>"O)!!1PX1@S(&#_=)RF+ Q(YLX4<_O^'W_
M%FMC$9580)6*B^;F_'29B!/NP\^>[WV,!_!^FU&Z'Z)KI_O?5V\#?X WX5ZE
M"O\_\NG?U=I>O?K*A$G;0_0#!K'SRG0[\#0<-^AYE6K]%>W]?U\Y[<[/5W=#
MLF@_P:!O^G#7IH3[.%T*QWSH/'P].JI_=6"HO;W<6%\?O_WU_J_.M\<'YT^8
M4\CV-+WVLV9O@]F,C'V78FKM]^?I;6/ -:90Z:9(MBARN?(5DL FX.T$JMO^
M87.8%NW3I&1]GX^SRO8?UMM2+Y9!-!1]JZ "LO"4TP=5W6]DU>!)^7&LL>C%
M>>8$A^TLRUBU5Z:.0T\$SFAE]4W!N@<_SNU0$%!IW$&(&9$BDYO.E-.M-G^4
M2WWFI3!FF6,<DI_P>J<;8\%S(._Q<*$;.;>#3^W3B=1VKD#;F8(<)D[T> DG
M?B*TITDG3ZV<A4IDHDJT%%*H3R2%E6 ;N8GEY( !B*7O7F,]=D\A35QP_QFP
M"1] &?X!="OX$_H)T0(QWA!:+H(*Q@/J"@,J_:>;ZZ7L9',]=O*C$YGO_1!;
M,7LF:.+A[E)VYR#9G2FN[1*==W+NV*2=GEX]'B_4T<HI%-_2(#D^.I &B>.3
M=$3&/QE$7]OX;J5:J7[]BO^JUNKP+WKR0K5;.GEPPZ]?VV"*^8.]/=3GA#KW
M@=R/7[N_GYT/+TYO1[__[RO^O\?!M]-A[TTM?%,]*@/9F&(O)JU:F(%O ]%C
M1;/@THM\-<9$3 Q$L<"ON?5E;,7&*T9PC?[[RGV(?O;B0<>/.D[;'=C]5Z;X
M1TCV($)WT#<_WYR]>EVU*H=-JWX$1Y6>^>L)9W>>G)T4T2BAYWZ$7Q^OOU6J
M?C <!&[GI0ZN8(7S/;_F4\_OX/C(:E:.9SV]4W%Z<)G"\C[""N]N)[(@G,<'
M.(^>'WSXUCLY^_R^^B+G43;G<2>2=KJDMO[@J5O?J-6M6JTRZ]:?%6P]K4"C
ML3$G\#\X =^]^'#I-A[??VB\^ D43/V)!W'XY(.H'%O']<-9#^)(' 31T W&
MHKCYTG7DX?X/A[5AI>P4/L,I'/UFQZ//)Q?>[R\CEXKG_<3-/YIR\]$] UJ(
M4R2*9CV PZ].'.[=VO80N,&)+K!7AH.*5]FN_P6[_L?MFX/COYW*9?UV@;N^
M4[SM8KH_IV;[Q!T_GI[<0YCY?U_M93>\5K&.&]7<KN\6!E3GY3U=HOI8GT _
M]3'J8UU13WT^ZN/?CO-;>/.A_^W/@Y55'^M*_:C/I'[4*D]7'QO'-:M^<+0
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M\MVS.L3J;J&GO/9C\;:FGZH6#OY#R9C5$N][\[AB-0X/RMXJ_,;8*,,R)]_
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M,%I37H#D& +NA6*'81R0'YFK;S./*4]Q%-@):D%.&AH%%*73"C;_Z[@P,XH
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M5TG'\?P!MB9".2"S=/4E)IURRI=$V;HB<3QYE47\B*.*R4+:OD>:.,//M..
MXG66D62H%YZ5SN&6&"0D'VCF\/K]LBV$8\6S"5&\1,B&V$\I<*FN@DDW]MPH
M-&34$856TF77DP])8;ASWW/(TRH%$>T/->&*T(.;)MW=#9!%GW*\*&/E5&EW
M"\_Q-&J'EH$/BH9+^*#P?8IP?&2+MS[8(]DYN+%OOAE1%( 0,ZT,ZV.9%JJ&
M8B ].J^ACU*-! *$2CEG* <K/ZI<URJX$.I:6:*QN:'"Q:*^4!C>4%!I16_
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MF<'AGPF"*1 !'C(GHT8C0V@?P-XQK> ARD\&/LZN)LT[@=7F'9"W)S"EH5J
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M?#V,Y41N.I&T:!D4XBPD8MR+M1-<5QH)KG'649IO&?,CQ+Y4D:,T/G28@6)
MYB'9"Y&LYE2IXX4%JUKMH9UBV02')'0R\4&%[,TY,E(I$[G.?'E:))\*<@<S
MTB(O)9!;,>\E]1.S(.? 8>"SU:>^VL7:RQJ1Z89_8XI@9',;C'R!8.3Q-ABY
MFHS$Q6 H2F4-!8C12Q*PC"+'C4,WZC:CYK2L8=,E(A64P-!24],9J86^DU/M
MY8*;1V#_)ZJME=9KA=*,*A\P Z&&AUIHQBBVE"_+IH@S(/=@IZB4/-U;")7=
M5"$ZCT18_85@)6.^FW&9T,7>%8V60(/DODJL!Z<+G$1%3SKEMTA7('>NH8W5
M=YV85'\]Z56!%"O7E:LKY91#W$?O^*252-=S"5B)**^R)E0;L=HD#G.=5 1*
M3_B\?[-OOA6.Z@MNO/#)?L#ZQ5 ([Q7.2Q@C#;0R32345N ZW2P*-[ CKMN@
M32CH/M'6-B'7B7H,"+=D,C,U,([8M^^EX2LS4ZFPA7-I9:@R"?;EFX(Q=I[O
M,&PX!5&#:"K4\+)5XIS6C&[=UTE2P7JGI90E1Q 23S[3@]J@D)\""4HV1]'*
MBE+I'KR 3"0,0P%Z' AQ[5R]PU5)@(G].DATV";@U@-%U5!%4X*<=.=M$@#-
M?"\WC)D=IJ@_6OG$C'0K'<JXUK]GAPF\"@H"4!1)ZK,_R**(@@PD9%).&/54
MYIN G$]\."+-I^7 $7L$]>=IP0(]7"^VC]N(4%A"9_.HAQ$+N'6B7J9"68ZA
M-F$'8W74&7WL<X;;S6Z"0DW1'&.I/%M8F2.;:]B>%#.,Q-11(>)-Z(%SD=N<
M1)J&#CL]E#*!  (ZLG-9XT"%MC,3X1)5HL9T[V=3"%)41)& DB'(WTJC*.+@
M\!/E_L.$'9G;%(Y9 7E$/=$VAM?LIH)/259<^C7N6T7E18J=V7?ST*9"@VY1
MNI-*^;$?'!7AT4^$=$N9GX)E2YQ%H3UBT!CB J<<%RE,DA?[?IBM.U$2HF#2
MXPLJ-H?TT42^]5$.H?J<^*'3-39PW@;RQ,")K+Q,+=O\"1<"B:LT>8UA*\I0
M$"=EI- 7\: XHJ;R)OG$=*(KS%L;\[F,\I6P\)TP5)2 %1E< :5.9C_/M;8>
M5D]V2TBMB,W&32P[ 4&1QLETW/><Q4M633/CA;XR8WHFRE-20D3TI5(V3AU_
ML7"1QR)WJV3?9Z+!#>!Z%)S4JT_8!"U4\EJ^;->5'  &KT;&F 0CD19,SX':
MZ'A);TXN?#7M/G79HW?1F8&(K61BN$*#8#G.TU' ZGKH3!P)77EEHU'\G0R=
M!TLFLP&KLPUEBI9H)G4TDPCBV:K=) %+HIZDDZ,P5NN"P4577E+'GTJSI%X*
MH&V[5*J/-W?)QJT3$3&ZL.\E?:36V[Z:U?8PB*YM3 M.MB!;.2!LI7WSRQ0/
MJV0-*T-C&8&7G8A^^Q6)O]P],^M]5V@MR9J#CI*CV<3E1+%$_]DZT?:&?V.*
MF-C!-B:V_)A8H[*-B:TF(XU/'_YN[CK,ARVXU<2?M?NKT PL-_Y2EQ8'X#A1
M*W-;&9ED]X*;*OU=Z=%8I\NG,.%QW4FLYY.F3&C5TH&<RU:;PN%;Y#>V&!>/
M[0/Q #<('5&55HDK3C0)(GC'KD.-Q1DH+,D<UD*SB+*.R4XR?5R#OP2A&Q(>
M$HC/KN-B@91L?HM.^() BJAHDP4V>>W*4)Y&;D"%J>RB7*7 ;W]4WVGMICWW
M[Z2Q9B6VK$PFS*3=<;)4(<L:Y0=1KG2B@W!6%=,R19K@B$)I;L<1.>Z41*C0
M1$OQ\.$]PBQ"A1.] !2%4]:\")OKJYO1L4*;@7Y(H@(*:>M^#NV[&A9.6HG'
MZ"\=HI5*QQU_D(1N1[TFQ+8GJS($U:1JR+A8,'NZ(ODN=4I/]'EI[N8=/#)#
M\^M2E%Q"V>0H;%<FZ=-R,CFP^F9FG8W<:1KS 84CQ^8)K+U,7]-\]9-Q;KEB
MZ6T(ZB4UXOKF<ZJ#'=9]AY%CSVCV\F!(1VI 3B;IE,LF8V:J#Q*5)!\G&2NU
MUHX\;^P^;0?WB5H[LA2ZJ$Y &*4+RY)VN(V/.M,>05O2N<J4(UD<,4-40S5N
M34LT<3N8;M?*:# ,M0T[G_\(SHAZ9(RASZZ$'"='HPKL[?@)H+"L8RV[%BP:
MP$@/D*Y0+I3G$O%99/AG9T^UQ;K>4G#IF?G[SLBXGG=5".$I6Z/6@P= GC"Z
MP_0C44UR8!P?._1IAV?H3ZX=/V-RUAG" T1N@D&=2DV[DND0G_,I=IO _XHO
MP^3RT!,$Y;5$062@H;@?I8JBQF0@IBN#9)J@*B]'3.*^[0XP\3&O_G?X5 06
M*FJVACXM2T\;O;-!"8K#5-4FB2Y*6Z4 BY!6B3;5M^_7B5I+OJ%@%0L"\ZDT
M3YG54U3.G!2,. ,^EY:3I-@*.\ 6@!<"0Y?:,:3S>ZQT03,9(ZDYB,\@[(LX
M730G-216JHO-FVZUH\J[',Z.&$RC AM6]".Z\ZE%%)"0.T #LB/5<O1(#5VM
MDE2?W#K10DI1EK"XK)'\8IX"8>^UT$&\QIU);B9D!KF>*JP#]4 VI,@4<&I5
M4^DL\_(*S#S"C^BIFD0X@\R^DYZBW",*^T-Z#! :1L%B!4X&&"OW.ZTO-:;F
MR,MV2)$EG%KS#;R][5O83]"Q#%6IB&EV_#=5O0B[Z R25+JVOX<*ENP-@G^Z
M\_,PKA1O5ACJY2Y&;<,-QH-BS@M%ZIQJ%S/V-"2R2L*X%#?@9C%Z4S*M+O2D
MWR^N+2 E,MW)FFP2Q2Y#'ZZ&$0H-SK5G&HC3^")%;\C&G7B?81Q=PSHHP-DU
MSOQ.9^\M'-DW\PN6!=Y$ 2*=7#L,TP)KQFSQ> !'#QP<"2WPI,U)A#@##OBG
M 'DIL7D0]V_)\X)7@D."-'LQJ!I;0U8BYY?#7N7)-;AK)#$W_!M3Q"H/M['*
M%XA55K>QRM5D)*K6P4=)/WCC>$Z7W(QK6)JC?-HZNF*J2$RI_(;6ZT3OUP0V
MG^CH1E LZ)],^CUY_CW=!!)W)2E7SS6G2'K%:)5MXB+IQACS$:B1!EN@,;:!
M80!)DYH!^_$PG12&NKYL/H^7GQ=3"CU#1?(GULKI4*;ONM2WF\H(J!#)#T,)
MIJEUWJ)['!0]K8VQW'+JV2?<-!--\DSQH%:'T06:@!TF?Q!7R\@VV[P-LM=V
M,>AX4 #BD52.D<1:YF'-=&]-/X_I;K!7*"3'W%DL=E\)49I<!)/N3[H7[QV\
M%G"0?N?5ZX^V0'>2@;KLY2*6KP:M#M-7BIH#K 2VQOOOJ]K4]WGA7?F$T\V/
MD[ZR*@57%NL%K==G> "!E-[FLC__!P9)Y-=GW?LU.Z8Q3*B&A9LU3D2&WWW6
MP4SW01F/6?B'/JN<B25\#(-V2_C,.[X'GDS!J)!.(^Q = )5XBWO=5!\^@'H
MM[>MG5K]R!+_LYL7B%F]7BS#A8/ ;=@[W*\WD3GE-/&9GTW^ZZO7)UYG9/[J
MC#B*<]K#NN7S!Z<=4V+Y9;?KMBF*U<%NLRZ6Z\GE%W)>R9Q>O?XANVN%2OQ1
MK5K-L7U^L+1XF&TBQ:)E7K-YSE%_Z;F1,^_S_>"V>[;3-T_VS=_L;M>69WPY
ME#U'Q1E;,MW'/(5)A? *NUJPXAOC=S<.*L.@"6_/?T'GOVA6?Q.XH(1>V8$;
MNI(,WKJ>[5%YMR"#[>FN$W>C-_>4(63S4IM!4LUW:#5NC_7%F%;8/ <'/^9]
M<$\_[8]Z;XBSI#=$[L0STZC]6*PRIY^J%LRU@!SDTR5.N6JC9E6KS;*W"K\Q
MUOGXG,F/';AT!0=5Z_#@\,DK6&F!@2245_7.54.4K?2827H(C_/J^4;)AOG
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M##KXUJKIE:!:$G>,5*IAJF %<-@%:L[LRAS>H(L.7E"WG1K 0>&M:?MRC$:
M>,,+6_]XTXLO("00]AG;) ?0[3HI]9MY_29,O^*13\^11PW[,JPJY%D*69EJ
M3^_D,=D[QX:TVYUSRHP>X L0@@= E@\)'FA2F&V<#"LX;*'0=IIMR_!@$=%[
M<0 [>%E CZ? @B74X[ ]PQG!:>#!EX$,UR/MZ,-6<HRIG\*8DP9&8=<3AHOQ
M"5FUK)).7Y/DWM"V3(7G9Y6)AC-98YS&'<2L^815D=H4GU>&S89HD2>*T CW
M&#D/^'1@8:VJ0@VA^8,Z?R<96^P);7=V:CP0?JL&6%\*3T#*/I5WK(X1[V\_
MQXCO(4:\]QPC?E0'Z:-6>N5N$!Y/9](0_) 5VU X,(:'25D1@JI148\6,Q#,
M<%^B6R=C12AI+J<%W%2_Y7*KA)EUT%K7VV+![7I9U2;4N6?5N)B(>PF\6U*<
M0([)>95VJX-6O$<(0P[P/>332CZV6:C NQ#U.+HN*#8Q7HR$%/N\!M(Y.\FC
M/!\KQD&R(Y9>/3)U7F]0^/%;YG@T0I*S<^#\77KQ)GT7;W=4;'"8[NT=IKL'
M.BP6XS8YEF'3VWUV1;,Z%"]U!H85N)M!J;+*QJ>RNBZ3:74-N&;A3Y4:%;)!
M@^*.&X_P&UQ7GL"E_5'R- 5&'SSL8@,L"[2 -][5^1!VDM5_;TBU[U&&:#&2
M;&H%ZO@F=-]U/])ID::Q!=T8<EQSNT@&3GH=17G DBBM!<';%D20&YI]-?XT
MS@M(6T*BY?QA219YOO!SP&H9YXV=ZQP6I*4H]JCUZ9?248W343><RA\[3+MG
M_"G$'3&F'!D?%R0 1$J$=IB1>+1WFUGS1PN^-A-\5ZQ(6AW'0BE\'<K14;68
M E>][?Q_\D X&B\R89?^7LSLAW;[_FFPO;5#\S>S=BC9[+'D+ZRXFD[[[$KT
M,?E>PDE #N*-/PT&6WM!V\IR6;9E*9#*#"C66!\75GZBC0W' 'O1Y"V'I^_#
M5O(6*3P\?0=/L'K*(,<YQ4>$Q["$J&'0DAS(&Y[:8;0>&4M]7(+'M,LIQ<QY
M*(#JC'7?AF>X[2AV]0EV:M_9E3EFD()'EW0&%]0D*Z:+.N^ZAB*UP_1/!.Z\
M68YN$;L;7-J7Y^\AFE5FWIE.>Q6FE!.25 NP(^UY@<ZI:B7E/QI5S5S*G !$
M K%473H+>N.$GEY[G913A*/E31#]QWAX9^S_\>[OX[$]V7;63U 7<\ZF8Z6,
M=&UY\VCS*M^N<88%9"0URW7Y_'<.BP>'!+9GLX#00C*V1XG=O?!D8<V2:PAL
M7A272:NZCO'*1 ?72KUI1S"L*/=^Z-1YD;VVP<$G]LA6<CFP]D]2&^ZZ&MV:
ME&- FP'^(M4<VN$&W-4=&PV/;O-#05XBY7F/;O^"B/ZJ17A+A/H=JN^<C\ \
M5]\]E+WT6=5W7$F0M"H)MI+'5DOPW-R#:6Z-,,#@.0QP#V& _><PP+T?CS6K
MP@Y[JL+V>ZO"CM_\_?VOI^^LU/]H'F=!6!]=:9 O7D,>'QI[S2<.5K 16Y60
MD&#0#YB-_V55VU)3H2?'Q.?Z"UF#*3@ RGR4-PT2TH))")3DUHQ59B0ZD9RS
MH":/:%&"16!_"GH3*F:QVQOLZ?!UL9-_)3K"AOR+IGAWLY7\U-;IHF?V-K<,
M6D@:TT-;1!W3XCU /(68WY.[O)(YKB<&>-C$ 0\I>K(X61Y,H5(GJ\,, 6_$
MZC59:Q$^8^J6^#A:4T?1&@&HY/4-N[N5'%O#Z=QQ"(./(0U<__B,'[9[G6&+
M37PJ*18OP !EK$X#QZV>J WGV7AYZYUG4.EWQZDQ54^*])*9P9 !A@I<L Q7
M&RI!\@(G V,^;L_9;\$1A5FH6=,H)R[OB=38'\XO>:-!/E!1+O*N'2+5+-GM
ML$;:6Z)GW&;9CK"["-U&2(A17B$Z3NQ2X[0F<A#0"K%-AKZ!2795U;(UXJWB
MAF$^=QC+9$+"7A,I(@&)X,YZYPDTO"O3<+1@0@;AHV8QG!5S+"/ X<MF%M=U
MQB33=7Y5?<(YFE%&[@U)SLNZJ&J.]-C'%X\K3OA5D8*>B#^B2QA^GBL"T]:>
M71$/81M]EBM"J:_/7HCGYIZ;^](NEYUGE\L]N%P.GETN]WX\>I8S\+>\=/X6
M>WN=G;S^]?3MQ_])WO_V[N3T[*>W'\#)\OKD]./QVW=(-F2^/WEW\L/;UV_!
M_X(_2H[?O4E^.7YW_.,)W&&/Z^*Z!6U@<U%=$X[#,"]S,$K!?I% *,04EZ0D
M9L[P!W6G'G-5'F464L+E_**N%N?$*8@U-A!ZI7I.1>&%3]O!7.3@K+CY*R0E
M)#DD+Y'F:$"G]!V$&ICKLDGV@P(9U%J[847FF(;C,\8(IH;>P -S$*P,#Q-\
M65HYH'!9C>"ROG*(+))K!+_FBJK5J*Y((@L029>/2;]=LKL4YZ2#GZ5]QBQ=
MC:B+?C&-VVVNYA12!B<(1V ;.5U,<\9]V!V_<%5B)[^S:7X\FF/N,,P\[#QK
MIIQ3=A07U. >NP8KNK"+#QQYXY165]DXYH)P4] 4PGI03)&"9@AJ"6T<^K"Z
MXD)TWFU<-V<;B+<H<Z$LPG<%F=)@)@ (/=I"=K?/;\PTNP9K/">/%>=(;R4?
M\AJD!<AEE:F I<]4M;=WF!Z^W$N/#O;ZSH%.FNP\O%O)K]&D&3=I+A>BJN:E
M>$+F;9F2ZI/+1X<?I;T03W7G))./+YMS.^@F/WS50"I1#1V$RL6_5,G@:#MY
MMY6\SDI(D*T+*,_:FU\D/TPK2%W]'I+C[%K\5%C=)K4_FQ9VAY9%EAQM[PRV
M[X>;5"M9L1)VZWX$.E:O+G9;;M(>Y6\8TT[2K:LZ'6IXP^] @X)]]KV_7=[#
MYJ4+E6[H/@XZUQD["OCE?__73I]6VNH8/?O5#.+C&5-*C*V...>4O'B,<$"=
MXO!U^X-T&O2FU=/Y,*:0Q9F=N&\T1Z^G6<-LFFJF[D#[N'K7A\CU[U $]N'7
MW_T,=)@5RWLF[:[YRB_WFF]#'WEP^.=573LNQ_8RR&\ _#[9V-GLFHNHU<%Z
M[(FQF;G63.VD^P>[Z<N7>VOTHX\M<HV^W6T$H675-X3]K9VC/W^QM8XHZU:\
M^Y?"ZH#Y-/E[-IEDR<9NYW)^T:T]V-\FJM#^Y5ISC6[+&KF\7__G&YRV%5WX
MOB[LMQ^RNFB*9&/O&ZS%(#TX.'S"2W&[PW!<SB^J\B;Y>%'-JLMJ,:WL9;?_
M]9?AI15@1X,GO QW/A$_Y65]DYQ9C?"\M/9)\O;MVV3CX.NOR-Y1NC-8>J4\
M\A6YW<'X>]7DEQ?)QH]U=K-IK=RKXML<C(/M=/?HY1->ACL?C%^LOI[5^3SY
MN<J;T<4W68U]U+6>\&K<[E#\?%.6@,!X#G[+;S'_AP?IX?;!$Y[_.Y^&-_56
M\OK&WMY%EGR$M)WZA155%]GLFZS+WLMT^_#H":]+?"X^H^OMV-TWFJLX6OC-
M]^BQE1(2UN@*9)1C'>UP88UD8U25#1?B59/DB+VYS=??U[OI]M%NNK>]<]NM
MO<JW\7)G]^BS?"CKO>A@:_?PZ]G5:^[)._N3/F>";^.C>BB>J-4NP?T_)T'F
M^WN,?'X$@(N3[@/EG(BW\1-^V4UXR\7X4F+JEH9O/0,),\H=1O$O60/8AP!!
MFOP\'V\E&X??X")-!T?;Z>%NI^'U]9?JY=9AC[P0QN@X%8097]M\KW\L)O+_
M(YD[W[WE2&>CXJL>"VKPYW:VSK<BW'W,2["SN[5G'^U:@IU#:'-=*OACCQ=V
M>:=0.-/D-"M#X8;R6$+8:X7@&@!4UVU UYY70C-%F1QL$Z%#5_3]^ZXDG +R
M(0B.FD+I&0+R(/Z 0^1V:&MSAC"&*^3<-E=C,@+3UC<2<P=,FCCD'G-?^!%O
M,;"!B8>$$?I,8OT73 F#\I*0W#&KNS.WB/#0.)'<PSC(=#:<-EU=0C9)D^I9
M)M3;U..O.TPYM4C4-?MR#W"\9-VP\,(^T(M#'OZ<EM+T+R6^>0Q(4I@T/\Q[
M<D,0#8)GCV%/*%W$#T2  B^96XW6X'(Q9T0BXTN(>.-UO IV@SXUDW AJ, '
M^T$<+$(],T<<84QNT2>FW2<3]*G[A#*"'"T5O6U+W55=4M6%=ON2F&YWEWWU
MQ];(W-U]SMR]A\S=PS]TYNX=M_N72?C]^IE/J]*;2#>)=&Q9Y\'E[^O$QW</
MX'?+E? 5&07=*,M+6WQ-_A.\8B I]N@HW3[<[<OOX_S9Y#@Y^_<"V0U^HDNE
M0;863%PD"H0@$0)NGG9*WKAHK&POT#!%!8&S9@?(QKA[N+^R%^H=DE4[>'F8
M[O<S2R*N$FIX"B@2U!0[E-.S7YNE;>\  \I@]>3\E/R8C:UJE[Q]\P/."W"(
M0(7;C6#73^ER_J7>TN^XLMW?<<U+<S*)/Q=(&?"QM@MK?VU_;,>YC$6S<ZR9
MJ*>7Q$Z BU4T+0JXY7KD+3T>P?'X'%.UE?GXI=Z_XMAU9WY\H6.W'Z]BH '+
M-H"]@GDHE!,^>%[[;[3VW9DF7VKMTY>[O2:D7GK.>X&EAV=ZA9!;>#1]4*2A
MW1%TJ>T1NR:/&$C"CBW $_!'WPG=T;(OM!-VUCK.+4Q"?:*;Y!S,5;((,4?>
MV:BW.^(AO. O2*[BDWYP6[X<0%9.3W_I&<J$P%_OOX14A?Y?-UL2JJ>?;T,L
M?>G/.;*,/S_<@]!OW]RAJQN&$(0^\<&] XA-]CSXA]O>W9E#7VA[4\[0*M4)
MMHW+9_K#+4!W$.$S%N"M*I<"C\HZD8RY)]I37SIF0.<$14FDZ[&RJZR8"F0'
M0V(C$Q=Y/W_):GN\!X=$K;N5!)M#0AM]1S%Y8Z4#PP6AGS$9[*>'+X_2O<,=
M>0;XX.KI#8$2J5O4$1EVLBFJ*>EF'=]*CCW*-QC9YQ4ZT;S_##UQ&$N;WKB=
M#+]6\Y=:Y>MU=C,#F)9F:D42:EVS2Q#6(YJGU"%N#R//'E1(<?/=3CXPW%IK
MRP2:\3@];28[4Y6;UG8O.\\=WHSJ_RN'Q&Q7!,&'OJ]NQJZ-7^!!F)9?<G$5
MMOJSI3Z"QE0[8 J.IEDQZW7DHM<WOZQJF+# 4S[*+QW:/U-[T.^+6M.!V?\N
MRB(CW@3$WB6$KJ*$DK0Q%]P%I%N]6R-57R%"NJ?0SI<_&744O:+NR6N$.")<
M)-="'"4 O@. 7)D6&$A"Y-[YO"Z&A#5\F=5S1-Z9M^M9[19L>7);(03B+\2>
MP-S:V=[;.CIR! EQH6OXM"_4"T:60E.,< ]BB)VZC7,,2_2!!$E/UY;H0 OD
M7)0I!IT'<89@71!W2F'@(V0-E_B%(M%*MOW!MMW*=C/:%QS;S;FP70?WT/]4
M]2?_+["]=G:Z;Z=V+/1AU+33_V[M%.6WJ.!]?ML3?=L:T8>]Y^C#/40?7OZA
MHP^/XG"MB>1ZY)!%&$ D.3WY^?CCV_?O %B$<$/PDY,WR8>3T[/W[Y*/I\?O
MSHY?XV\>%Y (U<W:0Y8!$$,^104 =#[2;/ 3JX)\H #V1\^AVSP6D#,/2WOR
M&GBE%SQ&1J!@Q9:&R7%Z117<&-1F&+R.U.2J@7)P8--B4PCQ$/TS5BD'3>B<
M:;UJ:I[G%;([2,=#0$FJ,B<^XEPT/E+I(3&)5,4_#7;0UPS8GX,_.S!**QLE
MT@^*807F9&:?(:(XH#-_ <"N$LF? O;?_!H!*2ZG.8QW8H=C'R+F<]>QZYP)
MNFNTK,@$RDBS!:Z\<FX(T(%_G\7S=Y&-D7X8,BT(;Y+-,TI*X7\+_86S!ZQ]
M$K=4-(040QSP80YE:B0A&9IU_RXKR*+15+]DVZ'IE+7LFY M=]_IV5KS33G\
M!$)B9JW" CGCLUEAU?H9D9!AXD-''Y/E?:SOV!_[(&'2E#<2V()]"HE$9),R
M*JN/=&%:1FQ#<ZXV+8NLYK(?(K68)O[IH%0!3&=^]U;R)F]&UC:"/N36,J%T
M'18W^IC%QP127.;78#HL2!+)0^$&>0IDPB%H4T$3/)N!I0SKH">I 01;\_>L
M7,"W _3D[,(!=0?70_W2@;U91][8?XB(2<*337L!*0];*<S^_#711I8,Z& K
M3\@)() 0M*G9"<;1EKN)C=0(GG-6HFS+[8210\R+X49&A$E;LB<7SN_0Y+(/
M/?[V[S>V8_9M*,8=0&H+Y2%(Y3:O50>>P.9\7R9_7U@QMT.;;3L-'(L!R6)F
M92$X^NQ"-4!<#],RM1-4-IAOX'@NT8L29"<<EP6[,(_KN7>8_71\['UEUQ<5
M<0J6< 4A++IN@_P*7?T"YGH[F@H/E.]ASGW+6SVSKW5WYH*S\2ZRVIY!R=N?
M5N=5XR21'3IXE\"3!KQ3\[D@&25_*[X[RT=0!OD+$0UF!:18OIXNAG_[2_$=
MM@6_L;(T^3G/W7._@"5PDQSBCPK8U&5)^Y.Z*++0[M'Q8D1.+7M%6[.+TQ^.
MCVD^R)N&XK,J*9KD?#[&C1\S*&6&.#9%?LFQ_;B^\22D;GZSND2.R:R>O9CF
MY3GXQ?C7"7JF8%GKZB:; @)QB=AI0) %_%Q68>).)O8<38O_P&9!!84ZA)T%
M[YR]/1:UI!N2CF+U&?N]HTG='3#U)W009&&J,SJL]!B3:]!V%V49]8C@VMWB
MX7%WF^ )G=G!$<[.SM(SBVF_C)#V<V67]#@\#O\#<OH'TG5.X%'8>42.^6.R
M\5__\\/)?VT*^!??+JBQ;NTGPMRY<?+KZ?MDL+4KGX#K>S2J%WC?L10WC-@_
M*7['9%8 D2_^8_]9,X?R_I]33M->C( $ B2P4SGLO5)48Y;>MO_VWBGG%U;'
M7S@D:U1_QQE>:!B:M9HOH#?7"212V7;PR!@O82ZGB\:_80;\VLBZ?9D5>,S*
M*H$]Q!?/WQ?6EMC=QAD_L)ILP%$;;M3X4[MK@_FROS'V@SWY(%5N="!H+1JQ
M/,9R7-]5XHL&*M<%W'>G"/6/_IQ)7<V\*8=: 4\*;PHG>:"8#YPW^,MA-H4,
M=--<Y#E0C]_J-'8,TNZ5!"?O3P<OT_UM^MV?#H[2O8.=UAA+;1; 9!J*7^T0
MV^\^;6KM"/<KQQT7-78*V_K::JY_&J2[^Q VW]G"@/39/)\ HDGQ?_]?.[O[
MKVSK$"5ZXS3VP(*@681E-C 8.%A6?[ "C -K^](O:[1=43XU/GU1Y),.I<$V
M;N?C,4D;1CV_*O+K5%%4ULFIO;L]<?PD\!+0D0W="(_/=? A(K6^KH$UH42]
M8$Z+"6+R>&'O6(PXP==YBK=:]"%!X3>7$'S%LXF&#TRJ9&42R03^96_-0/\?
M5GC1LBX+AK&PU&OKW$<*8=MR0,JH&V_1I(FG/.[1[D/,U+0=&.RS5'UP,&V9
MRX;,Y:;?PL09B$H(D+EBAHT3@;LKEFDD7(M5R&.\V)R%2 -G)?^MU>.3/2MT
M[)M/G1?(G+WX1XI6[9W\%>(XX]$$:^6M#,%)91LCJ498L#)V]!FX3Y 303$)
M1/O&BVC9<WSGL$#<#<+D:_8$?5O2'9--YL($PRSJFE&'0^I1MQZ7 'MN[JLB
MUN\_1Y[N(?)T]!QYNO?CL09B_<ZV1JQ__?[-"6+4OW_WYM?7'S&H=/+QI[>O
M'UG\J$=N_\:>2+S40!FV-T9]6:$M][H:YY1?5H+W LV=$WLMC>CR_\U>4/-I
M/IQBQ>H'X+:ZX31:* ]F,CN/Q>X5E@B-?78YK6YR*&T]MN?_\L;K\ZWW)_1^
MP\I$-81;'4#$)W7N'$#G>4I8W\B9131OH@A"? @SFL+$NPJO:>CE=3YL"B@:
MG8/'Y_KZ>NN3O<8K>SW/[85:-5NC:@;N'FN8N!"35=G.K;9#>N&-M:ZMO46^
MS'F%(8#KK( Z6K1,T@2UQL8[,4$I&G,QJ1]I3C/M)O0&^ARI>MZ2\H#X\.RD
M**U=A1J@P%@(4QC0P5%AMDKM>XN);; @J+T,7JE=\".4*D%SD@_GU:/)K6;,
MH([&YC"43B>O&<;F%-/5H$\_5/4L>?GB'V(N3^ %PT4#&F1#2=@*XOR".!)=
MG$WFW4_Y8])ZUA%- RV:WG_\Z>0T^>7XX\>3TZ<AC8[=B?#KVG;QIY[ "\)Y
M_Z#=AHP#^'Q9L5%B#8$YDP<.'0E:3H%610*0D/XM5)3@'&CQ4?YDA=P5A G#
MED$.$5F -9FP4IVNV;Z&,%0+(D*QM4&:'W,TXM^8;%E-D$W0&UCTQH2)V!!)
M?XA\'O/XE3$_*HR61]A!*)=Z$E"N_R]!JM$LS:R\G#OZ0IEH$25 /]</@A"P
MKAG-NO;4#N6./I3'[][]>OQS<GKRX?WIQ[_\\/[T%_O2%_]X$L?SO17&Z#?D
M'<9R&Q+=D3AXEA7,3,B!#Q-0%]K;S0- \$9IGV[(=[\L/(!&QPLS>PO@F]QN
M$Y2-^/J%HV3-]DA=<%RGI"W L0#]@'ER99N?T?65 EOH5MI-;_&W9G'YW?S"
M+K_][TJF"X-,%VER#*H('(N_JGN6 E!9?4-JD%6*"A@$A'I0*8(Q9-.F"@;"
M(@L='64^=W>Q78F2?\)G'F?(W=#V"M\ZKZ[@6DY18["_ IUD+GZF5HLK]:%'
M>ZB?W_$'?L<:SI*#9V?)MW>6[&\_.TL>PT'JUHAV \Z_C^]?_^.G]S^_L<:*
M\,^>)58S2H"=%J*P"2M-OYR<?'S[[L<GH2L%")/ F0<W:HG*D; Q"Z,R9($:
M5G4.8H.!@B)P>P/[6C+8RUZ\I!AW7E)Z*S@( E9XJK-S#/*L '1H&G'@M*SF
M1D7*761X3RH1S\+78#> [)PU?DR])<U+H9^1]97;^7%Q-'0#-(Z:KA7>-C@3
MI!A*-.<I9! NV13DK5*3:]76P&CUUFEKCT!PO1B3!6@;@*0+TI^_Y+8QR[:-
M3K#X(1_6E/9(%:P'K\CC-08_W878T?C^(C3V2SMGF+'@8FB47H)[C'(N#5$-
M8O=\3'.7"_0Q\A^[A2XA:ELMFK!E;C*E.CU\)L_&4T@TQ\Q.>PTT54E%ND5H
MU_.XC5V8<8-EAM%.=5EI'8NUY=C9%2X>S*";>'2-P3LA:=E.0,X!3ZK18ZO;
MN2OHJ(3S1*X#M[ 4R>;6P?%GVTYEL_SN /JHI!5=$*!PC&!@,A!9 #!"[%Z>
M3GU5(63:VWT!27/UC1'0HH4UL(C5OI0W45](GHV*>K2804:(W:P)(U.[5";I
MVDT+2I%BI]IWXW=O<X&UF$.P?NI/^=A(YS,QM_S&;8M".P&/A\#P*[U#85F@
M2,KF13.Y$5>K3P'0DCXU<RY4N/&+MRC1WPVY67X9T\#O%(L_VG':&65-:G(+
M3UKY^$R*28>_Z_YPOT.1Q^('3A"4KY+HRVE[<X]U>3X/#V6,DYZ#(Y6$K!E/
MH_0R+M[?Y_PR\Y:+;N4$H60J,#N@5XZQ4.+N:EPBW1U)=!/A*A*;.F-G[6#;
MI<X9%(^2QM#VG(=BEL_-8'NNDN\@(R_VO>/QIAR7R\70KB"T5"WLH9[YZG+]
M)M,2Z,FDJ$&+R,:/*D6ATV@:?M<K([Z:3NM>+</[JN^AEWS._Q[;33A-*"]O
M_]$N^/,[GM_Q_(X_T#O6\!,>/OL)[\%/.'CV$SZ&@R2\'5$-_\Z>\Q0>7UY:
M1;/X/3E^S/X_!5: L=_W/R3'OYR\>V/__V/R\3VX//\VK/_RG?GQY-W;7\^2
M[T^/W[TY2]Z^^WAR^@ZQ"XY_3NV?K[?H9U#*!W_:Q]_^\R3Y\//QNZ\V/=]6
MH"Z%8_OMIY/3D^,SWAJ4GT\9Y5"LX]+'-#S9WXKO\!<0C'08;"H]) CGQD^R
M_1@\2[%C]/KD#<B"HKG(Q]B5'_.R6#3)]S7"D[W%6"G:CH EANW3NI6P'2!9
M_\/4#C9Z)WRF7XC 88]_87GIR,&$XX:*'@S*,_D!I.1#XG^:Y),)51(90;Z[
M2;AF9R]EX 9PQ)'?;9;]7LP6LTYHKNX:*5V)?VEMV*MLNLB3/VUO;6\/H&2!
M&@@6AF#(#'IJW5;P@'W@4SIGIHM)<@S5BYQF0-X!:X/O0WGV$HC2I[C.4NW1
M0-TLYGW.<BY%Q2TPK\S:2QE"DMYFYC/OO\JF2];!/*5UN*L@58LU6=3H3FLM
MFCVJDRE2T$"2*KF\.&)3VA_#C*X6A1TI-0:^^$/.OW;FG5$>+75RL+-UN#'<
M%%D&"Z"/5IO/)URKF#!(*L\Y4?$/.=?A[+GZ*,P3H_@$E"UC#MJQ2QUF[RA.
M*OP2'G6YC/AS#L0%SNPH(L;OPK:-:_M54E;7*<DL4"M21"R=/Z)E81BP_7[4
MNZ4+='IR]O[G?YZ\42O$DXG3C1#8=3Z\$6TAA:CHOWA'8TZ\Z N*)TR\RT%"
MKQ2]4BIM*D++^Z^I"G,QS>KFK]]J<IX,C]SVUN$J*K_!UAI$<J\2'OL+%&M_
MI=DCH!VY7_IW!R<6*-VM6]4'5=R$JO@6:W::\6J-:8C\&CUNCEL,M(6:_746
M8^=S%N-,'4%72]ZM<(=YY<'UMK<UV,C@=C-+%G1X(PJ_A)A(/[?BTOX00\48
M%R12-LEH[]'ZZ+T]P/@&&T'QT]%-!&ONMEALY\;8"XB.PXZR-B+B=I-H 6'B
M'$@/8D<E7___[FF@>.1Y=QJ^MN/2*KC:H4=6U.ZEM[,\8HV*R9K([N"$<B&1
M&#O #0/U[H'<LLU3N03NYP5^"8  @UUGGQ"CHT<#<#N_W:LZA]1N3+$(+".$
M? ;')QI#INMT[FP/]B.71'C!CF'*40GJJ.G@8Y+ "1EM)E*CTAZ%&Z_KH$O$
MP.F"(?E>T*C>,RD'S !%]C.:9V?>=4CLI[NSO_T1_DH7S^[G7#PG!%AO92N<
M000N 7CV)I]SW@:!TM.Q#N#HPW-' AR.C5F4G';AD;)(T??BGAZCW\,YF"SL
MG_9]#,5/&NA6.TSPF)W5_R]@FP&3R!PR R&6(=?9%C@H_[_'[HS_%O[^U?'!
MEZ]$SOT57B4"M2MHN"K"]_6"BH\N:'C\XBYAP^>HX6,X7.MR][Q+?GO[\=W)
MV5F"+J#W/P0N(''*@"<'*4.Z?#Z RFC?*=_][__^KT#0_:_^/TZ$_W;2ZNL3
MMB[)%[@3E^LJ>BCW>_L66*7__J\=#)=V&N\4Z^PAIKHMT=1G]7 %2=9=^\(+
ML;?_YQ5.HWXVW-Y'O[_Y:^=SJVX7$7F?T:?!_I\[%=FOME3+?H_"_TY49O>R
MZY;]_B- &W^%L3Q4,I[GYIZ;>V[NL36WAC%T]&SWW(?=L_-L]]S[^5@O,7*_
MG1CY_5?+_/.=^,I5)"H]\EC%5TXYOD)I<Y08]_5[\(_CTX_OW[]+SC[^^N;M
M^S-.N_P&+_Z629WJM5]Y;3V*%T=<!LD'HJ\DO'./SC;A)7Z(MU?GF/C#PF[8
M4D5&V8,WV!HD=GIYL#"_6P9"V$S>&4>Q$0&@FE5S"0DA2GZ<0C*\X<(^PB^<
MY?.+:IQ<<\048JFNHMX!*+;24,JQ@3CEL6-!31/(,8JPG5UB;?1L$C^+ :H1
ML B,<Y!)L)A(()11.J[O,$"K%Z-<6%Q-?ZL22L. #X@#'\JM\]FBS.O,D3*[
M5FMX><W"P]Y@U0((ML:4,0I0ADC&$7#6</VA8YF:\TR& >>""HKK@HJ"':E
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M_[)J8#69I(:FE'_@JWPG[@*R1X0#1[7P!-H'\YK]PTX@AG7.DKHNH.@>#Y!
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MB\4?UO =?4JY<H.4XQZWZ890F0QO7'TFJGV^0M,J01O%%56 !'62O:$EQ.#
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MQ,,!Z1>2'[J<^O0ZMP/)*&SB8PW.*_*41,"!CAO3^?^AQ;>D'>EI[UV2J5T
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MV,F#B!>.=+\\]V,-XJ'C_+)J"D5^1:T5 "I)U=O@1D(&"5+="(\#6731$]U
M\W1#H39H5ZNJ&<EO:(<(BFQ%J'BBB-A9E+KIF,MNXFH PG*I<'W-9^TUPD94
M<+=<K!-P>!!N,=X^B@<D0KA9;QF?D$S%*+V2$JS1M#7QVPK--KR\- %W6"<K
M>2"I)^ _Q0:$$UO"*J3KZ_@SRL @O'55S?,>L<DYL+Z^&[;GW!>-IWQ .,9A
M+WB06 VE1/J8RAJY:4XSZ;0DR*7O4$MA#],?RP,Q4:G/G?,L<>+H3 1901YE
M:/+EKCV" %BZ47 -J>INK',3_/*(M<A0#S,FD]&Y@$':H;\9K1$T*:A,V X\
MPVB98AGJ$JZ2V #R)I;'MYR2SIMLO.R.[LM]LBK0*\F_7+F.CBJH(W84M+E#
MWG_5IH2=FAQ<+W0AI$XKMP?$ON,\3UV8P/ZK''%\ PLVB1:R1\@#B6B!6 UT
M^S _55$JN(K9\@EZ19FHXTT$C\);BNM!NZYM8J>.;VVC;VWP? @J65>\LXL<
MO;6FN!2C#*@>,\WKU.O>P"LGRIE]2I<+ILB\AN 1X]GQ[=)%)>X)1+L\9Q")
MZTVE0>>.AZ_B>!5GU$1&:FLI1// :H,U%&VE0'#BA7I;HRUDAX(4IZ?$51/!
MGC5]57Z^Y0!:.MRGL>=%N0R'>>Q.\[&S)IMF-?++<C5U:H95N5" *E"#D9<-
M^:)XLAL-_QSGY/GKRTDE.&2*/:<O__0IG8 #2H(4\%VC-K>79F2VOB_;5GPL
M=OJ\LUJUP?CSO&@F'!!EP<A!4I^FO=K (9V!U?=(L5":_')+5YT7"OF3Z.S2
MXUN5#6NW'.6O.S=LZUG)G.K4%'17,8, KD6"Z0[DB4Y6#5W'=Q@ RXD4Y[G'
M(ID+17RO18)@%/WZ[FJ[J6T=M>VIB*>\Q_Z$EN:^",[A4+']K6@0147!=I@B
MAWZUN6HFS6W&YA5!:[>ZT3Q0,?-UFUL6?G_Y''Z_C_#[T7/X_=Y/R8KP^U%;
MJOY:%O.GP^%Y=']!^/YX.<TQ$V]P[K>N%>IWPF!F9#'G9,HK*?YQ!!V0IS9.
MNX X4LEI;Z6G">18]RM;%6)]9%TJS1WN1$PLTY9G5^+;$9CH-$^F=YXZ&8D]
M;$@:6<9:R^MTK&A83L[UCI+D39 D+W3.FLF9)KS,*3D9UP^V'\CE*-F ?'I.
MSU%Z;N?37O7XOK(_,NY'<RO4YJR/0%XG$HM,;SKH*V\=Z3Y2,]R/@F*>H)?X
MB(+>I[ +NJ0#D9BWE]_CO M9S=1!N_JX)FTNS(*@6?3FZ1)3!_?\7Q_O%#O0
M_V/*YN^0*2SY*+!<1YSRO6) ?'= #H>..Y!T5E<;>P=>#1^1#R^*D8@;3Y6"
M*(8='6Q>'5]MQ[FQ%>>#;-<4** *WB4D&Q[[*ENC]\RE=37:?64ZW%=H;(:Y
M/SQ5#/H;1(5I.RC"0LH40=^8,X,51WO6L=V"O"%>O1"\&^TY,,E:_$U.)GJP
M</A=M9BO'M==$ZJZQN 3QMJ>Q95G)F#*S.;FSKE8 ?O$.AE8CWUKCS:7*'#&
M2R3MKAWG)(/<YFA&5O.!6\"K(E@_G:F+EJE+ ZC&--AB&X ?Z9!CU7L,)D0B
MWJ7S.*A"7?'<QAX'S,E85;2!91]>F*F#ED]S3FCBY"R'-H=!M@DF>@64"[Q+
M:]:M)Y(:V<J.\B^27,;H'"6.9)S@K'$BLJDD92">CD(W"O0^J"^5PI;MHV.?
M@P \$DO/3T@FO3+<&Q3@+_$EK0MDWK5^JU<-2U17BPC4;U K1:I;BF?RSL<.
MXOD&J5?TYQYY#'R?QJ6\P8:\P8]>)HPW4=OND@LFUE1$+HC&[O>D1/(E2B I
ME\F).[K-5N>G#J<JGV/8@5,I88?]I>*J)#2D6N57DA(8V;E8SB6220=EL/BU
M.W6Q*V>1#:@>,=F-5P#[*MI\W;2N;>#'Q[Z/\DV@ER8"F**VBBG(D!$:HE$2
M!!FB^2S)QE=",=O^!0;^0WW7"CTK"GH\ 7$X&9F&E,O#D8)FW4(#@4+0R)3]
M%&FXJ+(]IF7R'K'!=H)Q73[DL-G?8X )A__B>R0'H2\?T?B6F\&#;?*2J8%_
M8U^9>C.G.?M/S'+_3RNT%^QL_A($G#4!BPYG3QM3^'1I P8'+!D<+6D>U91J
MITNF!B6B?.A)W-#=,KHHK(W@\ CL:^CLSA;3>7%),P:>'Y 7IL+IL&]M1*U4
MWXIBN2S[XW.\1WKSF'4<2 ]>@#_TYM:(=!T]1[KN(](UV'X.==W[ ;G;Q8<.
MX-8-;]0MR/>_U_J[K2 R]"K]6S)6:\?AUH6//@15#)$4$" =,0 0X4!4.4-7
M!+B=^UX< ?YZCNYYY>P/50[5&NT+/UH-!V]OV+Z)X4O36M[H$,JNLF)*V(L-
M90AB$$N1GZ&U@6:+W&W!3/6 =\!<-+H9QM\R0=*6,RE<%G/1=&1I;?4J<C*!
M4I_6'WRCRC52(4POJ-*:$3,7Y1'7R/(JSQZ@*8/V4\_0XK!<!("J"U<Y2?/N
M&H$)3M63T A6V0H#R'-S"M=3LPH&9!6\X8IL<.3@\6Z-F<1DA['04;_@Z[MU
M]8R+ JE<6:8D2AFLK5VQW>?0TO:;?4'OJ>\>S&/:BBL7$&\W-43SWID,3X5;
M'+8=H]C7JN[>="QM9R9!A]FE'WS_N3:6428>\"J!,5?5@2$'J#P-,HZ'Q;_>
M:YP&CPX7UC"$$A+.!0'G?R..G./)I)@66($75MF9=JYK8X=6Q4R9J;J.L( $
MSPDJ+JGP735TD.N.\:;P"=S/65TT+E1EAVLG[[RN%I?@H,3ORP(VP'(448F^
M-Z V^1#\"FD3>!W\+2IUZ'@%=QX*I<,MPW6DW82UE9B07 B&1=!W!X,6<M10
M?6%[VYF>;2?(BN1"6+*I\9H&';-&_\2C/]S#S6B50<TB=0**Q81&JO,@N4DA
MDM6<*^- %^*8BSI/%?'8VQ[4F;5;[4+5-W;7Y9!<A&2MYUG!7M*J0?A#1C'$
M>B#:&@:#< VYBC!+X)*#JM1(075(H\4,(26OI$ 8]Q05&S62);V@\BJKHY4C
M</I@"\Q7#XN;OQA7UR[_'8*N<R*TGTP7H_F"KNH"^?-R.\L<.AS=>/0S*#MD
M %3D?[<?U^><K(+^,VBG)JUQG- X[(K]AZLDZLI*W%G#1D+7 OPUV;C91!J,
M*YA,>ZP5>BJKVQY"#H.G[B^ZGKD2ZC^;7CL'M<O.7AT2?-%Y'@,9UIR"IT-[
M'8RLGCZ%0V]G2>0E,"$/FV)<0)=< 0@(T1!O0'+>J_I3XSJ,H36WX[B630(R
M3L=M>=@>T2%4BNU.\F->VOT[33XXX^41C62%7K3#[FXZ"T5I+;ER7E?3IZ(2
MO66@CRM7-T9#-8@DCD/M""/9<[,(BR:2RBHUYU164J4AR'-;A(;);QL^NU4D
M )[K31"U&.6R<FLQN]15\ZX^78?565GG@V6%RU6!4))HUKOJ5GOX[0>O2%S3
M#Q4T9L_#)G@89XI>QL5L0^C$O,B0T$/"I:07>-CH5E=?L;@/2>\4:$HW5ZIA
M>X=*/S3P=&&G6\!A5'EW#^5J1S-TTR".N40RF)@/U;G9+!\7Q".(N7'&Q5<@
MY,O%5K2R7L+%/$ZP:Q:E1[#NZ$8,<3H'.)/N46R^PAO/A"XC3)>RV]=>QL7(
M9S_#QWH9N,F.'DC O(UJC[<[_&DG>=E0#0_UEL.#QL/176WV3*%_PDTG^4IX
M<P%&Z!4?H7GV2:.,!7"A<=3=&[TK7$WDT0-D7[L;D%$^3H!]Y6+SJ>&D-DYH
MZ\Y2TR>]#D^F[7H 50M?2GH1Z&0P6CA,B+6:>N6[(:0.VR[.E7&-Y@J? 34Q
M!$V ,FS;%->!Z6D-O5A119JU(:P(SJ;B3.."\S!/P8<B3>"XM9,/0T+'%RN#
M5P]5'WCHS:T.?1UN/X>^[B7T-7@.?=W[ ;F53?VV?6/ZS#&Y&WS0(T1J @E'
M-B2(-2L(\6:33PA4NPT-7B?VGAKKV)D87PH/B3&]%6P)&KCT.];V,%J6-;[X
MN\ZK^CPKV3)-K?UI[=@Z960,/.3\#>AZ"*' 6C^'-7SEKQZST6/N>.DHNRSF
MSB"&G)/1%(H2)ESED;K78)B/=!6!/&PNK2X'S]A3WN3AA_9^&GK^1N.GR^/Q
M*?P%[@8UX?QVT^)3'J+M,_L"PHJC/X0R8D7/XQO5%S"C#^^:</ORWS,H\C>4
MXCU7W_C,'WJ;XQ+UEW$/#KT _%-X##\)5!BOVY/:WD"PC[6O()K@L8XDT96V
M8%=Z-2:G=2DH"HE):;R;H"H5\S"V1]J1T=J1'TB0RX?.E50#4Z2!4J77H>7!
MF_L,;9CV]N'QQ\8PNR@>:68YC,'RW>]OM..[P\A:>YGL_T"A0"5+1:EB((K/
M*VC/;A286VG?03^%JF<'$)2=M]*QK\H,11-$%53"SDA '9B:9KJ![L]$H=S;
MV</YC-._T0FM:S]4LC=UQ1JY8W6X4?-K1*Q849=?9U,N8Z)%,.3E)<R<0L 5
MI-@B'XL>[LY,AK0-]/ #51+OYFK!$-1'[_^&,WSB*AV>BLL%:HS)8T;!T!.!
MIC*WQ<XM/!J;"R#XRA ^"HX+%R.H4'KS0JHP//E*7E\A-R6^S;A, ]CK ,@X
MSB]S' ::2D!H5M5Q\Y0K[(Q2N2BDWJHS2;T?NH)A=HWV./B1$(BN CG,2.I9
M>3!9U'@OV.]&]$-R:3SZG3/$G?-S#H$K,(6M\6LOCYY2U(Y(%BS"N34K2T#9
MIC8R:B.D!HEYH=6&0H2WIG%?\;99MX1MTJ*%DO06,-^S5K_29+P [FZ*T/V'
MLZ(H8A71"&';,W!\@0.1^P4^NZ88?4)_/G)EBS<2)X2[TL=,!*=K?I$KK8 H
MS+"3X\H. 50<,//MHT?;@%TL89(B&(Z1:29.&6;G=$^L/T8G%-"C$)]AE5ZL
ME@R*(A<9IDSE8\/\[E#R8[6Q!8/V\9%.0X<N5^XMV0\=E'#KTF69I7+-I5J-
M\UC/"+J8X<FF=R%$$2G2X:9MJF1:072JT0$;<?DTAIU8I9O1R(YY]()CM$FI
M.=D<O9EO'),>R0YW_=P:NOU+7S^&8Z5WO'X"VVO<'FY7.4QWRH#1O)(@F_P@
M@HH!1FMT4])P4"$; <]W33>5*_H'B&'[7X\L045\KZ0FBT(!!$1,4(C.P(4*
MVXS.T[R:B_YXHUXT]GATT*MDNIC9';:8Q;DA_M]^R4 6P/Q9I<3JK456%V0Y
M. #/C-#P(DT=A7KJM@@+.9&3D=2(:XA<S_E[Z7W: 9/@1C9>L#PPRKD+U0XS
M4A!F* (UD)FB$B6A'PSR$1_MMO*,P/ 87^!L5$SDL0/_Z#9OI$LG[RJP@;"<
MCW6P" Y4-KBOZ+4:EH?4TY=3*R^U"Y0V]0[W"3E[V-*Q6Y[R+N0;>K%+!+CQ
MUYMSUG-?29IT=(?+9>%\^T0GC..!$Q/<3C(^<%)$19=K-H?'R\VO[XX.0\D@
MO$PAZQ-Q>!DF (T_5R^5)CY4TI47#.VH]V0.Z'*8SZ\!XDV_M@WQBTLJ0S!/
MYK9K'PG$]7Z'Z2BYMRB_1Q$ @O<=WB8!RX8+,D6VF:(7&N;3ZAI]#[Q51*K,
MNY65,(<0HL2CXI*\ \;W+ 7\T5R ANF"O;BY!*DEKH0VXK!'(R;0DIK0(6I.
MTO%H%YD]DK/+L ,(MXBOMQLR1#GV+\[7>2T=97JGCWZ[T5]5Q1B9NUOSY<L/
MV-JC\VAW0XFR.K%;%,0W*.X4#M2IF.-\."<4)]0)FA1_#NO(%YA5$SPE\P<"
M#M'PT'A1<5^:K437*QA6,0DTQH/(],''*-"8;J 2^Q&YQ!V1%2OC5]5T8<5O
M74SQ<-JG73H8& _3[-H%$\&?6DP=$JG]JB%=IQD)S.U8&=$)V5NJJ/#?"[OB
MZ.L<V]O1'J(1IPS2K8P: OHB%?"T?< )"=$BW-+J\"ARWP10H&W#,.G%-NFI
M;L#Z> (7J6IAO2*YK;RX[!Z;+XIYM6A\_7F0@QFBE%(\0AZ6#<G"U7D=DDDV
M@X69Y;"X*?]I['5%4>+ !ZU3>SL:#H7R7U 0][V):BS@N@GOH>MJ,477AY3%
MP@5/6-L_0"7-V8N72@B=^8C)\6CN^D2T*U[WHA,[U8:/#W#$A;0TE_(7.*DK
MJ/61*6<[+\XH>"N8RMRJY$1@(S0H/G!TF@E5!ARN'HAC9P SOK>ST[VMV/%#
M_@>WK<*P!K^#L3[&7(Q;G9?6\O90(;3?,)5)-A)A79!B"T9!UO3]U!<_9XT)
M6-QUI@P*3T8+BME",K3_YWFI2$D22M&<$90U91N-%,9Q5=_$S8 F58!F<JX2
M8.->8EUQM2C)A/8J]\J,9BA]YE*T1N=8.HV%,QZL>,FOB((8E7987ON5B! *
M(^6^KHT:\]X0WV$KH'^0M'2X400(:5PMAG.XCCMU65U]# J!XQ-D]P;N .::
MSY(> I<'JA0]].;6R,08/&=BW$LFQLYS)L:]'Y"[V31()_&F&N&U@%<XN_$\
M6JC7SC#D,B)9B/(?[Y -OE]2PN>JJ]+J@1H29G,-Y OU/DIY1[';3=S0Q6"J
M#*J PM1AN(=4%VA$75Y2@B>IW'9/E^"C).H$N)6A;?M?0R':V*DO;NB&+B%K
M/V?L.U;3>[@QW'R@XOYN^^4@KLMT%C [P=C0S4B;P3*LB\KO(2FW=OIV9.-2
ML,D5:BH'VXVW],2IZ HD*,><@=E<W]I+":L#C@KPWSNU2#\!)1O+WNC<.BJ5
MH)2Z<\K0"*E$(+.F$TE.<@WTV_U)<VG3G+T (/O%5$&(LL6*7NF)4QZ;)Q;!
M/XPC^+#BQW!0GW($_U>7L6*4WX=]GG#5*?8%YRW$O [XB?T+0?%<HC1LM1!M
MH"L21O:]Q],#=1M2J$NP*0"74XSV$[<W@4Z%RB'=T1WF08]4W"/8N*W&D\[&
MY8"G_B0;/LDIB?#FDH0VIJGI$KB:\V9"V5[P46&?<]&XL*2 G/4 %>D!<F.&
M?TF>!D>BF<GN#"E)U(G&ZH<Q9TSI1E1R>Q(FMZ,=UVI8C&GA$*%+*G-65TR9
M&UB%[#C#[81)7W9KPHHL[/.S/!>@S%7MR(RJWQC7CZ+QMK&;US&G=DSR,99Y
M@2,.(D;@?Z(PT?EBJG+[",M:(&K1W'?%A+"T"ZO5X6[[]Z*:LQR]:>R%;-8!
M5^8UG192^@"MP )0TJ9;FTXP;I\[1N;XT('62EDE8SWC]@F-0!^MU+/+D-TX
M?8]>M%&*R2\J?\W!-7!.$,P^[NNP ,*#,6BAYSR==GK0$V1/$SDY@2JURO@#
M*B9SJ7S1J8'P*VR7&FNK3&'7HJA]H,:]7I$/04!%D>M!?(FS5S ZR\Y47#F5
M68DRMHMY8&\+'4]0"@B9N./%*#?DX>"$4DJB!)P:E28I'B[[)(!24!T1%/$X
M\;;TYPX3FY-4,(0*+\(42?O/*9JPJ:$#"#/MF"?CMJ2V)NHP5>$T"=]=0OG=
M&M5<5[?T#LNL-:P573D'Y@)-0-YBH&#(6TI6[6!+C>:,!4_OU$RDO"O(##KV
MI7VPES3 KCOK$#P-HN'V<?) T9TN,E[\F1K#YRZGZ';"31Q^QA\G.[T!9/==
M 9#O*N0-"?EF+0C]EI2W<SAF*:\JX.?9[]X+KY)4*#+BKB;PCNKA/6)!W5:Y
M7Z(Z"A7G&#4T'H;TU%W,C8?=X3K=C@A^3Q5@9Q 3 +W"Z4Z%( 7Q@-V+C=>S
M^.0TDJUU[OILY4JF,#=Y\443T<!4**%$,RLYE8[J+%1, ]43(FWA-DQO4,0^
M/SC:W?68')W#<#O=/QQL]Z:IK,5)LZJW=[RI38?J0GYME:86@ODW/#:,+?IA
MG,CKCT?SK@H.2B9O."4*E\E.' 9$K8ZC#S\\,\W/D8-3B0"D2JX2H&1'_M^L
M;XXAK9$([%=-<KS%D-O:2X HTZS)ZZ)#-*!L$R8D@E=7V'6AD<3YF$,<"=CC
ME!P%]LC4A9DA(& O5)P:'1F"!&,TX=$KT#/U3TJ4'($H^<VN$5QV]K@%R<6!
M#JRDB*?+7@*&!]EK>,_:^9?U#VZ\U9D31FT--D52-D1@D:<5$"K!A7#M!Q!*
M_>2'OL?T(] $))I%.-7B_TJ-0^!U2@R/Y+VK6[:Z!5;$R"\]UE1*57"7A0^_
M!JEQT0EI(Y>UT<UNBV4FI5)9R(_*.1)=L$(:^Z\36"AU+E<J64H3H4-"KY=3
M4G2$61"@5F(I9E,KPX!X_%JE%6M$E[I:G*.X-7H=51&4^+6)0(6'H0A[4UJI
M7J!HS=?).IU\XP*7FD_<'&SMK^-#?QLD!=#7DPQ(XC'?$_<*5>+5-0@<+@'K
M#OKR2R(RG8BN%'<@2EV,!BPY1GE+&.+DYM,X3QXOG[)] T618.-#Y?9YS&KI
M0OP;0^HK.H\([,\36ML_J;C-K>9X$2\D(@@016T.N2X)$SR' P5318]3M[[>
MF+N961\R)N"],:H>[CR'>.\EQ+O['.*]]V-R"S7,W@6NZF(BJ=<^"&J<GW%]
MY,/4(Y\A'![>&QQ=1<O9*7%-']XT:W8WR09E*X(//0/<N*G_"GIF>]&0F;^I
M+]X8?=I?H_R+6HK_*%[@<O5&X B2ZS;L:\H0V884M*)N.XG6R#O,EU6]:!^_
M2E&DTHM(Q337X*MA%PC0JN;0[47#&:;+YGQD[0]?0M;E:A;F-:K6@OL^T'!\
M6V9#H+]7/(-H?KC!Q)V/!CK>_] _J<_3:V5OX;J:\FTI 8XZC]1"=#?Y&#W-
M%*,/0$0%<,)IT>/)6::TRR3%2=1@\0M"=2J%H(LZA_+QR6)J#3=KN1FG=SL,
MB6)6 "K@D_4&#;8YYQT!+)OB"K'+?*VE=P2YB)9&5 M"9$'.I*_2@ 0*.9[H
M.]"L+J0(7MJCYK)OJ3$PX."-&KNA<%FA@8*KP13R&:''4K%]J(8[KS=('+(T
M%=06>A- F 2_L-\8<OBZ8X_.YBZ_ ;FM=,_8[<"9V^<4 X;R37\2JL 1B3G1
M8-H0R,0(R:N>V(Y#@,2/L"/PHD+5^-2KQF2'<M$%8$0B'BCMP^^IA.UR[EDM
MI=AH$9>6KE.32#Y?=OF)F8&@]X&-%:1_$O<0M##V?G-/*8HKETW57@T)!> )
M3,KG<S*W]EI)>#>,SYJ&90V((-%D4XP)!&U!?+<J%W@9BY4H>YVM&C95Q"ZB
M78N?",@$7/VUFPS.3^>"2R/9Z)>XQQF;%?TS5NL>]151N5JAN#(6T",]9 G.
M<Y", Z&:<3[*\6K2*V#67@$WM53KVS$74)\ F=(+*GY![-4,JE2$%[*#;)=&
M1QG)^'R8GN\XTE7YH*H5H='YN8]Z@.@GV V$C^2Y;P7B_TB%6 -$]OC5WLR8
MB.$OHG<L2O7$E"NVG3_$VEAO<KN!SJ7D5L?T>MQ*N,A(WZZS7K!5+GNE+4->
M,Q\?4/Y)A?UB/V/6E 6/DNE1'!A.<'!\79FNB!=,W9=]L9BJ@YJ3X#"EN?QW
MZ'PSO0GS*[4I@?E%KMA=P:%?57";&B<V.,!^-TY1ER\8)<")T2!I*-A0YT8P
MZVV$5.))?=PI@:R!=* $RW?R533*]';#8!$U5&5!$;GL@Z#6+,K5X:J[WHZS
M"NL6(4:6#'W@F"]K6)H.YU%5%Z6O< U<8%^ 3Q8PV#"HCHL2/1JJ.^V<"ND?
M*M@S?9$$>98WO=Y[5 UIXBGI%P?!>A-TS-X=54PJ( YJ?<'W3"3ZG=$C"T0U
MI)WAK=1I#4<!>"DRH090HV5M&+:' IX+5$ (B>4Y743: (O&$.N3ZQ?"Y;]#
ML"\HI5_6GZ(AJ*AF[I0O:$6D$)F!P8EX6C?+K@]_@_#Z.;OV)DZX&2G>C <A
M%0<_FS0,IE]341%QO.,9YPI+#&G.>?^]RZ^R<?:T9A$KI4]^SPEZMS'HCG$_
M.( (ZL^%A@U)WF)&"4P,E-.7K8IYMY\];)D$^QHNOF3R#(4<#9+<*V&5 ?W;
M6_UA?R0!505C@[I4*'>.AM'Y3% A6VJID\M\F V5,Z;Z:^7KZ%-977,9L$+N
MH9L&P4ZH)\RRS8/;C%1G/7$XG4@G>Q/-C8FHRZ!FNQ&G"H?"P_AJ$'NL6P%+
MNJ#;7' =R6>(KLT6OXG#I7(5^FN=>[@QP@MURL1UK*HA20QK2Z45I1ZY.Q6E
M27TKG8Z_@]$;S&.Z(C 3^,YVG+\>UM6GO'X!E=N8;@$:(5J4TIX\$N XDCF'
M]:C>\@Q]3UV[T'R+7;AE?SA"SI%S2)HL)J'6DR 4J3TQ=.'8'E\*+Y[&J/'0
M5:L2P$X70.]P,'RQ2Q&^* HL=3IJ_E)R OHNN9GPHA82OSF%FW.\PX+1*$>M
ME$*-2"-8TMFFPF4T>B,R!R'4C:K=2KM]I5AY6J(>"\@D4+WS<OO'H(:AP]_"
MT0ATSFM'"WLU6"?IQ" 1F;9!Q>Y.C=LD%5G"[Z8(W1H5VQYP*=<+QV?$:RFJ
M%6_U9$/R--46\8[-L !XL+_I@!>R*;-2S*MSA,AC5!;2]P5SJ')VD.Z,<A:X
MR$5@V/NQIBQ/M+$H0NHRLTK[!7S$[V.A9#:0ZFHB=<PR E@NG8O92E.;.R&^
MF7*143RGRGJ&5&9W_J9(ZS-WWI7:4#:N_8CC\\[596^8Q103OZPE"8E3RHW,
MCXOGI+V4D:U \9+ MP_F+#IF[=5"<$\N%_7HZ"@8/]HAT(#5\S.F8L#KA3()
MX)GPD,<SV$%B"5]KT,1:FA+0.C&2U"Z)]V20;!M"TH9>*'I_(*5&%0& 8%CO
MO*K&D!-B-Z8(:N,U!<@.<;G-$7680]L3/[WO4(%2E4ON*NXW7_8/5-@]].;6
M2(38?4Z$N)=$B+WG1(A[/R!WU%6P>#D*BAOBT/%6OC,PV;A<XDQ3@00%_>93
MT# 2HD*7RE^'>7@Q=G^3FI!50'EII$P!ZH+0_UE@-)M0^.'>$F9.H=!C781X
M"5+%29 #L)55=^F?8/<$U?K,+9@+WU 5$N7":]V[*%<]?VI!;RP[?@M2XA(R
M2CPJ NR/ZPIV!6M<##@3&Y/\<=/SN7/FPZT:?&5%JS,D SL&DQQ(83"A'XK-
M'TB;AX@9NBXYW3QBDPIZ+EJN#[=O\9N?U%*^E"-OE6<@7$6MIZ\6*0;ITS%B
M^PZ '(=4)0_0:C\MF*6-L-9<?10;U+$YBLC4Y8U16JZR5-H!7(TR.E>(S<I^
MZ91/'603JH31@ST:K>-IW&[QF%2E GD3IXONI6S7I00(K9E.'+"U-WW /:?Y
M,UPXH]MX@28WLLV-G<V-[S>1L$L7E07'H8_H5]3>R%EKD)FOKJPU X2B1$F"
MOK*(G5Z9;1N2-TX)"!)G9^)!-&>YCNZ":#$ND @&P;+$M HM']D39OF>"+)J
M,/5=%76/,_:<@N>S^#V9V;-W8<<V!1=^2=_[DO\Q>Z2=1PSL20>D81A6619\
M(YS5T"Z*UWL3)BB7EB&ER![Z#VQ+0JD_'#UN>5.GTW4T:' #S>BF+1DSC9.0
MSB5J&QXLGGI_QY$-[6$4<.)"0UQA%C)FNW9%C#G$'DV2HSZ0"%@\3B^W.UX9
M0BU+"4'<1.HJ21%YUEK4J9$089U#@15GV='(T<26]U%"55'["MQF=&&W^?2A
M&FJW$/L?U:$&]:I!3%4%.HUQM=KJ:!#PFE-<5<6K[:^]+R]<F*"<EV%M8H>I
MJ&8>>GKIP6U,Y+F V*HZ3^2N%!?/:CG<Y5-N25VHC!]7Q!'I$B8%2"_ Y8.T
M&6KE\6\,K0]@3=HQQVHS03 Z6PQ?P"($I3G@RO@1=@H&F"#X\NO6V1:C7EMQ
MONEM!A\&;D,..1C/@+76KM:+2WRCVP:DU\6L%KQ(Z'71Q8Q2$)F&5<L28KS*
MK,BR4OY?]F?-F,O!=&=IX_O.,;D2]PH3LS&C$]U!DH7;!$H&@W0AYVZVR7P6
M[>Q-?)]GI/?56_$!:%1(';3:QG@?$_KY.7$3H1>&F\+51/LVFW;76L%>5Q5;
MI8]N^U!%^_526Y7/O)_+Z#YL)<=8]N1G!J<KRO;N2A!D/O$HJ<0>3-17?(L2
M9+B$J H&O7Q=JJ:;<JP5>JE;.-V]@*6"@3NJ+@M5@N^[H:IAV<C5+S(NN8V)
M9YT<<BDYKJDG)4EV,#/Z9[_= 6XF"FIW8#HD+O^G,[G(WD'*T( P&-5P [5A
MG4.-7FH?F%@- ]"R'<-(C07O\R2B#Y2KGV&O.<PF18J<A.- F"\K!(U7B3AI
MY\4GM#>C:5;,TF1:-0HJ^T8J4NV]!*S?5DP1#VW+'M&#KJFKN%_4^(<">XT6
M%H^B*W^,7?_$><9;V.<PU4;RPQW^K5?"\]^M*)T3_H-&><G T0E*PBTFO^V)
MURMA8#/-2KNY\'1"Q-LJ'O6,PLAP^._P&@<(#O\>+XBZD)Q.!,7M TS9&!*
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M+1[3%LKIHG5B6, ]6OH1X7\* _#8-P8.!V? 4M=7E/OE'E8)0$E??U817T'
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M[EE\@2C>":;6-FPK\/@ZN$B C8E0&=AX@ 68X#0_\T)6R$8]H4@^Z'M4UTY
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MTCL$""0TZ8D(1&G7WQGWW/MR'L[YCSMN&>-^>\VG5?::>ZV]YOSVV'?+=YL
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M<RA1O(I6^"C_K#%_SM$H]%TBGZY^DF:7TO:W1WV_6_YM@7UM0MQ5_Z8QX]S
MLV;0U0AZ?;?C^KK&^]W ZTZ.1WW5]3TJ8 5HID?!<!%GYJYH!*S 4D[?]?.
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M'=1(:=(!JKJ7YPMD5RCZ\7QGA =<*YUSH,GW2*Y!!_ Z7[)/D@3X]JE\<(=
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MXG-1&;W==P/PX6Y.*;JD^:R+1AP*92A)"+3GSQU\'1+S<KY,.RV"F%6HYT]
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M0-]9 R;L?0%CM;_5W2L7U#JK:-:5@4'.U:N6&>E :BDCR?7O+8<F\K;M',]
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MP^6R/06F_BY69XCJ2YQ#2-RJWU6Z<&8 J3N76HTPE);%>F<CL;KPF!FVD@G
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M.!^<BV(S?G\R"53AP_D/)+R5FR:J1G_PI!D;-96T@KB^OWHV\[2&)_*$%OK
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MFU@2X\TUM%(TZFQ'=+9I9)C1^MA^K&XL6M']$'5/\XWN'<JF-U.W"D-AC0O
MN>TFY'R1\ZFI-O'XZ*J-UEXM+H(;&%8_JFM>ZFP57KOK5(QAP%\5_KPD#SR_
M'"SSH/T^OJGXQ2^;(B:SP[- :9S='/7N2V1SJ7O&(]/MS\X<75=JUR[-'3BM
M+^50?I,"O8;VKJ;I7X-8XP6TAXEBGKP1)KR#2WU[Q>H0U<]++6GG9:Q,M[D[
MP!E[RY2LP\&$C7"3#;30L-(CF*GU9#H",B-"'3WBJ>,)SH='+TZW!%<6R/P+
MKT/2S::D=421KQ;(2DE^DP&K:EA$,G\:[;V8&F(A^)AM>Z5R73Z<C376%_WB
M<*6KC5E]>HLRFB_IANA_1DP[Q3^]4IOY>L:=O7Z'-R_NO27<3^WX@"[#,D)9
M<E,UMEO@I_5#^ 2*\?+-_!.T64C1_N[3CHZS8U%1:Q8+5='M.SP"54*/A0/J
MB>"!I@D_51&[0R(6S^+.,)0UMFD'U&9R'.R=_=XZIPD7!2 CA]-Y/G#]YV>C
MW^UA]U1MS%9& CUW]$$BZ2=^IV6.(M$^A>^T[." )[MR=BGE@L*O[@VJWH5I
MXLJ_AK+,BC"AC,!/S%<L1GPZ6I(K-,.^K*P0)H5DT8V//I-X+")T43CK]%SK
MM6=0Z;4G/K(.QK[0'!RB(M]\Q>Z/2)?BH)_-*(I29\NFS'&2Y8WLR4(E..HF
M?HZ[?*HS[[K$;CP%GS=A(>3X'#>&78A&V!"[8G^J<$X+2XD(T@X*L<LLB6P\
MU>5W>WA?0I?_[I?/5.DP$5SGEJ,*>6,*7L,R2.I9,,AA%LD?(/K;G$ZOW8]%
MEG*T!Q3QQ*4O".[(G("]'>U6P8UW864F@/63'L)(O^F?FQ#1TSZ@>+;H0PEB
M4_,$-[N4$Z&="QNYE3&6.MNB<!6KF*VL01&^R_WIW:^L\+++@%S_2AN27^9H
M>?*WC>5+U<>1@Z(\,GPV(N0D VG\O"@)4B0_[FQSH"?\E@=L+8M]\59Y-V+4
ME+9B>J>EM:LE#L3Z"ZWSAUQ4$LR(7V$@XWGWO,UJXM?VZSE$,$5HGQ[[R\%E
MP\:4*N7F%2%A=^/(QX)?(^&OM L!D_=&6WL8NGGVF5BM8A*5R'C7TN!"><XS
MNMBU<NZED?N]PK0:"CHC/AR[%(W2(K2%M"[D6N,UN/)-ZWBL05_^PUE$KK[L
MP.5.R[D$Z"\ F[AN)5U-X&&NO;A5,)'Z_6NYE^V3JY9PH3UTG7\Y>FT8PCN
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MH7K0NZA0TK8NO!V&76.P$1^#B@=5=I>';)*!?N23B(J<D+0V9D(:1VE,F'?
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MD>"#8?A8]ZKRY9/'_@:QH=134E4A!H8XDUB[LA4UT4)DQZQ=$HN=Z'L>4V=
M(<C>ZNN6Q,-]E*KTM=!-SJW M?R<DF3ERIHKZ]'@^W-#D=+Y!JXJ#:*D0M<
M/8[\3B:FE(S8-(U3>=#'9M?]@J:P?J$>"JCGR^;NR<-:&*>32YGK@LF?4U(Q
M[GC#QG90J82%3KWN]J+6G:B\P$Z7< F"7Z(-.+:^?/:F&8_?-G1[:*>R,H*&
M_+-7<?2=A'>4RIP)3ED,1O*+YTNFKD,PR31NZ):,4FBR[NQO9=X6-QF3P"D]
MZ73'A!=Q \7R)LRV"IS/S^I88$JXC/.*CL$LR&>W/Y?)\# ,QVS-[^4E6L4
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MTG00Z93MCGAF+[[TPEWCC=+,6"#M-J8;O8.KN+Z5 #'#N&YQIDRU=08X/<O
MS;BM,^HYU$<Z\9<+D14$]'*G@,21Y KEK2J(5*.P)3Z":3J63GRO3@KJ9?&R
M8:8PC&'#]CR*)M,W=8Q$M!=VH'T&\OD1/-?URC9P]MT+3[#Y5I-A:V-YYL"\
M*I*SPS2R')E!]WK>,$:.Y>_C-LC1"_6Q0VC?,':)]*"&T-T<Z.9&8L-:>SZH
M;ZYKK6V81)O [>YGL,79^T1)J3]M%M9\OW'WY=?$OF>#D* ;WE#XL_$]H"'^
MJ(/3,=95<:I]R?E"8=*I&97D6M *CU7OHC"P_DGS:\BZ.=!&_0&9\,P>BWH.
M/FRUVTS%/81E3:7E6[)2CDBC@JPY^DB3@:W:P#$)# Q$^,3F"MUYGO/9[DOC
M>;FWA$RH'$FW$<]DB7!DOFM UUW\_&G4L58RS8^7[=VB@]?_[%]S/R18JQ?B
M=SI5:&<PMN'^]-ASSP?)S^NFK_^)\/<LH=F);G@HQ5V]7], 2_P:^X+C,TOL
M6X"PCE<0A0S)"5=:0G+"'W3XG.H4_:K/:X+'*:H6QR2!:T4<*I7>_'!PX'_<
M: 9(I34':-S&M^U)X/A893[NNUW)F+,6"?!4>6URB04QPP(YH'D-Q6C@ANNE
MB3C1%'#O#_QMH;YY)"%SP77CX(*%GB1Y"2 ^R+\$?-3JFVL^LSV7V;/1V<LV
M2T3U'[5Y;L 628$V$C4S:!J<E'*7O!4"AKWB/T4:JM\44]#RW_1LMA;][@4U
MK-6]T/'N%_&R:582"9WI5#=W7=/PR[M_3DH' N1MB1!LBWP[TFVZ9A[2JCH%
M$] ^XZ\W XO61K%^ZJFC[4K5H(9VA=_FG ZJ$RXO7+'E(GZ@(TL*ND%\*^5R
M8-2(9FBR2D;46.@]X)/*\U,R)KZ$V]/:28-JW;]BGE2489PYI2MR$8'W^"PG
M:RMN94:D#9)= D9'YH(;J9D$J^S8A+[O2PRVBA)MOW=4(-:<^>A(@L5;@=*H
M#S.FZ#8"="^V.Y?[C:^&/JV/7)F#5A.%OES'M03$C4!.U]9[A*[6DE40&=&G
M>UJ3O:5AC 0K,?CU5S6;7FG00I-N>*8;..X3DOCE^FW*G\L8+F-B'S[<DI"=
M@C5PC=YA?08KW#KMP=BU#!6P27%[?G[^I_17K?"CEP9,8FX.H=;T)Y\F_>$\
M4R,A)*[S_*(>!Y&*:YC6KZ>>BY#M;H4405<?AR3]UXU4\76/'L99^_\H;7R%
MM64FR4_*N 7R$>G;BS2]ZF)%)H%@/ZA"'I<Y<A0MT.YM:H[3^T/-7MT9&H=@
M5X']7#2P@=%O+@D2@[#G3!T9UB$0B,=5"GFV8]_6^U%(S;$.+^\QL#Z\+ISF
M3GU/] -9/"Y^7GQ EVB$K> QWV0]G-VYX,]\@+J8F@KLH*6J'HSV!+8^_^O\
MD/\S5)6<%PQ3!OJ>F8$^M-(2M7J"\+%S"Z (H=1[N^6*(=>,JI=P7F? )2V.
MP4N $PW@3K93%J^/$PLHJI5Z429&%#UZP86P?3YAUQAV,E1'S[EM*L:]_3JA
M/U5VSN :_<;#1N=A*_+F@^KIU&3\B-D,_P1:#9<3SLM0B__$N-QOVM.%0E50
M-T5A15Z\WWUMJLMFW%/9^SU2M)>BRQ(0HG]>\&U&1G&>2TKT8=.4E+^N:%B9
MUZR_9NOF<-)PML,V3=#Q0S&H9'2\0G4<&=#DW&DUKN4J+GMS%?ZB+Z?5V5@O
M ?A$(RA2M9;"A)'!!>G6YDQ-T[UKU3' 8MUI:EJ'#S(;A]6U@#JRJ<>]#?\Y
MW8)-0\$XD2K8O4:97T!"IY0C:_7?P5_^<A0PM)ZDAH)1R&E]!2Y "<9,Y-*N
MGU@UG][>GL'=1!8;O.&7$N)S1J6."Z$E^ %<X:^_(X9'"\@IL0=['F7^3ZK&
MVBK]^?(6E[>;8GQDW0@2=5^TRT1;G->SW/K $=. "BJ=&PY&.<4\?]I!<<OX
M>N^/<3P\"@%R.[JUTUY'05X[ 7!:O*;,YP1?=?##,$\FE<?K]H]9N#[-2.!R
MWL.?;J=.7W 1?;_J%T"J++6*EG+X7##:L^92ZZ'*PBWY*Q\;LZ667-D,,T?Z
MOV=> NA)U#@UMIY4SKH_[X&*>6"MUQA[SZVEJY+LSG&MOLM?6YW:?4? 5.D$
M^]%1G<EC08>*LFI,FYGJ3EX4X/_/65<7<^'E'R.1EVVKLS5,2-5%2_@TQ=;Y
M64A+]7^5W#:^+^B6<HV\^8/FSRU;Z>7 .5X%O%&(0H!9U]--,^5W?SHRV]BW
M!O(WX0?<\$PIS/32R^I^4_Z-7J&4*!F:(]&@*D4I]66SB?(RZ=4CJ'N>LTB\
MAW7OCU+:D,0$HT?8-2+EBGYM<\#]8\FY>>)K(XH>OGG1OU[I+"Q[-1OV:P]S
MT**#?Q'N3S1SU!"E)PW$T&\[F%I6C$UD$0+V.+77A5>D85P&MG?<F?FHKID"
M=T?X)LMZMC;CFJ0K^P+[EYE79Z:!$^H"1,%2?U!T^\FI2 5]A-2!.UW=\5OT
MS!Z-)=776N<U,OL$*W4:B?@41+?A.XK&,VF2 H%Y)LG669G^9%G2NH>UPH\6
M+L&#-MU,RGO,^O P-_)1I;C/V@=]4503GC?$%V=(;I/\1/.[L](?U@RWL>:\
M^:Y[,8_>,W^\'6'''1*+MA.]S7?;.G!A26'<'T*@?Q+ I3FUI\"%-!['8"1<
M2\6@Z"QC'O5Q_:)$S/VQ)6^9M>*YJAK4;3/O52.,!$ZF?9;D5$2,FF]O2JW!
M6JL^(7!/;%6-7&_9SU3L3!AQCQ3JRF_B!?O:UT@DY;\<>M?U9W<>/V^<X2L#
ME*$;R[9^!$EUC<P2=OU#[]MB@ UI*KTN2-5_X_KM%^]L=X?PRWK5K)4(W_7X
MO9.F3_'PXD4K ^!T9V:0DKZP4^J]/N'7;\="0E#O-9P1$X$3EP"F-BP3'A0)
M!:IBSVV-B!'5%L2W-+(B>RH7^A9(QE.C>Z5%<R'H5G-3LP_:JX*\I01*G&@,
MLE4 88;]]7$XA"VBCDY\U;QUJJ[4-WO\WDO$:X<HJG53)_CG6[0YXB6BWE[U
M('(2T[?YK>F3)IEDV+>=:D3J,$M3S@!J4HB1,H4MD,4H2V:_9_]P;6]$T0G'
MU\Y'37IQ,1S$"$FRMMH:W'/RA?BJI4RUXLD_9E/J,]\E%^>B)+^-"P9&K_S:
MTRWVUSG_"G18\6N&RIQ1/DJLG:=[-(!(@CY8NC>TX$[#4)OVJ2=8'>PKIU_!
M0X2>N9.,B*%8A BJ!I]S$KO^)WS7%+\%K_QIIU3H+40AQI^T CPSN?;!?(&_
MCSL[QY!H=F)&?+82H*4QZ<5W#8(Q+<T=_L/ZKK Q$09O:FK+]&@>_,*2^-/"
MHD?M'GNIQYD02;QA?-?K2AKH.(9-=P]/MR^ 768JT1[@QQ-@TM;=UV.]N_UK
M!UP1P_>^*MRGTSI)(.BDG0']7Q"LN]/S*V+\*0-\"Y]4_JV&S#S_(?!*H'P%
MR^%HE>M?2L&!:PH*S6%':^)&8EI5\$&14F5>;./V*<<MPF7N@LU-518/(?[2
M'.B2O&3!]5C-F(0R_?(Z=0HB)R@,?L4_JZ,"T>UF6P*+L[H*WV>XYCUK^KD&
MG>SZWL['(RWQ!^V@&PBS[@Q4M->>DC:!M;B"9^AWU]H?6H:"(\Y[T[H.H338
M*!T6?<#J>PV^NXBBD[5_?>M6]D>=^D1? JB5PU9G="/VIL4>BBG6;D&+"@2'
M^B/7&^H]DY9O)_-$'-N&7P)JX]IPC8$,YLOF$!],?5OI-H8M$KER<P#B;>?J
M(1CPY>">*>+9>^C?.,UAW_+53K[J2T#[ 0LBTV+F=SR5I8M*:HTWQ+>XKG-"
M0?DMF%_/OQ?^U^VK;#\+YM?UD%M41:#=9'PN[A#I+W$>>V.;_GL/:WCQXE8)
MW<"/V[X"8-^GNDW"-QZ\Y%T5RB#7ZG$X+U$7=>65(SQ)SK4@ZMSS!_%%P@JM
M'RVM<64&R#\UL(_1JWG/U:3^.-3BK?HFCYI\IRTW6AM'$_311YVR>OSXW!;'
MFB52P3,286SQM1(5AQ%;I/6HA0J%CV@#5(Y?OS--^;,;CL]Y_L7 &YO^#?K'
M6(_+K'4>A'%DLI(L_?7ZA2_@=1S'6TJ6.<0JEOYCH,"6BF-6N?..5&LJSE"M
M[%=JOZL23<T?N1^]A-@B=Y9@P1 -/NEM$,HLLI;'3Z]^"@@JZ"C2A)6!$1].
MZ.7TD-)[,MJ?Y+O/>D[E1X1N:-'&*Q_X-ZH9O0^"!$6TJA!?X2X!C%NGTB'P
M[PB?'LVIS"=Q' G6\PM;IJB9*D&.)W.@@#L17][7D5.LE\[,GT")+J>V)S"2
M0/W J_/H?VF>FK+Q[UQBZQ;?8H))-7I1&[:_,\.T[#-*OUX,\MT$RI0%02"6
MBGLI/ZNB#1&XZ0I2I-1J#?C.%/:(A))P__X^W> -EVJK"[E6^GBK$G'@*5$U
MGV208W %$RD#<'TC6#\O>02%WSTL@WCP,T*9/GHWO%;7?EP^KK.-OP0 +I9Y
M%0B_/M2Y;GKQW)RQ&C]NN[4S8UJM*?NBLK;R@Q_UC<AJX)Q[GNG]-<%@Y@3=
M.=-E^F,:HW "0D#M?A"6-=J 4VYK1+#I/$9[+2*:T3Q>9KWOOGKC1D,\_45_
M&PU0"E(&A@2R&)C7!=!?,#3OVBQ491IAGO<MC#.J/X]="5_Q7[A!KO6#!#WS
M<HWTA=*'(LOLZJ&J#_RBL^PZFK*)[C"8T(>5PM;-]6P%;1W-6\*9;VA[WIOA
M=/?Z5NG#X-G"]>C*,1ED&4G>*:!HAZYPR4);I$3%0/*-X;7QOXEEB>!A$_/2
ML/AK21U\^L3FDS=$W]7(W#3ST<)LA-ONKD &W:/])3UL;<IZ_8VQ1X6/] 7O
MOH$S^HJ2LRC&S\&P:1%>='8Z4_[W18I>E6DZ0 -.AI[L0QP-='SJSW<>V=.&
M6:B__/E9EE8/%SPZ3!PCA-L2802F'TTN6G8%1%73S(%)M'Z)^8+U@V2./+T]
M\@?;4DL:!_46;],!=DC$:>"<C?BD@I[0)2 *WC%D5[2M,EQ3:K,%GSDA6':5
M+LQJ5,V#[Z<)@>7[^%^7S "XZ0M)$'Q:>QN#(E3P&>%FEDBA>HKX$)3)YDGJ
M^M3T0SF-.,%,U^^5C!( '>VWF)'=4CS*=G2W-G.$-BAW+KHSNG=2^FO:0%/Z
M1F/D>IP)/$I?R$>VAOD7>P\S&7;T8G[I]M4$E>Z-]:T=XH>ZH^T*-RU%\M<>
MEP2X2J:6OKL[_H]HK,QM[TU9T3L^7U /SLO4!1')[2-!3LJA$\;-!.N*,"32
M"3]=D("AKKLOV5GQ9N8?U?PZ\I30L'$]-UZ)36J08UO8H6(T*LQ.QJZB"^?G
M>/;B+&_2+N[>^$O_X??\$;Y!;W:OE0"G;4ERMAWTN\V+"LY-2;/62])?IW=P
M/'I"<!K9+P94;'R-,,7T(]XE0[+<7MO R8SP4)#3)2#RXBY!*BZ3/A)(7[RX
M:2R<V6QA:_,UOM>Y@P?+4Q0AMR_9X/$EZI>_Q9DM(K-]F>R"CSA7JZ:T8]E,
M$'!>$IF CNNSWK'[L.&7+O7F[\*81G5/0]N P =JQ3W/P.%+P$UW?Y8BXH.@
M&Q8+")?N<^^'$XZ^O&+EFG8;1JDB*TF=B=+X'@Y*<H8M4$U0A_4UG0S;C[O'
M\\Z_4PC7?$QA0DI5RU+-X$C3ZZ\X-T0<[C#S#S]*'B++77DGL_>*(-C=9),2
M@.T%\CY#JU40DW[M55I1[;^:^*U3&W>OP(+ @*BO\KFI;+]"_GXK\"YQ'K?X
MNF>E"B_$*9WE36!4;K@JGSB,Z\?Z&,C(NY*(@IC]OTI,P_)?/**F+@%A:D3=
M\_@\B%9[7(9[+%0M*RO/!57*CLKV]%"0NY/))/@(SI+\9E,V^+IW*X@HNC(2
M.?U.JBA"(5TX1-L1JN8&*Y<TK-\<?,P\WQL.B4G!('X*,I,=?;A84D:I5+1O
MYH]YS?M!GU!+DVQX'3]MC=)I>TVF+G8 !DYB#[E+ [?>@M!L/7RU:5W+9"Y+
MRO6M3?@7TTM\A)N)7R6OGI/";V%)2[; SC2W0U^/P8'UKPN[%*"F@,RGYPGJ
MM-NI,Z,V_BIC[DF'XUR,#I'I*V%"L]'NG1O+Y$*?'S'V> @W(BMN78RH_T,P
M::UB+<RW,CRO\',J7C+@+8(SCUMA'B:"'PGI:^4+Z(2(ZSQ:6UL;Y>1EJPB<
MS&$ *HM&>7NRA2D&T2&T],>\#8T%"Y>V4&E]_H>EGZ^-)]/<CA:X;R>IWZU9
M4;[3-W\E41R4&B%E5L3 U:>M]7&8NY@PI)\W=]Y"C89CG'ZZB+UDIT)4)Z-O
MA=8H2;Z(^!9J"J9:C_UMT-W6="0M]$EA,.)CL0\_A:!MXMW&OFY](7+3J#M?
M-?^U5M16E>1$-"DC-N.Z]@N+B!HN;&:6K#EV^<3*/I>V664/&ZL!R3G?:]L^
M?33TPER^3Y'OAP(8_K7P&9LS-W[P=+I,F"#3H<;H^6JU1=<LZ63U<:7<XNS0
M>0&A9N DDC,H&RQ'7J#]9"0%7=TAJDM4)IB"6#5+B14_I[/Y\<-MQ7P,Q.0.
M4\R@<JQ4;]SVG;T,B??,HJ\7S8-;[7IB;RN=KRN?9VJ3-QX]7*;VAXO4% _D
M;6%@X?[\'KB*FRZ)B+<&=T(73.NK(.U/D[7A:YU5 5DS PRM_M]F];P%:4YB
MB18$UY[LNP29"*!BKN6"Y?Q6$M'U25VRI;DCNJ:I+E&ZP/S1WY<<^[?]^^24
M%*;:>8A!R#M?Z<,=S[^0H':$#_K>!X"*3A#55BN'.L\H3!A=#1&$SN]M?#82
M;P+>V*/.N#M^Z_TDXQJ](;$4K]MU(4+0;5=[K.6*XT +.[EC4H[;0;4C'CP7
MZ1*9OCR378*%=1VLM\,T"(S9SJ^.D<S71Q+560.'E6L0?-C --Q!V#NZEH-P
M?\V3+(V^0O/;J>1%1ER/!].4^9Q]OH!3$_ZZK=O9,>[V_O)W.%,B:1$CBTB2
MHUP=EM!/ZC03[@JNF2.,A?7Y1<OR\]7"_>"",\S=T8>ZGUFFONG,+H%OG/E$
M_?.K+Y",*$B@U"+F8$=N*<9.H<+W%<]<SXT,)^ONN$M+L?+12Q4\W]<1WW?T
MS4V#",>\:8K]6K4X!7(: AL1"X-P,"IG7C[\12$H]M7DA$7:DZAG)WR[IF&O
M"3V2QO=<BX*2$:K+@QVTR<<M5R\7[:8.(&E,>/^>.B#)\+:5:R&2+?7Z'$22
M]KVAQKXV?K[[M(EB8=MLNA%]DMJ5RMBQ,R/>P&'UVP10?*LPL75*"KJ__PUU
M,1"WR$C38KQ@8:GM 96:?3M 'O$K]K5XKCWL;A5[S\3D4S9U44+/[C*NC0W1
MZ1K(B[^>$PJ4<H("I[/9F\%,'BS]=9G U,#'>]>S)G>8"CQ+WH0)##/W-<"(
MOT[LI_F;9H3PMJ$*B_S2Z->G^=)?1BT"*@PY99)&4Q_<B'3RBZA\Q['8"TBM
M*'?^*NVO16 Z@1,.(NHJ&'9:R?&>""8C=<XIA7/5]D-K"TWNHP5=5^9>PGP_
M0?>7CI #9OYA:E5SRH+FB5$,Z.9O'K@UJJD)+^^O.0'N&"JR,$=V?0]RL-T7
M6K@$%.B]AY?$^%:Y)P*SV38JWN4%J]-.@AP/8FRXJO%)70[*T:O1W?&X+!>A
MR9<6I$WW@G^<'X_G)7J2Z_BP6L>S@BET>L;:Z"[8%F?]+6?0S_WLBF>=D\'"
M^[$%+DSS31 X"B;H\HI1Q%^U]FDOV(]NALGMMFK([E7L_N<%$WP"@=.8/U&M
M0OY>1$\\5\<%?S,^+ 4GH?_;&F8Z,0\=3!V+!'ERW313?_ZK2K*Q]QIW@.L%
M]2\\J+V9R9)P$*6 4CJRIM^C9^P@<WY%\\O@2$?]X5)F9MZ!U:I O;IP4+]!
M(,,E8+8P@%1>VG!>U.84$+1J%NU_O=PY[=2Z$?_=QHI&#>P'MK4"3AMWT!*^
M\^#YJAL"WQ9T_U"2U=1-D=F]CN?4\XXTP[%%9$AQLC1.+B#R_JF750ATZ;L_
M=U8G2\)F BK4[I=[7G#(G)@?24Y<L#ETGXUR3@5A[]<,KC1J/(__[&YJHUK"
MH^V#H=]-)B@;A..RIGY%HN5+MOD8:V,=>6Q XCA!)[@'E8&"/G[)G\%_YTB;
M2Z!WC6*8XA+0L3RGVFG#-.4O/8.IS_+C3<:IZ9HV3C&:@>>+W;U2:V+V;I6Y
M2KYE)G>?$F,/Y$[Y>I/+Z/QCD-.015UH%3&MW*8^CJ-.%H9K]J6+L-J7?P6"
MQW#O]SQRS#RCN1A1F7P'WKH:UNM*CZ=,X1.8^:[Z0YJNC^2RT2Y\=W6HI%"J
MFAQ=7G*!5WPV#13-WS2;:>688.O@Y>%D3??X%IES9H^<*FQO.66?>:T\^\-Y
MLF_P4.D *TG0W?5<E>%$-*UVRV]G\(7[:PLUI19!8(4+AE+UF0%"*FY*\S0/
MLUU49OM%'4UZOP0CIX-E%4&S6B<!8UY(P>>3@<*N]9SN5>N7 ,<E:T3YTCT8
MO-C^T#J!6OD?*LP33?:R$?J+'KX:T6A%*C<%4(PR9NAXG.IU_00) @%6WS=]
M^;VX()6?>\4SU&YV!DDL/?$BQ,ZT+X=@E-[[%FQ=R.(=$RD^7]Q6/A*P3+R.
M?O[WC>_--(^V)$_N/&#P1[DO4['@$Q^"-O*DM&RS>M-XNXJD;<L)F49Y&M#*
M@Z]<*DQ'96A'9HCTI;PW\6@__0+P9;:MLMV=4Z]SS=<EN#Y/-FORB5LVLF7'
M9$:FVSO/&:LU?P[7?0# )H8_=7E^QA XK&4\4;M*,#/E#,L7['* 7$V[ :A,
MKRW!ASN,T(&41!ZJIV_Z?QQ2E6)L=VU7SZ2X.B_X,@[:Y;<N)#],G&F]2 *'
M-8YO&)S-]W&.,]WD#O&MXREX0/LJZJ2DEGZVI\>2/LS? _O>&ZLZ!.K&1"\N
M;1^A-_[H&]4;B-,X''J(,53?6R#\?5N38/4R@5S[$O#!CT1+$"GYOM5D%.]O
M^-U%Y7'TS7PG!YRS8\;0\*YD;U4RARJ8+!@D=OS=S+8R9_>/G5^ DR=!W@K5
M7*F_UHQ*ZTK=$6[JX-27URN4^Z"0I/S:H\Y:_X= 2S@VOL.6SU^(D-HF%9N:
MZ8%5@UOJ1NNBIG@=)NQ\W1V;6I8E]0;0Z)=@_@3*MUK717G-". 3 4)\/-""
M0 F>^#W$9]0P#:H7&A>&?%MDLIG?JA^LN1,1C+Q>M^NFZ>8[EL"^=N>:TB6@
M4N:'P0@3_<V?!*9.>41PQTEB00\N@O.@_X>ZTR<FGX5;<#ONJ*5+0/CK?WUA
MR0WIX2.JV%XHVH3@>["P^ N&)=?I#&C:Q]](T/.I@JFP$C\_C^N'Z04Q S1Y
M\PT>G+[17# .:LX4JU3>WQKQB2#L;!L-:/,EH>?B9MHE(/;9E53N(EI< K0H
MXT!XKS:22VMS7G#CH2A)E0WK=$[+>^\2\'/\$D#X_N^69C->5YWDX7\XIOL?
MEJ?[5YVT-P>_:QN:<WP7L7H)H#2X!'07_X>IK?68AM5?I@N>:'S-11@]=]#*
M5A!QBN_?#4MWFN[0Y @$=50%L@:-_ER-)_'(7 (X\__-+@"N3>:Y9D3TD6D?
M.64'>EP"0@HO :LO_MVNHGSSJE-%_D<@XO_=TN3WXK\DR+\'PI0BYXS<GWP*
M;1* S>2+:+W=0A".<02W\"YWW=7W=0\NEA+B5RX>*!*B;VW-:\54A%Z((,S,
M\!6=(U%WMX)8]FKIC)\%K1H@>;D&!F"55X"R0X6I:68O+:#'NX08Y2UJ@&^+
MHT/[%LC&MVWQAD$?592RO(M=>,4)L;&A989J75/#Z,0N6A<:^6;V'R8 1OT5
M,G/8&57@2-7"PGQ;9XNWNY1]?10BL\L'B_,+770O5W)XG/^)\B#.3/' ]A^O
M3*C33U[YL=]!# O$]E.HT].ZJ0S<_C;B:YSG+TTH>Y:9"S)KJ)*?8K0K[(E$
MISI;8&>@$AX>19(M<[D0&I>);4@R=-H]?,R[[^KJ"ZU-,[;C.!RW'OGR*@&Z
MJ,%XQ3@_@8%4UEIY _1Q_L\4+&?I"OOX(@4<VB@$[]YEX#O0346*#N1\8MV4
M-ZUM(XK\^3GDSE$X@;;&G1%SL\$6-C.=#+TE"N[&>K-E3C?CRLJ*$C0I$VV"
M</1SRYVV5,<@>LCI):!354VP,V.ZBN_$M.%"<,H&MVJ1UC%N+E N8,<9_2/.
M88&\':=LPM##Y4;4Q8[$^&NM0F&/\4Z=#46-(2;3WB#&3097SO(<NIG,LN'*
M@K=E +!<K;++ 6! X:7_)O:'O/O1!?4!7MD(->W41/@5B?PZYG%>(K0D',K:
M(5L6,B("6@S<F[IP\R^C?R!NRQCT4U7]!D)9NV%:\1+ A2C5&H?6__USFA:!
M0WV0&F2 ZQ%"K6K$8[+UR5N>$XIV@PA^G8%\!)$<T9CC/1OHNY&^E@QKFZ,G
MX,SWWR#3I9XJ6C34]2V%HX<YX@-ON+,ZG$\.YAFY5"\![^&8@(V:\Y"31;!>
M'%=77<:&IL"VTN'UN#NOTI=T&!*BURLE7_#*.9/W'L.((E>)&&& ^#1E)^,N
M 6PN[Z"3K\%^ Z!;N@KR_)N].QRT],6*/+](3#DKK3EED%/#F1B2!?3[]C\Z
M-569G<^$_@C<I0U3D-U_\_7#O.8/0<51UV6*0!E$S9F9\54AE_8J#!GH)2HT
MMQ@?'K9O2FP1.JZ]G1.BYJE!_G -RV)P&& ^G*2EX54\_PR$E_B[C9*"\A"E
MCYW])2!.1<[OW-'N[AL9#.+ZO@HH;90V,'JCI]DM-V%E;_$P^"VG$8EI><6]
MI<1ZZ]0I'FA8O#RW?V:(+(I\E6JNU$]0.C;OL])G+GZK?NS>\N)]Q7^@N+GB
M?1N5(GTXB L=4+*M,ASM*5)U#24+F88__O.F0ZFF9+%'*+%:>DKL;4D#(TW/
M;0Z:Y&.Z?]2%"/!=)CPEEN03C\N)N"JRL*2]09^]4N)WFF?RM Y/>T,\.+CI
MGX''K@(K%\@\Q-F$B.X>CE&6D*XON/7NEO_W4U5<>,B!/_3K5KVIO!9,L1Y5
MN/WX*(DR#>I'NT]!]C>J6X-'3D>/>^8Z_A<6%.=U":!%%.D1E"/+;Z>]&,--
MO&ZMFJF0^06N3"[#Q$#E<NM\@;V?-1G$."*@[L[D_3#02D8;5>UL$KB-F=@_
MK9QTSV1C)I%<;Y?A%A/;DJ/#4Y4D#>Z,TBOJNK9%E'"B* %>*!*L;FT%$2X!
M0MD"D:83:Q:@=X^#FO]R@#=Z^G\<*TY!VJZK2RPL&3C@*J+TU::_CRW7YQ1M
MIYFN:RU;]I5H42Q6G"!RP^Y\%:2E6_@9!;NVLME6S1?GM1Q^^BVI]79=?=N4
M0M>X#-3,JC6[W9Q-RT#X=4RP;XY+U'WEW86JV-R&>8WN;3Z\H>U'2\/8H;V#
M*'\')P<HUQ6!=:,CN9\5"V=][@I]2B:4#6 >(?K,_+P$H+0<KM2%4XSZO(*4
M!TO;"2G0/E'LZ;CX7U]QFJ]";V@JBDN7[A-%5Q>?ZQ.D(]DZH^6_*9A9OC#\
MCL@@#&>CE-F0M&P,U96-D*_HJG"O71L9,4NUM9A3^G]MK N4QX]T&U2P(**-
M49-N;$:392\_N2K#C546;+N 9-!"39;O/;3Z# RR-Y^9QVOH9OU[T_B^=Q79
M&:(6;SYK]I(X(6IY@&F$IV0FX1$AUP1.L[[V/4W#2,,Z0-NM#Z^[VM+2%N58
M3QA"IUEF[4Y8S@WA5+'7JP<< L@5GD#GL"9)?O>3Z)>NN[Y]&+S'CS';W<&!
M^3B$FN!1R#UO:]'GZ"ER+9S$G#1=RS[2R3LR3_ ?I0_CAWQB*)W]W(NC^QJT
M5S1+%*EHEQ+OQIW\Z5*7JZE!Q19FX%9M'L8)/4MUM&,% .R3QXO^H]]:-,T$
M U]]7=[V0,2O\F9AH[.4VY^S?H#QV3I4K E0_?8+31!-I&EF.=39S/>VSHQ<
M+2(^PQ]UV? 2X[%@'KY.5-H2><+VN[WUH6]%\  ';W>8M/U$HK307_^YP"4;
M>QUH>[O<X,_N%=J*_\\F7)Z)HV\',<^2'A!82XH08=/3/5V67Z"05YZK/%IZ
M2;@U"$[XX=W\6V.9O@X,/8GBC4O,X&_OXEDA3:BHVF6:I<T<IET[%'XPYQ4A
MY5@E/(4Y07=MR&M0 %IEU#3W_)?$>I>G1YBQ+^"([S^ZNI'YE8R$D;CQ^VF>
M)2ZM,@2?]"++W"2_@9%;NK2R=[:']]AOJ/65*+1]"%0C1J[$,IF-J0O/NKZ+
MS1R4_-W,Q[*T#.;(>=Q8FW$N=$,CL5PH3-.-+(Z?.RI.N1)F@2:*(G>6 <=M
MUUPP0^=+2(I")U^UWR=M:D,=NJP%:9)MT#AV(9_#3]_YI!XEA(#NO ,<7DT.
M'^Q($B^I"/2QO< /BO^O\4(.Q(>IRX[Z&V&;*]A(VH9,FE"7.P?4A-CCMZX3
MRAA:"<Y[L5"+K+Q+P,/W4?=HY?SK* N)Z_@<'"P>Z'G]$O 1;7+^/E\WWVKN
MKX=K6JK]P@#,EQT>=F>.SRT)H]++P0,L.KL$B(S2J_]'U3S]5U=7#&2P,?2F
MY14C?)JP[!5HB%/SY<A]&X6UHFHU-AFK]+NK1E7>-/.S518OVJ.'O@2P;X^1
M%%!Q4$="G:'.OK,4]&4T%$T/OW\;G<9F9MS;//O7] VEJ@_22QU(5%M=9D*@
M.C/*<U9ILM3G<IO2'M2'6[34QV%VY[?ZW!VC) 4[J^=MY 4IC:75MZ1G 8>^
MH)4OEX#KN*FT1T$<Q"I%I?GZ/K3VK<_[%AQOLFWV33DB5A.9<K#WKMK@!T\2
M6WW<^@8A)UK  !RQ)^I$8-;0!F8"&S)E2>5+;N;/^XZ8^!".PSEG:B3+\=]&
MZB">V:U6B50IE2T+M&&Q=7W9:4#+],EG?7:'^M3][=F^?]QC&19HDW+K]T%.
MH"AERY0HEVP96V;(FVU.$TST)>#6,OC\R[Q:3'+_2SV,:EC*7I& &)7>@(38
M]7G 8-M_E*.MX963KB3^:84SOQUZ%D3W:?>&8BI-)M17*.Z%('_*1_N[@KDL
M=B^(!H3E;DXK']:<6PJE-(N\\X\G'!O&_9_[.[*E5O:.6QE=Q-?6=B.R#>#/
M6QXX:@8;C;51^?/#\9< +.PC6CY(4GX9PFG=$G,(9K1SBE,T?I%P4^Y>+S/5
MWX'_8OK[O\ (8T\B1Q'X=F?.+*Q(-].Z5-*BT?2EQ* S/YV+V;2AQHE'O5OK
M!UNU?XWM[Y#OWV+>'\$H'LI$@];OV-!> JI]12]2K$<I9U[\3S_55W](3+D$
MB$D1=2\!KU/^'#95E.^L&47:'B8M?PPZ$;,-DKCR^7W"$K)C;K@^29=E+O:C
MW./0,5L^,8?K!@"/!*J1XAU;8<TS4\3!3U,Q)&)X7GOZV-S_&7(3GD!TU4]=
MVE:%RBV=ZI>SC: =A#+-EV$FV@ETNV9\UC.]@=?/<]%<. D.2;0W'H<97')%
M[=9705C?:KZ">1<;%D:6&V&$Y/4]9!NBS"+ENM9HLRT8>\GV;*_>Q3F6'(>*
M\]?&(MET"<Q:VK[Y4,<S X37#BI*.^[%A]>!CJ8O;R04-?1NH)VN%$!]W+<V
M9B LEYAC5-LX?MRB\^?)!/38C_IE2ZK]5+)1?03PR/=Y.FV4Y4/9 K>[:^XL
M(_X<YTA_Y:)9EU9)@O('A5(9!AN+^84A;RR/^!UWWGXUD?Z3;8LE"RV5!^Z5
MQ1PY[J/%G4S6MN&!:B1* F7G54XI+4BJ43+,B&SSO"DIH5&WE .'U)6_I6_A
M%[_S!4>255M-:6F2HP +T2<G1%_%KL%G6]E"B5*U9SM]Y8(UH7GZ97O?&K/[
MOCS6:&#0%+P.$GQY:^VN8F[AQ91H5QL+D UKS=7!F9T#*=Y.X_0I]49JW_@K
MG?$B;8 VT+KC;C*?DU U,V:7;.'F,A!_T"/S87GV@J>%(-H1J^9>CI:%>7LB
MP42;854]Z*^)@P(P3&8HU8$.!GF7;;Z4J_]@-C! &0N+;^4C/2-&GN>_PO=;
M"W;Y"/8'N#Z;\,)ZNEW_POBPU>NY*A9Y\$_YPHIOU#R"EHR^JP+S2X<8F"T_
M<;S(9CSEW7)SFJ@I*"3FI+A7%]&2],_C4A%&"D9Y-\R+NSI.[9DY#*WBQ/D.
M&P#11"UR]/B D5AC4CL!VYAVLT9"_0>XHB.IHB0J/H6]-SOW#*9>;U#<Y@SO
MR*'>QA1>% 5@8SG_&+?5NM(,#,2JBXDTUCM@1O76WQ)25G*%&+K%C9@1E!V\
M]\:AQVT,1$_]F>,!7U9GMSH#]O)74=K&W[?C"K6N.P+>)[#''9,=S73DS&NX
MCIGS.&DV-:/;_+C8)=$@MSBZP8KOE.F.J5BM'P.%S17]A5HR<N[]WDL,Y^4D
MM=4!&?J^7(1N-QL<0_I#701!<?HK>5IITGKH_7&98=)ETC!&I.N]'>0*[;W]
MKE8=@&]IV4.NV7"-"S;7'0:.O$F5I>8_-'X8;@?MW]7?,.E99.RE(.<>M_T8
M2 $V1Z;]#.1E'5WF,;ZGDT+1B19B>DLQ2/TV_T_(QHIG%\"7/N02 (71[6#8
M0BL4C6ZZJJ@-USG9>0-=1HWH(EN2S'?'ONB577@^.'O$CZ$ZNN9TVWN9%@0Q
MI,2EMN1M*67PMN19N7(R$L.Z?A>_#!6M<[K1K#38-5LJD?#^0ZDTKC!8+;2B
M'41NOFBQ,(^0Z9C^HV0#J<N0$K^. (Y;6G\4,?-UE(HKC//,:"L@,G58WLR]
M?I&.791XTHJJCG\<MC'>?Z<P;DRV>M'B!0/CRBO*_KMW[Y#W NW.[!%V/[.5
M6O"=K4R$;\@ U^+6C EGS(,EG2'NNT/ 8*'0DX=I=UF%-<]7,%R4]--M;C!J
MY_H_9L;.@?S9[1QU0@8-K^OF@2I^+*T-VJ[!%U:2=[7$>^>X&+KU?AN"L3DA
MOP_DSXS:,WCS-VQB]2]FBK2D=RJC/JSL/T]_D"=]"6CY^.P+F0E,_2:1YFEK
M<TL37C=<&B8CG72R@8.*+*YE8.6KG5ZG.UD/A0%C>[*=R0>1(+<1JD5B>X<F
M)V6D(/C<%"HR_QPAU3H@E+A<&-+7>?'2J-;@QMK7>RE/U,WFD[]=+-E<1X?1
M1 ^1=ZFH%9P:G4R:L:76#R+=H=+2"3B)\)<C/%G39.2?X]YPT/AYDA3Q,6F)
MUJA0+]/F,'A3G,]$KG0R<.?-(<5\PAX0(O:JS\L4=)<B'8)O_IG*B!F 8GEN
M+('-C3&+V(E7SVD-N!,+G!^0O@MFV]^X1R,9DG]+ YC\Y+P6+8,XY;1&:'5C
M!+>3=A&_8X6E;/KHI@JK!\2!N3%0X?-Z3GY1VJ FC^'YBX53 ]>9F4,BW,SV
MVB7 <0NEI&SK%.HN[)H9W3LT&.<.;$#Z@,4HGG.%-#"D/K/9*2+QX5F37>GJ
MXC\ [SM!;_H70X\S$6/R"IX\7T4H#UZ%/0'%";E_IPKV9R!Z55OI <FP'L*=
M6][REP [L*-^0I4^^^[Z3SA__.WF=QF (<*?GEA*[$AL;?R-;1_+3TWU5=Q2
MWY"U'I_03DUQ<_DQM=%'.HYQNKT '8-_] 0:]MA.!O'JC;[?YKOLD ^\[[]F
ME3.\QB\MM19UJ+>OR<13A3H):,>>]-Y<^$HI..ZOB6][1-#ME*$E-C_+V, =
M=$2"3J#I# '98HZ&\:"%(YI=58\V9^Z]$86MUEN(F[C^BV';:T0?L,%984LS
M*D"$G*>K/<D4PN;(\U.4]JV.D0)9'S'Z) ,?_[&5"V'6D]%I&9>#S6& !&%2
M_R1U\>V3U9Z]>/.(_(N! ,4+DP6:$NLYB>9H@O)>S5?G"PZ"4JX=5BWPX.G8
M\=E\[Z[[4$ME8](0UJ 7'FG5/:JPA:X^9$&W*0/XO)KQ1N$PTGU7[%D6N4'#
MJ)0I,VK\6TTL\I5YU.</#\U</HHW:_!)C\6\S@71 \4Q816!_O+YF7NOF6 E
MU@$?9)1.!>[:I==O:/>PNT4!L*WL@6,8W2X0MZL-6S4>%:V0B10:8NFZ*/EV
MK=(UPMHN>U%:$*Z3I!Q00![RX47E3W7#PHN);+49H,EWYS=T%#_W@;  K)K*
MGZ>CL+R:VKC%"G8#J9\-#(N]6\YL Q][ZI8W!&_SY:-5\3/MO/23.4]'_27R
MG#-"YH4SK2$8+Z7#6BIF(>TQS3NY+ZX/ YZ]_U&B2!_>RCI5:S#$^:?#4FTC
MWL]#>'$ZQ^,5T_R(?",\956B+NM+JJ2.OM 5 -?IZ$]&">5(0E"[.O-%_VA&
M_^F&E/J),U2:4[4$5"=35IB]M#FPWL.7YBC\,-'B2ZJVT)%-+J'T)&5:G1L1
MWVEY,PU+O?]K'*J@^GOR6ZH8?Y/!GHEDAE#$HW(^6&;5Y_<M-U>8Q9*G1SIL
MJ5B"^6YL?M3D0<O2[VX&P;D9.5YJ_T68KSEZD8>^UOMYO^1W!1G1J3/CDTI<
M!791],4DOW:41/,\^[<4!@<+$Y,Y?8!>Q IYAP#J*1W ES7\S X![N2]/XX6
M=L4&L;=6>*I:+O]]IY=-Q_D*KOAMON]UXAA9!C7 2_HSQV+,ZE+I9UCH!5V
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MFT@4<^!KJ33<$%9U2DYSU5RV"^87GO.=7%9W=M^Q*$75!#:YH!N/84+04(O
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MAWS=56?J+IV*%S15':DS =[/.ILZ<(;ME!>VF9XW@'N54=@*,;"SD.WU:$1
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M2R5\TQ,>HO5BB]W$UG$O3C.I:?0^C9NK*1QE63<7-MI4^%OSJ@$YPFTQ[Z#
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M%=X-P Z'11['R<@+_S&Z,(J6Y.?+..?GO #??9FHY2)D__/%!N$F/@US5W"
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M:C/=1AVI8EZ'^A8\1Y6TFE@1(6QACTX2]@S%:FET/[(46!CVL)]-+MHY2[,
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M,.RS*H7EIH/.LX>:_KX<E/V&6C+*+\A>AE$4@AH&G_,4#LB&+XNC(G;S>6X
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M/TO'@')0K\3[CC>*?.O(\/NE6+J4* \$*+0TZ)/5@GO)-+2C^+OYFNGRTAW
M^9,#C98)/#B\>?,&'^RCO-T36E.0@7:"8&PVZZ-@(LR#+^8N*%Z(6#\AI_>H
M05XFZ:0KT"]5O4P>YXPW;(K-U6$,[DA;:>"<-)KO=O6*^BOZR1]BB2NV> 6[
M Z0D=(2PY,Q0[XT#G"7ZEM^5M7P38F=\XLBKS=>G B6.AMX!2 ;K<?%:TT_2
M\490ZL''BU'V36VY3)X<(XE?8H45EGX2)CXC7R6]VN]Z$C9NGE58U;/%)@%F
M"*ZQL5JIR/?TMPB)VV@"YLLX<@ELN03VT(V$Y@<IE!$J9-7M66+A/_)?6^&
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MRV!IW]R__*2S_!?*XUM+ZGZ[$]S?)=DA2YX9Q!.OD:L3J/4']2(\6-3'*@Z
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M;-*TQ.O<+G9I.^?R$^TZ%-C5UCWDD)1^^O83(XN1:SK%./=E("ZT^-<9**"
MXP[P(NO6ZLW;@DNT4]8!T+DEW<0YM9D^7N?Q=FH@[9^V(G*(V&4=S@J"VE]D
M#H_=[8S^>P!DS*7@N[A\G:%.P%.D_E4OS]?ST]ARQM,M>8A-=#@'@AOKNL _
MY3AGO ,=N@")>/T>30B()%7>^SJ61R!+JL^89= 6*#;^>OI__O Q*'*#\HH8
M08DA7AK+ Q,3&GH:U B98GJS+'OO5&+&1Q+KSY^*-_4BPR@Q;\H?7&94KFHH
M=7[.M6IMG1<]L8?# DU<[)+-S.RMAKYQ,CXL^@\@0)#1>%.GS PL6CZ0,S\L
M<LDL=U,2O44_\&I.B+NO<^FX5LTQ-@[U8!2E^F:B5A\VM4ZI*(;N5$":5\;9
M-B_*4*A)=UAHP;_FB%H_XWD[I%LJY.]U3L,@>>_;-CD2+W0MY6)(ZB<TFO .
MJ'T[Z@VQ 1)HN9*T))6"1J#>V\<O'B9FQ,]._=O9.B'.ZVW+7*WPA?:%4'"N
M?V>V=7=6X(AJ$FNZXDY9+ 32*MXF42CH [V74GP[8\V.U;AME2[S+0=5ES2Y
MFG]F,([SORGUP0SNE/:T93],3!<0V%65XR3?\M+ W6R$4P4Y'5HWS]4_*G07
M 0JC-+;E:,C2'S0F$W\&"GQI>"N0R+A-GJHAA^QN/HVX%K(/=*QT.2^'3,_^
M&?2NMEIY8,&D."J=,I:):$7;9B:)MVXQHNO^79],C.NOR?**=,P2++FPDI+K
M+&@[F87>N9F4J]7/)2=!.+[G/-(T5?Q>6C!>)XA8[T?KG(QV@@XK227R;[1C
M_IHT/3:%6^P9R,"<;BQ6/?K=3[QK/_X=6#SS1 W[>.K_8N^]HIKJHG#1("@@
MO?<B300"TJ6C2!.1HM30I!<#TH.$+KV#@(#2JS1I";T&D";2)4 @H9= @@B1
MYO4_Y_$^W#O.&&?<^W >ULL>^V&O/<OW?6O-,>>(>Q-'8F*RT)DPKR,LN#)^
MR_6)0 VEL4)<VH8#53MKG4Z8RQJQ9C7(%I83Y.L-]J4ZY#LV[2IX=.20H<"\
MKO6+B8$EFFUK^ _U]1:\9S-L:0=]F.=<7:F+;BMOG)<5_6QS0BXNY)2WCR$'
M;J=M_04D/"BS+MWB: +PTA*][VV%#WJL4?X%>.U>I%1C5*0G(H5RM*8EQ&_)
MP/7>5"$THS,G7E^6/(T.,GE3[PG'2J^KJ*X99KY:"!W+@RX:6:\L6]@8N'F^
MSG9< HZDT0GRW5$U4HKG%<)]FRKV_H=IXB=*[PO6S/.Q=,.9+07WYBPJ7#?I
M-44;"R6DI"I&/^;2\MVV8U*O"[F4@2K,95\H)=]Q@?6Z;78ULW]&+EN-2C^;
M$DN+?Z*<F_>D22K;(,?-.K'EULZ5Q/$M;;03GO%B+MM2&WF_-<BKY3(_,,$<
M[-B1[IBB,[^!H%,.[P@?])2R?KR]<5VK3!Z,\0#RZW7G6WGL-$:2SKZI+Q<5
M7*V%&[&%^3#Q/1RNZY*FM3C_0K94T[+00PV11UB^J*QPM^24AREFE]ZI\Z=L
MTGF:8U@KRIF[FAX-CW^6) K0N,46,?K?* >)V'<J8RMN-YS6JOZ=H*WLF1.,
M$ .YIR )4YIWQ\DFTV6YH&2:X6T BRKUE?V,JA3$=/S5UX3M@3^'=9[',N/C
M;NB,Y:DXG2(V!PT1GH]B57*JP_WK&]WU@0.]-*<T)$URB96)?!W^!1F28JF)
M("->>.JVPSE)D^_<T>:GN[M5=#N%;,K>=1"M?YH#Q2U'NW\CM.@P7=PUAT5A
M4',<P8FQZ26Z_&ZJ(&?#XL4<TD>L,E VS#&K^95I%\XL4:)%Q1&6D#=4=Y-8
MH5]Y>'WY!*_L8S7526!]Z'3#JZUA%BH%X0'A_4)IYZ"*8D+S5]+U([6#+M4K
M*BTLZJ 54!=81)O__KC/!)G6EOHPM7M.E#+_!L5QPF*!+-XI);:4:?JE=NO7
M:7^%5JI_7-&MP"Q#SU7N+^!6]-TUA.ZN,-N^S'\]%P:';Q[BP5-#0(E^58;.
M:;\@Q^F=!<]6H,>+?$/C:F7#,EW&0%J[3'Y)GYVC"/BG1#72+J\&2,'!<(=\
M/.A%V_R59%V84_=9%EBPA45G 78NC&$3S$J+>,N8*MEN%?7]M@$G1'OHK)=)
MIH$#\FSJZ0*W"ON&5L?L[[IG8&7 KR$I/<[&Y:G,#TXBAOXD\B0FO5$HLL4N
M2?\-:Q=$325H_^;^0F\K]\BS]HQMBE<@4+#C8YGTI]]UX)0&V5TPP(8 V^[<
M?[N(@%IL''-"M?##\>@0V\%0[EFHA+^'';9F-Y ]:=%XW(UJ]I'K,7! V&+Z
M"3K%)"7H5D=#Y(UB)R$3-ZB.YR[VHJJ[WA03MX=-?1#4=EVIP.@8?],AR2 "
M9"ZT:^(*4Z_H\#PCBFO1IZE4A"A]O.9\W265K57;;$5KMN@CL,6M$:='_GPD
M=LL?MN)& (MF.-N^Q3"J'E97;LXY\7L=O<W1R1.PI9.D>BS_^Q4B$;9O).$Z
M@#1%0^G6AO3_1ET_>()SN<X<53O]<M33\7][%/Z_-@JV:V.]<,CC7]+) VY]
MKRL>0H=8SD\[3]L$QW; 3*T:/F4NJ[_ZQ,E(G1QI\I/R!__T018A&C<X:,LD
MTPE60EP$[S-GGW1-EP6^!*5-4:8] C)4BTQ/\F4)5%-]6W?XTJ!$6,,GT$3>
M,$69@D5" O:#HSC?A;1$"+B6)A^)EY-$W7Q!LFTN)S5J/HY<_W'GTW\:%[RA
ME\H,LK!:.CB7#CJ7-^V(GN#;ZFK;N.4ZHYY199Y)MO^*5@?0S*!M2*!93P99
MA]@<Z^0%5W19/W8(>;)S.&TMECZ^,^*U'63TS490;+<(/L&:=DBE\O(LA1!2
MYK[8X7@Q.9$#2V9GQ<K4C$=(ZRR,U1!K,U!$Y2\_CTO,^C7[:/)EU%D9 >R_
M<UUHT=/AZJAC#3Q5^L,QZ6H9)B#2IYMEG[RZP:/\FK7-NA(PR?$7L/2K+R^M
MRT*FIJJD.Q*#/.&P-CTA.\+D66RG"^ELF7P(RC&C[.S_Z03N=!^NQDGTL[>>
M)TC4^[&Z=.%%D7I?E&?&]OS.:AL\+>0W[GZK=%^7>[A$LJ!:=_D2*C'MQU'G
MOC-T%VG2< 6U7OZY\CTM5=656"%%"%DGV((VQ_53/!!Y+']XH^!J")&BH3U(
ME,MB&JZK<J.U7'XL>SJKZZ$R\<;XD8/X4LJ,[@N6+<.E1\:NQ/+HQ<._ ">T
M+0FD=S"4=XX# >MYD#MYX=61S,S<DK XFES1GN?/;<6[.:$C%H E4N^NOOEN
M2_,[D4I\YD"KS6F6:MQBDKLFB NA[_VH[?/[<>&TYC%Y9F"!SG?R._"H,%<P
M,>(O@.;*8".Q+%\?5Y]:O?*S' =OSZV_%XUP7M>Z1U*C\"8HU.ZN@EW_M(QL
M Y*B[QUU%'K5^< \]W2*UNW$O2-DJ"+?WT>@16=&][XWXW-[35W#9AU&\2/O
MJ' *YC!B*$L%(<SH!U:FNDZF\[PYPYQW3ORE8W;C(%-7^L-,/_%$KSO<4K7/
MW1'9VS5_ 8-J$(9+>Q63EL1X_]L%%-7B@O/BJ_5.X4_N!2>-04]BD,RV\@%<
M@:FYN4E&-],V1!GGAZ5F'=J7OGO#NC+YB+CGS8F>C@_?D\T6"@K>=_C&1I>;
M%5[J<6D,E>MJTJMJ3?P+ -;UK!CK4QCJTL_:JR%1<N%2(&PZ34&?]A1J_0=[
M]ILPYZE89-A99589JO>LM64AK["P=DW_NI2QQ/# M\=AYR^@(=\MT_O)9O5+
M2^;>6U=<3NC+;FY1H,;AN67.&0(N48OJ/EZ6$PD:#W"6KGFC:563FL-?S+L)
MQRKAUD=+ACLN:_-63Y'.V;-[YX9#0?[,Q%H9+8]I!(3?8!W2RM(T-2M"9VS8
MP?(#S0?,%S'I<IUH/[R.J!MPJ(L6GM9CD!=_.1JXPO=%Y,C^E1U+TD-2??1:
M5 \UKO#,=?I4IY9%OP.T_#3!0F[P81/SO<CLX=M-<6>G&X]6)QW<>IO#PF4^
M<_DM@T7^W$L=O52>JEU3F<Q#Z,8#Z]D=@!WBVP-/Q]J<6?MEO6P(O]>]**Y4
MN.7G9>/%KJ3/8EN"AV>/] :EE$8$?!#\4EK?\!U?_3DL=![)CAX4MJ9&M7C%
M(0-C]/M ;'9S%9T+GNB.2++D@J?5%!P^.22,^;ZBT;:"$8()-435LZ/_<1FM
MM;,0^P<D!P$9&A@N+?F$=:WIW VG3XQ9TRNZ?.@RU.6XIT++&C&4_MCYN"37
ML;D 5&4#&EU]WX32#.;/L!6SQ+"6*36/;13S#GKA?_6=,UQ_;@4EZO4^?+*0
M@W1:K4-X.K5&FV"R!?T$C^LDVRCCLV+',^[AUK!4Z[;,[A?4N97N9L._K"/$
M_7YW3#?493OZMT%&@UZ;/-ES>[M;_]@_U2?R;@9@DN7,%\<3"VXA^$TJ&37*
M40ZSH1<E%D(J'O%+*O>$_N%;\GC3\[)9Z-YC^!;3W#]VV_M##4TS<P6\+E#[
MZM?O#,LN>%/8P=S L7RU#.=*IG3)\(5_VMR9_&V+[!RPE$"0*\L'>]18@):M
MULQ1[H'LX&\);-B9R9-;B*7W=;M"SB()_*-*UJQ'N[TM.8.%#!"SX=![T\JZ
MU(T5!'6]Z_J%QI[=YZX33V*()[Z9WC430=@QJ+.HH;4([FM6BL.?Y1K+]H%!
M9[",6;-V87GKD4!E789.;4;?\;M!-?05O\7*T"G6-5=W<9[=&+"734]3;[[1
M0I'>/X0A?$+5,FC%&4MNB@W(+K4U91F:C/K?NW'?:9% >@RJX>)W+6,3^=MP
M]<UA@ENM"RE?]4/?B .%:%?%F@;97J7(.UX?'#ZIK_O$_A-7B*5;Y^%875IV
M8Q]"-*-(/)S:9XZP7:>0>D'MI''Z6"T]I0Q.)X,/6K[AZCPNEZH$YA'CUI[4
M9QU!1<UY?2.J-4%B\K238AG?X;1=%4I1 AG?CF9JFAO'Z=6'%R-#F0AFZ"Y]
MFN@65S\*L[QM].'I&:0.I;O*K>T:\1,D666L9:2%0);5>;^3P&JN%[)!HC1F
ME!] D=BALV(OE[?LY%BJ6M^E56N-A_2('ONO+7;_^%2PP"EI7LY9[RP09-K<
M]D,HT:(57ZM*#YN]F<WTI<P!OY&E6E;5::9:8U53:=<??.M._'+WF>C@YC6L
MATP[ )B*H&"0G./1&UA>>?AKKNIU.K><TUQ0X=N=F.K#7@];P'B1I<<B/!#I
MG!E4N;Q/*X8T.4 )^ BN1)='\(+3XPXKPAY*/WCE_,@Z:9U[5O.M' ^7,E>-
M!SLLRR$D."BLPG(5-<ZH:+)D40++&?W4=V,Z'ID!C;87#WQ[Q[WW7SZGN0-!
M7RG<3M[:ZC[J=J.:+V_=>H]?'_=<)*<8;4$TLQIMGIP?"9>'B\;PIFJ5='T_
M^(>U82Y"1:DUJZ/7A=Z!8#^<&TM3&=!]#/YB(BV+[NGWXJVI[/(8<^>F*XI+
M/4CPT")[]*?=,V1Y#SRD=,2ALM\_3 A8KH,,2@H@1*L%,[ (#$>^6A7R 9!^
M-;)Q6*=!4@RJ*N->=&)<>Y; %;OW5-?>+K"HOG1>$,TXNRRQ$$IU'(\YF?]H
M=TCTH<#&8%D)W3J'XLS1GA=:\ NQW-81G.?]VDD+PK8$AW]!:0E^Q A<*A;*
M2TN,_PP/;F7ZM3J"S4+7*0YL[QC.'AWJMG7 8#%Z>K-\0<;[9,W61:VK7@SB
MG_D96E>E+DOOYN=W=%V7=)':_2I#?L9#RA\*1VGU?+#Z)N[0Z@<7);]\;+&5
M(D?GB9P@M@]7$4G 7QXC,_OI;7<O/&-#D0LUU<GB^QRV?,%O%\S@I@M[/DW*
M(',))$:0:+7P U9AN#+AOV97-Q3SLBI*YO,-0'&_O84%<(?*87K+8:-4/V,\
MN46YJ++V>%+SZ^:D.WVD%48VMD&7SZ$*L\6=>0=6;;"8!:T$7:&9!B:]VE0&
M$09JSMJJUTJ^\<^>AD%V*^\8+(NB57.^Z)6YWXBW-"V4RFL>OH9WYF;]DXOW
M>M^6Z<9Q?OSV_?%R%]@9<+8O.GHC# UM)+PK8 6!5?5-CQ%:*Q86HTPKTO:@
M3G/Y;S7@>_&,UK>6SV#KZ=&")ZTWO*&S-ER$X(WWN,GM_%I]93/3-)N5P0JK
M<4Y=7Z] &2_:E/MNW^2<GA7UH5X89*/552(3\//7#:KT!E_<+<&5B3DOYV0(
MZ(Q@:VF#SLZT>,>81P@/QN=.]N>T]7,KCT/5^X=[(_\"W&ABU>B4)3$2M 0O
M1.,!NT%LO^*'A87F[/#;$FU:#JCU*@%&8PY2MB(:O9(N[1N.E^O??H"L_@+>
M3X0YB*7U^=,<CD_Q3V;+I?/3;&(E&BT27'S" XFL8Y-492&^?:%\8 F+MESK
M(G@V:\L!Q_AECE0B;%N8%\JK]R#_K<,YQUO;#VVD(9I!Y:G8>[@#XWP3/5O:
M/P?E/U?<S:3+DZ<R@.LI"D)^.>-+0H@\OB?,:HKXR;>JS->-,FNT^XO3*-<Z
M-)9O\3RYVOTO  PW8G"?JM3LDOU(]VV8S6KX4"ZM)H-DBDQZ-T]TI/48V8E>
M?%\<?$SK 2[:$^(PBP'KZ?? V](K/9)[VS)6S>^!+,C>O@CH>1).8>6%=.BK
MPX#YU>%M\YZ_@2]-0[A7':8]Y]D=I<52ZO%?1NF5J5/%G++(C1$/5M5334K:
M:.B@@3CMZ-:E%KUK&UML5;U^Y1FXOM#7UU<@4EB0[U%)<IXZ_3[Q!Q+HIHM(
MGW=@&*QW  CT)_<WH%MQ/8/E5-N)2[1T5LT$6=[.?>\POA(@2L3+R[I,%+X2
M':[R/0%==R,'43SN>U>9A)ZK%\ MY(NEK=A2*>ZP:=W=8AA?XXMYA(K(B=G9
M>H28Z74SN..!HL,7QK<,?EG;[6%N2C3LZ$A]GFNZS28V@V5?\TE]^/&SSR/1
M-'.1+'NB_0]F"?>QX'5]12^&?W"IZ^N/3@QA+:L6+ZY<;4""D1PL**+W]NH7
M[R5;B/T2GF64!K*K"EY7=+&4$)0&0P6;NC)-9I1UJ5:0SJ54K?W-0]TMS>T%
M3^.1=#!FUI]3:6_?BX(!O[^(CF/_.5MJK#0APYKRH'G9=OB<;#*H' 5:OMG
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M=A:&9C$X?7%@NDE\_#UCO8PR.(<J.X%J/95LGQUXE%,V17DA(SGHL+TO_U(
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M8OADQ)N8OT9[T9M$<B/<?6V@-]8,=5OU?L^";&*(KS6>N?JZ.L37Q7XA8'^
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M_06TG,>$LA(&#@8[LG/J;*R6]YKW@?Z5_8RPRY*((ZI&7^$E)4T.Q=H(#>I
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MF$15F\<?7J^'3,*H[Y^JU.<^9A^P];O@!B/$,6RP^WU]<$%9S00/7).(:%?
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M&H@7(NJ,6^+&?.J@Z-A^ ^<^!U .@PCREJF: #]B4B?1>7@BP$5!]/,>8^>
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M!):ZZ?4I&<5RMDWVJ&O:<5G&!&-[JI]&X3Z7U(GJ%/\M>/Q1_5WG@(OPP\X
MI6ET.SU"L7W&ZW3I_K#V5']P8M]%?_^82"NCQM3KGAU#L36]58]3*"B**8N0
M.'9]K'?#2UZ<!:;_U!Y57F[7W(RY\$PNTVNP9$Q&?SXJL]"*^>W[&(Y&FYO/
M/A7> IQX$MA<B'D$4^"O/$*;.&_ZA?]*PY_:ZEBA;N451DB1+B8!54Y(<U]3
ME>AN-OS03FD!0LM+"+S?O0R&*4AI2(D-USKW9_.:A]9DG ,89<?"H90$(8V<
MW94+!,Y%)^;F/=/=1TBX]>(8<[;L&P_C3_FNXV,>7V^#G_5=)-%:5:>8(CJ
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M+P/9B'D,C2[O*F_#T/OK\0H5?"0V:8]-5W5R &6* !JVMI* Z0"Y&?'EW7/
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M3(S_^1(BDNO/W""E("6E8*2AHF'\+R_"+P ].4DP\4\2(CX ,3T1"3T1H1/
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M,%BF%+X2":LKQ)=IHIB?L^YW^WP.<!-OA&W+$@"C93@<7#I10K;)@P H !$
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MX28_4Y-00K/FH_W2%25N9D.??%B[^JVO+H5BY8B9^#*XM[PGWB+3!EK0MI@
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M%[Y!?K^#H)-3B#1_(W6N2B6]#T)I9LUIVK:>;PJ6$XDM.%[7':28?QG.RKI
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M$%$'Y#RE>C"XO>:-R&K]'.C??_&R5!2X6'P-@$";4JX!+R_=H\[Y+E>(XCQ
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M>'E<2MFV5^ CC&DXWDVYXQI MJ4$^#6Y>Z)GWCU_(/5457W]P1E7#X-J/?_
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M4_=PFTN QPQ^UU3KUOA]RY_G'_;[LL4SJ4O0:29I_3\T"&(GLT8H0[W6R&O
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MLSAY@_'F!X[H6+6VX^F->654W]-NT+I&XL>G.JCBH*9U5NCN(E:]Z_-&//R
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MECBBZA*@4Q;(A]-9<F7:>>A$X,2 PN%[YG?-T*WCQR6B]K%O4HW?LI("'O
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ME/N$"]9[1&CS=2L=7']6'-KWO&ZD;MU'<SBW=SZVH<JNDJYC.7S:8T]IZM(
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MDQ/W"]?/&0]_8:7_N9PC)VR>L?L5LXR99#4"L3=4$ZQ?*=1R#2!5QMVJ\'?
M> 4%E)@O;O\&PK]\&Q+_7?_D#I-K"ITU8^P\M?#?"K-[[U5(W$3.NBF)MM+K
MJHOFP6YMW@7F>@&?F02D-<AN+!0,Z3)JS!\95<I#Q&)*$WBG,K%J.[TVC<HG
M6=NO?$]3Y!YJ]1]?@\[SZ$=^$W#&HT+ =ZV^5;JA@3?^[)?R\T"\(D8CKKA"
MCZZE" 1UV$9("/[G4.S;?/#$H%=O2B)ER+ D&"=/MZ/?EXN;"*^F38?=PJ*R
M@WU0^5%=J_8Q&!3-QC N^1W.JG2X80Q/;9]]$W\I8=#0E BK9*AX2HR._;XO
M.&?#(40%N#MA1I#"*;WU*$DVK'>4>KS/&ZJ9Y?E]],'=3[77@*:K/[%_39[N
MHGRDNG' 4S<H$5[L&O!5K;\SQU$@D#\.?=&;36V7)*%NRZ,C*-$9X74-J&".
MX(FA@ONU+=8<L[&.Q&7XEK9]<N7+*3?3H\LICGX<O&@9D-M<0-$NI?J-=,@F
M>T)_RNL(,8?".^<,[!IH!!SC=Q>W6_<&AHCPP&KL5%QE;1;_($2)7)!5_5_3
MV#Z$UX8GKJR/[\T\H_'RMX?:"MBH!2Q__#'TP39=:GINZY>Y;V\:XE\VI$Z0
MUFM0Z2=^S^>-8)>G:-@RRWZ @U9N*CW.>#NEH .&R9Q^8+)XB'*T&^;JWEVP
MH9;,R$)\BBW_\X=E4KES*-@;]$A!CR[/,X,!1F/^?O'5* J[E_[@7^'>]W_E
MI+WM-<YV[3&/IL?FK1"7BUO6X -EW8"^:T#LX$I'MLRH_UO/ (K4,]/;@YI1
M.@O=/C_M33]8LPP&\79PWZG.N/OI;2 'KF491+ISY(!*N>J4F<2J*_:D6;L)
M2X_T_4ML'N.QDTWYP>#B=6?MV98A3OF/S (SUJZAPJ#4+"- :W_KPBK[-/'^
M$6/SEKH>AV\$Y\LH:J\''/A<WWA:?S$L>[2_)QK3"&M-6[9TU:T>VS?2%5<8
M*Y/JR>1R$SS7^ZW2E,7B_R<HP<%D]!J@O$-@X6U"]%]< \+D?@0^P9DPPLUB
MYU=:,SR$[1\Y>KLP+>6<B--&G(]Z"]"AB7ALTN- L8%D"$1=:H EC##,WA?E
M]VPE)8M'.UU,)$$FD^TYFXG"T'?_^C)$#LGZ)9-B6!5K93FX<J!RQF+ P3;J
M&<];;H?5&.TBC<.U1!_/9QS8&--G98%#9ZB)@:)<;W1+>DOAY<Y' XCU6GOC
MC^E@&\9OR53M8>R/$5Q:O/VT@KE58C(IA#7HU+ZNO5M_E5C.^MY%P(&>\!6I
M-BYT^>KS8?=DAR$]O0S2Z?#]88&)LMTW#;=Z6F8O;;6LZ=48NUIXU4-' AM0
M9MSEWF_+>2U[TJ?5Y)+AQ 5?W)+_\-_AH2@P3<:9_@<R/=@C%OBQ&K%)LUH5
M3I,8+<<R[221PJC*G88\LYPUQS5&$K/,/3O6-Y_Y.UV)V-E]Q(Q&N)L) XU9
M)KJZUP">%Q 7;L\DQF J&9K$1]6)6?4#8K\+I\KP'N>..Q\O]17EE(^N :+S
MGD^J6N5P:LH43N:PL&I7'^%]L0KM#UFO]TP2=81'&K2S4HQMWEMPD]FXH/LH
M^",)RN9;J:V\TJDRKWJ7KX!ZOQK2C_0;'_:R=IYN<6MZB9Z2RD-(S))HOPAJ
M?H)< ^R$P,\43#BP=\LAL$WV&?'9EA);1 /X R(=DW7N[;/\!;+"S)S<O%(R
MT4H]OVT>5]D/4Z?+*EG<2L]0<=9]D6RNXS)-Y?N3QK..-/:'4>=J4!W\A4"/
MU=3E! %X/G,FXKZ)7YPO1+[!3^5.^8"Z4/8Q%79-HVL_1AG3%QSV8;;P=$;
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MB#N,*'&,Q7;C#ZN-X5BE9'D\/? :\($OLLRA[F%7 6TJ;;-0)&_"X/-8!A6
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M>:TSQ[ZN/GO_[)6VU.-]Y66NIO23E8BG&I*O?_PK"[*SG8NY1?70G4*@QSO
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M-$_N[>[]R.0VB7=-,?@3H!"JE:@-GA?_;95B/&:T<%ZW::B@.>#7IHND3QX
M^T+QMO$NM<:MI./C^@WAK^.&GWB<(!9VC)4T9\TQ1$S1>VQ%BU%WI/9H?;TG
M?.66SG9S_DIM>/@(A??!I+Y/E/+%)LX),8E<%LLQ&W;FF8X]:PK6!>TSW"*[
MW5*ZP9;!%.RM::-'51264]:UV[EVC.GC0X'&=()GWYLE ,#IHKNN66<_O-V?
MJSY66L@ANWZ">5$>XU@G$^W.=]]6\R#7X%\'+Q^E\>K&5$AM!O)VT<2U\LZC
M_5_? ")+7,9]?2:K*=2['D%DO/EJ4_F+'?+_#7F5^*6(K\WF]I[_%WF/AT6V
M@K,!^Q6PWRO0H\PAG<EP*8+WO7X\FO5H!N&]>9NTH\W$KY)/YWZC'+C_\[V4
M+BDM?:52EJ@Z2-U:4>#+L5^;Z\;750MW?87C2)E^VQ@(^2^+)U:QP=CZ"T!/
MW&75WT#[>0D4L@3^[/O!SV,I7?.%YOG! C!*H3[3N,U4H#)%QY/W(%0U'9XS
M8\H4=AAQ;VVR[ H*V[H<XCPSB]^ G"^<O[P!>#;""-G=Z.!P_J"\#68G^=JJ
M(MA!=G.S3#FWYI<<>(P6#V41X+Z.L#QY[/J!_U]T27B)KL,2BQ=4BDUQ 4(E
M4V*%2!8M1:V%D5 _^UY8%?N](N(9CP+D[VXUDM+W]:C3^I]3^JDZ6C)(L4+H
M=GZPR>Q2O'5%I79SR-L (O+C>U5EBJ2+T90;>WDC[T5V:@811PS10\F1 [8.
M=R7O";A*#/>HJ8M_,@WMYH-<8&^W_17RMV1D@\AJVSH!#.XL H?Y\^,90J"^
M\M=L-14-/D.6Z+%%L(44T:!G.Q&-SG0>HM=I.H-@MVQ4O-CV8 Y,* 8>2KG'
M@U(6])F34S;U(:Z2Q CLW5_?#1Z?Y=]Y1]W2 NZFER<-*^7<;RT8EQ[LO<HF
M]QP?@3W]9JVZQCM*9\V53DK^H']34G]DO[>3P<Q<WOW<0,^*"EW;+E5Y*]"<
MO</V05],<^]6FEW$NZN0-6R+<-+B. -&K]+X8H^0%U$6E$G'0XCPL'_H\'%/
M]UDRA\:DL4&U1ZR.116QW@^Z]P/&$41]G--W_"[TL [R'C53V3__I;C-H4<*
MU6%>.,-@'925WV>M5@ [G*NVBW+N3J,&[\.C,K*AI;*'!*5#T_$:MI?+:OJ\
M!Q:.#--U*[RFFM:23:TC,9GQJQ\.R=?Y*8R7V@+;*H\V\B"13\<Z'L%@7E8E
M<S,2W3Q$Y4./"_[DUL8P?1L6'Z+"Z4*G=V\ $MF_3NO^=S6KQ5#D/SYEIAM1
MJ9O#:VQTB-5P(Y_NX*W32&3<R?%B>O8+5H.NXW0R9;W$R/F'7*AN*CV9@E:G
M/^I,L:WRS#N:U_U0YE6;)3(U>0A]$GBZO>7Y^2Y/9[$@SYXQI-17>O^5&R(3
M/"DLLI-I5!TD[:<)2?K&"&VWGVO=YQ$\;>Y&=SK&^>N'-X([6QYVHW;?RP?]
MP6/F5"E6I\K@'A+=RHG69,)Q58!7XC&J9YZ7]?V#X_N7WG0L0N"VC7/EOX?%
M96B5&0=YT^:J_=U,E".5:[B(5I>( UUC)^NK#<5X$$^OTD;V73'A_?:ZCXU#
M$%QU[:VKNE/1;S +@4&._3!Q4+_E_>VL1$F!5(5>UI*B9D$NQKN_XQ[3TVNU
M@Q\*OQ=F_C47BEZ^4/5H6O(VC;5RF@MMQN7JWQN[\-=8_@)JG ZLO@%0V]>>
M&\ZA4\S:ZR!FCM-&XS*/RT:D#(2CV^7F>@6(5S[;^RC \B]IA"S (]=W?L]<
MFDWNU>A4HSB -5,UD/"-,;Z&R?^,7#OI4-6E_5*>W<E <\XW^J%S)N6,1)'[
MQCN<4BB&SA3G?+:TTWF-Y G_!=2OA;V&[P74:H:1O8G/S'<ME79Q]\N,D8'^
M--<C8<-L,I#['U)W:&0R_5PAPKHK)1R\L=JE15;_&?P,4M#4A$CJ$.#[%ZI0
M&=VG2]4UXRA.<9'@%C=B*)0E\\E X3/3&)G5>RJ_ XQCM+-?VV#TVB&$&T G
MZINQ/GP!/*+7J0[JMI2:/+J=6^,7PN>_FBGI.[;3IQS.$Q1I^ETL'X-LPM2&
MA]+( 7?C3%RH^/9O5U!F%\<W^:G&OS_<'[BG*T%EE'=T?N2X97V'U<QP4_JT
MKGVH?L+[**K)>'\ZZ)IOWOS6!AT3#W42=94<2F"B3C9J?5'[55W_+.[;SQ3R
MN44MAW<,=K;>X=[AC :"UJO'WZF5OHGQ+49,WE/[4B\&H/3:^,_3&+MSV-)Z
M--ETV6$!K5Q8;<-E9JW*]T;[PI5J"G_7TI,[*=I \V94847]U!GT53H/7\^K
MH#.;*5_S*B8\]"R$2A,PQ6TG$:.(3Y!(M1X>NIYDDME$+"]PO3;NS8:SC?6;
MH$$2 ?O;>$JI"X\G,'2^(41L5OTWNFD\'8LE\=GX^LF\E\;0(\1_""?=SO5)
M[3#-95:)GN":<HRK:ZY,P2?G9?0:--8FA+\:KV67H_O.Q!0*^*S:^_JIE7O<
MQ0U@_W&;U&Q.R1Y,;*B.(!6KU06F%972"ZY5XJ\9W_8H+FYP>A\VU:N/A?+,
MS6G<%W2Q8OG.Y-;TOH^-Q(T!R2K=HOPN7J=A/S?-.S=AJ,-1P2,8@G@?AA:*
MES+PRW3_VOODSD.N^?O#2HZ;OH;[F2_Q#)TSBBS.(_D.XN9FP" OM@%U-]95
M^!Y5PV4E>6K=74S#"ZC#K6PNA9:D+][7'OS1E:JT=&2H'-X=*^*-%(Y78)(H
M"#^,#S(D GQ,JTT2&]ROV[IR?#@5>6W'4>CK,GFID">]6[,$ ?WGQZ_KC14Y
M1DJE/K$4J_8*RGH3S^N634R2\,WF\-Z=9QMMU9(+2)N<##;JN:V*6?-_+J4_
M2V$_Z]-C&CI\(Q^KVGJPE',P/1_R\&PCOF2#<"1*84)Q[&8Y<+/(B8W'KGV5
MO/HE<=2QSN_X^3K8PA[&_"1_X;;(GEFP.55GYO?O+V[<Z9BQ.MZ.C"6<+'6>
MOS[*.&81\+IOTO!=_/3GIYM;>EO@$8W5,C\N 8ALV?'XWM:A4=6.HA<N9!\9
MO#;Q"R3H3+<<]02V:QT@9YHF^G>T6RA13L'0ZF,O4<0*PF^]._)M3Z;MI,C0
M26 C5&8*0IQA\X ;@IMRNJ>-H2P8@'-7&'4^63&N=\Q@&&TVSN[-L01*KWC2
M]E[TB:V&K3'%JAI):FYQM][GW24.7N<\'.S</UU:#]K9D3JJ0[-?*[@;M=37
MQV#]<A9^>HH.U?]YE=.P_ER1^DE0MH&$'V_K%@COU'21"LF]?KVW#TZNPNTQ
M.3;:?9.Z(E49W?'P,]N<\EEC.-VQ(W;I&LTZFQ(T:7!X0S(;<8\W H!H"YY_
M-GG-Z6LT(2TGDC*N J::T7-P]C %_G>HX\+QI_8=C60\_5AWJGVD9WSSEW\9
M3_?9(Y<%:N(-PC:<1=1+9(T8QF=?ARW"]&1(M68P[Q*&'Q@^'XC0RR(H:.Y/
M=NKFSFA][!DCHRB/HU:E_%]KR+H]V9JR:GR&VY>7,D"+&\#2#4#-LFCP''.^
M<9ZABH.Q([8)30:5 1WM2Q5XC82$K\\V*]77>TX"U.(S>5;5VWR0)9R162!
MLL<>VEF9"JV9Y&V9 "E6JQNSG%V ]#O5UZ1U]#ONT3OS?LKYE1#QWO?/U\]^
M\L@0;XJ14!;+N"FK0JF*X2[+U]P2/4VTZO>1PO7@),^Y&(  P%!$?8DC6/K!
MUP7;ULIZ6G/@2:2L85/EC^250[Y[VC::3\%KZ-=_O>^\9<F)WSOG.RM.X$]M
M/+C$(%,J&*);N<T)>IUH2U3^ABL8,Z_]"Y2Z%2J"*L&)5YU5]<6^[$LCF7L+
M*)]36:O?N^_[:EKJRG:3[:U>7:9J*YYN+1-6U%HRPONJHO\9NW[X70#/4Y8_
MI*U_W"Q3<9FD&_,2XV.]!GXJ($%>5%2NFRWXZ;OB:@DNCW9E(5J%94XC'H1R
MNPO6E& ^HUEIZV=)QCI8E1_/<XR)T*O[\/RLGM6:^5"F,1_6?OU PGWU)5@9
M)-5&'ZTT?@.PW[$SFA9Q%Q)[L''J78,=*O$\R$.YL47$#%&L_#+, /':$6V_
MEHBM3%\,[N.47SA)9T[H7C%['6*' JX.GW@V.I>*.E>0;SQ*+> )S;@3+$'Q
MR^AIA$Q(!_NA*D%HB8-RZYGC5*)LG.,;QE?&LHTH+"8_@76TYTZ*44>1^?#=
MH[/^'A5NA#\MP7MB/MQHRNECD[ EV0O_Z_MOJ@,TQ7OB@[XEFJ\]:Y:DC/@]
MAT*ZYT/*DBYIDC)I@C/WUQ:Z1F!V?B\ZU8GISVTV4N9UUI+?AQ+O,+/E8M7%
M58S7%I<SE?%U48JF)5OS'/N=&_2-%@=;GAN%?-'?G+EUH"L!7A\/UJ.PUIS5
M5 W:KZW(#H7B7NCZDBU=*)/J+/54<<SXL/:S'O9MZUCQ:(]5,8@U)QV2.6,/
M[12GG ,7D:2S6'6Z0+_:ZWG[&E>^GGSIU5';*.U?R2MQFK%_\U.*ZQ,6E_/O
MI4W_2[F\/>'G\2<B4R-X(W X+]XNHD97MLL;%G)$P3UM-%DF8M<"VR$[J0IX
M\M'^;]S6XQ*3ZH*[7WN(:#4!BJCUGATMO0H_6QB%^@W@_DJ2;*),G4[AHT^'
MO_E6EPY4M+&+L>H/F(+??&=ZWS(=IO@@&]'AHQ"I*?2]J8JRW-($K&?CRMPJ
M^S.15 O]_RF3UT93 K.X]S5G0J#)3]Z!V4HR%=Y6#['V2D@TI2422&*-8#OD
M?F+5,OQI* U[YE0W?4VZ=.V];59SC#F_;O0\](6V]5(]ZE8,--@W#,JAGSKW
M.YZ+@: D>1GB&)=G\F;A?;FLE7%% (O264Z^LIX%>D<&&BV'Q4CIN.U-7=M#
MR'9J=F7F0&SNW8EML1A#8R3X1ZE0.?YU^.(-@ J=7 ,Q5=M4&P'2_*Y[U*\<
M-\+7[!B[:U6=]%'EWP.K+STU^9_=6>AK[(5E6*R;M-O\N-!U$@\$6.L4?A"-
MO)ZA<YO:9?>\:%N*6'(?RTRX 92!TJ2C>X$HLZZM1"56X_V21Z88[+P>LG)7
MMCZ*84"%Y^EF $ZD:R _!)U/UGCZV5]H<_[I9'6XGUZGY[E&7H6#!_S#B]8\
M9_,26LT(/O6'Q,*\Y#)5^_>?2^?:[$>W:QX\0 G_N/JR&('N+!B&1B3^*R;3
M!<0/QOUG&$W!747QS>V@5-9]C^1?HY##)S/3,Y%<5>F6K$.+YH*5IV.4)KO]
M&BLK$:YAGUQ;IA;VE?.O/T;N.,"ND.!?BC> W@5Z18WL&T '[$.>_;E'[EIL
MGA[\@TQA 9"\+I5+2Z*;83:975I8E5M-_0EY$2/U#8!@;H9-S"RP-"=X#H H
M2-[K>JZ)Z#?WY2"RDUM'F.KNOJ\89*$=XC  /%\W\)/\W;C:DADAFM<TX72I
M^MBSM@SNY272Q(?.><E3ZRE(N6^H\\Y 5D9[T/"8(+FDD8+6K&[]WL%#'N\X
M'<?7F^C&5*_Y'=5N^<R&4L60* CP)*]5C/?*Z!8GS!P.MCYMUTWC:]KX7904
M"=T%& 0[IGO:*-;>DB;:M/)@[^>$M4__$D,ARP-.DX!?]=C>E#EJ1O*8UJ1"
MQ/!6Y_6=I"[YVO@3G^IORB<V+0,#&&Q +T?RYZ90&^*KOSJKG_L'QJ_9"4^W
M3"91(C\;XD"@^MW2ZF4_^,ES.UM0D/OGMKB<6M9M<UJ0LE=5\=(50\?Y0@#O
M6/4_^L/.MTP[%"4]FBKTFE':$]J?BDI*BK(?_J2H!QB .R&H/0+?.<T-0$QL
M;*'X!B#YIY4+<=B-_C[52N_'/ *<[,G.JUDLQ]-UZ?<[N/*&_5+XMA.G FSG
M+G]8#WA?BR-M>H+^Z>.]UJ KM@0+/DI@-\R=[%IP"-Z>6]ADD(53\)H>5 E7
M2B:8IW%!L]U<^TLK,Q(APS>  '"*%7RM#>A?=DVZ.K;T_Z]L*^S_N158$*)?
MW?CBG#O)LR[F:4$_;^'ONZWP?<KD,E\Y@K)2?!'!QWBR6<,K%ZV-;DG!:DCM
MQ[+:RD*0"ZI\E0U7?Q#"!:^0DL_!V=(O7F*TQIWW]OA,1$0^>JTE-'(_$>ZZ
M DBOPI6KDT)*MI-%+<<PYE^D^O?<DX_O3^YP-3>8J&M[!T>:*)0^D\CV9)2F
MF=?QJ+S<.5W8)[/H/FEIH]I:<[F5OJ(D3ID>$=71:]Z&_[R_VIS2U"V66;2A
M9#_T)= K#J88T3+<SOLU30E 9#^RGY'D]9, !([M+>*/40E188DGSS:R#0^-
MC8Q=G\64B; KC:PF/ZCC^=/> UG X."!V:,H#T^\;7"C[D3/_/SEYIMO_-_M
MGL0YH_\\0Y J,BM"ES'*=SMS!SULD+Z-03/5T=LTPJF,V3+K@^2BCR,.^Q_/
M#R@XP)3!%OX7SR)*FHXO8:?N1XV* 8/7CSAVR, [R@2=MB6EZ_'*D=GKR:OP
M$PZL7_8M8O]"%E]HS5_M)4<@2:"^#']]59?.FA^?!XV$BK[.7O+,-+W&-#<T
M//!%.=TF+!HRG$[/)%E,/N?.<C/>N)N-H_U:='\A!!:W428][1YF;T5!T?KL
M\9^NR"_81.G?<K9$$^%M^Q7-_![AZ9R(3$UY5&63GM55%E4F[4^^0?Z=@<=W
M7VLQKA5)5K8T73\<N5S(R$$/QH\?-MX ^%:SNA!K#NY@#BWED*PI9^G(-VC3
M32/Q#;B(C1NTY7O_2;=*XL%_T4)W^9A^DP E:+H)]*"%$/J4AV0<C#+)$/H:
M.S_8B>[+X]:9\=\GVW2!].K,P%K#/^^K?']7C-3:_^^_3R'<$^O4EWB9Z,).
MUE%,<R(<_[)8*(W7NIA5DOWNL4 N/PK/TN'/T1"\\ ZO&9DWIRNDRFKL_55<
MH:\)SAW\'DBQ$2/'DC1AY-OXZ1A^:;SAIX@^$M01&)HY&WE7CF?/7=*5$:/&
M$-;6+>.F5:!*+/^U^OA2<6+]"M^>6KZ/>65]> W-\CP,P]R.^S7[@A4)179
MKW*O0CE.&$[T,,@5KK6AMATEX\$F9=L;0'09%CH"DV@!6A)ZK9:0=PE)W6:)
MJ5Y\B2%(OGC,QJ*>(L;6)) [O8&W7,'M;'*$UM?\KZ(L<G%0AZ+[*$.X >2G
M.,L9J_9]85U;A^4CDP9V9(B;W.W=0G62Q.8-X B%FOWJ-W0.1N[N^6^UQ78@
ME+NI%D>8''=P"BC/$Z&&.+$=A4&_ET((Y[P&[>RJL >D\9SS-P#>J:W(T*2M
ME@OE<'J&:=22;'E=??K.L6<R&LL4 3Q1R"5W_>MLPW3\7F&J"G'1GA*<ZE7
M0?//6-X_Z3FH.-N/K-OAV?,["YX\OFF?5-<J,<OP0.MIOM'M8ZRR_H155<"E
M.A0)N^BS]2L8,%.A8G1N\_@>L0OXDZ3HY7WFB?5O$U.HQ9VQ).D=CA^#E85X
M!JS^*H*7RA[:X]%SA(X#A2$RW4QSAS+G4AA1^+?6Z96DCZ.O/GA5QD+]E33F
MZ%O*?I^BC4\L6A(3&]=C*]8TISG;#BO6J-5U/&77/5U*W.J(*>H+J_]7-3Y5
M(]2B\!HO&HTL,".%A -!A)Q$ZA!(DL9'8X?%%1?OJ5<+3(H\,B'(PG_HR<PP
MJPI[DBYYD@G9N![^&,T(0_!G'0'>*+J*-,,!;]EQX].V?J=66]? 49$C< #8
M9VO3*Z1KCR)2W0SOSE"^.<W @?%FK[D_QM=HBM&+7 Q3"7=6[U^MAE,:JCZU
M-@+04@"A2S#J?W5Q6XT,E[Q$!LUX$<(%7W=W7[4,"BH7T=+$(2SX_;]Y*]&=
M+HH97 OP%2'D7E;QOY.QV4$K:(F#,KK6;:[<Z,PS^6.L-\_30::+7CG_5 F'
M?S< UF:2$H1'S03>.1*2*[(RQ>'8.,$923Y:)22*(ZQP?1A^&8.E (;K]$*G
MK^/:3B9:K]?2!HP\;P_P#OBL[M1#B^E"80@'"D]7/4Z81'V\H"C+A)3H%=QZ
MB-/@664V%J,6QI(5=<]^VC'A(2/]T9!6N[<[.O>DP0%"UQ;*7QDW),T.+RHW
MIZSOT:?26Z)3[UYX= 0F=DQY+-]]%9R>MQDJ2?'Z_)@S6"(L2!,4C&V+TGI]
M7"P6I2A'<9)LP]^6V^M5Q!G7@2VSHK4H9**@W?T3R#8M]7I2M-7,ZP8 =A4_
M?;%WB]!OAR]%RBPW%A[V?CUZP?!N]-(N_Q^,F-K"05;(OJZ0E+')_C+T3CRI
MBUN30*O*\F[UD)59W%AO9Q7B9$$UPT).VD%:\)A1].N"4_B? ^L?H32*F5+:
M'[B?/5P,C+=LHNI^\5"9U5&)?D*:3?G5Q%(<XX[(+BQ;IPS>4W91CR%W ;':
M)N,XPM#L29!/[H-7RN:MU1-.U5N#+,!_?VJ'7#W86JW)Z@L-5G8X[3ZP>C P
MN4V\Q=:VL+3.IUR=/(INV$Y,%YL&^<O[BS7@,B3'?/47%^YNH6LR\G$3]1&(
M,&QNPX3S*K5I+\Q]*HJHXJ&ZU@.=U@M:);=&E+F%8RQZDRS7C+"VW"D+R=?B
M&RY ]S=4-5U=C$CP.M5]T@JJT]3^]JTJ@IHX8>L68"[%<6(,ZHL_1*NCJ?N]
M*":\(]/@KJ^A4\^(M*1X%&76#%C8[J\E61)F%_4H-IB/CZZ?CJ[J/I3UN?"!
M$"SM9>)RF61702[HQ\MKRRB-W;BC2^61PXGQEB3C@Y:2I-S6'2K:42D]5L?Y
M1[?JPK0QB1;F$FQXQW@>@<W.ZAR\D.75)/V)ZLQFJWP2XD:ZF*KX.8*:,O5F
M)F.SUE+D:]P)DOR?@\C!H,CX\^8+Q+WG'&FQE)B?U/MT2SP_>[,(J3C-^*5,
MBAG(%]&:2/ES^X_!4'YQEZ\O?PL'M<]41*R[OJ=2C5-Y/K0\0HE0[TH)3K99
M.MM!80P"*-X:5=0&*)CLE7IZ?82E:1\H)U.:\]Q9XU]CQ6'6$E!8T/3YQ9'D
MO*PE.*#N>'/^7S%.F7S#C.3T<[/<3Y->&U[O\<TWW91(5]H<E)N8P'.8PJ#2
M85@A/KJSWPLW<L]Q!(8R%VE.,EJ_$-ECHUGY\M76Y.=S-"A@N,G%I?=>W:4.
MWD?[KTFX G"$EM?HT-)"Y]</6Y VMQMKU&J.^8Z'QTQJYI/?@IRC=G@WX(2B
M*LE7>N;PC4-LNA*;$R_2*FY]4,)+_33#UN7^G-5L/12;(20HYL# LH<\N %\
MV3IE\#?*Q1PUMX':1'Q'>,=]E<L0I+\;=2-KRL)JA"!MY!OX^5Z1DU][$+>U
MKJA_7# 9_O_@ML$47[_V )C(]K?4)U;P>@$U+0A$T3_0W.:)S*FD1E'7746\
M=$7* UZX]NQ_F2_:>1YFI081S?RO85!>.?C2YS;J/;#@&W=D'FC24-0/#KA+
M]-@T54Z=O_^N"YQQQK7'=*DMG)DCM&:$R4$_/%4H\^%P^4+-YE,>KFA$B@3C
M;G2(>1K;:'DOD[S<_.O\XC,P^/+>B479S/ SE["0_.MX6,_TH3U.28Y@OH H
MTYHT&C=OA&U;&.OI;?<TQW$IAM($68?1OKG7E6QGD?^0<;]F$()F"&]^E%V3
M^+558**Z7^J*'321^J;52_4PCT&-29\OD?\)]UR,J*$_KG"MI6PILTM$ 9<?
M<'0#>+0A<YI8RY"GSVKVE5NPIY]9LD'"<R6+\U$:31J[4%S\R=?Q#[6'Z_LC
MWSA-ZZX^2Z Y=BB2]#'/OH4'/ Y)E+P89S>LE*?F2>@P;W$?']M=B,I+FQ_E
M6YG.0$$.Z@;6HCLY=HP(%LHGN=C+MY(65QDZM+N0)@2\+;%MXUFO8FG@YQ'V
M]8?Y:\-Z"02D1E.\T7YPMH<#;BMD[%@A7/M8;G7J!-N$+DM23*P2CV/\DZPY
M3ZX.\<68M2B8$+"4(5E;==.6M/B[\_8N?E7Z8ZJ5%Z]DFJQMTAZYK3;*)G"R
ML*4^504$6A@@I@8&.ZU ^(?(#BZ'>J$;@+,YIG=UY7-3.A^B!Z>IY'2X]1H(
MKUV8O+ANFN^8!IXB)UOW$J<:#K?;]I,BQ;2N!]GE99$VX=>/]&K\JCQ]";>H
M6.&5*99<MV-RP<"BM#>T,C64D5F@CG<447]9@W^S_\C!\X&'J\0FSQN?KTTM
M3R*<23/VBY4L5(>GPJ.?U/B0+SQN9H#)9#YN%?UKE?0F2LYI]/BYNGE.A)%,
MA/-9)[4*#V>,2H$'++3Q=2B>1VW?<,+8H7#+J IK-G>_O?9J2O*1S';HPUT;
MQG::-L7W_W+V(!#XF>5\^*]_%!>5EL!#L_/6]:A9@E;W-?U^7^/^+/[A5M(>
MCDIB'H<S"I 8&^&KT.95>J7%)2,SB6V*PX1*I+)97IA7*M'7X=^=/Y8U^I2%
MEP=+]B)X&LBW3MK7OC[\,(><7(ELDSD_&D1&6=+ :!!U.LT3;[7TR <A)+NY
M13IL-:DZSZ&AK*6_Q4E>9F3*$O&RNM>VRNP?'Z=:8"!HF^Y?.1),N.;(&-Y\
M&IG%F<Z,QS< !J<I73>AH_'+Z;.R9B#VM1AJ>N,&0#3V[\Q[<[IK:FW^0K4<
M/SE?R/Z%F'DNI=-1O.W'=&W>#G35VM-8O*3WBL;DO2U7C%#9?GZPKRDN4HVJ
M!DP('NX043#T4Z)OG5B.$DS1IB=N\/FV&/<I9]AXR. A!ZX'@BY3A#G8+4<J
M=^S9^</$H+F-P IGC:*O/6_ZM ?3UAW7 ;Z83PVHGY?:8\TZRY$^'2?ZV!?S
MX8\EYBRJWX/D8NH/EIU6D\FM91F)O\2IWP'3KMY.LHP<./<\BQ]8]@*7(,E$
M_*!ER-AE;ZIOPD? ,BI'VQ>?EE4"-8"0%H7!":[*T2[Z,>&L9.2H@,+T@'BY
M!&D[\>*3/9'J2*3*5>81A0Q?<[1E=<5X%F*'"6W]%$]J,7C(*KJHYT()R2$$
MX:E]Y<=7)THOE8L=Y5]44[CY%,RP6+'E.&JN><19QY9+S$2R+NGY$IDMXZ;2
M2;_EC-]++@1"Z%:\G5(:><'6P 8:"TZY&)WZD CG^V_=/INP+C7(84^1Q5<V
M,(LZLB=\LV+CEXFMH S@BZ@J'!6#)4$<V@PLV9 ?SE]WE#_)AA6T0TC2W'2$
M$S,L^@Y<,+1T"("Q5C\1H%;DD#!MC-<L8T_G"*].!5T(9;E!F#>[S%Y)DQE&
M]+HI_#AE3%GZ7&NHTM1@0Q9MD[IL4Q/A/>&=%'2\(V0PMH/:HTQU/=%,P0GF
MVF>+5\,I.!8,[L,-Q#/2IB$_-Y/DNZ,SX=GS_S[M"9V 3K_D_.X=^F$=ZX*<
M'V%[:I7;.*O<#=K?61A>'80CQ0[;EMNP64L9;#5XVU1\J-0:\VI+0FG>:*>;
M%[)H'F3N\&MF)R+XRTX=_5GSK, AO/1!^WWW-GNR:+K>LAF-W,[B2,%J3"#%
M?+QK@=:)S\Y@I0[M -HSR?&@\ E-W9_[5I]? -_B3X+R9M'F2(=9<Q1V<V-?
M&%XNEBJ;PNUNL)N5S.*Y0EPWH&(P\S9$N3<ZY"^A=+P3LLQ&N6Q:G[PH$^/X
M1C&F[V=<Y1/?++Z7GS5U&+//8./XL85]/P]*5!D!"KL5P;AZ\+BO $Y@4OB8
M;&OAD0[<!P<L!OX;?],,-"R7&0<8B+1_U%UBLGY3\H#Q0YHQ33Y!R*">H.6V
MA+?!K=:4[V\+BN3$;6JOG2@$V)C4/7-0>O.,1[A$O$[1> P^+[U_DI1_U7IJ
M.2XB[/^G+M,QXT JO(_WCBAN9@;XA&(\=D2Z#\+!<I3ZXF6_U%K5E'MQK+UF
M(<0_$O#((M63ZSL=UWUAKVTM-@>/".^=PRKPVI5._"GON?/UQ76A-[L"3AJO
M$57L[3XDV56\Y#/8=!OK!#T@P%C966&C>5.E$:CTX-)_-P#A\/+&F+/WOZKW
MJK'^IUUF:I -W)!65P4A&IAL.<RRL VK>/I[A/\O2>-GG)'"[^^RYJ)"_[XI
M:N1:O.\LG/U#43D?+>KNA*GU'&J_""&E^+N,^F3,P:[$H7X5\Q$?%>+#7N@M
M+));-?$S@;S5-)XD<)G%\P:PX'"U9*9Q,/#"W MY#W4X-KV311OVW;I1"=:M
M<!D'/YX8( PM'?KA.$+.&SN+AZY2B[5--N(L$J+]<C8C>3W7OQ^2.YI^_\P8
MH%9E]VA)[&3DDE>>_09  "I-7B4)7/+> # W ,<+,8P;^P+/\-4\_(QP(;9[
MXK$\6&;2A+<-_;!^56PZOM,<7E"2>U@:Z]L4ZNGUIE:/\MK:Y]T!O/1.7]$8
MXJ*3NK:\$A&MHSEJ^N@MA1^UC/#BXT>7"TW"]SEE)#.>6N4?7\&GK[%G&Z))
MUVVEF9*#U]P@PHX_/QN'BGRV@_S$FTU( 6\<F<\#%-W@;_!SC?3K'L56(BK%
MPT.[\.GF%X6$U [XB:<^8M-'/ZL:/2&?T_C]4^NO*K4^D4YJ\T4+&Y$JFK-G
M5/U@]3G$0F<M/"4W[?PZB60^P4E,FLQ+C,=4>)$S5K@())X%2!_ZTKZ6E]IM
MQM?LIB-:\8%6E1AN4(7EI.GDXI9CC.\0-[H33>K0^U)_U*'L:/IX_?%I/7!^
M&K:!!"M-*4IV3&<\;234."FV>(_H,8><*Z*_-E:I*B6?@.-D@W8B&W4R?_0+
M_X*):UOUJ6==O+8D! F_LF2OG5Z:X!S;=78JJS:I48B6^&<U^+G3=H,=I\)5
M*O'9FN2]N7&QHS*U%(6 46-%RZ03E'EX!FLQ^.*(!E6T"CBD2Y-?_V/PP*(Y
M(N9E8,(2563&/?QN+M+F)Z)8>S*W*ETDN61O*<'&4^6WIN'P;HXKUL13"G?-
M H'UYJ^7I1XS^Z*:D$G(QN'Y%'=-L0XHB:_R,NQ;.*_\'S@#.L>XD.\HZ1,&
M^,@,%#FJ^+4[\YEV[IO=.RJ<3]X\!XV$V"[W6'*-3U$]5C]98$0[TIKWNB%7
MKY*VM<FZY3Z&'H:H6;T?D(G^3MQ;O7D+*P)9.C#V7%PD@U[<FBGG;>J__U&B
M+X)F5/W9W$"7(%&,]KT*]\P(>39L1-[UJ=Y8C4Q+6U7-N*C8\B.+JY0U$UG-
M?'),A.EO4I:*88FW<9%Y)SIB#=VW8%MT WBVZEOZXNBL>OHL0PRW0-"3FODU
MGJ#XZMRFR?'O#%@+7L24E> \ ](1K*G+  69U'Y_Y+_3 X?Q&I?Y@AHG4)=4
M>>TG%FIK/N$_/C8UC2DMM(X__&,[:SWHLM&BMFT@V>S<$6CL*X!/[5!ZLN_D
MSZ7$/0I]'S9,AM) 5B]YC$>$4?9G\MBR""62Q5&Q%;]4#F.G2-U64 1E*6,F
MY\>=<Q]<J.7MK"FGKI-55&JZ5I\S?PH/6TF\#0?MUYG630]T="^TM_<.VLX\
M]S81]T)_(9:-]C-J"BVQA'X/7;%.0?Y8QI3SZ:$FX.!5T$_15Y6,8]."@K%A
ME<[8M(Q17P6<B4?-%%<37@AL@4@\F->V:6F O*N0.?R&OP,3X9GGX5;YN1(A
M0RE4-=$JB]#2R_PO#1&HD:0ZT?JW#8-$QX2;S'-F\E_N\";UR));M;A+$DX[
M91H3T_-U<2+\(NH&&G$#8\!_B:!<6.,HEU/]\^=/*1V "["UUI/,A?PYJ>WX
MG7.MI,/IB?T>/"Q4FNW>P-R_ZV=I&(3S\*"!),;1,PC&C(AS,,2128TPAWSZ
MP%O>1Q&@/4W@L,,Q*>I_@!?W%L^!.FV*09T^1:98E35)'R*U^PUVWVWN/.7]
MA#'&$!5-72O]4V(E>"%Q+UZOOQ[?PX6_B1O7:IK(#@.-0WAC=R+*B1/%H\)<
MS"E]CGMQ D'+]6VUJ5W>_S%XNW,XM-7%77/QY2"(FXM 3WY*',RP1IO5\.>.
M7(OUG%Z4[LPZ6R^F2]-5U5T#82/ 4Q_V#\M[#R"-O6$>6__$+@V=&0Q'=Z!6
MXQYD!>_IH_ BR[SV[51]!\[QQ'FR=TLDS<LBDGH:M6:E5@*[IBTY I:-PH2^
ME1UKU$=VQ5[%S@--!.J3[S*%G7WNF6$)Y2+Q,2'T+]*./L'W!@_JTF2(7Z%@
M21%WNWM'!CX_Z%L&3"[C.3J L-PYCL?VORCT_WC2W@#LU6MW DF$:+"AE+A[
M#(II1JZ1U<>73FUD"I[05#<H<@O9:>$;>S@5GW^IAI=!P?,0T1=F(FK@.@V_
M%RWS*+K<G;+9.97RGW5 >\;RH-,'7Y,I48-T*#8J]6EI/8*F>ZH,/B$D1*G]
ME[K260V9CG["WO5$[HH0]R<N\D]*8"%2%@H?CG E<81DNZ?9RGEFJ'O]VNA[
M688IB \#FMO\[IV(<L[T <#S_@^;@D-XG_:3DT/S>4*\UKB3D4T8RV"+P>3'
M>BSYIX"OV@C,TWV,GHM,@FWU41L!>>\&H!!O9\?!WR(&&QB8UXK:BMEB5LKD
M]>?.[.78CY[)JV%+0[\Z75L> L6?V*:8Z*5L<@WW?O_11]P@X%"F5E^/IYC>
MO@%D#=GP7:*[4IS33C^I_9E&T1SHCJJ?1O2(R1+[8BJB7,V4Y"=:Z<'F&Q3+
M0F6D<^92_OXIZ.W$DC69I_#.M;0=7@&A=BZ_X@(\5804%6FW\_EN7=Z_V#GE
M)")'!E=,*"/YCL6*]7)YH;&^J_?\0J#/:<OV99S*]J9@F2P,!)T5\A?>7]V/
M[ V]U/\Y".&(X.BHE;^DG94IA!>VNS+))"G;PP_3;0_JSNZ\:KX[S+#JQ+Z\
MW(M>&G,?3)63'@P568W3VTYG?J'Z.NN FMMKN]6>4AL]_-*NX(5Q63Q.]BNN
M9:)DH9OYJ:5#;/7TU$Z!&F^U1L]Z MSFL;5U+:"OP+TLS))\NDQX1VJ!P5X^
M<G+I Y2D-)>\3.DOT,GP(PC NIPGN&?=@A0[H$A?T(!UMTW@(2\H]2BW4KI1
M0VV1.T=R-6>E-<KEP*(A(9[?>3.]O#;IV0O-RK,S,6H/E/2-FSFNZM''/_ _
M\4DG\.]M,QPVL@2AD_Z3JZ;MN;,,K9E3O^+5GNW#M6D'L5Z3'#Q@7&J/%!%N
M$J:KZ2>Z\*;*AZ2N/H/8]H= LGOT5T%NV@$EZ_>24Z7]^%\=<M;UUYU3H,Y1
MRW0E,,U3U1/>[SJK,EJIZX]-_=5PW#]7UNV%:8T#HN,N2UK]@JJ2BMM0N].7
M1#W-CQ9O(=^1X[ZO9!8B;KS+R'ML[A\HNTJ61A5FQ8JW&GA*&O^T ":5ILWB
M2LRI)@\I%GD+G%1J+U..M-ZW04UELS6GO$-'3$=R/9-N2Q9ID)70JBE5J^"3
M %C%)"P,XC/UHASLF/G+K]F"CS8.$)$&5!6\O\!\E:VP] J;,[)O88'QZ3_+
MG4/PXYWSG.,>P"9[#V*HK"68RARD^S#GEV<#_18G2?E'6X7 P(' 'E6SI@:%
M4QA^%>P]-N^\G%'IAIQL2&]3.!-B-\[?N'X:# 1&T[7COI6(BHI05O"'U9%Y
MB4H=%)C,7N,_)]DC!3X31@8;&U#W.-@=ILXU(N@M><=1OO'\\1YP_GRF8/B$
MLYEF4P :;9B03-&Z],G0LT(HHHD*7D^8M<NU )M!E-BFI8#_1)8; J;^@;1/
MBWFW[@IK,F'A4F7,7[CT6B6_I)F!P\;T<N?GS!#JX-:6\5W+Z3=C. A??95-
MJ W)X%R)$Q.[A&(=LE7^/>YM7=LX<GS?S_M!;RIVJV[E!D!WFF$(_[5E1AF2
MYSC-X"\]*>U08Z'I4"V=:633!*ZI_/W+A 7ZT^3$B>I;NDDB*<OXQITS8Z*?
ME^]O,2;7!I:%0)I.HD2=A&MX"KI/[!>#67[V2.!,QUY]CM!^Y^39CVLZASZ_
M0#GQV=D&_%^/EX;'0?]W67@1\/_Y15/\TFIIIOG#$AM,+4/]L7SZ]RD][F-]
M[L>\?I*6QL6^TGB[\+RHM?-!G3K0A1^Y(_6<A;A];GFKY  -O8PIK88M&BA(
M#- 28.\MM.S-VS@U_M1/+@[J&FM.HO5R+7BC(SRC8!SU^CG=,C-XYP%J\W0*
M;5CVM61UJE2:S.=Y[TGZ'R,H:^WTH]!$!Z?86:U9<]\*.CEB\152^O'QW,SE
M?)Q"DUCFOX7%,'\) A=N:X_%<9YS5%I(*O@:U(?N+C6@^*L'LV$:[+?Y= =K
M_[LH_^DF?/_=A5V(>^Y?7^4\AX+A03LH7;T#[R'C5Y4&D2_U^&DBI8!FGRXP
MLZ)J*4+9-%QU?TX9/97R8F<X:\UQC:I2ZJTN+!Q.'2_$$&!DT,$59)X@$-74
ME:'4O __<OG""TJ245PPKT%+!L(4?UM-.U/XT5..&>$MZ]%^\#=.CU$H-9'"
MW0A\;G"Y=_I/4*@?#K^E!_!FE%6O\IV:3/;-#(E).[S-5*Q7 5\U\SMZ\79>
M:BW'_Z:&N!+ON>!6,S0/9A%HR=@4S]Q]F,7DY5.1?"@_FR74\="HWC['C=ZN
M.H/UWD$G+7F1'-$JZ89F](7*IMEQ0FF9P]+SD)!DJ:3ZALRW@AY,K330!Z1Q
MZEZVAM@D\ZAD16.=1;'PP%Y++BB[B-!VG:?1>&M)F\/""=/8ZL\H82>6R\['
MPRRK9_JO*7=)]1#*TJ>F;?W>1T+)9<CS25-_*O5'Y@2MDA>3-6O?W6LR!CHU
M@\F\<A#9<4"A_.389"OH-\/]$KIO<F=^7AR,OLR$!%P;!2'UM=>129(EP_:)
MS/GJ:C7]P9^BBB9%SXO=NP6<V4X&WH%-9*-@_]&XC5;.B:/>OZBR2:X,7?DM
MW98,;><<8 'TJQYOXFA/B27NQ3QHL(HB(]#SU0V X7CD'J&X"\[^I"(%K>#S
M!VFWD1*&_6VE*[[.PFSRYO)/"R"<JE^XS?M[^J3&U-Z>XPT@[JAFE(/(T@A,
M>%AY>0V?V,DCV!7J+K88:QV6#'7/-Z?\$O><726KSWOJ;[Z+_FK%V,^ZG();
MOLJ0WN!M#?/[.+*=6/<&34 .SK-WOC+V,J4:O*YS#_M,]3VW63$P98>+@"K>
M:.6OV+\!?%-4@.1O)L6#O@T%YTV_.9,XR_9<"Y:91]&0>"X&&S >$%-??IR4
MYGBLD>LPSU*70GP][M-4'/FJ>U7#[E.YS6,U#';PWL.77P(3-]):IE"CR)U"
M\"X0;^_=(_KB!G"RA=E#YL>NUR*K;@!1V55CNR"3NA#0J'\G74[Y)K77VW;G
M^)\1!>-T'S#K,-U^.=*("&<%3V5B7V#^;$TUJ9[-A$@V:+UQ(D4KV&:"K]DV
M(C<'PMV0'"RC404 =)1JX2^Z:!#. ]>'[8DNF\P)B>E^^:;JJ&2ZJ=U-(9?*
M/NCTH+4D#UO1XN&0GBO^PF ?7]^ OP6ZZB'^J8,]O?K&RDG=\="='9M&6Q/T
M_4.:*&Y9>J,YURH.::@HI!4F<V44C?<^"Q/*$-2RLSGU&=S']*%P5 'P)'8B
M"U%0.,@Z5'JM(7&*2>!C7:N/H/:DK/9"L\& '"^UA*NQ$D5_&2*P]UH0SU^<
MI?[+=#!WH]&F/HJLH'DZ:#=]6!2Z& ]X_>-,YH1<^_GP6)L#"];_NE=GS%WD
MD=$43$QD4=4*)_XBS74(YB9C7:_]@%9@ELWL60A+3+ <*IKL\@U>-JR5$^$\
M))6N-*C9.'XLTQ99AM:Q:JAIBL)>MLU1;#*FYU3N4L4]+C 8BTO(!!_ #AZ-
M/7!?V(,<:UD5VM>AZ[J@S&=+!]7IW&->]!\'DTMM.T@ K)]CB^-C ZQ?V9&R
M\B?LK_=8,DY]G-AVNE0N'(2(HLBI+1TEU2I5O3Q%_PL*JCISSE5[?">0*'V9
MY?5)!?[C#>#UI(=QH$KP>F>*9O:]9*3_]*KH?Y7W0^U_'H0UBF6RZ\2"0CK2
M**8NQ? ,[Z9:V3:5A">DA/SD&;,RUL:FV%2&#S48G1CX^6@2GR)8]N_+C1 Q
M\#$>OHB#W9K6X@O%6O1JSLJ9L5'K\0V %*E<_UN9_%)KJ9@C!#SC:I_2/1(L
MDE^7\>*EE_ R4H(S.2A.\"5 %4#M#TYJU>++OQY1>C(&*UFT>#VUI9$NM8R$
MD4QX!@C4I0U^"S1]M1TVU/ 82'^_1W.GLSA\V;:!.-%(/OHK"NK18C:/7M:I
M"3&6Z'R2'+:3\?;NCS  4VU)(.FJ,")?!U]E'&*FRXVDF)FU5/5'^V?#/8H&
M&GT?T05HQPJ ;.?&^ 82:(55*BO7GP^'*OD<MZV.[R&]TL?-/"]/;$-"_1DL
MMXPMG]8'E1A8F-T =!K#M(29#,:TTP.I6_RUA"(BZIQ2#J](3[SQ-KFM"9#"
MS<33A9F>*1:A_-97B@\*T'.#C8\K(@,K,=;.*>"TV,P?-5 "$'<:+4VUO2,#
M)ON'CJI"*M5P*Y]@.HE=9BV%N4Q;^W0$_CQ\UKQ-[EH?U)9__9>!>2I0^=O1
M'D4QPNUU,%K7"%)\ Q#=Q>8&R\U^#+*R21K4B8FS?I46-"S'F6;VW1MRCOQ]
M20%RC4Z\ ;BQ+2*#E?C_]^MOL\#)C!37+X+S\/DP"\8GU/)D^U6?88HD;8G=
M@Z0["VZLZV'KTF(!EL_Q_"B4A>/IN6^E^3_FVEBZY<UIR;-*\WXR-?_A#R:H
M42-A&O:U%>M621#J0M5B0]YBJJX,X<BFH$)6)%W375NX/B(PD]Z^P/)?.*,K
M"[5O3R]@N2 _UW^4N>Q;C?T1])'*7X](\'J<J7"S[KH)KQH7)_>2R(^DX57!
MU0AJ2I?90H.5TR8! M;_E\$DJ/BRY@5#MS_'I*_%HF3>(%MZ5+%XG1</,"21
M6%!"X0Y7I&GPX\7OK"=T?R"9%+ZJ?J5;,K55#LN=C5-55B5S<X.2X<6>GT&[
M0=PT"2XW !N]M+Y<WY[%13LFI/U&2;.H=+I=YTFCFJ6)R2:SXU!Q6>(&_%D8
MEQN/9O$=@P'SLA^ 83*:@$3E:O[BLH80U?WY^.(A*-3/S4?1^QH*J+77Y$R&
M8H;G!0P>O ,$DQ*_)5@O0*Z9VQH'5L0\^#8(.Z='\E3T"*WN\\1"O\(-<?N_
M6,<4\Q3I";AQY?>Z""!7\-+]P-/(6B,1FOL2*K3OG>7FV0G 4H0_5$PU"OKB
MDB]_\];F:;#)F3NE*L*<XEX^@$.3NN0U.WM,58N3KRA^JFU9CQI1LF!J"OI7
M>X!AD\MJM$L=O-UWGV-]<P&Q_'I_9G@+^EBB*7)]50BA18AH36RN@QOV!N (
M,8+8L=<(&Y61TY*\%2)S6I59<HG0<4IO> [N1$8O>YS*(@E$R.;(^<*-TYZ%
M\Y=UEVRZ'$R^]Z8O+;QP6"=$I9^L16MC;?T8"C5UK^JK:;D/7T(&D8SBT.X2
M(Q+U7G*B&Z?WQ9)S6FRM/E!_?/NM\81MM$6$5)2H5*%O7MQC!:T]^']O'OW6
MR9'K[U:X9@Y_';>EI5%1'B0*/3HKW=D]_H9K57?__12#V>9?'NRS4XB/;JI?
M>0?/K,Z=3\[=@#,'AV8Y&#/GR!K7NFQ:\H$\XJ;NO5-64"%-V]ZJY;S? Y0_
MRE*VG4Z8QD*N-H1.C0]9S-&^MUSL-ST^C'V]L)2768(PVKSHA)N9B6:2S6WJ
M;XZ^\BUD7CM9T_CRID!.>X!>[K<H8,1LC6'Q50KL<TY CQ"HC?ZJT Z8>G$1
M\I6S#9@7RI;PYTD[@Q#SG7I*2DECD>OG\XZ>XELIR) /21V5EIB-8A^W BEC
M32_T\[]7:6J_-?D2I436G#G$[ZNPU"C=G8,PAWS6S"J-_C^TO5=44\\?MQL+
MHB(@35"Z-)4FO8.(-/D! E)#49$:(=)#C8+T#@)*E0Y20@N!$(AT$ 'I$$I(
M:-(3:H 0#O^;<_5>G/6N=2[VY:PU,_L[GWF>M?>:(7U;L)U_N26C 'N=*//5
M3?+AR1NW7_& 5P"^%$W3G!/D!:!3K3^E".9S ;AVBCZLS:LD*Q*%XJ3%N:Q=
MJXJG0;D\?[->--0W-*<$ M_3J$[Z9_([BHRE>+!AF 'T_ >V"H3&BI]J$3*<
MO"+N<-K;!_.BN?E2G==Q/U+N<;TK_.K F$Y;B[2_YJOMHBG<8LD\?[Q/_H#F
M3[Q93Z*ON@ XDI\'1DM''=(S_]L%<7R4^E;ESH7?<WS6\_2_-W.]^Y]H)%L^
MV%+Y<#.ILFURB4P85!796%IMI"MZQDN"2H*T@SG611R.JH-*;AL1O.#3]ID'
MIX]5W-Q$$>GIMU0=Y^!ME$!H,NZ>&E60'2[6TSO88"@P-BN098)^UJ$F]56:
M[1ZP?JV7J8%W%:E]YT?M[8&]Y0<=A-WV''L#(NRS], G3?A7DP52;'^"_[:[
M<DNSF/<!L-STOX24/UOJ T%%C9(TP8\US:565_?1N%/&B<G62B]5'D+W9!5^
MD-HD N>V6!.Z]]B">R'LR0^S9Z_#0HOVM]MA2B,AK)M0:A_A<[#6^*$=VZQV
MT>SZ)%)_$],KVG4!<$[[OI(B;,KCZ+;Z7SI_GP67,*:LW'8324%7Q&\T0ZO&
MSNEE2/DX&"NIWFK43>2#-/ "<$L]MF)6:=X8I%N]P]*>(#OK]NAIM1Q#DDUC
M6/AU%5H3W%2,T/ANE=O0UU.6201UE/*,6)'>EW3QQY3!FN>O"_5NY\GY/F]F
MOW5-M5Z39GX"? &@4AL41\Y>.T90&D"'4/]E51:"> RZ-DA;*!8E@[.!VDRF
MRZ(87>L&7;P:<&Z_6_-V%N/U6-@\+5+\WTWXX?(B?:"1IPV9SPB'\>D9E=8V
MKN![R0IG-^)8>.)YHMC& E]2WI?>8KO>]S$@SZ@@T]=O#W%(@IK3D[PZ?!(_
M!5PF2 (\^*72&?V6VK:PBJ%NO:-/H/^#O4D\N8TY,6OK4XE:C,L5#!W(<PIG
M"R]R:6./&/3N?U\W#E>HGBB%9/2C4APE>1EDUYE?THTR2_0M*.99%:1.9A91
M&.;WO7RP:]C3S0V(9EZG6K3LD:Q1KVIDR6")<WJF-*/%ADFT6(I"H<OW(EEL
MTS[?\T+7OE>YMRX]CIU$CU<1 \,W&-?[<[38UWD2*!LG:4ROY$1R/]3NIC5R
M.$2*_A/^I_AX?O_QH3XZRP^::-@4R=:D&,R)IG(@<7$2S'$[S04D\>YCV6/Q
MM^78ADDNSJQ7=<ZV P9A?X#74UC9/QGO3+^Y=4>2^F55/IF76)('4T4KNGAN
MT$#MO=.G%,_GU[)Y(S8>ZQD*-#TRQ&@\X0]4-7[:/!@XP6P'/ WA7IMJ-EP@
M0UG [6[31,-H[!7P)2!NK!Z*5[F1U?S?M@7ZSJ_1&CQ:B9G$:8TVF6;7\B]+
MWUW\Z/$;Q%VW4(L?IFTOW31'Z@W"7#)J2,WY^[?GYG7V##\0&+\+W]EKMB'Q
M/C]F@Q67E3>F4RY3(V^QA;EH#'U8C,:= W>&\PK/<WW.-30(_I-@[ZQ!WV=N
M*'O):.4<K8E))A&/JV@UV49B_&)0^/!U?*/J S+#1) 28=>(4!I=/';X=7Q[
M>=1=G#?S&7&=J+EL^>-.GM*)OU/_J^I=Q,?N0'T6S]24E-US%PQF%H[U?1&\
M /2FH&&:TR>;.N=Y*!/!%(>I0UIN(^*-?-!#URF&[]=-?KM7W7]Z^WT9HN&U
M D7$(RQY"A*&NP#$L'=;E906:Q99JPM6.%7.BJYLU=3W,]]R)S19V+FF47WY
M5#O$7*+J>ACP6'8>A1ZZ 'PK9.$"!5=1-D.TAT*>D,2)?%TA-R8.M) C&6<V
M/N:90UBKE@9$**A\?LF3.+O;9*J-,6I\S+/\%)SAVHNCCCD =@4_=3'S&O2'
M'&?6;9BX9XZ"9F,_?SAJ4]=]6O]Q92(YY_?R5>ZYLJ+#1"'#S=.#,7M;W]U-
M:-XA:;-Y23)(@*B5^./?/0HW:FQ+[&"7WO+?:)13H(=0FK3^$_Y008F*AWWY
M'>G&,P N;95BRC#70S ]J7IA9].@%CVQ5?WF<V%KWJNG#1EN\MJ9>)71Q^RF
ML==R0ZP][#1&]!&/%7RF+@""K?\[$-E$@+FP?\R0G-X?HIT X<8)MKQ=HK%C
MA'S>=AJGZNZ:NC-5[OUGV.W.S7_&OV=,&WM^AUAOT^QS+-H[0Z^AC/(A6OL=
M(XVQ*A&UM"FV&Z)>3X;?O(UX%(5(['_X[#KOW_I>>'8VA]?N5Z-ZY![Y]K^E
MN9,U6Q(K_I P%2L]_UA9J4P?;_-P\V6FOL&J<_</4$5_H<_LM9-/5=@GOF\+
MK]\;9G%7<[)CL;/85-3?*09!2]6.*C.#4FP+>$ ]OL(BPN\XXG34!7%[1D#P
M,[2.D;YNOMY"3"RE06]/^QLD%:<_U%P.\KN-]-?;MM="JS]5V*M<B9X!KBB3
MXQL\);7Y!)O 3"'#"T_01/JHZ@^'PKZC/@=-<%1MPJ'HRT[^/=VD7?N/?D^_
M+@MEA,;X<=T^9]#\+W@R\W(?RUN.0;<,K)-LL=_W*]'UV)@=M\-MR36ST)T.
MS4ENO:; <?T4V^\W&3L:U?O.U^_H=^[%S!K>;LV(H+!M)I,U4KL?H *L;=V6
MIQPQ&-R:!&M-0V-'_8OO2C]2L^G3(LNO33XJ+,X#W9CE%H%D_6KC(T C'0F^
M6<7 3;_3R<A2%Y.7C>8]PF;A1:^,?1J=7^)BK_ GL_7->37=/G(S?T:T(F&F
MNDY#\@IL#!I3UU,L%UP9NQB9GD)6$XS<NZ2HV/$S<=N=.=_!Z@4YA\:!FZ3U
M$^OO_+MKX$Z[H>%E"'4TA8J4U[7 A"!4YDV_6L^TQ^JYE-%$6X&6E$UZ&"&H
M;"UZS/V<L/[F) Y:K+@N?C<\8&6&J+\3>9Z267P$+W5MU-J>9SI_(,_ZH;*V
MEEM:/^Y:^W:J+4)3+': /'9.C1T$KIQ+#4O;A>]#0L9P\\7P/UZ:N-YTO?X2
M?EW//: >>]]3!<=TXS7Y#4/X6WW"4@\MKF+X^N.1K(XI<\_TB<P-HX!T3X-1
MU,/9_FGK&Q+1RK@>;G>ML2UF4P4Y,<?G,2][$P<)2]W;N*S_MU5JA<QXP:'(
M<DZQLR8BM:;ICCVC?V><ZEQ\J=!K$DVUL+,?1G\G"US>"9-9*$NI/S%OO&82
M^"_UXW_1]OQN_'>5^[6)-V"^!2GNLB#OW6/6D>H+P-3A-.',,")$?K)*)G;W
M+N;?75+!SNKHJ=*9BG%@U.>&9LNJK0Z9GVR+)Q;WJ+*\ZMT4 +IX^L@+P%VX
MGK[IV\3GID3!XJ-X]PD??YP$1@#UL1C%%&LF\GYO;\=(Y\YO%*ZWT4A;S_L"
M$'$!$#B7\_,+O #8C?[S9XVAW%N %+X:>6]X$Z*GBX2?,5P OH32E 8_[WZ;
MI!"!O5?V\M/MQY(_NN+3>DQ;?6,>H4]26/:@[6HG.JS;[!> -^<T%P"= EBE
M\*5<AT+WDL0Q<I3V4U9*LJ9.X?_--8V2)57%5B"DS6H6].J\Q<+SH_UVH?D4
M.>/*TNE034^,4/ON;1+T=:)Q8P,JZU4"9.<2D%\C6S+^Z!2'TZT7OWN6X/_Z
M6N_@& \#QNCYV%NH7<@:3540(\$O2B1S=%>_R8(?^#7-S8>]PDO2^N7H($>$
M G-?W%:OO8.6 8"EZG)*,[FC*P\V0=/NR=*'C]T$XL^[BVK+]<.#^MZ;/S$'
MA.K(7]^C\OYJW)C.>=C<[P*]'21:\$]#JVZ4G",MFAD5,B+LX7H7N =4$T_/
M.>E5Z"^!T./F5&G'R485>C*MD[5XE6=VMG- 8' .W70*V]_'CFI/M"3U..HE
MEN0YPUG,_<"7UOR9HF,C\E&"3$-X[6?.E".)=\R<#!076S)!IC_*SWR1\B)&
M]FLE#\JY<X"FH:Q'XK4:[OF_IYM_;9[?R7R?8JA:Z%+6[P&5S1=)[YF^+Y3K
MI'3]/W/'L6QQGCO<^@49&7UR\A#*'8B!DG"LEPM4ZC]",ZII8E>@1>.6($^&
MZ./TIT6UMQ.HA^:">N64Y0BP3BZF>//_QI8C/YA+@--W7'+2\4;29YG:[[J7
MK\0R&@1P@2H+$C<)B)72'U [WUYQN4YQ6FOU4@W!+*2**@T(9+J_<C[W48_C
M+VQA[4.RUHR"D#N=.D_;&:XW4H9GP*]$H$-F"QG&GZ)@EJO#=8LM?IJGEZ]Z
M;&\_VRESW;ED-O"$HHANW:&9'X%: ??&QC121U59_ST021>_[2I'^_:C6)5:
M@TQ@2_OUT,>\5-='&T=6!AYN<WC225YA @;)$\YS\TOM@%;Z;CZE SXB]+3+
MZX-=;1]POX)TJ@39[5?4KP'>F.MKL@9&ZG&4Y!/0G0&E473U7O92"](CUOT/
M%@S2Q_39KBHX(,P9=#;A3W>^Q$</]S4U>RQN"A#TL1'>Q".:QY4K#8F[NBO4
M9O=/$H!4T<N3YRR,,5_];;L?R_?KNOL?Q1+$.ZQ40[T[77Q\D#20!QO!6NNK
MZK?^V/X7_QARM5:D0/!5$=%L=A$;GHFA\46,6]U<E6/4PG3C@.4TPO>:N?Q.
MU4_NAIR%L#P_7Q!N+&A8==OWD5K1]3Q0[GU]GD=6*H?\[#5C<C5+/UHO8VUH
MF!#G%00U\_IS*3#Z2(B]"^KY)'S_UB^^G&95.I*67JRN^4L09+LP5* >WI++
MKGOO[O7G0&\/YA; *^7N#U1<H2V*3\RB!<9.S_7<6H=LEW!Y$6#IZ8:S^"<*
M6_9G9M,"R3/04;^3Q="YB'WNL&RG. _=0K+,WP.%Q4R&<AM]0)*F8'&%S4+#
MVPFCCN_%05=9(!Q.N469&\Y%AZVGT2ZU?7-!0H2JR;0;V:?V-!8B/\9PMWPD
ME5_]PN%NXCJ%^0 =SS1"K\R;?0CA_!<0<C-F;T,=I)*1 RV;FQ]8_O-[E-?_
MO2-/FK77WM*U:S&7Y7&('29B=S>XI^81\^_?.(=0C:!DRO6#2V8'0=*31*!.
MZ(YC=(K,Z^?OQ$P@IJ98A ?@JL>K=31= ZV0;88%'/Y=O"C=96\J%:6S=P&H
M>A^=70#F$W*-RPW8MQ%E5O%C23&SFS+L6W)398#8&[34--<BVL:*ZF+8^.XI
MPN>1NAS:$I5E*>'?[B2?_9JY'I:D4XJ]'-[$8>YWMR/0@$2)-K]LJ@LF9R*;
MV,M+-388H>E9]#.E..IW^<8-Q=-'3W:.%61)EKB2J0P+D%)$"Y- ?SQLA[;^
M3PR+8"!4ZK?_,YJS'N,94X6^ZZ[KJBQCWC+U>FQKC3$CCCKYP/(@V$*3GTAX
M8_.<O,@MZQKC*PI3!:$!<X\*8FXP&VD"_O]Z_C]F_[/ARLN>7/]?BZ!FP@6
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M&8KUX$W7LUE2-4F)\@-HJ1N%)6-2#6<0W+$43O'6DO,'ARXR0S $60KJZ1*
MU<BM.R]0Y=QX< $(D]:#,FH*EB[1<&]STF&WQNCALUOB: $)[M^ET;=S;_9
M*FP92-N+4,Z-OR[(>XBCS?ZM'7&\NHORV\70Q=D!'J=G1;?4;5&']SFF>LS0
M=>CN83IGY%%%Z;^[\Y#"]M/XG+S/1K"J=N38NV:DX[O5_[21PB@6SU*&!"G;
MTDMEGU$RAA,3/XFZ)]26_E-D_427ZE'N'+"<Z0TKR_J27&A_O9RO@HF/J\Q
MTBLF0!JS?];L\(CR4A0JU1@NXP0V;%O76ZD:VX*5;X+/S(*D]@X$PZS&9:Y5
M6\H6ON7*^;'!"A9%]KV39(ZY\?Y*#S:;;J&@H5K->3?2K&K))Z,K*G$Q*1[6
M>Z1[/'/CO@EBX$_8PM.)O>'0"X#3<)0J;1/)W*,<(MS-2OS7QIBEVYK8T?8(
M,5;-@P0M25:FT#2AIH\\GSD:Z_3UX=7BN>ORNH(]!_#8*&6A@IXVH:G#F:HE
M>,H.%65BI!31:$85]]FH,%-T$Q4JB^:6D_G=7!6LLMOQ4N)LK&5OPNW-RVWH
M+#IMY?@#ZL )LR!&G(Q<5*.V(U78M)[1A;T%'U7$H@5U9;5[!VN9:S?D 9G[
MZVH@M?#:?R.NVEVL^AR9H>OO)J2!1RA6??:7M?"RL"%C(\O/CZY<"S.FC-A2
M32G[G\E!$!U(SHQ9G\UMOJW&H[8/'KNI*R=^+52<]/QX5&$O=YU9!>=4J#M*
MJ1H2L6N7US5YFHO&9V552 6#F,VDU-D??IM\6&;Y^DE/[QU#E1=JT=69P-5#
M\LV$FKC<([\385AK;K??F1Y9MH'0%HVG)^E2#>5524>7]CHX>'GY?!S)?GD/
M(X_YD,_VQF2%(F+B \6 <(VQN'B:+B9(=+5WE:>+V\&)]+GBQIYN4;QED0:S
MA%(AC]G<?76;4OENB'D'-NP"P-!&CX7(=:L1ON0Q; 3H)U3E;R!]&LL_9+"Z
MJ?QKLC%@33?B<NBQN3\2L77E%W,?U!'*M8')^R+#'H$D5'5? .)]H$RN53\6
M9J4Q''*R\1P>A2\K4Q1X-;YJW4^.HAR:PA"'NU98^;.I]7IS84UTWC)V-:41
M,>\<6 7;5B?,&DU)S_,93(G! ^>?8Q;VL&?"VFVHV/[OW]_YI3^RY*-*BQP:
MB+_LK2YN%V./ZXU1?K/ -G9X K1DE9,%<?9\]P,SU\^F",4\+HJV3QX#.1A%
M_Q(JAD0DGBFZ<M^FJ%CIXW9O01"O"/J-R246EECG7*&8?C.+TDS=S#TI'R9K
M,8<[KPO#TJ_X=QL3J+<VB=0=ES/2('YW0S8CH#$A5Y1(M?G/9,'J1-'5YG[(
M8%DG_/,[TY@Z):4K8L_+;Z0V;IYAPUZJ00\= L7R_"@IL^1+Z90#G=\O" H@
MB$=E=7"_F5*>('I[Z1;H"F03!1:_,/'<(7ZJ! B!TMY=X7GP+XAA:9 &+QOA
MDTAG!W5Q"0EJ'/"NZ7^@0VS6GK;1.KQ31&U=WGM]JL^(?)\4CE>;/L7BJG8[
MJ\PUB7D154O-(W#UBFG \;O%['9^<X&D$V-Y@8[06_>'A+<,J4EV!@3#<._X
M:[H->IQR^O"$R84%U:BH'U=V()L+547-K=[[-A< PU[]\.J\Q,.U8'+FOKR-
M\-$W4G UU!T>4?C31J- 8 QKW8L[U^Z+ ]9:=@P<!:=()FF-BQC07>FV1)T7
MMG%:3 \'4 020#K2,D3^,0QF6%&[M+;C3_?=)3]YC?ULCL?M,"82^Z(:)UD@
MLF=OD'#<;7[:E:'8O?+%$U(RTP#"*JX7?68<7V")GI9<P0CP@/O[V_%!<F>B
M9"T2B)"'+PT5E58RO'L!Z'##C?EF3)H 9\\37S\Q/2!P::H^F__V+:AB_WW<
MI.(>%B9*\0V VE2ATAKJ5A$&H*!J.!EJ4S!<QGH41Z F\^Z1"H*M]@U'4G"B
MC/IZVJT-F?[95Z/O,';4_;'@NNXZL\9)ZTPR60*'D5VJ+%P>V.;[G)<'NZ@<
MW/-#.LQGE["]MUA^5_\B_.-.(6VH5]+-513C%,XNOO(@+Y+R<!3%CM>5,;RQ
M2>\G%T&VP4?!UM )0*EKK0VKJ^_C\A5>^&D.[7SO7T?I4G=9A@A#]/!IB9W"
M9^F(D=T#)2RM*NQ-QE__5$U^D\A]5(3)RMUGJ1_GY%6$S7\7NV=> -;E;!%I
MR9DM,<'0Q8TV/9/J"30(''XJD!.^,@0OERD^[)R9M09" HV;$G1'G3X7T'*V
MT%+>N^<'9+^_>E/(4/.\2)D:3\\J'N%]-F^U9'7^*P5+8=C6-+LF_<[BRRC[
MQZ24.#I^![[\]NOFB>L7@"M!;J5D6I)+OGY)NUBK_5(+E'$CO?'8Z&O]9]A*
M<Q+X78'&@[XKLRDZ2NI5M#2XO!AI0TQ]SX(0D@"+$9-6<:3T $7-=8D<LAC/
M(M]HYG@?1['DDLZK .=L8C<_PGCG D#%O>]Z%EAL,.G.V7"&(:?X8DW&E.^?
M&9!EB!> *%%O??8N?<%"R%ZW<T:FST2F#>I%]+U;@M&,QL5 7AJ&,-O$"M?T
M4\$,_[(%*8'B(G'E/\D-<0ROZ^_^I)'XI0RXQ.8E;*0==8B '<0)UQOJ Z/B
MOK.^P$RT;N-O(=).%H,DOM_;\"^,P<CS^\WA3<W$:ZXT>66>1N)@,7!Q;I*L
M*-"*,-$;OHI,][81._GVA]?R/I\_2_)MUF?<;[G%MMZ/-YR(<UX %H75VC9F
MUSU^CY2#ZR\'18E6VJZ*TQ/'\.$6\F$DJ1<((K^Q:\C36LK(WVW*X-,SF[:.
MLST3!O)/2%+Y8IQ33"CV*)T$]G$2&+?EPX*Y<H(KOE/%#]$69[>9_BD\AC[5
M7KHF@"Q[.Q@4Z7,F'&3]5UQ9K_+? C>B95*9V]\!M,ATM.DM9Q5@8Z,<HZ=[
MAM+T9(Z<S1-Y\^! )?#(@>B>@=OFTQKQ_AS(<DFSAIV&3YO#E0<-O)BNGV0'
M'S->#L#;[ZV&2_=O5>CI?\7<OR5"W#',!:T%80$NL,''(7Z&=1O!*CY$I4XS
M.T+T"29]F/2RR*(!//<R9+SGWC<ZUN5S3'W068 ]C*4*#V9T6: E[)3"0*S<
M]J,-LR[B8CNR4B<>#]-],3]J?UU?O I:%07JDM+*G2\ -\3&<%H-&2%4X^]
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M^FGFD5J#7V>51L=Q+D]DE\:9[- IK>R6KI,'9S?\SZB(A[9HBY9 7+WBYV;
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MLVZ_2<\&0>L0Z,/AA@R;4]"W(PT#OLB6YKT%0S&9^XZ83[6G /V/BM!M?<*
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MP*+.4U#"9<"-"X#+9)"Z:G[90-%<CE$USYE^:T]V3)(^T\V/G*'D$V.ZU5\
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M[0Y3>[6:[?DWLBALTVH2)GI4Y?;3U>H\(_K>SH)SV,P\IB=9*.4_IYM]699
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MJ;HRC%8"DZ5(#J#;9,?*FJV<.N(E6)S,8?OVY_S]TRVTH-&PSF-Z(X;%M *
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MF6>6Y")4/Q4*@1\O*?[;;"""^(X22=$H3H);7Y*S$0%'T22:%@/=N+)=&V@
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M7X<SY1>A?V(8X'"2\5'0M+HV=Q+D:;-J2A*L-R>YM0+8K-0Y%_QR1I!._DF
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M1BGDO96A74=FKN-;CRUX3>6&*W;5#^68=6+<&]PX'HGT($22C'%>=:MWD<Y
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M@%UH "8&@=O+GF$"T])O#Z/(:B;T6->63-'KB;7NG],=.",^W/?/U HRMY,
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M HNS/_Z/7H[[+P;[Y?3_ E!+ P04    " #,@X-:E;ICM'H$  #W&   $0
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M+ ]A^(02=M#6>6 ?)Y3&8S;2X[H\P20?OZW^GP$<=P.J;O($Q^%_4$L#!!0
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M@O]K5,)&_-+HZ.WHAZ/]ES3:*Q^^>(($)_ &+H!HYC%=/S(EI3$7PEYQ[9[
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M0OS%?(J9$^]52=@\5 /:U:J"L'X^6P(Q\;V1@4U -6"ZJMZ+S'8,:((CC/B
MT?7J2SG;\:LMV[&J( A)',A:4"P$ 1(?94UVC&/*@&@*^EFZ+(#$91#68;]#
M,<?>TGY7,9IE:Z'3D0K/H4J-ZXIF!33+2EV-XHXF\["0]#R;&;BI%0*+;^2/
M4<B1^.3_4$L! A0#%     @ S(.#6GVQ9T="$   *!$   T
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M 0 ;VP$ #0              @ $]+0( <')O>'E?,# Q+FIP9U!+ 0(4 Q0
M   ( ,R#@UH_L]*8W7$! !.F 0 -              "  <?8 P!P<F]X>5\P
M,#(N:G!G4$L! A0#%     @ S(.#6I6Z8[1Z!   ]Q@  !$
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64$L%!@     *  H < (  ,AT!0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>kartoon_idef14a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:TOON="http://kartoonstudios.com/20241231"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="toon-20241231.xsd" xlink:type="simple"/>
    <context id="From2024-01-01to2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AndyHeywardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AndyHeywardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AndyHeywardMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AndyHeywardMember_custom_FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AndyHeywardMember_custom_YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AndyHeywardMember_custom_ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AndyHeywardMember_custom_ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AndyHeywardMember_custom_FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AndyHeywardMember_custom_YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AndyHeywardMember_custom_ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AndyHeywardMember_custom_ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AndyHeywardMember_custom_FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AndyHeywardMember_custom_YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AndyHeywardMember_custom_ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AndyHeywardMember_custom_ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_PeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">TOON:AndyHeywardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001355848</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">TOON:AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2024-01-01to2024-12-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="From2024-01-01to2024-12-31" id="Fact000004">0001355848</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0010">DEF 14A</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="From2024-01-01to2024-12-31" id="Fact000011">Kartoon Studios, Inc.</dei:EntityRegistrantName>
    <ecd:PvpTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000013">&lt;table cellpadding="0" cellspacing="0" id="xdx_883_eecd--PvpTableTextBlock_zkYLYdkzxeX1" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="text-align: center; padding-left: 2.75pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: top; padding-left: 1.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;Andy Heyward (1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 6%; padding-left: 1.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;Year&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; width: 15%"&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center"&gt;Summary Compensation Table Total&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center"&gt;(2)&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; width: 15%; padding-left: 1.4pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 19%"&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center"&gt;Average Summary Compensation Table Total
for Non-PEO NEOs&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center"&gt;(3)&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 15%"&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center"&gt;Average Compensation Actually Paid to
Non-PEO NEOs&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center"&gt;(4)&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 15%"&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center"&gt;Value of Initial Fixed $100 Investment
Based on Cumulative TSR&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center"&gt;(5)&lt;/p&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 15%"&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center"&gt;Net Loss (in 000s)&lt;/p&gt;
    &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.4pt; text-align: center"&gt;(6)&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(238,238,238)"&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: center; padding-left: 2.75pt"&gt;&lt;span style="font-size: 10pt"&gt;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eecd--PeoTotalCompAmt_c20240101__20241231__ecd--IndividualAxis__custom--AndyHeywardMember_fKDEpICgyKQ_____zmkCphB2sB18" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;1,075,384&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eecd--PeoActuallyPaidCompAmt_c20240101__20241231__ecd--IndividualAxis__custom--AndyHeywardMember_fKDEp_zRk01orpmrid" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;698,509&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eecd--NonPeoNeoAvgTotalCompAmt_c20240101__20241231_fKDMp_zhorMkhADUL1" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;423,220&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20240101__20241231_fKDQp_zoiIMOi4zLM4" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;409,937&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eecd--TotalShareholderRtnAmt_pp2p0_c20240101__20241231_fKDUp_z8JauyUAInKd" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eus-gaap--NetIncomeLoss_c20240101__20241231_fKDYp_zVgB69Ze0O3g" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;(20,941)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: center; padding-left: 2.75pt"&gt;&lt;span style="font-size: 10pt"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--PeoTotalCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AndyHeywardMember_fKDEpICgyKQ_____zZeeJsSMlkX6" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;1,492,368&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eecd--PeoActuallyPaidCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AndyHeywardMember_fKDEp_zWQFyDRnVbEj" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;(1,861,069)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_fKDMp_zNcwrWD4oBeb" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;359,086&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_fKDQp_zOgRqUrf4CM7" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;247,838&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--TotalShareholderRtnAmt_pp2p0_c20230101__20231231_fKDUp_zl53Id9qCtRc" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;13&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eus-gaap--NetIncomeLoss_c20230101__20231231_fKDYp_z67WfJXLiLu3" style="border-bottom: black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;(77,103)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center; padding-left: 2.75pt"&gt;&lt;span style="font-size: 10pt"&gt;2022&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eecd--PeoTotalCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AndyHeywardMember_fKDEpICgyKQ_____zcGmukttk2Cl" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;1,450,384&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eecd--PeoActuallyPaidCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AndyHeywardMember_fKDEp_zrxsC3HzhIA8" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;(5,369,928)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_fKDMp_zZJEPx2OdNC6" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;494,981&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_fKDQp_zO03IdrUvEUg" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;173,217&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eecd--TotalShareholderRtnAmt_pp2p0_c20220101__20221231_fKDUp_z2G4qW5ENAs8" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;44&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eus-gaap--NetIncomeLoss_c20220101__20221231_fKDYp_zAg3pUCmF2z8" style="text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;(45,595)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2024-01-012024-12-31_custom_AndyHeywardMember"
      decimals="0"
      id="Fact000014"
      unitRef="USD">1075384</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2024-01-012024-12-31_custom_AndyHeywardMember"
      decimals="0"
      id="Fact000015"
      unitRef="USD">698509</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000016"
      unitRef="USD">423220</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000017"
      unitRef="USD">409937</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="2"
      id="Fact000018"
      unitRef="USD">6</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000019"
      unitRef="USD">-20941</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-01-012023-12-31_custom_AndyHeywardMember"
      decimals="0"
      id="Fact000020"
      unitRef="USD">1492368</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-01-012023-12-31_custom_AndyHeywardMember"
      decimals="0"
      id="Fact000021"
      unitRef="USD">-1861069</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000022"
      unitRef="USD">359086</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000023"
      unitRef="USD">247838</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2023-01-012023-12-31"
      decimals="2"
      id="Fact000024"
      unitRef="USD">13</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000025"
      unitRef="USD">-77103</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="From2022-01-012022-12-31_custom_AndyHeywardMember"
      decimals="0"
      id="Fact000026"
      unitRef="USD">1450384</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2022-01-012022-12-31_custom_AndyHeywardMember"
      decimals="0"
      id="Fact000027"
      unitRef="USD">-5369928</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000028"
      unitRef="USD">494981</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000029"
      unitRef="USD">173217</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2022-01-012022-12-31"
      decimals="2"
      id="Fact000030"
      unitRef="USD">44</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000031"
      unitRef="USD">-45595</us-gaap:NetIncomeLoss>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000033">&lt;p id="xdx_84B_eecd--NamedExecutiveOfficersFnTextBlock_dU_zIsBTIUCZq4d" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td id="xdx_F05_zt0c8QeZGnt9" style="width: 0.25in"&gt;(1)&lt;/td&gt;&lt;td id="xdx_F11_zQZNX91jSvs5" style="text-align: justify"&gt;Mr. &lt;span id="xdx_90C_eecd--PeoName_c20240101__20241231_zOtsbvXUYKe3"&gt;&lt;span id="xdx_904_eecd--PeoName_c20230101__20231231_zVv5wMCiLhsi"&gt;&lt;span id="xdx_90A_eecd--PeoName_c20220101__20221231_zoyWD43L29Pg"&gt;Heyward&lt;/span&gt;&lt;/span&gt;&lt;/span&gt; served as our  Chief Executive Officer and Chairman during each of the three years presented
in the table.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td id="xdx_F06_zjJ8m53QAZn1"&gt;(2)&lt;/td&gt;&lt;td id="xdx_F19_zBoDoaRtiL47" style="text-align: justify"&gt;The values reflected in this column reflect the &#x201c;Total&#x201d; compensation set forth in the Summary
Compensation Table (&#x201c;SCT&#x201d;) in each applicable year.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td id="xdx_F0F_ziSMDf5zdzX4"&gt;(3)&lt;/td&gt;&lt;td id="xdx_F18_zfizCwFNU2Tg" style="text-align: justify"&gt;The dollar amounts reported in this column represent the average of the amounts reported for Non-PEO NEOs
in the &#x201c;Total&#x201d; column of the SCT in each applicable year. The names of each of the Non-PEO NEOs included for purposes of calculating
the average amounts in 2024 were Brian Parisi and Michael A. Jaffa; in 2023 were Brian Parisi, Michael A. Jaffa, and Michael Hirsh; and
in 2022 were Michael A. Jaffa and Michael Hirsh.&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.25in"&gt;&lt;/td&gt;&lt;td id="xdx_F0E_zdztcojDxbia" style="width: 0.25in"&gt;(4)&lt;/td&gt;&lt;td id="xdx_F17_zzropABX62I9" style="text-align: justify"&gt;The dollar amounts reported in this column represent the average amount of CAP to Non-PEO NEOs as a group,
as computed in accordance with SEC rules described below.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td id="xdx_F00_zHhSO0bkgHf2"&gt;(5)&lt;/td&gt;&lt;td id="xdx_F1A_zwLAZA7Ml006" style="text-align: justify"&gt;The cumulative total shareholder return (&#x201c;TSR&#x201d;) is determined based on the value of an initial
fixed investment of $100 in the Company&#x2019;s common stock at December 31, 2021. The Company did not issue dividends during any of the
covered periods.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td&gt;&lt;/td&gt;&lt;td id="xdx_F00_zPMcDK90Mkub"&gt;(6)&lt;/td&gt;&lt;td id="xdx_F1B_z3p1Zu6tYBg" style="text-align: justify"&gt;The dollar amounts reported in this column are the Company&#x2019;s net income amounts reflected in the
Company&#x2019;s audited financial statements for the applicable year.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName contextRef="From2024-01-01to2024-12-31" id="Fact000035">Heyward</ecd:PeoName>
    <ecd:PeoName contextRef="From2023-01-012023-12-31" id="Fact000036">Heyward</ecd:PeoName>
    <ecd:PeoName contextRef="From2022-01-012022-12-31" id="Fact000037">Heyward</ecd:PeoName>
    <ecd:AdjToPeoCompFnTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000044">&lt;p id="xdx_84F_eecd--AdjToPeoCompFnTextBlock_dU_zn22kE0ORiI" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;SEC rules require certain adjustments be made
to the Summary Compensation Table totals to determine CAP as reported in the Pay versus Performance table. CAP does not necessarily represent
cash and/or equity value transferred to the applicable NEO without restriction, but rather is a value calculated under applicable SEC
rules. A significant portion of the CAP amounts shown relate to changes in values of unvested awards over the course of the applicable
reporting year. Our NEOs do not participate in a defined benefit plan so no adjustment for pension benefits is included in the table
below.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following tables below detail these adjustments
to compensation as reported in the Summary Compensation Table:&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Andy Heyward&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 83%; font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Reported Summary Compensation Table Total for 2024&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eecd--PeoTotalCompAmt_c20240101__20241231__ecd--IndividualAxis__custom--AndyHeywardMember_zmOfjsJDrrl7" style="border-bottom: Black 1pt solid; width: 13%; text-align: right"&gt;1,075,384&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Deduct: Fair Value of Equity Awards Under the &#x201c;Stock Awards&#x201d; and &#x201c;Option Awards&#x201d; Column in SCT&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eecd--AdjToCompAmt_d0_c20240101__20241231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zbhGV8mc2g0j" style="text-align: right" title="Adjustment to compensation amount"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Add: Year End Fair Value of Equity Awards Granted During the Year that are Outstanding and Unvested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eecd--AdjToCompAmt_d0_c20240101__20241231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zavd5szJZFTl" style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Add: Change in Year Over Year End Fair Value of Equity Awards Granted in Prior Years that are Outstanding and Unvested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eecd--AdjToCompAmt_d0_c20240101__20241231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zzmOaufRMo8f" style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-style: italic; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"&gt;Add: Change in Prior Year End Fair Value and Vesting Date Fair Value of Equity Awards Granted in Prior Years that Vested During the Year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eecd--AdjToCompAmt_c20240101__20241231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zcfttWJbQpci" style="border-bottom: Black 1pt solid; text-align: right"&gt;(376,875&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Compensation Actually Paid for 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eecd--PeoActuallyPaidCompAmt_c20240101__20241231__ecd--IndividualAxis__custom--AndyHeywardMember_zMrat5uOvS56" style="border-bottom: Black 2.5pt double; text-align: right"&gt;698,509&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Reported Summary Compensation Table Total for 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eecd--PeoTotalCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AndyHeywardMember_z6c3P0u5yp29" style="border-bottom: Black 1pt solid; text-align: right"&gt;1,492,368&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Deduct: Fair Value of Equity Awards Under the &#x201c;Stock Awards&#x201d; and &#x201c;Option Awards&#x201d; Column in SCT&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zk5Gv7vOVjFl" style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Add: Year End Fair Value of Equity Awards Granted During the Year that are Outstanding and Unvested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zuMZLk6t5i5i" style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Add: Change in Year Over Year End Fair Value of Equity Awards Granted in Prior Years that are Outstanding and Unvested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_ziw9bKIBIhrb" style="text-align: right"&gt;(3,056,250&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"&gt;Add: Change in Prior Year End Fair Value and Vesting Date Fair Value of Equity Awards Granted in Prior Years that Vested During the Year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zXt0WvhLtYr7" style="border-bottom: Black 1pt solid; text-align: right"&gt;(297,188&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Compensation Actually Paid for 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eecd--PeoActuallyPaidCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AndyHeywardMember_zWPuAudMcavh" style="border-bottom: Black 2.5pt double; text-align: right"&gt;(1,861,069&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Reported Summary Compensation Table Total for 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eecd--PeoTotalCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AndyHeywardMember_zp8BBDWIKtu5" style="border-bottom: Black 1pt solid; text-align: right"&gt;1,450,384&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Deduct: Fair Value of Equity Awards Under the &#x201c;Stock Awards&#x201d; and &#x201c;Option Awards&#x201d; Column in SCT&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eecd--AdjToCompAmt_d0_c20220101__20221231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zcTtckllbGol" style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Add: Year End Fair Value of Equity Awards Granted During the Year that are Outstanding and Unvested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eecd--AdjToCompAmt_d0_c20220101__20221231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zhhixwzhhukf" style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Add: Change in Year Over Year End Fair Value of Equity Awards Granted in Prior Years that are Outstanding and Unvested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eecd--AdjToCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zLa8BLae7O4a" style="text-align: right"&gt;(6,032,813&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-style: italic; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"&gt;Add: Change in Prior Year End Fair Value and Vesting Date Fair Value of Equity Awards Granted in Prior Years that Vested During the Year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eecd--AdjToCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AndyHeywardMember__ecd--AdjToCompAxis__custom--ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember_zsD04e6ep0Kc" style="border-bottom: Black 1pt solid; text-align: right"&gt;(787,500&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Compensation Actually Paid for 2022&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eecd--PeoActuallyPaidCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AndyHeywardMember_zL6hkqS17CY5" style="border-bottom: Black 2.5pt double; text-align: right"&gt;(5,369,928&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


</ecd:AdjToPeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2024-01-012024-12-31_custom_AndyHeywardMember"
      decimals="0"
      id="Fact000045"
      unitRef="USD">1075384</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_AndyHeywardMember_custom_FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember_ecd_PeoMember"
      decimals="0"
      id="Fact000047"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_AndyHeywardMember_custom_YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_PeoMember"
      decimals="0"
      id="Fact000048"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_AndyHeywardMember_custom_ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_PeoMember"
      decimals="0"
      id="Fact000049"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_AndyHeywardMember_custom_ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_PeoMember"
      decimals="0"
      id="Fact000050"
      unitRef="USD">-376875</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2024-01-012024-12-31_custom_AndyHeywardMember"
      decimals="0"
      id="Fact000051"
      unitRef="USD">698509</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-01-012023-12-31_custom_AndyHeywardMember"
      decimals="0"
      id="Fact000052"
      unitRef="USD">1492368</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_AndyHeywardMember_custom_FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember_ecd_PeoMember"
      decimals="0"
      id="Fact000053"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_AndyHeywardMember_custom_YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_PeoMember"
      decimals="0"
      id="Fact000054"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_AndyHeywardMember_custom_ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_PeoMember"
      decimals="0"
      id="Fact000055"
      unitRef="USD">-3056250</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_AndyHeywardMember_custom_ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_PeoMember"
      decimals="0"
      id="Fact000056"
      unitRef="USD">-297188</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-01-012023-12-31_custom_AndyHeywardMember"
      decimals="0"
      id="Fact000057"
      unitRef="USD">-1861069</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2022-01-012022-12-31_custom_AndyHeywardMember"
      decimals="0"
      id="Fact000058"
      unitRef="USD">1450384</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_AndyHeywardMember_custom_FairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember_ecd_PeoMember"
      decimals="0"
      id="Fact000059"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_AndyHeywardMember_custom_YearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_PeoMember"
      decimals="0"
      id="Fact000060"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_AndyHeywardMember_custom_ChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_PeoMember"
      decimals="0"
      id="Fact000061"
      unitRef="USD">-6032813</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_AndyHeywardMember_custom_ChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_PeoMember"
      decimals="0"
      id="Fact000062"
      unitRef="USD">-787500</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2022-01-012022-12-31_custom_AndyHeywardMember"
      decimals="0"
      id="Fact000063"
      unitRef="USD">-5369928</ecd:PeoActuallyPaidCompAmt>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000065">&lt;p id="xdx_84E_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_z3GS7WQmaxm5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Average Non-PEO NEOs&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 83%; font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Average Reported Summary Compensation Table Total for 2024&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eecd--NonPeoNeoAvgTotalCompAmt_c20240101__20241231_zAXUtODhzXn7" style="border-bottom: Black 1pt solid; width: 13%; text-align: right"&gt;423,220&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Deduct: Average Fair Value of Equity Awards Under the "Stock Awards" and "Option Awards" Column in SCT&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eecd--AdjToCompAmt_d0_c20240101__20241231__ecd--AdjToCompAxis__custom--AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zLARZr8GtEp4" style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Add: Average Year End Fair Value of Equity Awards Granted During the Year that are Outstanding and Unvested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eecd--AdjToCompAmt_d0_c20240101__20241231__ecd--AdjToCompAxis__custom--AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zE03P9EB8hLb" style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Add: Average Change in Year Over Year End Fair Value of Equity Awards Granted in Prior Years that are Outstanding and Unvested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zmqNqzIbCbw6" style="text-align: right"&gt;(8,680&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-style: italic; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"&gt;Add: Average Change in Prior Year End Fair Value and Vesting Date Fair Value of Equity Awards Granted in Prior Years that Vested During the Year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eecd--AdjToCompAmt_c20240101__20241231__ecd--AdjToCompAxis__custom--AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zWryXa3DpnJb" style="border-bottom: Black 1pt solid; text-align: right"&gt;(4,603&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Average Compensation Actually Paid for 2024&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20240101__20241231_zNuRS21gwACi" style="border-bottom: Black 2.5pt double; text-align: right"&gt;409,937&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Average Reported Summary Compensation Table Total for 2023&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_zR4oZBU5sNf3" style="border-bottom: Black 1pt solid; text-align: right"&gt;359,086&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Deduct: Average Fair Value of Equity Awards Under the "Stock Awards" and "Option Awards" Column in SCT&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_z56L4HEcjuWa" style="text-align: right"&gt;(16,683&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Add: Average Year End Fair Value of Equity Awards Granted During the Year that are Outstanding and Unvested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_z0bZskGjznd7" style="text-align: right"&gt;16,217&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Add: Average Change in Year Over Year End Fair Value of Equity Awards Granted in Prior Years that are Outstanding and Unvested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--AdjToCompAxis__custom--AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_za5Dfub0Rpf6" style="text-align: right"&gt;&#x2013;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"&gt;Add: Average Change in Prior Year End Fair Value and Vesting Date Fair Value of Equity Awards Granted in Prior Years that Vested During the Year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zZB9IhnKCDV5" style="border-bottom: Black 1pt solid; text-align: right"&gt;(110,781&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Average Compensation Actually Paid for 2023&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_zAkmCFisuaR9" style="border-bottom: Black 2.5pt double; text-align: right"&gt;247,838&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1pt"&gt;Average Reported Summary Compensation Table Total for 2022&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_z2eYccZahR34" style="border-bottom: Black 1pt solid; text-align: right"&gt;494,981&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Deduct: Average Fair Value of Equity Awards Under the "Stock Awards" and "Option Awards" Column in SCT&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zB6ua50Cvxua" style="text-align: right"&gt;(235,494&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Add: Average Year End Fair Value of Equity Awards Granted During the Year that are Outstanding and Unvested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_z0pG42yG0nh5" style="text-align: right"&gt;143,403&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-style: italic; text-align: left; text-indent: -10pt; padding-left: 20pt"&gt;Add: Average Change in Year Over Year End Fair Value of Equity Awards Granted in Prior Years that are Outstanding and Unvested&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zm8JnQZZ1Zii" style="text-align: right"&gt;(138,690&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="font-style: italic; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt"&gt;Add: Average Change in Prior Year End Fair Value and Vesting Date Fair Value of Equity Awards Granted in Prior Years that Vested During the Year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zdWbnOv7E72g" style="border-bottom: Black 1pt solid; text-align: right"&gt;(90,983&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"&gt;Average Compensation Actually Paid for 2022&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_zywv8Bp7rDxf" style="border-bottom: Black 2.5pt double; text-align: right"&gt;173,217&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000066"
      unitRef="USD">423220</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000067"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000068"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000069"
      unitRef="USD">-8680</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000070"
      unitRef="USD">-4603</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000071"
      unitRef="USD">409937</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000072"
      unitRef="USD">359086</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000073"
      unitRef="USD">-16683</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000074"
      unitRef="USD">16217</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000075"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000076"
      unitRef="USD">-110781</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000077"
      unitRef="USD">247838</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000078"
      unitRef="USD">494981</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_AverageFairValueOfEquityAwardsUnderTheStockAwardsAndOptionAwardsColumnInSCTMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000079"
      unitRef="USD">-235494</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_AverageYearEndFairValueOfEquityAwardsGrantedDuringTheYearThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000080"
      unitRef="USD">143403</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_AverageChangeInYearOverYearEndFairValueOfEquityAwardsGrantedInPriorYearsThatAreOutstandingAndUnvestedMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000081"
      unitRef="USD">-138690</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_AverageChangeInPriorYearEndFairValueAndVestingDateFairValueOfEquityAwardsGrantedInPriorYearsThatVestedDuringTheYearMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000082"
      unitRef="USD">-90983</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000083"
      unitRef="USD">173217</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000085">&lt;p id="xdx_848_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_z1C49S1odVW6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Compensation Actually Paid and Cumulative Total Shareholder Return&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The graph below compares the compensation actually
paid to our PEOs and the average of the compensation actually paid to our remaining NEOs, with our cumulative total shareholder return
for the fiscal years ended December 31, 2024, 2023, and 2022. Total shareholder return amounts reported in the graph assume an initial
fixed investment of $100 on December 31, 2021.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;img alt="" src="image_004.jpg" style="height: 353px; width: 619px"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000087">&lt;p id="xdx_842_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zzpzDoXJ85Ih" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;i&gt;Compensation Actually Paid and Net Loss&lt;/i&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The graph below compares the compensation actually
paid to our PEOs and the average of the compensation actually paid to our remaining NEOs, with our net loss for the fiscal years ended
December 31, 2024, 2023, and 2022.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;img alt="" src="image_005.jpg" style="height: 317px; width: 619px"/&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000014"
          xlink:label="Fact000014"
          xlink:type="locator"/>
        <link:footnote id="Footnote000034" xlink:label="Footnote000034" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Mr. <xhtml:span id="xdx_90C_eecd--PeoName_c20240101__20241231_zOtsbvXUYKe3"><xhtml:span id="xdx_904_eecd--PeoName_c20230101__20231231_zVv5wMCiLhsi"><xhtml:span id="xdx_90A_eecd--PeoName_c20220101__20221231_zoyWD43L29Pg">Heyward</xhtml:span></xhtml:span></xhtml:span> served as our  Chief Executive Officer and Chairman during each of the three years presented
in the table.</link:footnote>
        <link:footnote id="Footnote000038" xlink:label="Footnote000038" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The values reflected in this column reflect the &#x201c;Total&#x201d; compensation set forth in the Summary
Compensation Table (&#x201c;SCT&#x201d;) in each applicable year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000014"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000014"
          xlink:to="Footnote000038"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000015"
          xlink:label="Fact000015"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000015"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000020"
          xlink:label="Fact000020"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000020"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000020"
          xlink:to="Footnote000038"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000021"
          xlink:label="Fact000021"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000021"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000026"
          xlink:label="Fact000026"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000026"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000026"
          xlink:to="Footnote000038"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000027"
          xlink:label="Fact000027"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000027"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000016"
          xlink:label="Fact000016"
          xlink:type="locator"/>
        <link:footnote id="Footnote000039" xlink:label="Footnote000039" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The dollar amounts reported in this column represent the average of the amounts reported for Non-PEO NEOs
in the &#x201c;Total&#x201d; column of the SCT in each applicable year. The names of each of the Non-PEO NEOs included for purposes of calculating
the average amounts in 2024 were Brian Parisi and Michael A. Jaffa; in 2023 were Brian Parisi, Michael A. Jaffa, and Michael Hirsh; and
in 2022 were Michael A. Jaffa and Michael Hirsh.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000016"
          xlink:to="Footnote000039"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000022"
          xlink:label="Fact000022"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000022"
          xlink:to="Footnote000039"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000028"
          xlink:label="Fact000028"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000028"
          xlink:to="Footnote000039"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000017"
          xlink:label="Fact000017"
          xlink:type="locator"/>
        <link:footnote id="Footnote000040" xlink:label="Footnote000040" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The dollar amounts reported in this column represent the average amount of CAP to Non-PEO NEOs as a group,
as computed in accordance with SEC rules described below.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000017"
          xlink:to="Footnote000040"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000023"
          xlink:label="Fact000023"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000023"
          xlink:to="Footnote000040"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000029"
          xlink:label="Fact000029"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000029"
          xlink:to="Footnote000040"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000018"
          xlink:label="Fact000018"
          xlink:type="locator"/>
        <link:footnote id="Footnote000041" xlink:label="Footnote000041" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The cumulative total shareholder return (&#x201c;TSR&#x201d;) is determined based on the value of an initial
fixed investment of $100 in the Company&#x2019;s common stock at December 31, 2021. The Company did not issue dividends during any of the
covered periods.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000018"
          xlink:to="Footnote000041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000024"
          xlink:label="Fact000024"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000024"
          xlink:to="Footnote000041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000030"
          xlink:label="Fact000030"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000030"
          xlink:to="Footnote000041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000019"
          xlink:label="Fact000019"
          xlink:type="locator"/>
        <link:footnote id="Footnote000042" xlink:label="Footnote000042" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The dollar amounts reported in this column are the Company&#x2019;s net income amounts reflected in the
Company&#x2019;s audited financial statements for the applicable year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000019"
          xlink:to="Footnote000042"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000025"
          xlink:label="Fact000025"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000025"
          xlink:to="Footnote000042"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000031"
          xlink:label="Fact000031"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000031"
          xlink:to="Footnote000042"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
